<html lang="en"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="shortcut icon" href="./favicon.png">
    <link rel="preload" href="./static/media/SourceSansPro-Regular.DZLUzqI4.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-SemiBold.sKQIyTMz.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-Bold.-6c9oR8J.woff2" as="font" type="font/woff2" crossorigin="">

    <title>app</title>

    <!-- initialize window.prerenderReady to false and then set to true in React app when app is ready for indexing -->
    <script>
      window.prerenderReady = false
    </script>
    <script type="module" crossorigin="" src="./static/js/index.BlylrL8P.js"></script>
    <link rel="stylesheet" crossorigin="" href="./static/css/index.DpJG_94W.css">
  <style media=""></style><style data-emotion="st-emotion-cache-global" data-s=""></style><style data-emotion="st-emotion-cache" data-s=""></style><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.BqlD3NTA.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.DW_MHI2K.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FormClearHelper.UtDFKbpT.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FileHelper.DV2KuUj6.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/ProgressBar.BtMHwdZZ.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/Hooks.YZgOFmbn.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/UploadFileInfo.C-jY39rj.js"></head>
  <body>
    <noscript>You need to enable JavaScript to run this app.</noscript>
    <div id="root"><div class=""><div class="withScreencast" data-testid="stScreencast"><div class="stApp stAppEmbeddingId-t7698vi9plct st-emotion-cache-1r4qj8v ee4bbma0" data-testid="stApp" data-test-script-state="notRunning" data-test-connection-state="CONNECTED"><header tabindex="-1" class="stAppHeader st-emotion-cache-12fmjuu e4hpqof0" data-testid="stHeader"><div class="stDecoration st-emotion-cache-1dp5vir e4hpqof1" data-testid="stDecoration" id="stDecoration"></div><div class="stAppToolbar st-emotion-cache-15ecox0 e4hpqof2" data-testid="stToolbar"><div class="stToolbarActions st-emotion-cache-1p1m4ay e1i26tt72" data-testid="stToolbarActions"></div><span id="MainMenu" class="stMainMenu st-emotion-cache-czk5ss ev04twb8" data-testid="stMainMenu" aria-haspopup="true" aria-expanded="false"><button kind="headerNoPadding" data-testid="stBaseButton-headerNoPadding" aria-label="" class="st-emotion-cache-l1ktzw em9zgd018"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M12 8c1.1 0 2-.9 2-2s-.9-2-2-2-2 .9-2 2 .9 2 2 2zm0 2c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2zm0 6c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2z"></path></svg></button></span></div></header><div class="stAppViewContainer appview-container st-emotion-cache-1yiq2ps eht7o1d0" data-testid="stAppViewContainer" data-layout="narrow"><section tabindex="0" class="stMain st-emotion-cache-bm2z3a eht7o1d1" data-testid="stMain"><div class="stMainBlockContainer block-container st-emotion-cache-mtjnbi eht7o1d4" data-testid="stMainBlockContainer"><div data-testid="stVerticalBlockBorderWrapper" data-test-scroll-behavior="normal" class="st-emotion-cache-0 eu6p4el5"><div class="st-emotion-cache-b95f0i eu6p4el4"><div class="stVerticalBlock st-emotion-cache-1n76uvr eu6p4el3" data-testid="stVerticalBlock" width="704"><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stHeading" data-testid="stHeading"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 id="olmocr">OLMOCR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#olmocr" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="st-emotion-cache-8atqhb e1mlolmg0"><div class="stFileUploader st-emotion-cache-0 e17y52ym15" data-testid="stFileUploader" width="704"><label data-testid="stWidgetLabel" aria-hidden="true" class="st-emotion-cache-1s2v671 e1dx5vew0"><div data-testid="stMarkdownContainer" class="st-emotion-cache-wq5ihp e1icttdg0"><p>Upload a PDF or Image</p></div></label><section role="presentation" tabindex="0" data-testid="stFileUploaderDropzone" aria-label="Upload a PDF or Image" class="st-emotion-cache-1gulkj5 e17y52ym0"><input data-testid="stFileUploaderDropzoneInput" accept="application/streamlit,.pdf,.png,.jpg,.jpeg" type="file" style="border: 0px; clip: rect(0px, 0px, 0px, 0px); clip-path: inset(50%); height: 1px; margin: 0px -1px -1px 0px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap;" tabindex="-1"><div data-testid="stFileUploaderDropzoneInstructions" class="st-emotion-cache-u8hs99 e17y52ym1"><span class="st-emotion-cache-nwtri e17y52ym2"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-6rlrad ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19.35 10.04A7.49 7.49 0 0012 4C9.11 4 6.6 5.64 5.35 8.04A5.994 5.994 0 000 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95A5.469 5.469 0 0112 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11A2.98 2.98 0 0122 15c0 1.65-1.35 3-3 3zM8 13h2.55v3h2.9v-3H16l-4-4z"></path></svg></span><div class="st-emotion-cache-j7qwjs e17y52ym4"><span class="st-emotion-cache-9ycgxx e17y52ym3">Drag and drop file here</span><small class="st-emotion-cache-1rpn56r ejh2rmr0">Limit 200MB per file • PDF, PNG, JPG, JPEG</small></div></div><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02">Browse files</button></section><div class="st-emotion-cache-fis6aj e17y52ym5"><ul class="st-emotion-cache-14m29r0 e17y52ym6"><li class="st-emotion-cache-1l95nvm e17y52ym7"><div class="stFileUploaderFile st-emotion-cache-12xsiil e17y52ym10" data-testid="stFileUploaderFile"><div class="st-emotion-cache-10ix4kq e17y52ym12"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-4mjat2 ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zM6 20V4h7v5h5v11H6z"></path></svg></div><div class="stFileUploaderFileData st-emotion-cache-1l4firl e17y52ym8"><div class="stFileUploaderFileName st-emotion-cache-1uixxvy e17y52ym9" data-testid="stFileUploaderFileName" title="General Pathology - Comprehensive Study Notes for Medical Students.pdf">General Pathology - Comprehensive Study Notes for Medical Students.pdf</div><small class="st-emotion-cache-1rpn56r ejh2rmr0">5.1MB</small></div><div data-testid="stFileUploaderDeleteBtn"><button kind="minimal" data-testid="stBaseButton-minimal" aria-label="" class="st-emotion-cache-8ccstr em9zgd06"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"></path></svg></button></div></div></li></ul></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stButton st-emotion-cache-8atqhb e1mlolmg0" data-testid="stButton"><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1hyd1ho e1icttdg0"><p>Submit</p></div></button></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><strong>Processing file:</strong> General Pathology - Comprehensive Study Notes for Medical Students.pdf</p></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="5-studocu">5 studocu<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-studocu" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="general-pathology-notes">General Pathology - Notes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-pathology-notes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="health-records-and-information-technology-kenya-medical-training-college">health records and information technology (Kenya Medical Training College)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#health-records-and-information-technology-kenya-medical-training-college" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251212-0a973543.jpeg" alt="img-0.jpeg"></p>
<p>Scan to open on Studocu</p>
<p>See discussions, stats, and author profiles for this publication at: <a href="https://www.researchgate.net/publication/331486239" target="_blank" rel="noopener noreferrer">https://www.researchgate.net/publication/331486239</a></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-pathology-for-medical-students">GENERAL PATHOLOGY FOR MEDICAL STUDENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-pathology-for-medical-students" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Book - January 2011</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="citations">CITATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#citations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>0</p>
<p>3 authors:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="soheir-mahmoud-mahfouz">Soheir Mahmoud Mahfouz<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#soheir-mahmoud-mahfouz" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cairo University
216 PUBLICATIONS 1,025 CITATIONS
SEE PROFILE</p>
<p>Sahar Talaat
Cairo University
13 PUBLICATIONS 40 CITATIONS
SEE PROFILE</p>
<p>Some of the authors of this publication are also working on these related projects:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="project">Project<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#project" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Breast pathology and cytology View project</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="project">Project<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#project" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Paleopathology View project</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="what-is-pathology">WHAT IS PATHOLOGY?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#what-is-pathology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="bold">P</mi></mrow><annotation encoding="application/x-tex">\mathbf{P}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6861em;"></span><span class="mord mathbf">P</span></span></span></span></span>athology is the science which deals with the study of diseases (abnormalities in structure &amp; function). It is the study of abnormal anatomy, abnormal histology, abnormal biochemistry and abnormal physiology.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathology-comprises-the-study-of">Pathology comprises the study of:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathology-comprises-the-study-of" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Definition and epidemiology: name of the disease, its incidence, prevalence in a population and its geographic distribution</li>
<li>Etiology (cause): Etiology means the causes of the disease and pathogenesis (mechanism): The aetiology includes:
a) Predisposing factors: Factors which help the development of the disease.
b) Exciting factor: Is the direct cause of the disease.
c) Pathogenesis: The mechanism by which the causative agent produces the pathological changes in the tissues.</li>
<li>Manifestations :Pathology entails the description of any deviation from normal on the tissue as well as the body level:
a) Organ morphology (gross pathology and microscopic pathology): deals with changes in the appearance of an organ (gross or macroscopic) and on the level of the tissue forming that organ (microscopic).</li>
</ol>
<ul>
<li>Gross picture (macroscopic picture): These are the changes in the tissues and organs detected on naked-eye examination.</li>
<li>Microscopic picture (histopathology): These are the changes in the tissues and organs detected on light microscopic examination.</li>
<li>Electron microscopic, immunohistochemical, cytogenetic and molecular are modes of study of diseased tissues and organs
b) Body reaction: Is the effect of damage in a particular organ affecting other body systems which are also involved in the process and this includes the clinical picture</li>
</ul>
<ol start="4">
<li>Sequelae: course or progress of the disease</li>
<li>Fate is the disease outcome or end result, which may be recovery with return to normal, or complications (unhealthy effects). These are additional pathological changes which may occur during or after the termination of the usual course of the disease. They may occur at the site of disease &amp; away from the site (spread to other organs).</li>
<li>Prognosis( prediction of the course of a disease)</li>
</ol>
<p>Good prognosis: cure or recovery
Bad prognosis: progression of disease (morbidity) or death (mortality)</p>
<p>Normal cell <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mover><mo stretchy="true" minsize="3.0em">→</mo><mpadded width="+0.6em" lspace="0.3em"><mtext>&nbsp;Injury&nbsp;</mtext></mpadded></mover></mrow><annotation encoding="application/x-tex">\xrightarrow{\text { Injury }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.1113em; vertical-align: -0.011em;"></span><span class="mrel x-arrow"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.1003em;"><span style="top: -3.322em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight x-arrow-pad"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">&nbsp;Injury&nbsp;</span></span></span></span></span><span class="svg-align" style="top: -2.689em;"><span class="pstrut" style="height: 2.7em;"></span><span class="hide-tail" style="height: 0.522em; min-width: 1.469em;"><svg xmlns="http://www.w3.org/2000/svg" width="400em" height="0.522em" viewBox="0 0 400000 522" preserveAspectRatio="xMaxYMin slice"><path d="M0 241v40h399891c-47.3 35.3-84 78-110 128
-16.7 32-27.7 63.7-33 95 0 1.3-.2 2.7-.5 4-.3 1.3-.5 2.3-.5 3 0 7.3 6.7 11 20
 11 8 0 13.2-.8 15.5-2.5 2.3-1.7 4.2-5.5 5.5-11.5 2-13.3 5.7-27 11-41 14.7-44.7
 39-84.5 73-119.5s73.7-60.2 119-75.5c6-2 9-5.7 9-11s-3-9-9-11c-45.3-15.3-85
-40.5-119-75.5s-58.3-74.8-73-119.5c-4.7-14-8.3-27.3-11-40-1.3-6.7-3.2-10.8-5.5
-12.5-2.3-1.7-7.5-2.5-15.5-2.5-14 0-21 3.7-21 11 0 2 2 10.3 6 25 20.7 83.3 67
 151.7 139 205zm0 0v40h399900v-40z"></path></svg></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.011em;"><span></span></span></span></span></span></span></span></span></span> Abnormal cell (disease) <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> Medicine-Surgery
Pathologic lesion
Clinical picture</p>
<ul>
<li>Function:biochem+physiology</li>
<li>Structure:anatomy+histology</li>
</ul>
<p>Diagnosis
Treatment
Follow up
Prevention</p>
<p>Damage at site
Local
Body reaction
General (systemic)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-1-etiology-pathogenesis">1.1 ETIOLOGY &amp; PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-1-etiology-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251212-582f723e.jpeg" alt="img-1.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-cell-injury">1) CELL INJURY:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-cell-injury" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Physical &amp; chemical
Microbial
Hormonal
Mechanical
Vascular &amp; circulatory
Immunological
(antibodies &amp; cell-mediated)
Nutritional</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-genetic">B. GENETIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-genetic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1-Normal genes
Susceptibility genes
Blood group genes
2- Abnormal genes (Mutations) 3) CIRCULATORY DISTURBANCE
Congenital: at birth
Hereditary: passed on from parents
Malformations(Hereditary &amp;congenital)
C. MULTIFACTORIAL <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo stretchy="false">(</mo><mi>A</mi><mo>+</mo><mi>B</mi><mo stretchy="false">)</mo></mrow><annotation encoding="application/x-tex">(A+B)</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord mathnormal">A</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal" style="margin-right: 0.05017em;">B</span><span class="mclose">)</span></span></span></span></span></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-growth-disturbances">4)GROWTH DISTURBANCES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-growth-disturbances" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Adaptations
Neoplasia (tumors)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-immunopathology">5) IMMUNOPATHOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-immunopathology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-2-manifestations-of-disease-lesions">1.2 MANIFESTATIONS OF DISEASE-LESIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-2-manifestations-of-disease-lesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251212-20b1cae0.jpeg" alt="img-2.jpeg"></p>
<ul>
<li>Please I: Functional disturbance stage: At this level of affection, samples obtained from body fluids reveal mostly functional changes, which can be diagnosed by hematology, chemical pathology or by molecular and genetic methods.</li>
<li>Phase II: Functional and early morphologic changes: At this level, cellular changes may be diagnosed from body fluids by hematology, chemical pathology and cytology or in tissue by biopsy and submitted for molecular and genetic methods as well as electron microscopy.</li>
<li>Phase III: Functional and morphologic changes diagnosed from body fluids submitted to hematological, cytological, molecular and genetic evaluation or tissue biopsy, to be evaluated like phase II of diseases, by microscopic examination in addition to gross organ or tissue evaluation.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="1-3-doctor-s-approach-to-patient">1.3 DOCTOR'S APPROACH TO PATIENT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-3-doctor-s-approach-to-patient" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-clinician">1) CLINICIAN<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-clinician" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>History taking to determine epidemiological data and symptoms of the patient</li>
<li>Clinical examination to determine signs of the disease discovered on examination</li>
<li>Provisional diagnosis &amp; differential diagnosis are based on signs &amp; symptoms</li>
<li>Final diagnosis usually after requesting special investigations or sample taking</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-pathologist-other-specialties">2) PATHOLOGIST/other specialties:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-pathologist-other-specialties" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Investigations: ------------x-ray, ultrasound, CT scan etc ...</li>
<li>Laboratory work out ------pathologists</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathology-sample">PATHOLOGY SAMPLE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathology-sample" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fluids">Fluids<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fluids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Blood or bone marrow (hematology lab)</li>
<li>Stools or urine (chemical pathology-microbiology)</li>
<li>Body fluids (cytology lab)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="organ-tissue-autopsy-biopsy">Organ/tissue (autopsy-biopsy)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#organ-tissue-autopsy-biopsy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Surgical pathology
(histopathology)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="role-of-pathologist">ROLE OF PATHOLOGIST:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#role-of-pathologist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Making the final diagnosis, monitoring of treatment and follow up of patients</p>
<p>BIOPSY: tissue removed during surgery from living patient
CYTOLOGY: study of cells derived from body fluids
AUTOPSY: tissue removed after death i.e. during a post mortem</p>
<p>IF diagnosis is difficult, pathologists resort to special staining:</p>
<ul>
<li>cyto/histochemistry</li>
<li>Immuno cyto/histochemistry</li>
<li>Molecular pathology &amp; Cytogenetics</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clinician-recieves-report-starts-treatment-based-on-final-diagnosis">CLINICIAN RECIEVES REPORT &amp; STARTS TREATMENT BASED ON FINAL DIAGNOSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinician-recieves-report-starts-treatment-based-on-final-diagnosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>TREATMENT is either curative (cures) or palliative (can't cure but helps symptom relief)</p>
<p>Treatment depends on diagnosis &amp; prognosis and follow up may be required in some cases even after recovery e.g. recurrent tumour</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cell-response-to-injury">CELL RESPONSE TO INJURY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cell-response-to-injury" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>REVERSIBLE (cell can revert to normal state) intracellular changes</li>
</ol>
<ul>
<li>Adaptive mechanisms: atrophy-hypertrophy-hyperplasia-metaplasia</li>
<li>Degeneration</li>
</ul>
<ol start="2">
<li>IRREVERSIBLE (cell death) intracellular changes</li>
</ol>
<ul>
<li>Apoptosis</li>
<li>Necrosis</li>
</ul>
<ol start="3">
<li>DEPOSITIONS - ABNORMAL PIGMENTATION- ABNORMAL CALCIFICATION</li>
</ol>
<ul>
<li>Extracellular depositions: Amyloid .</li>
<li>Extra &amp; intracellular depositions accumulations: Protein (hyalinosis), Mucin (myxomatous change), pigment disorders &amp; abnormal calcification.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="injurious-agents">INJURIOUS AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#injurious-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-environmental">1. ENVIRONMENTAL<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-environmental" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Physical: Excessive heat - Excessive cold (frost bite) - Irradiation</li>
<li>Chemical: toxins - free radicals - acids - alkalis</li>
<li>Infections: bacteria, viruses, parasites</li>
<li>Immunological: self antigen (autoimmunity) - foreign proteins (antigens)</li>
<li>Circulatory: hypoxia or ischemia</li>
<li>Nutritional: protein calorie deficiency-vitamin deficiency</li>
<li>Mechanical: trauma</li>
<li>Hormonal</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-genetic">2. GENETIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-genetic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Congenital: Down's syndrome</li>
<li>Hereditary: metabolic enzyme disorders</li>
<li>Mutations: cancer</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-multifactorial">3. MULTIFACTORIAL<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-multifactorial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism-of-action-of-injurious-agent">Mechanism of action of injurious agent:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action-of-injurious-agent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Hypoxia: deficient oxygenation to tissues</li>
<li>Toxic: free radicals and other poisonous chemicals</li>
<li>Direct: injury to cell</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="type-of-damage-depends-on-tissue-type-severity-duration-of-injurious-agent">Type of damage depends on tissue type, severity &amp;duration of injurious agent:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#type-of-damage-depends-on-tissue-type-severity-duration-of-injurious-agent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Type of tissue:</li>
</ol>
<ul>
<li>Labile cells (rapid regeneration e.g. skin) divide continuously.</li>
<li>Stable cells (cells of parenchymatous organs &amp; connective tissue) divide only when injured.</li>
<li>Permanent cells (never divides e.g. striated muscle-neurons).</li>
</ul>
<ol start="2">
<li>Severity of injury &amp; its duration:</li>
</ol>
<ul>
<li>Short mild-moderate injury results in reversible damage</li>
<li>Severe short or mild to moderate &amp; prolonged injury results in irreversible damage</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="terminology">TERMINOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#terminology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Degenerations: Concentration of metabolites or changes which occur inside metabolically active cells (parenchymatous epithelial cells) i.e. not in macrophages or other connective tissue cells or lymphoid cells e.g. hydropic &amp; fatty change.</li>
<li>Accumulations: Concentration of material formed outside the cell (carbohydrate, protein or lipid), inside any cell (epithelial or mesenchymal), due to deranged metabolism or excess storage e.g. hyalinosis &amp; storage diseases.</li>
<li>Depositions: Concentration of material outside cells i.e. on fibers, basement membranes e.g. amyloidosis, necrotic material, products of inflammation &amp; organizing thrombus e.g. dystrophic calcification.</li>
</ul>
<p>ACCUMULATIONS &amp; DEPOSITIONS</p>
<table><thead><tr><th style="text-align: left;">Intracellular</th><th style="text-align: left;">Extra+intracellular</th><th style="text-align: left;">Extracellular</th></tr></thead><tbody><tr><td style="text-align: left;">Water=hydropic/vacuolar</td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Fat =fatty change &lt;br&gt; lipid storage disease &lt;br&gt; atherosclerosis</td><td style="text-align: left;"></td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">CHO =mucoid change</td><td style="text-align: left;">myxomatous change</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Glycogen = storage disease</td><td style="text-align: left;"></td><td style="text-align: left;">Amyloid</td></tr><tr><td style="text-align: left;">Protein =hyaline change</td><td style="text-align: left;">Hyaline change</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Pigment = lipochrome &lt;br&gt; Melanin</td><td style="text-align: left;">Carbon (tattoo) &lt;br&gt; Hemosiderin/hemochromatosis &lt;br&gt; Jaundice (bilirubin) &lt;br&gt; Calcium(dystrophic&amp;metastatic)</td><td style="text-align: left;"></td></tr></tbody></table>
<p>MOST FORMS OF DAMAGE are usually accompanied by a BODY REACTION and both together (damage + body reaction), form a pathologic lesion or disease (5 main disease patterns:</p>
<p>Inflammatory, degenerative, circulatory disorders, growth disturbances, immunological)</p>
<p>Subcellular response to injury (reversible &amp; irreversible) (plate 1.2)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-first-line-of-injury">1. First line of injury:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-first-line-of-injury" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A. Mitochondria: Are respiratory organelles (ATP energy source) &amp; source of some lipids. They are altered in acute cell injury or death</p>
<ul>
<li>Increased Number =Hypertrophy ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> cell size)</li>
<li>Decreased Number = Atrophy ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> cell size)</li>
<li>Large size =Hydropic change &amp; Oncocytoma (a tumour)
B. Rough Endoplasmic Reticulum (RER)</li>
</ul>
<p>Injury causes loss of ribosomes affecting protein synthesis, whilst dilatation of the RER produces vacuolar change.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-second-line-ofinjury">2. Second line ofinjury:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-second-line-ofinjury" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A. Smooth Endoplasmic Reticulum (SER):</p>
<p>Important in cell adaptation, lipid synthesis &amp; drug storage</p>
<ul>
<li>Drug tolerance results in swelling of SER leading to cell hypertrophy</li>
<li>Injury releases heat &amp; shock (stress) proteins these can protect from tissue damage i.e. limitation of damage</li>
<li>Lipid accumulation: fatty change &amp; storage disorders
B. Cytoskeletal abnormalities:</li>
</ul>
<p>Result in loss of support with change in cell shape and decreased cell motility</p>
<ul>
<li>Defective cell movement diminishes migration of inflammatory celis with subsequent decreased phagocytosis</li>
<li>Defective organelle movement results in decreased ciliary action e.g. in respiratory tract this encourages infection Mitotic spindle abnormalities in spermatozoa result in infertility</li>
<li>Defective intracellular accumulation of fibrils e.g. Alzheimer neurofibrillary tanglesn replacing functioning brain tissue and resulting in dementia
C. Lysosomal catabolism: they contain digestive enzymes</li>
</ul>
<p>1ry lysosomes fusion with membrane bound vesicles of endocytosisis (pinocytosis or phagocytosis <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> 2ry lysosome or phagolysosome
<img src="assets/images/image-20251212-3712a02d.jpeg" alt="img-3.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="residual-body-e-g">Residual body e.g.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#residual-body-e-g" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a. undigested debris (lipochrome)
b. undigested pigment (tattoo)</p>
<p>Lysosomes normally can sequester or store material which cannot be metabolized but in case of enzyme deficiencies (metabolic disorders) producing lysosomal storage disease.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-final-step">3. Final step<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-final-step" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Plasma &amp; nuclear membrane damage occurs in cell death i.e. necrosis</p>
<ul>
<li>Nucleus is important in mitosis &amp; protein synthesis</li>
<li>Plasma membrane is important in carrying receptors that recognize environment <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">&amp;</mi></mrow><annotation encoding="application/x-tex">\&amp;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord">&amp;</span></span></span></span></span> is responsible for the passage of molecules to &amp; from the cell (phagocytosis-pinocytosis-selective permeability)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="loss-of-these-functions-results-in-cell-death">LOSS OF THESE FUNCTIONS RESULTS IN CELL DEATH<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#loss-of-these-functions-results-in-cell-death" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="plate-1-1">PLATE 1-1<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#plate-1-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251212-a85057d0.jpeg" alt="img-4.jpeg"></p>
<p>Cell Ultrastucture from homepage.smc.edulwissmann_paul/cell/Default.html</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="plate-1-2">PLATE 1.2<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#plate-1-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="diagram-of-subcellular-changes-in-cell-injury">Diagram of SUBCELLULAR CHANGES in cell Injury<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagram-of-subcellular-changes-in-cell-injury" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251212-9ad78ddd.jpeg" alt="img-5.jpeg"></p>
<ul>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> Ribosomes in RER <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mspace width="2em"></mspace></mrow><annotation encoding="application/x-tex">\qquad</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0em;"></span><span class="mspace" style="margin-right: 2em;"></span></span></span></span></span> <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> of protein synthesis</li>
<li>Dilatation of SER <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mspace width="2em"></mspace></mrow><annotation encoding="application/x-tex">\qquad</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0em;"></span><span class="mspace" style="margin-right: 2em;"></span></span></span></span></span> <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> lipid accumulation <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mspace width="2em"></mspace></mrow><annotation encoding="application/x-tex">\qquad</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0em;"></span><span class="mspace" style="margin-right: 2em;"></span></span></span></span></span> Fatty change</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> plasma membrane demage <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo><mo>↑</mo><mo>↑</mo><msup><mrow><mi mathvariant="normal">C</mi><mi mathvariant="normal">a</mi></mrow><mrow><mo>+</mo><mo>+</mo></mrow></msup></mrow><annotation encoding="application/x-tex">\longrightarrow \uparrow \uparrow \mathrm{Ca}^{++}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">⟶↑↑</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.8446em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Ca</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">++</span></span></span></span></span></span></span></span></span></span></span></span></span>influx</li>
</ul>
<p>Loss of ptn:
<img src="assets/images/image-20251212-f6747d32.jpeg" alt="img-6.jpeg">
a. Coenzmes
b. RNA + metabolites
<img src="assets/images/image-20251212-f03e3a99.jpeg" alt="img-7.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="i-reversible-cell-changes">I) Reversible cell changes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-reversible-cell-changes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-cell-adaptation-of-growth-size-or-number-differentiation">A. CELL ADAPTATION of growth (size or number) &amp; differentiation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-cell-adaptation-of-growth-size-or-number-differentiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cells adapt to acceptable changes in their environment by modification of their metabolism &amp; growth pattern (increased or decreased cell activity or altered structure)
A. PHYSIOLOGIC: A physiologic ability to maintain normal function according to demand as changes that occur under the effect of hormones e.g. breast enlargement during lactation due to increased cell activity &amp; altered cell morphology.
B. PATHOLOGIC: Severer changes in cell environment outside an acceptable range of normality. This involves the following:</p>
<ol>
<li>Synthesis of new proteins e.g. stress proteins</li>
<li>Over production of specific proteins e.g. in chronic inflammation with <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> collagen <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">&amp;</mi><mo>↑</mo></mrow><annotation encoding="application/x-tex">\&amp; \uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord">&amp;</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">↑</span></span></span></span></span> extracellular matrix proteins.</li>
<li>Adaptation in cell growth ( see growth disturbances)</li>
</ol>
<ul>
<li>Atrophy <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo><mo>↓</mo></mrow><annotation encoding="application/x-tex">=\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">=↓</span></span></span></span></span> cell size resulting in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> weight &amp; size of organ</li>
<li>Involution <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo><mo>↓</mo></mrow><annotation encoding="application/x-tex">=\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">=↓</span></span></span></span></span> cell number resulting in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> weight &amp; size of organ (occurs in physiological process of apoptosis)</li>
<li>Hypertrophy <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo><mo>↑</mo></mrow><annotation encoding="application/x-tex">=\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">=↑</span></span></span></span></span> cell size resulting in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> organ weight &amp; size</li>
<li>Hyperplasia <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo><mo>↑</mo></mrow><annotation encoding="application/x-tex">=\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">=↑</span></span></span></span></span> cell number resulting in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> organ weight &amp; size</li>
<li>Metaplasia <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo><mo>↑</mo></mrow><annotation encoding="application/x-tex">=\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">=↑</span></span></span></span></span> cell number &amp; change in cell type e.g. columnar cells : Changes to squamous or vice versa (see growth disturbances)</li>
</ul>
<p>NB: Hypoplasia &amp; agensis are also decreased cell numbers, bur of developmental origin</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="atrophy-plate-2">ATROPHY (plate 2)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#atrophy-plate-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Decrease in size of cells with decrease in size &amp; weight of organ after organ had reached its adult size.
A. Physiologic:
a) Localized atrophy as thymus after puberty &amp; breasts after menopause.
b) Generalized atrophy in case of senility. aging results in diminution in organ size &amp; function e.g brown atrophy of the heart.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="b-pathologic">B. Pathologic:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-pathologic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>a) Generalized atrophy: It affects all organs. Heart is small, skin is wrinkled due to loss of elastic fibers, bones and muscle are week, teeth fall ... etc. Causes include:
i. Decreased anabolism in cases of chronic malnutrition and starvation.
ii. Increased catabolism as in advanced stages of malignancy (cachexia) &amp; thyrotoxicosis.
b) Localized atrophy: Mechanism &amp; types</p>
<ol>
<li>Hormonal atrophy / endocrinal (due to loss of hormonal stimulation) e.g. breast atrophy following bilateral excision of ovaries &amp; pituitary deficiency with diminished hormone production e.g. atrophy of thyroid, gonads &amp; adrenals.</li>
<li>Vascular atrophy: e.g.</li>
</ol>
<ul>
<li>Atherosclerosis of renal artery <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> narrowing of lumen &amp; renal atrophy.</li>
<li>Pressure atrophy due to compression of blood vessels from outside example aneurysm <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> atrophy of the underlying vertebral bodies.</li>
</ul>
<ol start="3">
<li>Pressure atrophy: same mechanism as vascular atrophy</li>
<li>Neuropathic atrophy: Atrophy of limb muscles due to loss of innervation as in poliomyelitis activity or diminished function ends in atrophy of muscle</li>
<li>Disuse atrophy: e.g. muscles after prolonged immobilization after a fracture of bone.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="brown-atrophy-of-the-heart">BROWN ATROPHY OF THE HEART:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#brown-atrophy-of-the-heart" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Aging results in wear and tear and an <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> in the wear &amp; tear pigment (lipochrome) as well as <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> function resulting in atrophy and dark brown coloration of cardiac muscle.</p>
<table><thead><tr><th style="text-align: left;">Gross</th><th style="text-align: left;">Microscopic</th></tr></thead><tbody><tr><td style="text-align: left;">Size &amp; wt : Decreased</td><td style="text-align: left;">Size of muscle fibers: Decreased &lt;br&gt; Paranuclear yellow-brown pigment</td></tr><tr><td style="text-align: left;">Surface:</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">- Loss of pericardial fat, which is</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">replaced by jelly like material</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">- Tortuous coronaries</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Color: dark brown</td><td style="text-align: left;"></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ageing">AGEING<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ageing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A. True aging: Aging not complicated by disease i.e. aging under minimal stress. The main controlling mechanism is intrinsic (genetic?) mitochondrial DNA changes:</p>
<ul>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> mitochondrial oxidative enzymes results in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> energy</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> synthesis of enzymes &amp; protein receptor responsible for metabolism &amp; growth</li>
</ul>
<p>NB: most cases are accelerated &amp; aggravated by 2 groups of extrinsic factors:</p>
<ol>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> stress of infection - degenerative diseases (e.g. cardiac)-accidents-wear &amp; tear with <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> free radical especially if exposed to irradiation- <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> antioxidants e.g. vitamin E &amp; or / glutathione peroxidase.</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> immune response with inability to respond to stress.</li>
</ol>
<p>Aging alone rarely causes death and usually one or more of the above accelerating or aggravating factors are present causing death.
B. Premature aging (progeria): Early aging is due to an error in DNA replication &amp; improper repair with DECREASED cell viability</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hypertrophy-plate-2">HYPERTROPHY (Plate 2)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hypertrophy-plate-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Increased size &amp; weight of organ due to increase in size of its cells, which have synthesized actively metabolic structural components, necessary for increasing the metabolism.</p>
<p>Physiologic: Pregnant uterus due to hormone stimulation &amp; muscle hypertrophy in athletes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathologic">Pathologic:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathologic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Adaptive type: It affects the muscle coat of hollow organs due to increased intra-luminal pressure.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples">Examples:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Left ventricular hypertrophy due to hypertension or aortic valve stenosis.</li>
<li>Urinary bladder hypertrophy due to stricture of the bladder neck</li>
</ul>
<p>b) Compensatory type: If one of a paired organ is out of function or surgically removed, the other organ undergoes compensatory hypertrophy e.g. kidney enlargement when the other kidney is surgically removed.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hyperplasia-plate-2">HYPERPLASIA (plate 2)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperplasia-plate-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition Increased size &amp; weight of organ due to Increase in number of its cells (Increased cell division). Hyperplasia can occur in any cell type capable of division.</p>
<table><thead><tr><th style="text-align: center;">Physiologic</th><th style="text-align: center;">Pathologic</th></tr></thead><tbody><tr><td style="text-align: center;">1) hormonal hyperplasia <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> mammary glands&amp; genitalia at puberty due to estrogen stimulation.</td><td style="text-align: center;">1) hormonal <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> endometrial hyperplasia in repeated anovulatory cycles &amp; benign prostatic hyperplasia due to estrogen stimulation.</td></tr><tr><td style="text-align: center;">2) compensatory <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> bone marrow hyperplasia after hemorrhage.</td><td style="text-align: center;">2) lymphoid hyperplasia in response to antigenic stimulation</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="metaplasia-plate-2">METAPLASIA (plate 2)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#metaplasia-plate-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Transformation of 1 mature differentiated cell type to another of the same histologic type( i.e epithelium to epithelium) in response to an injurious agent, which is more resistant to chronic injury it involves an increase in number of cells &amp; change in their morphology.
N.B.: Like hyperplasia it is precancerous.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clerk-2">CLERK 2<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clerk-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="plate-2-adaptations-from-webpath">PLATE 2 Adaptations from WebPath<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#plate-2-adaptations-from-webpath" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251212-69a6219a.jpeg" alt="img-8.jpeg"></p>
<p>Endometrial hyperplasia Prostatic gland hyperplasia Esophageal metaplasia</p>
<p>PLATE 3 CELL DEATH FROM WebPath
<img src="assets/images/image-20251212-9c61fa79.jpeg" alt="img-9.jpeg"></p>
<p>Coagulative Necrosis
heart Infarction</p>
<p>Liquifactive
Necrosis (pus)</p>
<p>Apoptotic bodies
arrows (liver)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="etiology-pathogenesis-types">Etiology, Pathogenesis &amp; Types<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#etiology-pathogenesis-types" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-epithelial-metaplasia">A. Epithelial Metaplasia:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-epithelial-metaplasia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Squamous Metaplasia: transformation of columnar or transitional cells to squamous epithelium which is tougher e.g. bilharzial epithelial urinary bladder changes &amp; chronic cervicitis. This is sometimes followed by leukoplakia.
b) Leukoplakia : columnar or transitional cells <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Keratinized squamous epithelium, which is tougher e.g. Bilharzial epithelial UB changes &amp; chronic cervicitis</p>
<p>Gross: Thick irregular white mucosal patches related to chronic irritation
Microscopic: Squamous epithelium + keratinization+ chronic inflammation in subepithelium
c) Intestinal Metaplasia: columnar cells change into mucous secreting cells like those of intestine e.g. gastritis and at the edges of peptic ulcers</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-mesenchymal-metaplasia">B. Mesenchymal Metaplasia:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-mesenchymal-metaplasia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Fibroblasts exposed to chronic injury change <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Osteoblasts
<img src="assets/images/image-20251212-c37f20c7.jpeg" alt="img-10.jpeg">
e.g. Myositis ossificans: muscle fiber injury causing necrosis results in granulation tissue. The fibroblasts of which undergo osteoblastic metaplasia to bone.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-intracellular-changes">B. INTRACELLULAR CHANGES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-intracellular-changes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="degeneration">DEGENERATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#degeneration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Acute reversible cell injury to parenchymatous cells, (i.e. metabolically active e.g. epithelial organs &amp; muscle) resulting in an accumulation of water or fat. (Carbohydrates &amp; proteins may also accumulate intracellularly).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-hydropic-swelling-cloudy-swelling-vacuolar-change">1. HYDROPIC SWELLING (cloudy swelling) &amp; VACUOLAR CHANGE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-hydropic-swelling-cloudy-swelling-vacuolar-change" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION Accumulation of water intracellularly. Hydropic swelling, formerly called cloudy swelling then proceeds to VACUOLAR CHANGE (dilatation of mitochondria &amp; RER with water leading to vacuoles).</p>
<p>PATHOGENESIS: Injurious agent (see before), of a toxic or hypoxic nature produce mitochondrial damage with <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> ATP production. This causes <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> plasma membrane <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">N</mi><mi mathvariant="normal">a</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Na}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8446em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Na</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span> pump action (ATP energy <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>+</mo><msup><mrow><mi mathvariant="normal">N</mi><mi mathvariant="normal">a</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">+\mathrm{Na}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.9279em; vertical-align: -0.0833em;"></span><span class="mord">+</span><span class="mord"><span class="mord"><span class="mord mathrm">Na</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span>enters the cell drawing with it water <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo fence="true">(</mo><msup><mrow><mi mathvariant="normal">N</mi><mi mathvariant="normal">a</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\left(\mathrm{Na}^{+}\right.</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.2em; vertical-align: -0.35em;"></span><span class="minner"><span class="mopen delimcenter" style="top: 0em;"><span class="delimsizing size1">(</span></span><span class="mord"><span class="mord"><span class="mord mathrm">Na</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span>osmosis) &amp; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mi mathvariant="normal">K</mi><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{K}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7713em;"></span><span class="mord"><span class="mord mathrm">K</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7713em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span> leave cells. The cell swell &amp; the beaded mitochondria give the cell the granular or cloudy appearance. More injury causing mitochondrial + RER swelling resulting in VACUOLAR CHANGE.</p>
<p>SITES: Parenchymatous organs e.g. liver, kidney tubules, heart and other glandular epithelium of organs.</p>
<table><thead><tr><th style="text-align: left;">GROSS</th><th style="text-align: left;">MICROSCOPIC</th></tr></thead><tbody><tr><td style="text-align: left;">Surface: Smooth-capsule stretched</td><td style="text-align: left;">a) Hydropic swelling: Cells swell &amp; have a &lt;br&gt; granular pale pink cytoplasm</td></tr><tr><td style="text-align: left;">Size &amp; weight : increased</td><td style="text-align: left;">b) Hydropic vacuolation: Cells swell &amp; &lt;br&gt; have vacuolated cytoplasm</td></tr><tr><td style="text-align: left;">Color: Pale grey or pale brown</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Cut section: Round edges &amp; bulging cut &lt;br&gt; surface</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Consistency: Soft (water)</td><td style="text-align: left;"></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-fatty-change-steatosis-plate-4">2. FATTY CHANGE (Steatosis) (Plate 4)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-fatty-change-steatosis-plate-4" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: Accumulation of neutral fat intracellularly in parenchymatous organs as a result of reversible cell injury e.g. in viral hepatitis C</p>
<p>AETIOLOGY &amp; PATHOGENESIS (see list of injurious agents)
E.G. HEPATIC STEATOSIS (Fatty change liver)</p>
<table><thead><tr><th style="text-align: center;">Liver</th><th style="text-align: center;">Mechanism of injury</th><th style="text-align: center;">Subcellular change</th></tr></thead><tbody><tr><td style="text-align: center;">Central zone</td><td style="text-align: center;">- Hypoxic injury</td><td style="text-align: center;">- Damage + dilatation of &lt;br&gt; 1. Mitochondrial &lt;br&gt; 2. RER &lt;br&gt; 3. SER</td></tr><tr><td style="text-align: center;">Peripheral zone</td><td style="text-align: center;">- Toxic injury: Bacteria, chemical or viral e.g. viral hepatitis C. &lt;br&gt; - Specific hepatocellular causes (site of fat metabolism) &lt;br&gt; 1) Deficiency of lipotropic factors (choline-methionine) &lt;br&gt; 2) 2) Starvation &amp; Diabetes mellitus due to tfat mobilization from stores &lt;br&gt; 3) Obesity &amp; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> fat diet due to overloading of hepatocyte with free fatty acids &lt;br&gt; 4) Alcohol due to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> free fatty acid synthesis (hepatotoxin): <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> fatty acid oxidation with <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> fat mobilization from stores.</td><td style="text-align: center;"></td></tr></tbody></table>
<table><thead><tr><th style="text-align: left;">GROSS</th><th style="text-align: left;">MICROSCOPIC</th></tr></thead><tbody><tr><td style="text-align: left;">Specimen: liver</td><td style="text-align: left;">Fat appears as empty vacuoles</td></tr><tr><td style="text-align: left;">Surface: Smooth - capsule stretched</td><td style="text-align: left;">Microvesicular: small vacuoles</td></tr><tr><td style="text-align: left;">Cut section: round edges-bulging cut &lt;br&gt; surface.</td><td style="text-align: left;">Signet ring cell: large vacuole which &lt;br&gt; causes cell swelling with pushing of nucleus &lt;br&gt; to one side i.e. eccentric nucleus.</td></tr><tr><td style="text-align: left;">Color: Yellow &lt;br&gt; Consistency: Soft</td><td style="text-align: left;"></td></tr></tbody></table>
<p>FATTY INFILTRATION: Excess adipose tissue in-between parenchymal cells e.g. in obesity there is both fatty infiltration as well as fatty change. Sites other than liver or heart become yellow, enlarged &amp; flabby-Kidney becomes yellow, enlarged &amp; soft.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sequlae-complications">SEQULAE &amp; COMPLICATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sequlae-complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Temporary disturbance in function.</li>
<li>If injury persists, fatty change may end in necrosis &amp; fibrosis with organ failure.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-irreversible-cellular-changes">II) Irreversible cellular changes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-irreversible-cellular-changes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="necrosis-cell-death-plate-3">NECROSIS &amp; CELL DEATH (plate 3)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#necrosis-cell-death-plate-3" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definitions-of-cell-death">DEFINITIONS OF CELL DEATH:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definitions-of-cell-death" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Necrosis: Irreversible injury, resulting in death of groups of cells, in a living tissue. It is accompanied by an acute inflammatory reaction.</li>
<li>Necrobiosis (apoptosis &amp; autophagy <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup></mrow><annotation encoding="application/x-tex">{ }^{1}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8141em;"></span><span class="mord"><span class="mord"></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8141em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span></span></span></span></span></span> ): programmed single cell death in a living tissue. It is not accompanied by inflammation.</li>
<li>Autolysis death of groups of cells and tissues because of death of the host. Dead cells release lysosomal enzymes, which cause further cell breakdown. It is not accompanied by inflammation but by decomposition (from bacteria escaping the gut).</li>
</ol>
<p>1 autophagy is another form of programmed cell death whereby the cell digests its internal organelles which are damaged.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-necrosis">TYPES OF NECROSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-necrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Coagulative or ischaemic necrosis: Dead tissue appears firm &amp; pale, e.g. renal, splenic or myocardial infarction. It is characterized by outline preservation since protein denaturation more than enzyme denaturation.</p>
</li>
<li>
<p>Liquefactive or colliquative necrosis: Dead tissue appears liquid &amp; pale e.g. pus &amp; brain infarction with loss of cell detail since enzyme denaturation more than protein denaturation. The necrotic area softens and becomes turbid fluid (gross and microscopic features of pus see Inflammation).</p>
</li>
<li>
<p>Caseous necrosis: Dead tissue appears soft &amp; creamy e.g. tuberculosis (TB) is a type of coagulative necrosis rich in lipids from the bacterial wall giving it a semi solid cheesy appearance (gross &amp; mic TB).</p>
</li>
<li>
<p>Gummatous necrosis: Dead tissue appears firm &amp; rubbery e.g. syphylis</p>
</li>
<li>
<p>Gangrenous necrosis e.g. Dry &amp; wet gangrene = ischaemic necrosis + putrefaction (see circulatory disturbances).</p>
</li>
<li>
<p>Fat necrosis &amp; enzymatic fat necrosis: Foci of hard yellow material in adipose tissue e.g. Traumatic fat necrosis of breast &amp; enzymatic necrosis of the omental fat in pancreatitis.</p>
</li>
<li>
<p>Fibrinoid necrosis e.g. Muscle in toxemia, Aschoff nodule &amp; wall of blood vessels in arteritis.</p>
</li>
<li>
<p>Hemorrhagic necrosis: Dead tissue is full of extravasated RBC's when the cause is venous obstruction.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="aetiology-pathogenesis">AETIOLOGY &amp;PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aetiology-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>See causes of cell injury
Severe irreversible damage with loss of nuclear &amp; cell membranes</p>
<ul>
<li>Lethal Injury results in loss of RNA &amp; protein denaturation responsible for the homogenous dark pink cytoplasm.</li>
<li>Sustained sublethal injury: The damaged cell membrane causes <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">N</mi><mi mathvariant="normal">a</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Na}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8446em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Na</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span>&amp; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">H</mi><mn>2</mn></msub><mi mathvariant="normal">O</mi></mrow><annotation encoding="application/x-tex">\mathrm{H}_{2} \mathrm{O}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">H</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mord mathrm">O</span></span></span></span></span> entry into the cell. <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> Osmotic pressure inside cell causes swelling of necrotic cells. <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mi mathvariant="normal">K</mi><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{K}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7713em;"></span><span class="mord"><span class="mord mathrm">K</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7713em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span> enzymes escape from the cell due to loss of <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">N</mi><mi mathvariant="normal">a</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Na}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8446em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Na</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span>pump mechanism and lysosomal membrane damage causes escape of enzymes and high level of enzymes in the blood.</li>
<li>Organelle breakdown also increased intracellular osmotic pressure,decreased mitochondrial RNA &amp; increased cytosolic calcium which activates protein kinases, proteases &amp; phosphokinases.</li>
<li>Nuclear membrane damage results in: Karyopyknosis - Karyorrhexis- Karyolysis
N.B.: Increased enzymes a) in the blood are the first signs of necrosis b) At site of injury, the enzymes &amp; chemical mediators released into the tissue cause irritation of the living tissues resulting in an acute inflammatory reaction and degenerative changes.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-coagulative-necrosis-ischaemic-necrosis">1. COAGULATIVE NECROSIS (ischaemic necrosis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-coagulative-necrosis-ischaemic-necrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: death of parts of tissues. It is usually secondary to lack of blood supply i.e. no oxygenation. e.g. infarction of solid organs: heart, spleen &amp; kidney.</p>
<p>TYPES: Pale &amp; Red infarctions</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-recent-infarction">A) Recent Infarction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-recent-infarction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>GROSS Pale: in most solid organs since the blood cells can be squeezed by the swollen necrotic cells. Such infarctions are usually swollen and bulge from surface.</p>
<p>Red (haemorrhagic): in loose tissue (intestine-lung) since blood cells can't be squeezed by the swollen necrotic cells so they accumulate in the alveoli. This can also occur in solid organs e.g. spleen if there was previous chronic venous congestion.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic">MICROSCOPIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Homogenous dark pink cytoplasm of necrotic cells (protein denaturation).</li>
<li>Swelling of cells(damaged plasma membrane allows Na &amp; H20 into the cell).</li>
<li>Nuclear membrane damage results in.</li>
</ul>
<p>Karyopyknosis: shrunken dark nucleus due to condensation of chromatin.
Karyorrhexis: fragmentation of nucleus.
Karyolysis: disappearance or lysis of nucleus or simply a pale fading nucleus.</p>
<ul>
<li>NECROTIC AREA IS PINK AND GRANULAR CONTAINING NUCLEAR DEBRIS. The more resistant connective tissue and cells retain some of their outlines and appear as ghosts. (BR).
B) Healed Infarctions (BR): Are pale, formed of fibrous tissue, which causes shrinkage of the lesion and thus the healed, infarcted area is depressed below the surface. They still retain the original pyramidal shape.
N.B.: Infarctions do not occur in healthy lungs or liver since both organs have a double blood supply.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-liquefactive-necrosis">2. LIQUEFACTIVE NECROSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-liquefactive-necrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pus: see chapter of inflammation (abscess)</li>
<li>Cerebral infarction: due to occlusion of cerebral arteries. It is rapidly liquefied due to the high fat content in the brain, which on cutting of tissue will leave a cavity</li>
</ul>
<ol start="3">
<li>CASEOUS NECROSIS: see tuberculosis (combination of coagulative &amp; liquifactive)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-fat-necrosis">4. FAT NECROSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-fat-necrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Enzymatic fat necrosis e.g. in pancreatitis release of pancreatic enzymes act on the omentum &amp; mesentery resulting in necrotic fat cells which release triglycerides producing fatty acids which unite with calcium producing insoluble soapy material. This appears white in color.
b) Traumatic fat necrosis occurs in the fat of the breast, resulting in a granulomatous reaction to the necrotic fat cells which release their irritating contents and produce an acute inflammatory reaction. This is followed by a localized form of chronic inflammation characterized by lakes of fat surrounded by lipid laden macrophages (foam cells) + lymphocytes, plasma cells, giant cells and fibrous tissue.
c) FIBRINOID NECROSIS: is a type of necrosis of connective tissue especially muscle fibers e.g. in immunological disorders arteritis &amp; rheumatic fever. The affected wall of the blood vessels becomes a swollen dark pink homogeneous mass with narrowing of the lumen. In Toxemia, the anterior abdominal wall muscle becomes a homogeneous pink mass with swelling of the muscle fibers.
d) GANGRENOUS NECROSIS: ischaemic necrosis associated with putrefaction (see circulatory disturbances) (combination of coagulative &amp; liquefactive).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fate-of-necrotic-tissue">Fate of necrotic tissue<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fate-of-necrotic-tissue" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="this-depends-on-amount-of-necrosis">(This depends on amount of necrosis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#this-depends-on-amount-of-necrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th style="text-align: left;">Minimal necrosis</th><th style="text-align: left;">The few necrotic cells are surrounded by &lt;br&gt; inflammation and the macrophages and &lt;br&gt; PNLs remove the debris.</th></tr></thead><tbody><tr><td style="text-align: left;">Excessive necrosis</td><td style="text-align: left;">The cells &amp; the connective tissue are both &lt;br&gt; damaged resulting in healing by &lt;br&gt; organization with replacement fibrosis.</td></tr></tbody></table>
<p>N.B.: If there is no organization or incomplete organization, the remaining necrotic tissue (alkaline medium) helps deposition of calcium salts (dystrophic calcification) e.g. TB and atherosclerosis.</p>
<p>OTHER FORMS OF CELL DEATH</p>
<table><thead><tr><th style="text-align: center;">AUTOLYSIS</th><th style="text-align: center;">APOPTOSIS (plate3)</th></tr></thead><tbody><tr><td style="text-align: center;">Postmortem change</td><td style="text-align: center;">During life</td></tr><tr><td style="text-align: center;">Self digestion of cells and tissues</td><td style="text-align: center;">Single cell suicide (programmed cell death) which occurd during life.</td></tr><tr><td style="text-align: center;">Depends on role of enzyme activity after death</td><td style="text-align: center;">1. Occurs in physiologic conditions as Embryogenesis, menstruation &amp; thymus involution. &lt;br&gt; 2. Pathologic states e.g in viral hepatitis &amp; defective apoptosis genes leading to tumor formation.</td></tr></tbody></table>
<p>APOPTOTIC CHANGES: are said to occur as a result of stimulation of endogenous endonucleases.</p>
<ul>
<li>Cells shrink because of organellar condensation, their cytoplasm also becomes deep pink. The chromatin in nucleus condenses beneath nuclear membrane</li>
<li>Shrunken cells form surface outgrowths called blebs, which contain some organelles and possibly nuclear fragments.</li>
<li>Blebs detach from cell surface with a complete plasma membrane around them. Some contain nuclear fragments others are devoid (Apoptotic bodies).</li>
<li>Macrophages phagocytose these bodies &amp; quickly get rid of them.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cell-responses-range-from-reversible-damage-to-irreversible-necrosis">CELL RESPONSES RANGE FROM REVERSIBLE DAMAGE TO IRREVERSIBLE NECROSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cell-responses-range-from-reversible-damage-to-irreversible-necrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>If damage is minimal cell can recover after removing stimulus. Damaged protein &amp; organelles are removed by cell stress response &amp; self digestion autophagy &amp; new structural components are synthesized.</p>
<p>If stimulus is sublethal &amp; cell cant recover or stimulus is lethal from start, a set of structural damage involving cell, organellar &amp; nuclear membrane damage occurs as well as protein coagulation(necrosis).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="iii-depositions-abnormal-pigmentation-abnormal-calcification">III) Depositions-abnormal pigmentation- abnormal calcification<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-depositions-abnormal-pigmentation-abnormal-calcification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-extracellular-depositions">A. EXTRACELLULAR DEPOSITIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-extracellular-depositions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="amyloid-glycoprotein-plate-4">AMYLOID (glycoprotein) (plate 4)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#amyloid-glycoprotein-plate-4" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Waxy extracellular deposit of abnormal protein (B pleated fibrils) and nonfibrillary glycoproteins (normal serum amyloid protein P (SAP) +carbohydrate heparan <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mrow><mi mathvariant="normal">S</mi><mi mathvariant="normal">O</mi></mrow><mn>4</mn></msub></mrow><annotation encoding="application/x-tex">\mathrm{SO}_{4}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">SO</span></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">4</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> (glycosaminoglycans GAG), on basement membranes of blood vessels &amp; epithelial acini, as well as on connective tissue reticular fibers.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="aetiology-pathogenesis">AETIOLOGY &amp; PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aetiology-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Old terminology: Primary amyloidosis: unknown cause &amp; Secondary amyloidosis: 2ry to chronic disease.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="new-terminology">New terminology:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#new-terminology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-systemic-amyloidosis">A. Systemic Amyloidosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-systemic-amyloidosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Systemic amyloidosis has been classified into three major types that are very different from each other. These are distinguished by a two-letter code that begins with an A (for amyloid). The second letter of the code stands for the protein that accumulates in the tissues in that particular type of amyloidosis. The types of systemic amyloidosis are currently categorized as primary (AL), secondary (AA), and hereditary (ATTR).</p>
<ol>
<li>Primary amyloidosis: or AL, occurs when a specialized cell in the bone marrow (plasma cell) spontaneously overproduces a particular protein portion of an antibody called the light chain. e.g. multiple myeloma.</li>
<li>Secondary amyloidosis: When amyloidosis occurs "secondarily" as a result of another illness, such as chronic infections (e.g, tuberculosis or osteomyelitis), or chronic inflammatory diseases (e.g, rheumatoid arthritis), the condition is referred to as secondary amyloidosis or AA.</li>
<li>Hereditary or Familial amyloidosis: Familial amyloidosis, or ATTR, is a rare form of inherited amyloidosis. The amyloid deposits in familial amyloidosis are composed of the protein transthyretin, or TTR, which is made in the liver. Familial amyloidosis is an inherited autosomal dominant in genetics terminology.</li>
</ol>
<p>B. Hemodialysis associated Amyloidosis: Beta-2 microglobulin amyloidosis occurs when amyloid deposits develop in patients with longstanding kidney failure on dialysis, The amyloid deposits are often found around joints.
C. Localized amyloidoses: Amyloid deposit restricted to one organ or tissue. The cause is unknown. The deposit occurs mainly in:</p>
<ol>
<li>Laryngeal wall forming small tumour-like nodule s</li>
<li>Skin, bronchi, lung, heart and urinary bladder.</li>
<li>Tumours of endocrine glands as medullary carcinoma of thyroid,</li>
<li>Cerebral grey matter in senile dementia. The amyloid deposit is amyloid protein (AB2).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathology-general-features">PATHOLOGY GENERAL FEATURES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathology-general-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross">GROSS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Specimen: liver, kidney, spleen, any tissue
Size: Increased size &amp; weight
Surface smooth-capsule stretched
Cut section: sharp edges flat surface
Consistency: firm
Color: pale brown</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-stains">Gross Stains:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-stains" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Lugol's lodine2:amyloid (starch-like): stains brown &amp; rest yellow color.</li>
<li>Iodine +H2504: stains amyloid blue.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic">MICROSCOPIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>H&amp;E: Homogenous pink material deposits on basement membranes &amp; BV Congo red stain: amyloid appears orange red which gives green birefrengence by polarizing light.
Metachromatic stains e.g. (methyl &amp; cresyl violet) .Amyloid stains rose red &amp; rest of tissue is violet
Electron microscopy: Extracellular, haphazardly arranged as non-branching fine fibrils <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>70</mn><msup><mrow><mtext>&nbsp;</mtext><mi mathvariant="normal">A</mi></mrow><mn>2</mn></msup></mrow><annotation encoding="application/x-tex">70 \mathrm{~A}^{2}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8873em;"></span><span class="mord">70</span><span class="mord"><span class="mord"><span class="mspace nobreak">&nbsp;</span><span class="mord mathrm">A</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8873em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span></span></span></span></span></span></span></span></span></span></span></span></span></p>
<p>2 Although amyloid is mostly protein in nature yet due to its blue color with iodine &amp; sulfuric acid it was termed starch-like. This pattern of staining is attributed to the small carbohydrate portion of the molecule (heparan sulphate glycoseaminoglycans GAG)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sequelae-complications">SEQUELAE &amp; COMPLICATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sequelae-complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pressure on adjacent tissue results in pressure atrophy</li>
<li>Blood vessels get narrowed with decreased blood flow and hypoxia induced fatty change.</li>
<li>Increased permeability of kidney tubules due to amyloid deposits produces excessive leakage of proteins (proteinuria) and casts in kidney.</li>
</ul>
<p>AMYLOID DEPOSITS IN DIFFERENT ORGANS: Almost any tissue can be affected without serious functional impairment except if fibrous tissue replacement of amyloid occurs</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="kidney">KIDNEY:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#kidney" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th style="text-align: left;">Gross</th><th style="text-align: left;">Microscopic</th></tr></thead><tbody><tr><td style="text-align: left;">Pale-firm, waxy with glomeruli &lt;br&gt; appearing as brown dots with iodine</td><td style="text-align: left;">- Deposits mainly on basement &lt;br&gt; membranes of glom capillaries &amp;tubules &lt;br&gt; with thickening of basement membranes &lt;br&gt; which are totally replaced by &lt;br&gt; homogenous pink amyloid and</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">- Gomeruli become swollen and tufts &lt;br&gt; replaced by acellular glassy pink &lt;br&gt; material (amyloid).</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">- Tubules with thick BM become atrophic. &lt;br&gt; - <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> permeability of glomeruli causing &lt;br&gt; leaking of protein Into lumen &amp; forming &lt;br&gt; protein casts which indicate heavy &lt;br&gt; proteinuria. This ends in nephrotic &lt;br&gt; syndrome.</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gastrointestinal-tract">GASTROINTESTINAL TRACT:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gastrointestinal-tract" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Amyloid deposits on BM of capillaries producing diarrhea &amp; protein loss, ALSO MALABSORPTION, NUTRITIONAL DEFICIENCY &amp; ELECTROLYTE IMBALANCE.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="heart">HEART<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#heart" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Deposition occurs on BM of capillaries and around muscle fibers, causing heart enlargement &amp; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> ventricular wall thickness.</p>
<p>Effects: Heart failure occurs mainly due to mechanical effect of amyloid preventing proper muscular contraction + malnutrition due to poor blood supply to muscle fibers ending in muscle atrophy.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="liver">LIVER<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#liver" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Amyloid deposits mostly in BM of sinusoids. Sinusoids by time they become occluded with homogenous pink material (amyloid) producing pressure atrophy on hepatocytes + vascular atrophy due to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo><msub><mi mathvariant="normal">O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">\downarrow \mathrm{O}_{2}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span>. Gross changes (describe basic reaction BR), but amyloid appears as brown streaks in a yellow background of fatty degeneration (since many hypoxic liver cells undergo hypoxic fatty change).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spleen">SPLEEN<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spleen" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Diffuse type: Amyloid deposits in basement membranes (BM) of sinusoids. Spleen is markedly enlarged (marked splenomegaly).</p>
<p>Sago spleen: Amyloid deposits in central arteriole of white pulp (WP) resulting in its atrophy. This atrophic WP appears grossly as brown dots of amyloid. Spleen is moderately enlarged (moderate splenomegaly).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-intra-extracellular-depositions-accumulations">B. INTRA &amp; EXTRACELLULAR DEPOSITIONS /ACCUMULATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-intra-extracellular-depositions-accumulations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-protein-deposit-or-accumulation-hyaline-change-hyalinosis">1. PROTEIN DEPOSIT or ACCUMULATION = HYALINE CHANGE (hyalinosis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-protein-deposit-or-accumulation-hyaline-change-hyalinosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Accumulation of intracellular protein or deposition of a glassy pink homogeneous protein in dead or dying tissues.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathogenesis">PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="intracellular">Intracellular<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#intracellular" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Excess protein is presented to cell e.g. kidney tubules in states of proteinuria.</li>
<li>Increased cell synthesis e.g. plasma cell full of immunoglobulin e.g. Russell body as in rhinoscleroma &amp; liver cell e.g. Mallory body in alcoholic hepatitis.</li>
</ol>
<p>Extracellular: Protein is deposited on: dead or dying tissue:</p>
<ol>
<li>Collagen in scars.</li>
<li>Muscle wall of arterioles in systemic hypertension &amp; diabetes Mellitus.</li>
<li>Mesenchymal tumors.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-mucin-accumulation-deposition-carbohydrates">2. MUCIN ACCUMULATION / deposition (CARBOHYDRATES)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-mucin-accumulation-deposition-carbohydrates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Intracellular mucin accumulation is known as mucoid change where as extracellular deposition= myxomatous change.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mucoid-change-intracellular">Mucoid change (intracellular)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mucoid-change-intracellular" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Catarrhal inflammation</li>
<li>Cells of mucoid carcinoma</li>
<li>Cells of mucinous cystadenoma</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="myxomatous-change-extracellular">Myxomatous change (extracellular)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#myxomatous-change-extracellular" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In mesenchymal (connective tissue) tumors</p>
<p>Gross: soft jelly like translucent material
Microscopic: clear swollen cells
Microscopic: stellate cells with outgrowths With signet ring appearance forming a loose network</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-storage-diseases">3. STORAGE DISEASES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-storage-diseases" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Glycogen (pompe's, McArdle,Von Gierke's disease)
Fat . (Gaucher's disease &amp; Nieman Pick's disease)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathogenesis">PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Enzyme deficiency leads to accumulation of glycogen or fat in connective tissue (CT) histiocytes as well as in parenchymatous cells</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-pigment-disorders-plate-4">4. PIGMENT DISORDERS (Plate 4)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-pigment-disorders-plate-4" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="endogenous">Endogenous<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#endogenous" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>MELANIN: Normally found in: skin, adrenals &amp; choroid plexus and abnormally in neoplasms Melanin is synthesized in melanocytes in the basal layer of epidermis. Pigment is then transported by macrophages called melanophores and remains in dermis giving the skin its color. This process is under the stimulatory effect of UV rays direct action on melanocytes which in turn stimulate pituitary melanocyte stimulating hormone (MSH), which regulates the amount of pigment synthesized under the inhibitory effect of adrenocortical hormones. Adrenal medullary hormones, on the other hand, have a direct inhibitory effect on skin melanocytes bypassing the pituitary.</li>
</ol>
<table><thead><tr><th style="text-align: left;">Local pigmentation</th><th style="text-align: left;">Generalized</th></tr></thead><tbody><tr><td style="text-align: left;">- Nevi (hamartoma)</td><td style="text-align: left;">- Suntan</td></tr><tr><td style="text-align: left;">- Malignant neoplasms: Melanoma</td><td style="text-align: left;">- Addison's disease &lt;br&gt; - Chloasma of pregnancy</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="n-b-hypopigmentation-absent-low-melanin-e-g-albinism-leukoderma">N.B.: HYPOPIGMENTATION (Absent / low melanin) e.g. Albinism &amp; Leukoderma<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b-hypopigmentation-absent-low-melanin-e-g-albinism-leukoderma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-blood-components">2. BLOOD COMPONENTS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-blood-components" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Hemoglobin breaks (in splenic reticuloendothelial cells) into.
<img src="assets/images/image-20251212-f06626cd.jpeg" alt="img-11.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-hemoglobin">a) Hemoglobin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-hemoglobin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Incompatible blood transfusion results in haemolysis which is responsible for tubular necrosis and acute renal failure. Hb is excreted in urine (haemoglobinuria) giving it a red colour.
b) Bilirubin (Non Fe containing pigment): Jaundice
c) Hemosiderin (Fe containing pigment):</p>
<p>Haemosiderosis: environmental
Hemochromatos: genetic
Haemosiderosis: It is the presence of excess iron in the form of hemosiderin. May be local or visceral.
A. Local Haemosiderosis: in local chronic venous congestion of the lung (heart failure cells) &amp; at sites of local trauma e.g. black eye. The RBC's break down in the tissue.</p>
<p>Area is at first red (extravasated RBC's), these become phagocytosed by macrophages (greenish blue color) . haemosiderin &amp; bilirubin are THEN released giving yellowish brown color.
B. Visceral siderosis: seen in liver &amp; spleen, in cases of haemolytic anemia &amp; in patients requiring repeated blood transfusion. The liver becomes deep brown. Fe is found in liver cells &amp; Kupffer cells (Fe can be demonstrated by a +ve Prussian blue reaction)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hemochromatosis-bronzed-diabetes-or-primary-hemochromatosis">Hemochromatosis (bronzed diabetes or Primary hemochromatosis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hemochromatosis-bronzed-diabetes-or-primary-hemochromatosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: This is a genetic defect in the <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">F</mi><mi mathvariant="normal">e</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Fe}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8446em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Fe</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span>absorption from the intestine, which becomes uncontrolled. This causes the system to be overloaded with Fe , which is deposited as haemosiderin in many sites. NB: ALL Organs become brown</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism">MECHANISM:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Normal mechanism: Fe in diet is taken up by intestinal epithelium, where some are bound to ferritin and returns to the lumen to be excreted. The rest according to body need is not combined and passes to blood, where it is transported on the protein transferrin to reach bone marrow, liver &amp; spleen i.e. sites of Fe utilization. The ferritin content of intestinal epithelium, Fe saturation of plasma, stores of Fe (in the liver, spleen &amp; bone marrow) &amp; t demand for Fe are considered as balancing mechanisms.</p>
<p>Pathological mechanism: Uncontrolled absorption of Fe from the intestine which overloads ferritin system.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="manifestations-of-hemochromatosis-clinical-picture-cpu">Manifestations of hemochromatosis (clinical picture (CPU))<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#manifestations-of-hemochromatosis-clinical-picture-cpu" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Pancreas: Pigment in islet cells is associated with fibrosis which ends in diabetes mellitus due to loss of islets.</p>
<p>Liver: deposits in hepatocytes &amp; Kupffer cells, associated with fibrosis ending in cirrhosis
Skin: deposits of haemosiderin around sweat glands &amp; with melanin results in bronze color</p>
<p>Heart: haemosiderin within cytoplasm of cardiac muscle fibers
Mesenteric lymph nodes pigment deposits in reticuloendothelial cells (REC).
Secondary hemochromatosis is a very severe deadly form of hemosiderosis.
d) Haematin: An Fe containing pigment in an unreactive form such as in bilharziasis and malaria.</p>
<p>Malaria parasite &amp; Bilharzia worm ingests <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mrow><mi mathvariant="normal">H</mi><mi mathvariant="normal">b</mi></mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\mathrm{Hb} \longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7054em; vertical-align: -0.011em;"></span><span class="mord"><span class="mord mathrm">Hb</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">⟶</span></span></span></span></span> Haematin (altered Hb ) which is phagocytosed by blood monocyte and goes to spleen &amp; liver.
3. LIPOCHROME (lipofuscin): is a wear &amp; tear pigment with a high lipid content. It is found in liver, heart, and testis e.g.: Brown atrophy of heart.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="exogenous">EXOGENOUS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#exogenous" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>INHALATION: Coal dust pigment which is carbon (anthracosis), blackens tissue Stone dust which is silica (silicosis) gives a grey coloration.</p>
<p>Particles are ingested by pulmonary macrophages get deposited in lung tissue and drained to regional lymph nodes.</p>
<p>Sequelae: fibrosis (Pneumoconiosis) i.e. dusts induced fibrotic diseases of the lung.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ingestion">INGESTION:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ingestion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Metals like mercury, silver &amp; lead produce a blue line in gums</li>
<li>Carrot eating produces a yellowish or orange skin pigmentation (carotinaemia)</li>
</ul>
<p>INJECTION: In skin tattoo carbon particles are injected into the skin forming a special design.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-pathological-calcification-plate-4">5. PATHOLOGICAL CALCIFICATION (plate 4)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-pathological-calcification-plate-4" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: deposition of calcium in tissues other than bone &amp; teeth.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types">TYPES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-dystrophic-calcification">A. Dystrophic calcification<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-dystrophic-calcification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Ca deposition in dead or dying tissues in presence of normal serum Ca levels.</p>
<ol>
<li>Deposition in dead fetus.</li>
<li>Old mesenchymal tumors.</li>
<li>Products of inflammation &amp; necrosis e.g. TB</li>
<li>Old thrombus.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-metastatic-calcification">B. Metastatic calcification<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-metastatic-calcification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition Deposition in living tissues in_cases of high levels of serum <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">C</mi><mi mathvariant="normal">a</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Ca}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8446em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Ca</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span>
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">C</mi><mi mathvariant="normal">a</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Ca}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8446em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Ca</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span>deposits in interstitial tissue, i.e. connective tissue &amp;lungs, kidney, stomach &amp; wall of arteries.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="gross-chalky-white-granular-material-br">Gross: chalky white granular material (BR)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-chalky-white-granular-material-br" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Microscopic: Blue deposits: intracellular in dead mitochondria or extracellular in connective tissue (collagen fibers).</p>
<p>PLATE 4 accumulations &amp; depositions from WebPath
<img src="assets/images/image-20251212-07266086.jpeg" alt="img-12.jpeg"></p>
<p>Fatty change liver
<img src="assets/images/image-20251212-ed67cb9f.jpeg" alt="img-13.jpeg"></p>
<p>Amyloid Kidney H &amp; E stain
<img src="assets/images/image-20251212-b1c385b1.jpeg" alt="img-14.jpeg"></p>
<p>Anthracosis lung
<img src="assets/images/image-20251212-77a483a3.jpeg" alt="img-15.jpeg"></p>
<p>Amyloid Congo red stain
<img src="assets/images/image-20251212-4e4919c8.jpeg" alt="img-16.jpeg"></p>
<p>Dystrophic calcification in artery &amp; stomach submucosa</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: center;">Topic</th><th style="text-align: center;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: center;">Basic reactions</td><td style="text-align: center;">All basic reactions</td></tr><tr><td style="text-align: center;">Cell response to injury &lt;br&gt; Accumulations &amp;depositions All basic reactions.</td><td style="text-align: center;">Causes &amp; effects of cell injury &lt;br&gt; Mechanisms &lt;br&gt; Hydropic &amp; vacuolar &lt;br&gt; Fatty Change &lt;br&gt; Hyalinosis &lt;br&gt; Amyloidosis &lt;br&gt; Mucoid &amp;myxomatous change &lt;br&gt; Pigmentations &lt;br&gt; Pathological calcification &lt;br&gt; Necrosis &amp; apoptosis</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="inflammation">INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: It is a reaction of living tissue to injury. The reaction consists of a local tissue reaction (vascular &amp;cellular) in addition to a systemic response. Such a reaction is important to kill &amp; remove the injurious agent, making way for repair.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="aetiology-types-pathogenesis">AETIOLOGY, TYPES, PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aetiology-types-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251212-62b097f0.jpeg" alt="img-17.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-inflamation">Types of inflamation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-inflamation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th style="text-align: center;"></th><th style="text-align: center;">Acute</th><th style="text-align: center;">Subacute</th><th style="text-align: center;">Chronic</th></tr></thead><tbody><tr><td style="text-align: center;">Onset</td><td style="text-align: center;">Rapid</td><td style="text-align: center;"></td><td style="text-align: center;">Gradual</td></tr><tr><td style="text-align: center;">Duration</td><td style="text-align: center;">Short (days)</td><td style="text-align: center;"></td><td style="text-align: center;">Prolonged (3 mths/ more</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="acute-inflammation-plate-5">ACUTE INFLAMMATION (plate 5)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acute-inflammation-plate-5" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: It is the first reaction to injury of living tissue, which is characterized by a rapid onset ( less than 48 hrs ) &amp;short duration. The reaction consists of a local tissue reaction (vascular &amp; cellular) in addition to a systemic response. Such a reaction is important to kill &amp; remove the injurious agent, making way for repair.</p>
<p>1 In diagnosis of inflammation should include: Type (Acute/Chronic) + Organ/ tissue+ itis e.g. Acute diffuse suppurative appendicitis (see terminology at end of chapter)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathogenesis">PATHOGENESIS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A- LOCAL REACTION (VASCULAR &amp; CELLULAR RESPONSE)</p>
<ol>
<li>Hyperemia: Increased blood flow. This proceeds in 3 steps:</li>
<li>Temporary vasoconstriction (direct injury) followed by capillary dilatation (chemical mediators).</li>
<li>Arteriolar dilation: 2ry to nerve reflex (direct stimulus).</li>
<li>Wheal formation as a result of exudation of fluid.</li>
</ol>
<p>This is compatible with Lewis's triple response: injurious stroke <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo><mn>1</mn></mrow><annotation encoding="application/x-tex">=1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">1</span></span></span></span></span> transient white line (vasoconstriction), followed by dull red line or flush (capillary dilatation) 2-flare or bright red zone around the line (arteriolar dilatation), 3-wheal Injury to normal tissue results in: a) direct vascular injury b) axon (nerve) reflexes acting on arterioles &amp; c) toxic, chemical mediator release from damaged cells. All 3 actions, produce vascular dilatation with increase in blood flow ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>1</mn><mtext>st&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">1^{\text {st }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7936em;"></span><span class="mord"><span class="mord">1</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7936em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">st&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> step of acute inflammation).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clinical-redness-hotness">Clinical: redness &amp; hotness<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-redness-hotness" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol start="2">
<li>Formation of fluid exudate i.e. Exudation: leakage of fluid exudate results in swelling of area.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism">Mechanism:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Transudation: very early, since there is <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> in hydrostatic pressure due to vasodilatation only produces fluid plasma, poor in protein &amp; large molecules (no cells) &amp; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> specific gravity.
b) Exudation: occurs after <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> permeability allowing fluid + large protein molecules (fibrinogen &amp; immunoglobulins i.e. antibodies) with <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> Sp.gr. to come out. Later, this is followed by cellular exudate, which increases the swelling.</p>
<p>Chemical mediators cause endothelial swelling &amp; contraction (increasing gaps), direct injury to endothelium &amp; leukocyte dependent injury produces gaps which result in increased vascular permeability.</p>
<p>Factors helping the exudation process:</p>
<ul>
<li>Increased Capillary hydrostatic pressure</li>
<li>Chemical mediator effect on wall ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> permeability)</li>
<li>Increased tissue osmotic pressure OP (from cell breakdown) which pulls fluid out from vessels.</li>
</ul>
<p>Importance of exudates. (see later)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-swelling-or-wheal">Clinical: swelling or wheal<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-swelling-or-wheal" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fate">Fate:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fate" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> Lymph flow &amp; venous drainage of exudate with return of area to normal (resolution)</li>
<li>Spread of organisms in fluid exudate to lymphatics produces lymphangitis &amp; to blood stream causing thrombophlebitis which is responsible for: toxemia (toxin in circulation), pyaemia (pus in circulation), bacteremia (few bacteria in circulation) or septicemia (bacteria multiplying in pus &amp; producing toxins in the circulation).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-formation-of-cellular-exudate">3. Formation of cellular exudate<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-formation-of-cellular-exudate" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>With exudation of fluid blood becomes more viscous &amp; the flow slows (congestion or stasis). Axial stream &amp; plasmatic zones are disturbed. Cells are thrown outwardsv&amp; line up against the endothelial wall, which is known as margination (pavementation). These cells carry surface adhesion molecules (integrins, selectins &amp; immunoglobulins) to help them stick to the endothelium &amp; so they do not get washed away by blood stream.</li>
<li>Emigration: polymorphonuclear leukocytes (PNLs) &amp; blood monocytes leave blood vessels to go to site of injury resulting in more swelling (importance, see later). Chemical mediators cause swelling of endothelium increasing gaps between cells. The PNLs find openings through which they send pseudopodia &amp; emigrate outwards, pulling with them some RBCs by diapedesis.</li>
</ul>
<p>Chemotaxis: Is the directed movement of PNLs (later macrophages) to site of injury under the effect of chemotactic chemical mediators e.g. C5a</p>
<ul>
<li>Diapedesis: Is the passive escape of red blood cells (RBCs) through the endothelial gaps widened by the migration of neutrophils</li>
<li>Phagocytosis: Process by which PNLs (microphages)&amp; macrophages (blood monocytes &amp; tissue histiocytes) engulf injurious agent. Destruction of agent by two mechanisms 02 dependent with H20 2 ! free radicle formation or 02 independent as lysosomal enzyme release.
a) Recognition + attachment: cells carry surface receptors for opsonins (antibodies) which attach to antigen &amp; complement. This facilitates the engulfment of the antigen and prevents its escape from the phagocytic cell by ensuring its proper attachment
b) Engulfment: pseudopodia form around antigen-antibody &amp; complement attached to receptor on cell surface.</li>
</ul>
<p>c) Degradation: <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">H</mi><mn>2</mn></msub><msub><mi mathvariant="normal">O</mi><mn>2</mn></msub></mrow><annotation encoding="application/x-tex">\mathrm{H}_{2} \mathrm{O}_{2}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">H</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mord"><span class="mord mathrm">O</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> &amp; lysosomal enzymes degrade the contents of the phagosome containing the antigen (after lysosomes fuse with the phagosome, forming a phagolysosome).
N.B.: Cell, may die (e.g. when neutrophil dies it becomes a pus cell) or live with bacteria inside it (e.g. macrophages containing TB bacilli). With exudation into tissue, the blood becomes more viscous with slowing of the flow (stasis). This process is called congestion.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical">Clinical:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>More swelling (fluid + inflammatory cells)</li>
<li>Pain: from direct injury-swelling-chemical mediators released from necrotic cells</li>
<li>Loss of function resulting from pain &amp; loss of tissue (necrosis)</li>
</ul>
<p>CHEMICAL MEDIATORS: are vasoactive amines &amp; polypeptides, which are chemical factors released during tissue injury from necrotic cells and cells of acute inflammation. They also include plasma complement, bacterial toxins as well as others.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-cellular-factors">A. CELLULAR FACTORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-cellular-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Vasoactive amines (histamine and serotonin released from Mast cells &amp; platelets).</li>
<li>Cytokines: lymphokines (from activated lymphocytes &amp; cytokines from other cells) e.g. (IL-1, TNF, IL-8, IL-12)</li>
</ul>
<p>Fibrinolytic system which dissolves fibrin</p>
<ul>
<li>Arachidonic acid metabolites</li>
</ul>
<p>Prostaglandins (released from most cells)
Leukotrines (produced by neutrophils)</p>
<ul>
<li>Platelet activating factor (PAF)</li>
<li>Nitric oxide (vasodilator, cytotoxin)</li>
<li>Lysosomal constituents of leukocytes</li>
<li>Oxygen derived free radicals
B. PLASMA FACTORS</li>
<li>Plasma factors</li>
</ul>
<p>Kinin system eg bradykinin
Complement system especially C3a &amp; C5a
Coagulation system changes fibrinogen to fibrin</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="they-are-capable-of">They are capable of:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#they-are-capable-of" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Vasodilatation (hyperemia) e.g. prostaglandin E, nitric oxide &amp; prostacyclins</li>
<li>Increased permeability (exudation) e.g. C3a, C4a, C5a, bradykinin</li>
<li>Cell emigration, chemotaxis (C5a) &amp; phagocytosis (C3b acts as an opsonin)</li>
<li>Fever &amp; leukocytosis e.g. interleukin 1&amp; 6 , prostaglandins &amp; TNF alpha</li>
<li>Tissue damage (a leukocyte exudation): Neutrophil and macrophage lysosomal enzymes-Oxygen metabolites-Nitric oxide</li>
<li>Pain: -Prostaglandins&amp; Bradykinin</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="steps-of-microbial-killing-in-acute-inflammation">Steps of microbial killing in acute inflammation:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#steps-of-microbial-killing-in-acute-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>PNLs &amp; macrophages (phagoicytosis).</li>
<li>Immune response: non specific opsonization or specific humoral or cell mediated immunity.
(specific responses occur only on 2nd exposures, see immunopathology)
IMPORTANCE OF INFLAMMATORY REACTION: The inflammatory reaction comprises the formation of the fluid + cellular exudate. Increased vascularity &amp; increased vascular permeability are important in:</li>
<li>cellular exudate: bringing important cells as PNLs &amp; monocytes (in addition to CT histiocytes &amp; PNLs) for phagocytosis &amp; elimination of the injurious agent. These cells also remove necrotic debris &amp; the blood; provides the</li>
<li>fluid exudate which: a) contains fibrinogen, which changes to fibrin in tissue. This is important for</li>
</ol>
<ul>
<li>preventing spread of infection (by surrounding the site &amp; blocking the lymphatics).</li>
<li>It also forms a scaffold (area outline) which helps bring phagocytic cells to site &amp;</li>
<li>later, binds the tissues and helps repair (by allowing more fibroblasts into the area) brings antibodies &amp; any circulating antibiotic or important drugs to the area. Fluid exudate also dilutes toxins &amp; irritants as well as decreasing their effect.
N.B.:The inflammatory exudate is composed of
A. fluid exudate is rich in the protein fibrinogen. This changes into fibrin threads in tissue outside BV).
Fluid in tissue is called edema but if it collects in serous membranes of body cavities e.g. pleura, pericardium &amp; peritoneum, it is called effusion. (plate 5)
B. Cellular exudate: PNLs &amp; macrophages</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="local-basic-reaction-br-for-all-types-of-acute-inflammation">LOCAL BASIC REACTION (BR) for all types of acute inflammation:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#local-basic-reaction-br-for-all-types-of-acute-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic">Microscopic:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Damage (cell injury) in the form of necrosis around injurious agent
Reaction around necrotic area in the form of acute inflammation
1-Acute inflammatory cells from connective tissue &amp; inflammatory cellular exudate from the blood =PNLs &amp; macrophages (tissue histiocytes or blood monocytes)
2-Dilated hyperemic BV
3-Inflammatory fluid exudate: edema &amp; fibrin
Gross: Redness &amp; swelling</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-general-or-systemic-reaction">B- GENERAL OR SYSTEMIC REACTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-general-or-systemic-reaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Fever: from pyrogens released from injurious agent or chemical mediators e.g. prostaglandins. These act on temperature regulating centers in brain stem.</li>
<li>Blood changes</li>
</ul>
<ol>
<li>Changes in white blood cells (leukocytosis i.e. Increased white blood cells in circulation).</li>
<li>Changes in plasma proteins:</li>
<li>High erythrocyte sedimentation rate (ESR)</li>
<li>Increased acute phase reactant proteins as C-reactive protein &amp; Alpha 1antitrypsin.</li>
<li>Immunoglobulins &amp; T lymphocytes</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fate-of-acute-inflammation-sequelae-complications">FATE OF ACUTE INFLAMMATION (SEQUELAE + COMPLICATIONS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fate-of-acute-inflammation-sequelae-complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I) HEALING: When body resistance takes upper hand over injury this will result in
a) Resolution: cure i.e. return to normal This occurs if there is minimal tissue damage, rapid removal of organism linjurious agent &amp; rapid removal of inflammatory exudate. e.g. lobar pneumonia.</p>
<p>Mechanism: after the bacteria are killed, the following occurs:</p>
<ol>
<li>Fibrin is lysed by PN Ls enzymes, fibrinolysin</li>
<li>Fluid exudate is removed by blood vessels (BV) &amp; lymphatics (LV)</li>
<li>Debris (dead fragments) are removed by PNLs &amp; macrophages &amp; drained to lymph nodes (LN)
4.Decreased hyperemia &amp; return to normal</li>
</ol>
<p>b) Regeneration or fibrosis: depends on extent &amp; type of tissue damage (see repair)
II) PROGRESSION: Body resistance &lt; injury <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Progression with more damage <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>+</mo><mi mathvariant="normal">/</mi><mo>−</mo></mrow><annotation encoding="application/x-tex">+/-</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">+</span><span class="mord">/</span><span class="mord">−</span></span></span></span></span> suppuration.
<img src="assets/images/image-20251212-20926299.jpeg" alt="img-18.jpeg"></p>
<p>COMPLICATIONS of acute inflammation</p>
<ol>
<li>Chronicity: Acute proceeds to chronic inflammation</li>
<li>Repair by organization with complications of healing by fibrosis (see repair). e.g. stenosis, adhesions</li>
<li>Spread (see above in progression &amp; chapter of infections): direct to surrounding organs &amp; distant by lymphatics or blood
III) CHRONICITY: When body resistance is of equal strength to injury, the lesion becomes chronic with tissue damage + repair (an ongoing processes of destruction &amp; healing) e.g. granulomas (TB) Complications: of repair by fibrosis &amp; chronicity (ulcer-sin us- fistulae, amyloidosis, neoplastic change, and see later).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types-of-acute-inflammation-plate-5">TYPES OF ACUTE INFLAMMATION (plate 5)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-acute-inflammation-plate-5" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-suppurative-inflammation">A. Suppurative Inflammation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-suppurative-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Localized acute inflammation e.g. acute abscess: localized area of suppuration.</li>
<li>Diffuse acute inflammation e.g. cellulitis: diffuse suppuration e.g. cellulitis of limbs &amp; acute diffuse suppurative appendicitis.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-others-non-suppurative">B. Others (Non-Suppurative)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-others-non-suppurative" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Catarrhal inflammation: occurs in mucous membranes e.g. common cold</p>
</li>
<li>
<p>Exudative inflammations: serous: e.g. burns, serofibrinous e.g. serous membrane as pleurisy or fibrinous e.g. lobar pneumonia</p>
</li>
<li>
<p>Pseudomembranous occurs on mucous membranes with a dirty grayish false membrane forming on surface e.g. bacillary dysentery &amp; diphtheria</p>
</li>
<li>
<p>Haemorrhagic: Inflammatory basic reaction + many RBCs e.g. small pox &amp; acute haemorrhagic pneumonia of influenza</p>
</li>
<li>
<p>Necrotizing: Inflammatory basic reaction + much necrosis e.g. necrotizing vasculitis &amp; cancrum oris (if it is complicated by putrefaction it is called gangrene)</p>
</li>
<li>
<p>Allergic inflammation e.g .. Hypersensitivity e.g. hay fever, bronchial asthma. This reaction IS CHARACTERIZED BY acute inflammatory basic reaction but there is a predominance of eosinophils (cells of allergy) or mononuclear cells e.g. typhoid &amp; much swelling due to edema e.g. urticaria weals, nasal polyps (see later immunopath). This inflammation is the result of an antigen antibody reaction (hypersensitivity) with resultant inflammation due to tissue injury.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a-acute-suppurative-inflammation">A. ACUTE SUPPURATIVE INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-acute-suppurative-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: Is an acute inflammation characterized by pus formation
PUS: is liquefied necrotic tissue secondary mostly to the pyogenic organism injury.
N.B.: pus never contains fibrin since it is liquefied by enzymes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="morphology-characters-of-pus">MORPHOLOGY (Characters of pus)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphology-characters-of-pus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th style="text-align: left;">Gross</th><th style="text-align: left;">Microscopic</th></tr></thead><tbody><tr><td style="text-align: left;">Yellowish, turbid, opaque</td><td style="text-align: left;">- Fluid exudate + high protein &lt;br&gt; (without fibrin)</td></tr><tr><td style="text-align: left;">Odorless, alkaline fluid</td><td style="text-align: left;">- Cellular exudate large numbers PNL &lt;br&gt; of Which many die and become pus &lt;br&gt; cells</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">- Bacteria, with its pigments &amp; toxins &lt;br&gt; - RBCs &lt;br&gt; - Necrotic host tissue (see BRnecrosis)</td></tr></tbody></table>
<p>ETIOLOGY &amp; PATHOGENESIS (mechanism of pus formation)
Pyogenic bacteria by direct &amp; toxic effect produce:
a) Marked necrosis &amp;
b) Attraction of large numbers of neutrophils &amp; death of many them from the high virulence of the organism this forms more pus cells. Release of PNL enzymes causes liquefaction of necrotic tissue &amp; fibrin (No fibrin in pus).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-localized-suppurative-inflammation">1. LOCALIZED SUPPURATIVE INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-localized-suppurative-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="abscess">ABSCESS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#abscess" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION an abscess is a localized collection of pus commonly caused by pyogenic (pus forming) organisms e.g. Staph aureus</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="etiology-pathogenesis">ETIOLOGY &amp; PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#etiology-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Pyogenic Bacteria by direct &amp; toxic effects produce pus (see above mechanism).</li>
<li>Staph aureus releases coagulase enzyme, which changes fibrinogen protein into fibrin threads, thereby localizing the area and walling it off from spread of infection (WALL).
N.B.: There are particular forms of abscesses e.g. furuncle (boil)-carbuncle.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross">GROSS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1 Small: yellow swollen area surrounded by a zone of redness (congestion).
4 Large: cavity with irregular wall, rough lining &amp; yellow in color. Its contents are liquid pus (describe BR above). The cavity is surrounded by a zone of congestion.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic">MICROSCOPIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Early: 2 zones: central zone of necrosis &amp; peripheral zone of acute inflammation
Later: 3 zones</p>
<ol>
<li>Central zone of pus (see BR of characters of pus, above for description).</li>
<li>Pyogenic membrane: new capillaries, PNLs, macrophages, pus cells, fibrin &amp; few fibroblasts (acute inflammation).</li>
<li>Outer zone of reversible damage or degeneration.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fate-of-an-abscess">FATE of an abscess<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fate-of-an-abscess" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>If the abscess is small &amp; superficial, it causes thinning of surface cover (pointing), followed by rupture &amp; discharge of pus producing an ulcer. But If, abscess is small &amp; deep. its contents become absorbed &amp; it heals by fibrosis, leaving a scar.</p>
</li>
<li>
<p>If large &amp; superficial, it produces an ulcer, which is an area devoid of its surface epithelium, this heals by organization &amp; fibrosis. If large &amp; deep, its contents become thick i.e. inspissiated +/- dystrophic calcification and the wall becomes fibrotic(see repair, healing by secondary intention &amp; chronic abscess)</p>
</li>
<li>
<p>Deep abscesses tend to track their pus to the surface to evacuate or into another hollow organ producing fibrous tracts called sinus tracts or fistulae(see repair complications)</p>
</li>
<li>
<p>Excessive damage
a) Spread of infection</p>
</li>
</ul>
<p>Direct (local)
Systemic (blood ego toxemia, septicemia etc.. )
b) Putrefaction on top of the necrosis resulting in gangrene</p>
<ul>
<li>Persistence of injurious agent produces a chronic abscess &amp; complications.</li>
<li>Hemorrhage with complications of anemia or shock, if bleeding is severe.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="boil-furuncle">BOIL (Furuncle):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#boil-furuncle" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: Staph aureus infection produces a small abscess related to hair follicle</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="carbuncle">CARBUNCLE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#carbuncle" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Multiple deep subcutaneous abscesses communicating with each other &amp; forming one cavity but open on the surface by separate openings. It occurs in special sites e.g. back of neck, scalp &amp; buttocks where subcutaneous fat is divided by fibrous septae perpendicular to surface. It is common in diabetics.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-acute-diffuse-suppurative-inflammation">2. ACUTE DIFFUSE SUPPURATIVE INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-acute-diffuse-suppurative-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Diffuse pus &amp; inflammation with no localization e. g.: cellulitis of arm &amp; Acute diffuse suppurative appendicitis.</p>
<p>CAUSE: Streptococcus hemolyticus
MECHANISM
Streptococci secrete streptokinase (fibrinolysin), an enzyme, which dissolves fibrin &amp; hyaluronidase enzymes, which liquefies the extracellular matrix, helping the spread of the organism and spread of pus. This is common in loose connective tissue.</p>
<p>Strept. hemolyticus produces thin sanguinous( bloody) pus &amp; large necrotic areas of tissue (sloughs) All layers of tissue are affected by the diffuse suppurative inflammation (grossly &amp; microscopically).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="acute-diffuse-suppurative-appendicitis">Acute diffuse suppurative appendicitis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acute-diffuse-suppurative-appendicitis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Gross: Appendix swollen- yellow (pus) with reddish areas of hemorrhage &amp; congestion Surface rough yellowish (septic peritonitis) Cut section shows necrotic, rough, yellow mucosal lining. Lumen contains pus Wall thick, yellow (pus) with areas of reddish (congestion)</p>
<p>Microscopic: Mucosal layer ulcerated with pus in lumen (describe pus) Acute inflammation &amp; pus in all layers of wall reaching serosa (describe acute inflammation <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mrow><mi mathvariant="normal">B</mi><mi mathvariant="normal">R</mi></mrow><mo>+</mo></mrow><annotation encoding="application/x-tex">\mathrm{BR}+</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7667em; vertical-align: -0.0833em;"></span><span class="mord"><span class="mord mathrm">BR</span></span><span class="mord">+</span></span></span></span></span> pus cells).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="b-acute-non-suppurative-inflammation-plate-5">B. ACUTE NON-SUPPURATIVE INFLAMMATION (plate 5)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-acute-non-suppurative-inflammation-plate-5" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>CATARRHAL INFLAMMATION e.g. rhinitis (common cold)</li>
</ol>
<p>DEF: Acute non-suppurative inflammation of mucous membranes (respiratory, GIT)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="morphology">MORPHOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>GROSS
Swollen mucosa (edema)
Redness (congestion)
Increased Mucus discharge
CP: blocked runny nose</p>
<p>MICROSCOPIC
Swollen columnar cell with mucin (mucoid change)
Acute Inflammation in mucosal connective tissue (BR)
Increased mucus on epithelial cell surface</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-exudative-inflammation">2) EXUDATIVE INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-exudative-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Occurs in body cavities and on skin surfaces
N.B.: lung alveoli may be considered as microscopic body cavities</p>
<ol>
<li>Serous inflammation: Acute inflammation characterized by more fluid than fibrin e.g
A. Surfaces: e.g. burn bleb (on skin)- Herpes simplex vesicle (on mucosa/skin). Burn bleb on surface of skin: epidermis is raised and full of inflammatory fluid exudate. Dermal CT contains acute inflammatory reaction (acute inflammatory cells congested BV + edema + minimal amounts of fibrin (BR)
B. Lining of cavities (pericardium, pleura, peritoneum, joints &amp; meninges) e.g. effusions.</li>
<li>Fibrinous Inflammation e.g. lobar pneumonia &amp; rheumatic pericarditis more fibrin than fluid
e.g. lobar pneumonia &amp; rheumatic pericarditis</li>
<li>Serofibrinous inflammation: fibrin = fluid e.g. effusions (pleural &amp; pericardial effusion &amp; ascitis in peritoneum).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="br-of-exudative-inflammation">BR of exudative inflammation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#br-of-exudative-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Microscopic:
a- fluid in a cavity (amount depends on type of inflammation)
b- acute inflammation (BR) in submesothelial CT
c- fibrin forms a network on surface of visceral and parietal layers, entangling acute inflammatory cells (amount depends on type of inflammation i.e. fibrinous or serofibrinous).</p>
<p>Gross: thick opaque rough serous membrane. The roughness is caused by the cotton-like yellowish white fibrin on surface, (BR).</p>
<p>Fate of exudative inflammation:
Serous <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> resolution: return to normal after fluid is totally absorbed
Serofibrinous <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> organization by fibrosis (adhesions) except in lobar pneumonia Fibrinous <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> total resolution occurs.
3) HEMORRHAGIC: Inflammation basic reaction + many RBCs e.g. small pox &amp; acute hemorrhagic pneumonia of influenza &amp; hemorrhagic tracheitis. Virus damages BV severely with loss of many RBCs.
4) NECROTIZING: Inflammatory basic reaction (BR) + extensive necrosis e.g. necrotizing tracheitis &amp; if necrosis is associated with putrefaction it is called gangrene.
5) PSEUDOMEMBRANOUS Severe acute inflammation caused by exotoxins of bacteria (Shigella or Diphtheria). This causes inflammation of mucosa &amp; submucosa. The denuded surface mucosa is covered by fibrin derived from submucosa. This network entangles the organisms, toxins, acute inflammatory cells (PNLs, macrophages), necrotic columnar cells and some RBCs forming a pseudomembrane. The underlying tissue shows the basic reaction of acute inflammation. Grossly, the pseudomembrane is characterized by its rough dirty greyish yellow color and its adherence (since, when pulled it leaves a raw bleeding surface).</p>
<p>Bacillary dysentery is due to Shigella infection, like diphtheria, it is another pseudomembranous type of inflammation where the organism cannot penetrate the tissue but sends its toxins to the submucosal blood vessels and produces the same picture as diphtheria. Complications: Toxins (toxemia) produce shock + systemic organ degeneration &amp; necrosis as well as local acute inflammation</p>
<ol start="6">
<li>ALLERGIC e.g. urticaria &amp; nasal polyp characterized byt edema, eosinophils, plasma cells or lymphocytes (see Immunopathology)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="chronic-inflammation-plate-5">CHRONIC INFLAMMATION (plate 5)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chronic-inflammation-plate-5" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: Reaction of living tissues to injury, which has a gradual onset (more than 48 hrs ) &amp; prolonged duration. The cell injury goes hand in hand with the repair process.
N.B.: In chronic inflammation, cellular exudate is more than the fluid component. The fluid is minimal as the vessels are very thick walled &amp; have narrow lumen (endarteritis obliterans).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="basic-reaction-br">Basic reaction (BR)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#basic-reaction-br" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th style="text-align: center;">Systemic</th><th style="text-align: center;">Local reaction</th><th style="text-align: center;"></th><th style="text-align: center;"></th></tr></thead><tbody><tr><td style="text-align: center;">Fever</td><td style="text-align: center;">Tissue destruction + Chronic inflam</td><td style="text-align: center;"></td><td style="text-align: center;">Repair(FT)</td></tr><tr><td style="text-align: center;">Malaise</td><td style="text-align: center;">necrosis</td><td style="text-align: center;">Lymphocytes</td><td style="text-align: center;">fibrous tissue:</td></tr><tr><td style="text-align: center;">Blood changes</td><td style="text-align: center;"></td><td style="text-align: center;">plasma cells</td><td style="text-align: center;">fibroblasts collagen</td></tr><tr><td style="text-align: center;">Lymphocytosis</td><td style="text-align: center;"></td><td style="text-align: center;">macrophages</td><td style="text-align: center;">+ BV (endarteritis</td></tr><tr><td style="text-align: center;">Plasma cells <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span></td><td style="text-align: center;"></td><td style="text-align: center;">+/- giant cells</td><td style="text-align: center;">obliterans)</td></tr><tr><td style="text-align: center;">Monocytosis</td><td style="text-align: center;"></td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="aetiology">AETIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aetiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Following acute inflammation(secondary): same injurious agents (see acute inflammation) which if not removed continue to cause damage e.g. chronic abscess</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-starts-as-chronic-from-the-start-primary">2. Starts as chronic from the start (primary)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-starts-as-chronic-from-the-start-primary" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) if organism has low toxicity e.g. TB or
b) long exposure to non-degradable material as silica or hemosiderin
c) autoimmunity (body reacts against its own tissues) e.g. rheumatoid arthritis (see later, immunopathology)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathogenesis">PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cell injury of a continuous, persistent nature, produces necrosis of tissue associated with healing by fibrosis at the same time, since the process occurs over a prolonged period. Necrosis results in release of chemical mediators and uncovering of cellular antigens (antigens hidden in cytoplasm), these excite a chronic cell population (see above), narrow thick walled BV (endarteritis obliterans &amp; endophlebitis) also granulation tissue &amp; fibrous tissue of repair.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types">TYPES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1- Non-specific (mostly after acute 2-Specific (chronic from the start) inflammation).</p>
<ul>
<li>Suppurative (chronic abscess)</li>
<li>granuloma</li>
<li>Non-suppurative (chronic ulcer)</li>
<li>diffuse (rare)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-non-specific">1) Non-specific<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-non-specific" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I) Chronic abscess</p>
<table><thead><tr><th style="text-align: left;">Gross</th><th style="text-align: left;">Microscopic</th></tr></thead><tbody><tr><td style="text-align: left;">Well defined round cavity</td><td style="text-align: left;">Central pus (see acute inflammation)</td></tr><tr><td style="text-align: left;">Wall is regular, smooth &amp;white cells,</td><td style="text-align: left;">surrounded by chronic inflammatory</td></tr><tr><td style="text-align: left;">Cavity contains thick pus</td><td style="text-align: left;">Endarteritis obliterans &amp; FT</td></tr><tr><td style="text-align: left;">Lining smooth as it is formed of fibrous &lt;br&gt; tissue</td><td style="text-align: left;"></td></tr></tbody></table>
<p>II) Chronic ulcer (see repair)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-specific-granuloma-plate-5">2) Specific (Granuloma) (plate 5)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-specific-granuloma-plate-5" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Localized collection of chronic inflammatory cells forming granules, nodules or a tumor-like mass. Such lesions have a predominance of macrophages &amp; have diagnostic microscopic picture i.e. specific features indicative of type of injurious agent. The macrophages may be modified &amp; have a pink ill-defined cytoplasm (hence called epithelioid cells) &amp; some types of granulomas have central necrosis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-granuloma">TYPES OF GRANULOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-granuloma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Infectious: bacterial(TB &amp; leprosy) - parasitic(bilharziasis) - fungal (histoplasma).</li>
<li>Foreign body type: e.g. reaction to surgical sutures, wood splinters, glass or sand.</li>
<li>Inorganic: reaction to inorganic material as silica &amp; asbestosis.</li>
<li>Granulomas of unknown etiology e.g. sarcoidosis &amp; Chron's disease.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="basic-reaction-br-of-granuloma">Basic reaction (BR) of GRANULOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#basic-reaction-br-of-granuloma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>GROSS: whitish firm tumor-like mass
MICROSCOPIC: e.g. TB tubercle which consists of:</p>
<ol>
<li>Central zone of necrosis (caseation).</li>
<li>Many macrophages of the epithelioid type in TB, surround the necrotic center.
N.B.: epithelioid cells are formed if the injurious agent persists &amp; is not destroyed within the macrophage, thereby changing its appearance to an epithelial like cell with abundant, foamy pale eosinophilic cytoplasm with unclear cell outlines. The nucleus is oval and pale. This cell is an activated macrophage with the ability to produce lysozyme as well as other enzymes but have poor phagocytic abilities.</li>
<li>Lymphocytes, few plasma cells</li>
<li>Giant cells: Large cells with many nuclei, they may be produced due to the fusion of several macrophages or the division of the nucleus of a macrophage repeatedly without the division of the cytoplasm. In TB they are called Langhan's giant cells with peripherally placed horse shoe like nuclei. In other granulomas as foreign body granulomas they are large cells with centrally placed multiple nuclei &amp; are called foreign body giant cells.
5)Zone of capillaries, fibroblasts &amp; chronic inflam cells i.e. granulation tissue.</li>
<li>Outer zone of fibroblasts + collagen fibers + endarteritis obliterans. (fibrous tissue)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fate-complications-of-chronic-inflammation">FATE &amp; COMPLICATIONS OF CHRONIC INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fate-complications-of-chronic-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Small area or treated lesion, undergoes fibrosis and with or without dystrophic calcification ending in scar tissue (see complications of scar repair) producing stenosis, obstruction, pressure atrophy on adjacent organs, dilatation or rupture</li>
<li>Complications of chronicity (chronic tissue destruction):</li>
</ol>
<ul>
<li>
<p>Hemorrhage, organ failure.</p>
</li>
<li>
<p>Chronic ulcer with repeated attacks of secondary infection. Such ulcers in certain areas may undergo MALIGNANT transformation.</p>
</li>
<li>
<p>Sinus: a sinus is a tract opened at one end (blind ended tract), lined by granulation tissue or FT resulting from opening of a chronically inflamed deep abscess cavity onto a surface. It is caused by the persistence of pus or the presence of a foreign body e.g. a) sinus of osteomyelitis: a suppurative inflammatory disease of bone &amp; b) pilonidal sinus: a nest of hairs which have penetrated deeply under the skin of the midline of sacrum and are associated with chronic inflammation</p>
</li>
<li>
<p>Fistula: is a track open at both ends, through which abnormal communication occurs i.e. 2 cavities or a body cavity &amp; surface.(a tract between 2 surfaces)</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="plate-5">PLATE 5<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#plate-5" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251212-f9ec7458.jpeg" alt="img-19.jpeg"></p>
<p>Serofibrinous pericarditis
<img src="assets/images/image-20251212-f73c186d.jpeg" alt="img-20.jpeg"></p>
<p>Pseudomembranous inflammation. Larynx
<img src="assets/images/image-20251212-3359de60.jpeg" alt="img-21.jpeg"></p>
<p>Pleural effusion (webPath)
<img src="assets/images/image-20251212-278ae174.jpeg" alt="img-22.jpeg"></p>
<p>Acute inflammation larynx(WebPath)
<img src="assets/images/image-20251212-4b6d897d.jpeg" alt="img-23.jpeg"></p>
<p>Chronic inflammation
<img src="assets/images/image-20251212-b3af2990.jpeg" alt="img-24.jpeg"></p>
<p>Granuloma (webPath)</p>
<p>a) congenital fistula: due to developmental abnormality
b) acquired due to trauma (e.g. postoperative biliary fistula), inflammation (gastrocolic fistula) or necrosis especially due to tumor (e.g. vesico-vaginal fistula following radionecrosis in treatment of cancer cervix).</p>
<ul>
<li>Systemic amyloidosis (AA): chronic tissue destruction resulting in abnormal fibrillary protein (8 pleated protein fibrils) + non fibrillary serum ptn. (SAP, circulating in blood) with CHO heparan sulphate.</li>
<li>Malignant transformation (rare) e.g. Marjolin ulcer</li>
<li>Distant spread of infection: by lymphatics &amp; may result in generalized lymphadenopathy. Spread may also occur by blood stream (bacteremia, pyaemia, toxemia or septicemia).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-complications-of-healing-by-fibrosis-see-repair">3. Complications of healing by fibrosis (see repair)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-complications-of-healing-by-fibrosis-see-repair" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="terminology-in-inflammation">TERMINOLOGY IN INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#terminology-in-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Rule: latin name of organ + itis <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> inflammation of this organ. There are some exceptions to this rule e.g. pneumonia and pleurisy.</p>
<table><thead><tr><th style="text-align: center;">C.V.S.</th><th style="text-align: center;"></th><th style="text-align: center;"></th></tr></thead><tbody><tr><td style="text-align: center;">Vein <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> phlebitis</td><td style="text-align: center;">Artery <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> arteritis</td><td style="text-align: center;">Pericardium <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> Pericarditis</td></tr><tr><td style="text-align: center;">Endocardium =endocarditis</td><td style="text-align: center;">Myocardium <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> myocarditis</td><td style="text-align: center;">Valve =valvulitis</td></tr><tr><td style="text-align: center;">Respiratory system</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Nasal mucosa <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> rhinitis</td><td style="text-align: center;">Sinuses <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> sinusitis</td><td style="text-align: center;">Laynx <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> laryngitis</td></tr><tr><td style="text-align: center;">Trachea <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> tracheitis</td><td style="text-align: center;">Bronchus <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> bronchitis</td><td style="text-align: center;">lung <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> pnuemonia</td></tr><tr><td style="text-align: center;">Pleura <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> pleurisy</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">G.I.T.</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Lip <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> cheilitis</td><td style="text-align: center;">Tongue <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> glossitis</td><td style="text-align: center;">Gingiva <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> Gingivitis</td></tr><tr><td style="text-align: center;">Parotid <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> parotitis</td><td style="text-align: center;">Salivary gland <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> sial adenitis</td><td style="text-align: center;">Pharynx <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> pharyngitis</td></tr><tr><td style="text-align: center;">Stomach <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> gastritis</td><td style="text-align: center;">Oesophagus=oesophagitis</td><td style="text-align: center;">Jejenum <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> jejenitis</td></tr><tr><td style="text-align: center;">Ileum <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> Ileitis</td><td style="text-align: center;">Duodenum <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> duodenitis</td><td style="text-align: center;">Appendix <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> appendicitis</td></tr><tr><td style="text-align: center;">Colon <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> colitis</td><td style="text-align: center;">Rectum <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> proctatitis</td><td style="text-align: center;">Peritoneum <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> peritonitis</td></tr><tr><td style="text-align: center;">Liver <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> hepatitis</td><td style="text-align: center;">Gall bladder <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> cholecystitis</td><td style="text-align: center;">Bile ducts=cholangitis</td></tr><tr><td style="text-align: center;">Urinary system</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Urinary bladder <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> cystitis Pelvis of kidney <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> pyeliris</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Kidney <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> nephritis (glomerulonephritis &amp; pyelonephritis)</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Male genital tract</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Testis - orchitis Epididymis = epididymitis</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Glans penis &amp; prepuce <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> balanoposthitis</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Female genital tract</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Breast - mastitis</td><td style="text-align: center;">Vulva <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> vulvitis</td><td style="text-align: center;">Vagina <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> vaginitis</td></tr><tr><td style="text-align: center;">Cervix <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> cervicitis</td><td style="text-align: center;">Endometrium <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> endometritis</td><td style="text-align: center;">Ovary <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> oophritis</td></tr><tr><td style="text-align: center;">Myometrium <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> myometritis</td><td style="text-align: center;">Fallopian tube <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> salpingitis</td><td style="text-align: center;"></td></tr></tbody></table>
<table><thead><tr><th style="text-align: left;">CNS Meninges <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> meningitis &lt;br&gt; Brain <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> encephalitis</th><th style="text-align: left;">Nerve <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> neuritis</th><th style="text-align: left;"></th></tr></thead><tbody><tr><td style="text-align: left;">Lymphoid tissue &lt;br&gt; Lymph node <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> lymphadenitis</td><td style="text-align: left;">Lymph vessel &lt;br&gt; lymphangitis</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Eye Lacrimal gland <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> dacryocystitis &lt;br&gt; Intraocular tissue <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> Endopthalmitis, &lt;br&gt; chorioretinitis, uveitis</td><td style="text-align: left;">Conjunctiva=conjunctivitis</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Ear External ear= otitis externa</td><td style="text-align: left;">Middle ear = otitis media</td><td style="text-align: left;"></td></tr><tr><td style="text-align: left;">Miscellaneous</td><td style="text-align: left;">Cartilage <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> chondritis &lt;br&gt; Hair follicle <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> folliculitis &lt;br&gt; Tendon <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> tenosynovitis</td><td style="text-align: left;">Fascia <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> fasciitis &lt;br&gt; Muscle <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> myositis &lt;br&gt; Subcutaneous fat &lt;br&gt; panniculitis</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Basic reactions</td><td style="text-align: left;">All basic reactions</td></tr><tr><td style="text-align: left;">Inflammation</td><td style="text-align: left;">All definitions</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">All Acute &amp; chronic infl</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="healing-repair">HEALING &amp; REPAIR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#healing-repair" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="healing-repair">Healing &amp; repair<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#healing-repair" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Healing &amp; repair follow most forms of cell injury.
Tissue destruction &amp; inflammatory reactions are followed by healing.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="healing-occurs-by">HEALING OCCURS BY:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#healing-occurs-by" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-resolution">1. RESOLUTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-resolution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Return of tissue to normal Occurs with.
a- minimal damage
b- rapid removal of injurious agent &amp; products of inflammation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="or">or<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#or" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-repair">2. REPAIR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-repair" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Replacement of damaged tissue by a new &amp; healthy one This may be:</p>
<p>REGENERATION ORGANIZATION</p>
<table><thead><tr><th style="text-align: center;">Regeneration</th><th style="text-align: center;">Organization</th></tr></thead><tbody><tr><td style="text-align: center;">Replacement by same cell type Only with minimal damage i.e. only cells.</td><td style="text-align: center;">Replacement by fibrous I glial tissue Occurs with <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> damage (cells + Connective tissue-CT frame).</td></tr><tr><td style="text-align: center;">Cell types affected: &lt;br&gt; 1- Labile cells e.g. epithelial cells, haemopoetic &amp; lymphopoetic cells These cells divide regularly during life. &lt;br&gt; 2- Stable cells: e.g., epithelium of glands, connective tissue cells &amp; peripheral nerves These cells only divide if damaged.</td><td style="text-align: center;">1- Labile &amp; stable if extensive damage to cells &amp; framework has occurred. &lt;br&gt; 2- Permanent cells e.g. striated muscle fibers (cardiac&amp;skeletal) &amp; CNS neurons.</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cell-cycle-and-types-of-cells">Cell cycle and types of cells<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cell-cycle-and-types-of-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The four main stages of the cell cycle are:
M phase: mitosis when the cell divides (about 1 hour)
Gl phase: gap 1, the preparation for <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>S</mi></mrow><annotation encoding="application/x-tex">S</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord mathnormal" style="margin-right: 0.05764em;">S</span></span></span></span></span> phase
S phase: DNA synthesis
G2 phase: gap 2 during which assembly of the apparatus for the distribution of chromosomes occurs.</p>
<p>Go phase: This phase is non-proliferative and is known as growth arrest. Cells in Go may re-enter the cell cycle at G1, thereby regaining the proliferative state. Locally</p>
<p>active small-molecular-weight proteins called growth factors are important in stimulating this re-entry.</p>
<p>Cells can undergo terminal differentiation, in which case they cannot re-enter the cell cycle (non dividing cells). In a permanent cell population, all the cells are terminally differentiated.</p>
<p>Premeiotic phase
<img src="assets/images/image-20251212-f486e725.jpeg" alt="img-25.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="control-of-the-cell-cycle">Control of the cell cycle<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#control-of-the-cell-cycle" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>a) Growth factors.</p>
<p>These are low-molecular-weight proteins which have a similar mechanism of action to hormones. In general, the growth factor is produced by a cell, for example a macrophage, and acts either on the cell itself (autocrine action) or on a neighbouring cell (paracrine action) by linking to cell surface receptors. This interaction activates the receptor and triggers a series of cytoplasmic events usually involving phosphorylatinn-dephosphorylation of proteins.</p>
<p>Ultimately, a signal reaches the nucleus where genes are switched on, new proteins produced and cell growth and division is initiated. Growth factors are thought to be particularly important in stimulating stable, non-proliferating (GO) cells to enter the cell cycle at G1 and undergo mitosis.
b) Cyclins</p>
<p>The cyclins are a family of proteins which seem to coordinate the journey of cells through the different phases of the cell cycle. They form complexes with a protein kinase (phosphorylating) enzyme. The cellular concentration and activity of different cyclins varies through the cycle.</p>
<p>FACTORS RESPONSIBLE FOR REPAIR (stimulatory - inhibitory</p>
<table><thead><tr><th style="text-align: left;">1. Stimulatory factors</th><th style="text-align: left;">2. Inhibitory factors</th></tr></thead><tbody><tr><td style="text-align: left;">- Growth factors (GF)</td><td style="text-align: left;">- Growth factors -GF</td></tr><tr><td style="text-align: left;">- Extracellular matrix proteins (ECM)</td><td style="text-align: left;">- Others:</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="n-b">N.B.:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Increased glucocorticoids, interferes with PNLs &amp; macrophages, thereby increasing the patient's susceptibility to infection.</li>
<li>Diabetes mellitus causes bad circulation &amp; high risk of infection.
A. Stimulatory factors:</li>
</ul>
<p>1- Growth factors (GF)
Macrophage <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> GF act on resting cell (Go into mitotic phase) ending in mitosis Platelets <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> Presynthetic phase</p>
<p>Epithelial cell injury causes Cytokine release
Types of GF</p>
<ul>
<li>EGF =epidermal growth factor</li>
<li>PDGF=platelet derived GF</li>
<li>FGF = fibroblast GF</li>
<li>PDGF &amp; FGF act on fibroblasts,smooth muscle of BV wall &amp; endothelial cells</li>
<li>TGFa =transforming GF acts on fibroblast chemotaxis</li>
<li>IL-1 = interleukin -1 (cytokine) with stimulation of collagen synthesis</li>
<li>TNF = tumor necrosis factor acts on fibroblast chemotaxis &amp; stimulation of collagen synthesis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-extracellular-matrix-proteins-ecm-glycoproteins">2- Extracellular matrix proteins (ECM glycoproteins)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-extracellular-matrix-proteins-ecm-glycoproteins" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>FN = fibronectin stimulates: migration, proliferation, differentiation,&amp; adhesion of the fibroblast</li>
<li>Laminin (same as FN)</li>
</ul>
<p>Cell matrix interaction (ECM)
The extra cellular matrix is formed of interstitial matrix (glycoproteins embedded in a gel of proteoglycans and fibrous proteins (collagens and elastin). The matrix is organized as a basement membrane around epithelial, endothelial and smooth muscle cells as well as in the supportive tissues. This provides a substrate where cells can adhere, migrate and proliferate. ECM with growth factors regulate cell growth, movement and differentiation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="b-inhibitory-factors">B. Inhibitory factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-inhibitory-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>TGF <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>α</mi></mrow><annotation encoding="application/x-tex">\alpha</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4306em;"></span><span class="mord mathnormal" style="margin-right: 0.0037em;">α</span></span></span></span></span> : stimulates collagen degradation.</li>
<li>TGF <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>β</mi></mrow><annotation encoding="application/x-tex">\beta</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord mathnormal" style="margin-right: 0.05278em;">β</span></span></span></span></span> : inhibits cell growth.</li>
</ul>
<p>Mechanism of cell-cell interaction: When cells are injured, healthy nearby cells proliferate to fill the gap. When these are exposed to each other, they stimulate the inhibitory receptors, which are carried on the surface of cells.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="regeneration">REGENERATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#regeneration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Replacement of damaged cells by the same cell type
AETIOLOGY: Any injurious agent (see cell injury) causing damage + acute inflammation</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism">MECHANISM:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Labile cells: these are cells which proliferate continuously during life</p>
<ul>
<li>Epithelial: surface cells e.g. skin abrasion &amp; superficial skin ulcer lining cells e.g. mucous membrane (catarrhal infl.) &amp; serous membranes (serous &amp; serofibrinous inflam.)</li>
<li>Haemopoietic(bone marrow) cells &amp; lymphopoietic(lymphoid) cells of lymph nodes, spleen &amp; thymus
B. Stable cells: These are cells which proliferate only if stimulated i.e. injured</li>
<li>Epithelial cells of parenchymatous organs i.e. cells with specialized function: e.g.liverpancreas - kidney (so long as the connective tissue framework is intact)e.g., acute hepatitis heals by regeneration &amp; similarly after partial hepatectomy.</li>
<li>Connective tissue (CT): fibrous tissue (FT)-bone - cartilage &amp; smooth muscle fibers.</li>
</ul>
<p>Dead cells at the site of damage are absorbed through the lymphatics and blood vessels &amp; healthy cells, surrounding the area of injury, proliferate to fill the gap.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="organization-or-healing-by-fibrosis">ORGANIZATION OR HEALING BY FIBROSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#organization-or-healing-by-fibrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION :Replacement of damaged cells /tissue by a stronger different tissue type (fibrous tissue or glial tissue in CNS healing)</p>
<p>MECHANISMS: This type of healing depends on:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-cell-type">A. Cell type:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-cell-type" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Labile or stable but with extensive damage to cells + framework e.g.:</li>
</ol>
<ul>
<li>Liver cirrhosis: hepatocytes have limited regeneration in the presence of diffuse destruction; therefore heal by regeneration &amp; fibrosis</li>
<li>Wound healing by 1ry &amp; 2ry intention</li>
</ul>
<ol start="2">
<li>Permanent: cells, which are unable to divide as striated muscle fibers (cardiac &amp; skeletal) and CNS neurons e.g.:</li>
</ol>
<ul>
<li>Cardiac muscle e.g. myocardial infarction heals by myocardial scarring</li>
<li>CNS e.g. cerebral infarction heals by gliosis
B. Presence of structureless material e.g. products of inflammation- thrombus inside a BV
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo><mo>↑</mo><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow \uparrow \uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑↑↑</span></span></span></span></span> Inflammatory exudate rich in cells, fibrin and fluid
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Organization
Large thrombus inside lumen of BV
Organization BY Fibrosis is the end result of wound healing &amp; chronic inflammation</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="steps-of-ft-formation-stages-of-scar-formation">Steps of FT formation (Stages of scar formation)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#steps-of-ft-formation-stages-of-scar-formation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Platelets, macrophages &amp; injured epithelial cells result in the release of peptide growth factors &amp; cytokines (chemical mediators), producing:
<img src="assets/images/image-20251212-143f6e19.jpeg" alt="img-26.jpeg"></p>
<ol>
<li>
<p>Migration of fibroblasts &amp; myofibroblasts + new capillaries (angiogenesis) = granulation tissue (GT).</p>
</li>
<li>
<p>Proliferation of fibroblasts &amp; myofibroblasts which synthesize collagen fibers (first type III then type I) in addition to proliferated BV forming fibrous tissue (FT).</p>
</li>
</ol>
<p>Fibrocytes &amp; primitive cells in CT &amp; around capillaries are stimulated to enlarge and become active fibroblasts. These are responsible for:
a) Protein synthesis (proline &amp; hydroxyproline).
b) Secretion of ground substance {extracellular matrix (ECM)} adhesive glycoprotein, FN which provides a framework for the tissue defect &amp; contributes to repair.
c) Secretion of procollagen (very fine fibrils seen only by EM). Procollagen condenses to form collagen III, further condensation to collagen I occurs.
3. Fibroblasts decrease whilst collagen I increases and is acted upon by a remodeling enzyme in addition to bonding of fibers resulting in high tensile mature tissue over a long period of time. This causes pressure on the BV shutting them down producing avascular fibrous tissue or SCAR.
4. Old scars undergo hyalinosis or dystrophic calcification.</p>
<p>Best example of a scar is myocardial scarring or healed myocardial infarction.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="n-b">N.B.:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Angiogenesis: formation of new capillary vessels. Basement membrane (BM) of vessel is digested by proteolytic enzymes &amp; endothelial cells proliferate under the GF effect producing solid buds of endothelial cells, which grow out of the basement membrane gap. With maturation, a tube is formed and collagen type IV deposits reforming BM &amp; a new blood vessel (BV) is formed.</li>
<li>Myofibroblast: is a cell with both fibroblastic &amp; muscle contraction abilities leading to wound contraction with decrease in wound size in addition to collagen synthesis.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="factors-influencing-healing-by-fibrosis">FACTORS INFLUENCING HEALING BY FIBROSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-influencing-healing-by-fibrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-local">1. Local<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-local" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Infection.</li>
<li>Poor blood supply.</li>
<li>Excessive movement (interferes with GT).</li>
<li>Presence of foreign body.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-general">2. General<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-general" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Vitamin C deficiency.</li>
<li>Deficiency of zinc &amp; amino acids (in malnutrition).</li>
<li>Adrenal glucocorticoids.</li>
<li>Debilitating (disabling) chronic disorders.</li>
</ul>
<p>The general causes are responsible for failure of proper collagen synthesis, with delayed healing and weak easily ruptured scars.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="healing-special-situations">HEALING - SPECIAL SITUATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#healing-special-situations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-repair-by-regeneration">A. REPAIR BY REGENERATION:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-repair-by-regeneration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I) Skin: healing of a superficial ulcer (abrasion)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="n-b">N.B.:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>ABRASION: Is a superficial ulceration or absence of the epidermis; it heals by regeneration.</li>
<li>ULCER': is a defect in the surface covering as well as underlying tissue as a result of necrosis and it is covered by inflammatory products.</li>
</ul>
<p>Healing of a superficial simple ulcer on skin or mucous membranes is by regeneration whereas deep ulcers will heal by fibrosis i.e. organization.</p>
<p>Mechanism: cells of the surface epithelium which have been lost as a result of necrosis, will be replaced by active mitosis in the cells at the healthy edge of the ulcer. The proliferating cells creep over the floor of the ulcer, which is composed of fibrin and debris. These are actively removed by the acute inflammation in the base. The result is a completely normal area.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="n-b">N.B.:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>If the irritant persists this ulcer proceeds into chronicity i.e. chronic ulcer. The base will contain chronic inflammatory cells &amp; FT, resulting in a fibrous scar on healing.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-ulcers">Types of ulcers:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-ulcers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Simple or inflammatory ulcers</li>
<li>Traumatic ulcers</li>
<li>Malignant ulcers</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ii-bone-healing-of-fractures">II)Bone: healing of fractures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-bone-healing-of-fractures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A fracture is usually accompanied by damage to or hemorrhage into the surrounding soft tissues, which are repaired by the process of organization, whereas the bone fragments repair by regeneration and are reunited.</p>
<ol>
<li>Immediate effects: Haematoma</li>
<li>Inflammatory reaction (first 4-5 days)</li>
</ol>
<ul>
<li>A haematoma forms between the 2 edges of fractured bone as well as in the surrounding soft tissue.</li>
<li>Both fractured ends of bone undergo necrosis.</li>
<li>The fractured ends of bone develop an acute inflammatory reaction providing the area with macrophages &amp; osteoclasts to phagocytose the debris &amp; necrotic tissue.</li>
<li>Invasion of the soft tissue haematoma by granulation tissue (capillaries &amp; fibroblasts) i.e. early stage of organization.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-early-bone-regeneration-after-1st-week-provisional-callus">3. Early bone regeneration (after 1st week) (PROVISIONAL CALLUS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-early-bone-regeneration-after-1st-week-provisional-callus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A provisional callus bridges the gap between the fractured ends of bone. It is composed of osteoblasts) osteoid tissue +non-mineralized bone). This callus is also present under the periosteum.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-well-formed-callus-after-3-weeks">4. Well formed callus (after 3 weeks)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-well-formed-callus-after-3-weeks" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Calcium &amp;phosphates are deposited in the area, with resultant mineralization of the osteoid into osseous tissue (woven bone trabeculae).
5. Remodeling of definitive callus &amp; bone marrow regeneration (weeks- months)</p>
<p>This phase is characterized by osteoblastic &amp; osteoclastic activity, to get rid of extra callus in subperiosteal &amp; medullary layers in addition to strengthening the prevailing callus changing it into lamellar bone.
6. Final reconstruction with return of bone to normal appearance (months later). Dense lamellar bone with trabeculae oriented along lines of stress is now present with scanty osteoblasts &amp; osteoclasts.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Bad healing results in pathological fracture</p>
</li>
<li>
<p>Loss of function. This may be due to either non-union or weak union (fibrous union)
Causes of bad healing:</p>
</li>
<li>
<p>Inadequate mobilization.</p>
</li>
<li>
<p>Soft tissue interposition.</p>
</li>
<li>
<p>Infection.</p>
</li>
<li>
<p>2ry to previous bone disease as osteoporosis, malignancy or due to compound.</p>
</li>
<li>
<p>Type of fracture.</p>
</li>
<li>
<p>General causes of improper healing (see above)</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="iii-peripheral-nerve-damage-heals-by-regeneration-e-g-spinal-motor-nerve">III) Peripheral nerve damage heals by regeneration e.g. spinal motor nerve:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-peripheral-nerve-damage-heals-by-regeneration-e-g-spinal-motor-nerve" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Cutting of axon and myelin sheath causes rapid degeneration of distal segment whilst proximal zone suffers minimally since the central neuron in the spinal cord is not directly damaged &amp; it just loses its pigment (Nissel granules).</li>
<li>Proximal segment changes (chromatolysis i.e. loss of Nissel substance in the neuron). These are mild degenerative neuronal changes and are reversible.</li>
<li>Distal segment changes(Wallerian Degeneration) Axon disintegrates, myelin disintegrates and only Schwann cells survive.</li>
<li>Motor end plates and muscle fibers: damage to distal segment results in neurogenic atrophy of supplied muscle fibers.</li>
<li>Regeneration begins by Schwann cell proliferation producing a continuous neurilemal tube. This is accompanied by phagocytosis of any debris and sprouting ofaxons from proximal segment with growth along track of the empty tube. Finally, the myelin sheath is reformed.</li>
</ul>
<p>Complications: poor apposition of the nerve ends, results in irregular sprouting ofaxons and proliferation of Schwann cells in the CT, forming a mass of tangled nerves called TRAUMATIC NEUROMA in addition to severe neurogenic muscle atrophy and the distal nerve segment fragment disappears.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="n-b-only-cns-heals-by-gliosis">N.B.: only CNS heals by gliosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b-only-cns-heals-by-gliosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>IV) Regeneration of stable cells following cell damage with survival of the supporting reticular framework</p>
<ul>
<li>Tubular necrosis of the kidney: necrosis of tubular epithelium only. The necrotic cells are replaced by proliferation of the surviving cells</li>
<li>Acute hepatitis: focal necrosis of hepatocytes are replaced by survivi ng cells with return of liver to normal</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-repair-by-fibrosis-organization">B. REPAIR BY FIBROSIS (organization)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-repair-by-fibrosis-organization" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-limited-regeneration-fibrosis">1. Limited REGENERATION + FIBROSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-limited-regeneration-fibrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This occurs when gross damage occurs in solid epithelial organs containing stable cells and including their supportive tissue e.g.:</p>
<ul>
<li>Liver cirrhosis e.g. post -viral hepatitis B. The virus causes destruction of diffuse areas of liver cells &amp; supportive tissue. Regeneration of surviving cells is minimal &amp; irregular producing regeneration nodules and areas of dense fibrosis surrounding these nodules(see special).</li>
<li>Wound healing:epidermis regenerates whilst dermis&amp; subcutis heal by FT</li>
<li>Chronic or deep ulcer: ulcers involving mucosa &amp; submucosa or epidermis &amp; dermis.</li>
</ul>
<table><thead><tr><th style="text-align: center;">Healing by 1ry intention (surgical incision)</th><th style="text-align: center;">Healing by 2ry intention</th></tr></thead><tbody><tr><td style="text-align: center;">- Clean &amp;small wound &lt;br&gt; - Minimal necrosis &lt;br&gt; - <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> Inflammation &amp; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> scar &lt;br&gt; - Short time to heal &lt;br&gt; - Few or no complications</td><td style="text-align: center;">- Large or infected wound &lt;br&gt; - Much necrosis &lt;br&gt; - <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> inflammation &amp; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> scar &lt;br&gt; - Longer since tnecrosis/infection &lt;br&gt; - Complications common (depends on size &amp; amount of damage)</td></tr><tr><td style="text-align: center;">24 hrs Little necrosis-clot-acute inflammation &lt;br&gt; Surface covered by dried clot (Scab)</td><td style="text-align: center;">Much necrosis - raw area - acute inflammation.</td></tr><tr><td style="text-align: center;">3-7days: <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> inflam-GT fills gap &lt;br&gt; - mitosis in basal cells to fill gap. &lt;br&gt; - BM forms on contact of basal cells.</td><td style="text-align: center;">- Wound starts to contract (myofibro blasts in GT)- tacute inflammation &lt;br&gt; - Mitosis in basal layer of epidermis with complete regeneration of epidermis occurs after GT has filled the entire gap</td></tr><tr><td style="text-align: center;">Weeks: FT &amp; scar with no adenexa Epidermis regenerates by prolifer -ation upward of basal layer to surface GT-FT, followed by scar.</td><td style="text-align: center;">- GT, FT, then scar. Time depends on size of wound &amp; amount of necrosis that has to be removed before healing.</td></tr></tbody></table>
<p>Complications of wound healing
1- Contracture &amp; deformity
2- <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> GT (proud flesh) which prevents proper epithelization since it grows above the surface
3- <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> GT <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Weak scar tends to rupture (deheisance)
Delayed healing
4- <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> hyalinosed collagen is known as Keloid, which is a raised deforming scar with hyalinosed, scar (swollen scar); it occurs in people with a hereditary predisposition. Attempts at surgical removal cause its reappearance. Treatment is by irradiation.</p>
<p>5- Chronic ulcer-fistula-sinus usually occurs if infection is persistent.
6- Epidermal cyst: some epidermal cells become trapped in the dermis during injury, they grow and form a cyst.
7- Malignant transformation (rare)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-repair-by-organization-by-fibrosis-gliosis-in-cns">2. REPAIR by ORGANIZATION by fibrosis (gliosis in CNS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-repair-by-organization-by-fibrosis-gliosis-in-cns" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>This occurs when gross damage occurs in solid epithelial organs containing stable cells and including their supportive tissue e.g.:</p>
<p>Infarction kidney (see circulatory disturbances) : necrotic tissue is removed &amp; organization occurs, ending in a scar (GT followed FT then Scar).</p>
<p>Healing of structurless material, i.e. not tissue, e.g. thrombus or products of inflammation (inflammatory exudate), as in serofibrinous or fibrinous inflammation. These heal by fibrosis are called adhesions as the FT causes white, firm bands which glue the two layers of the serous membranes together.</p>
<table><thead><tr><th style="text-align: left;">MORPHOLOGY (BR)</th><th style="text-align: left;"></th><th style="text-align: left;"></th></tr></thead><tbody><tr><td style="text-align: left;"></td><td style="text-align: left;">GROSS</td><td style="text-align: left;">MICROSCOPIC</td></tr><tr><td style="text-align: left;">GT</td><td style="text-align: left;">Pink granular, bleeds easily.</td><td style="text-align: left;">Fibroblasts+new capillaries &lt;br&gt; (+/-inflammatory cells)</td></tr><tr><td style="text-align: left;">FT</td><td style="text-align: left;">White, firm, smooth tissue causes &lt;br&gt; shrinkage.</td><td style="text-align: left;">Fibroblasts+ BV +collagen</td></tr><tr><td style="text-align: left;">Scar</td><td style="text-align: left;">Same as FT</td><td style="text-align: left;"><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> fibroblasts +tcollagen (no BV)</td></tr></tbody></table>
<p>Gross Appearance of FT / Scar: depends on site</p>
<ul>
<li>Body cavities <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> adhesions (white firm, smooth, bands joining visceral to parietal layer)</li>
<li>Abscess cavity <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> smooth thick white wall around cavity</li>
<li>Hollow structure (intestine - urinary tract etc.) resulting in Stricture, which causes narrowing of lumen i.e. stenosis. If a stricture doesn't form, the whole wall may be thinned out and dilates, producing a pouch, i.e. dilatation or aneurysm (if in a vessel wall). This area is usually weak and may rupture.</li>
<li>Solid organs e.g. liver: bands or irregular patches of white firm, smooth tissue which shrinks and causes surface depression (irregularity or nodularity on surface).</li>
</ul>
<p>PLATE 6
<img src="assets/images/image-20251212-a7041201.jpeg" alt="img-27.jpeg">
<img src="assets/images/image-20251212-3953dd19.jpeg" alt="img-28.jpeg">
<img src="assets/images/image-20251212-edbcb951.jpeg" alt="img-29.jpeg"></p>
<p>SUMMARY OF FATE &amp; COMPLICATIONS
OF CHRONIC INFLAMMATION &amp; REPAIR BY FIBROSIS
<img src="assets/images/image-20251212-37eb6b89.jpeg" alt="img-30.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a-complications-of-chronic-inflammation">A. COMPLICATIONS OF CHRONIC INFLAMMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-complications-of-chronic-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>LOCAL TISSUE DESTRUCTION</li>
</ol>
<ul>
<li>Hemorrhage</li>
<li>Organ failure (loss of function due to tissue destruction)</li>
<li>Dystrophic calcification</li>
<li>Systemic amyloidosis</li>
<li>Malignant transformation due to chronic irritation</li>
</ul>
<ol start="2">
<li>SPREAD
(a) Direct</li>
</ol>
<ul>
<li>Spread of the inflammation &amp; necrosis resulting in ulcer, sinus or fistula formation.</li>
<li>Transluminal (respiratory or biliary tract spread etc... )</li>
<li>Transcoelomic e.g. septic peritonitis i.e. in body cavities
(b) Distant</li>
<li>Lymphatic spread: at first regional lymphangitis and regional lymphadenitis then generalized lymphadenopathy.</li>
<li>Blood stream spread: bacteremia-septicemia-toxemia-pyaemia (see infections).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-complications-of-healing-by-fibrosis">B. COMPLICATIONS OF HEALING BY FIBROSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-complications-of-healing-by-fibrosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>In solid organs with loss of function e.g. liver cirrhosis ends in liver failure.</li>
<li>Surfaces: Skin: deformity or contracture.</li>
<li>Body cavities e.g. pleura etc... leads to adhesions.</li>
<li>Hollow structure e.g. intestine etc... <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> stenosis (narrowing of lumen/obstruction) or dilatation (bronchiectasis lor pouch formation with weakening &amp; thinning of wall (vascular aneurysms)</li>
</ol>
<p>N.B.: dilated areas may cause pressure on surrounding structures or may rupture e.g. aneurysms (see special).
5. Keloids (increase in hyalinosed collagen) &amp; proud flesh (increased GT).
6. Epiderrmal cyst.
7. Dystrophic calcification.
8. Weak surgical scar may rupture under pressure (wound deheisance) or inscisional hernia may occur (see special).</p>
<p>SUMMARY OF CELL INJURY - INFLAMMATION &amp; REPAIR
Irreversible or reversible INJURY
<img src="assets/images/image-20251212-29e1c05c.jpeg" alt="img-31.jpeg"></p>
<p>Vascular + cellular responses of A.lnfl are followed by resolution, regeneration or fibrosis.
Vascular + cellular responses + repair by fibrosis &amp; or regeneration occur during C.infl.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="healing">HEALING<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#healing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="resolution">RESOLUTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#resolution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Injurious agent destroyed quickly</p>
<p>Little or no necrosis.
Healing depends on amount of products of inftammation.
Little exudate
resolves
<img src="assets/images/image-20251212-696d41d6.jpeg" alt="img-32.jpeg"></p>
<p>SCARRING
e.g.</p>
<p>Lobar pneumonia
<img src="assets/images/image-20251212-58b51586.jpeg" alt="img-33.jpeg"></p>
<p>Small thrombus
<img src="assets/images/image-20251212-1e58a499.jpeg" alt="img-34.jpeg"></p>
<p>REPAIR
Injurious agent not destroyed quickly
necrosis of
Labile cells Permanent cells Stable cells
<img src="assets/images/image-20251212-ff5e2cb9.jpeg" alt="img-35.jpeg"></p>
<p>SCARRING SCARRING
e.g. A.hepatitis Liver Cirrhosis Myocardial Tubular necrosis Kidney infarct</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="stem-cells">Stem Cells<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stem-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Stem cells are the master cells of the human body. They can divide to produce copies of themselves and many other types of cell. They are found in various parts of the human body at every stage of development from embryo to adult. Stem cells taken from embryos that are just a few days old, can turn into any of the 300 different types of cell that make up the adult body.</li>
<li>Stem cells are unspecialized cells that are thought to be able to reproduce themselves indefinitely and, under the right conditions, to develop into mature cells, e.g., nerve, skin, pancreas, with specialized functions. They are found in embryos at very early stages of development (see figure) and in some adult organs, e.g., bone marrow and brain.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="importance-of-stem-cells">Importance of stem cells<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#importance-of-stem-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Because stem cells are so versatile, they could potentially be used to repair and replace damaged human tissue. In future it is hoped that stem cells could be used to treat and cure a variety of diseases and injuries including Parkinson's disease, stroke and diabetes.</p>
<p>Unlike muscle cells, blood cells, or nerve cells-which do not normally replicate themselves-stem cells may replicate many times.</p>
<p>Under certain physiological or experimental conditions, they can be induced to differentiate. This means that they can divide into cells with special functions</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-stem-cells-fig-1">Types of Stem Cells: (Fig. 1)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-stem-cells-fig-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Totipotent cells. In mammals, totipotent cells have the potential to form an entire body ie a single cell can divide and produce all the differentiated cells (from ectoderm, endoderm &amp; mesoderm), including extraembryonic tissues (yolk sac &amp; trophoblast)</li>
<li>Pluripotent stem cells. These are true stem cells, with the potential to make any differentiated cell in the body. A pluripotent cell can create all cell types except for extra embryonic tissue, Three types of pluripotent stem cells have been found:</li>
</ol>
<ol>
<li>
<p>Embryonic Stem (ES) Cells. These can be isolated from the inner cell mass (ICM) of the blastocyst - the stage of embryonic development when implantation occurs. For humans, excess embryos produced during in vitro fertilization (IVF) procedures are used.</p>
</li>
<li>
<p>Embryonic Germ (EG) Cells. These can be isolated from the precursor to the gonads in aborted fetuses.</p>
</li>
<li>
<p>Embryonic Carcinoma (EC) Cells. These can be isolated from teratocarcinomas, a tumor that occasionally occurs in a gonad of a fetus. Unlike the other two, they are usually aneuploid.</p>
</li>
</ol>
<p>All three of these types of pluripotent stem cells can only be isolated from embryonic or fetal tissue.
3. Multipotent stem cells. These are true stem cells but can only differentiate into a limited number of types. For example, the bone marrow contains multipotent stem cells that give rise to all the cells of the blood but not to other types of cells. Multipotent stem cells are found in adult animals and in most organs in the body where they can replace dead or damaged cells.
<img src="assets/images/image-20251212-2df6d33e.jpeg" alt="img-36.jpeg"></p>
<p>Fig. 1 Types of stem cells</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-adult-stem-cells">4. Adult Stem Cells<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-adult-stem-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Many adult tissues (such as the bone marrow, liver and gut) contain stem cells. Like embryonic stem cells, adult stem cells can make identical copies of themselves for long periods of time (self renewal). At the same time, they can give rise to mature cell types that have characteristic shapes and specialized functions e.g. hematopoietic cells.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="stem-cell-plasticity">Stem cell plasticity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stem-cell-plasticity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Stem cells from one tissue may be able to give rise to cell types of a completely different tissue. This phenomenon is known as 'stem cell plasticity'. Examples of such plasticity include bone marrow stem cells becoming neurons, or pancreatic islet cells that are capable of producing insulin.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="how-to-obtain-stem-cells">How to obtain Stem Cells?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#how-to-obtain-stem-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Aborted fetuses or fertilized eggs:</li>
<li>Bone marrow, peripheral blood or umbilical cord blood: These sources for stem cells are ethical and legal.</li>
<li>Skin,pulp of milk teeth, fat cells: recent sources of adult stem cells</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="potential-therapeutic-applications-of-stem-cells">Potential Therapeutic Applications of Stem Cells<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#potential-therapeutic-applications-of-stem-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Generation of different types of neurons for the treatment of Alzheimer's disease, spinal cord injuries, or Parkinson's disease.</li>
<li>Production of heart muscle cells for heart attack survivors may also be possible.</li>
<li>Generation of insulin-secreting pancreatic islet cells for the treatment of type-1 diabetes.</li>
<li>Generation of hair follicle stem cells for the treatment of certain types of baldness.</li>
<li>Production of complete organs including livers, kidneys, eyes, hearts, or even parts of the brain.</li>
<li>Drug testing,</li>
<li>Cancer research.</li>
<li>Fundamental research on embryonic development.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Basic reactions</td><td style="text-align: left;">All basic reactions</td></tr><tr><td style="text-align: left;">Repair</td><td style="text-align: left;">All definitions</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">All Acute &amp; chronic infl</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Factors affecting repair</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Types of repair</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Repair of bone</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Repair in CNS &amp;PNS</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Healing by fibrosis &amp; healing Qf</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">wounCfS</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Healing of serofibrinous inflammation</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Control mechanisms in repair</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Cell cycle</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Stem cells: definition&amp; types rest</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">category c</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="immunopathology">IMMUNOPATHOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunopathology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="immunity-immune-response">IMMUNITY-Immune response<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunity-immune-response" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Immunity is our protection from foreign macromolecules or invading organisms and our response to them, these include viruses, bacteria, protozoa, or even larger parasites and tumor antigens. The immune response is vital for life since when they are defective as in the immune-deficiency states this can lead to life threatening diseases.</p>
<p>The mechanisms of protection against infection and disease are diverse. Primarily they can be divided into two major categories:</p>
<ol>
<li>Innate immune response.</li>
<li>Adaptive immune response (acquired immunity).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-non-specific-natural-or-innate-immunity">1. Non Specific Natural or innate immunity:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-non-specific-natural-or-innate-immunity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Mechanical (skin).
b) Physical ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> temperature).
c) Chemical (lysozyme-tears-saliva).
d) Cellular (micro &amp; macrophages).
e) Natural killer lymphocytes (non specific cytotoxic cells) &amp; opsonins (antibodies which help phagocytic process by causing roughening of the surface).
2. Acquired (Specific immunity) :Is the second line of defense.</p>
<ul>
<li>Includes humoral and cell mediated responses.</li>
<li>The response is more rapid on re-exposure to the pathogen due to activation of memory cells and improves upon repeated exposure.</li>
</ul>
<table><thead><tr><th style="text-align: left;">Non specific immunity</th><th style="text-align: left;">Specific immunity</th></tr></thead><tbody><tr><td style="text-align: left;">Response is antigen independent.</td><td style="text-align: left;">Response is antigen dependant.</td></tr><tr><td style="text-align: left;">There is immediate maximal response.</td><td style="text-align: left;">There is lag time between exposure and &lt;br&gt; maximal response.</td></tr><tr><td style="text-align: left;">No antigen specific.</td><td style="text-align: left;">antigen specific.</td></tr><tr><td style="text-align: left;">Exposure results in no immunologic &lt;br&gt; memory.</td><td style="text-align: left;">Exposure results in no immunologic &lt;br&gt; memory.</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sources-of-immune-cells">SOURCES OF IMMUNE CELLS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sources-of-immune-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Bone marrow stem cells are differentiatted into: T lymphocytes, B lymphocytes and non T &amp; non B lymphocytes (natural killer NK cells).</p>
</li>
<li>
<p>These cells go and populate lymphoid organs: lymph nodes and spleen Follicles in cortex contain B cells &amp; Paracortex contains T cells.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="immunopathology">IMMUNOPATHOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunopathology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: It is the study of abnormal immune responses
Abnormal Immune Response</p>
<table><thead><tr><th style="text-align: left;">EXAGGERATED &lt;br&gt; Hypersensitivity</th><th style="text-align: left;">DEFICIENT &lt;br&gt; Immunodeficiency</th><th style="text-align: left;">LOSS OF TOLERANCE &lt;br&gt; Autoimmunity</th></tr></thead><tbody><tr><td style="text-align: left;">Types I-V</td><td style="text-align: left;"><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> B or &lt;br&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> T lymphocytes &lt;br&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> macrophages &lt;br&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> complement &lt;br&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> phagocytosis &lt;br&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> number or function)</td><td style="text-align: left;">Hypersensitivity Types II-V</td></tr><tr><td style="text-align: left;">Harmful: tissue destruction</td><td style="text-align: left;"><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> or <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="bold-italic">n</mi><mi mathvariant="bold-italic">o</mi></mrow><annotation encoding="application/x-tex">\boldsymbol{n} \boldsymbol{o}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4444em;"></span><span class="mord"><span class="mord"><span class="mord boldsymbol">n</span></span></span><span class="mord"><span class="mord"><span class="mord boldsymbol">o</span></span></span></span></span></span></span> immune reaction</td><td style="text-align: left;">Immune reaction to self</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-hypersensitmty">I) HYPERSENSITMTY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-hypersensitmty" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is a harmful exaggerated immune response on re-exposure to antigen (i.e. 2nd exposure). This harmful reaction of the immune system in response to entry or presence of a foreign or altered protein (antigen) is in the form of a humoral (antibody), cell mediated (lymphoid cells, T cell) response or both combined in an attempt to destroy the antigen, BUT HOST TISSUE is also destroyed.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-hypersensitivity">TYPES OF HYPERSENSITIVITY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-hypersensitivity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>HUMORAL MECHANISMS</li>
</ol>
<p>Type I: Allergy - Anaphylaxis (systemic) &amp; Atopy (local) (Immediate hypersensitivity).
Type II: Antibody mediated cytotoxicity.
Type III: Immune complex.
2) DELAYED HYPERSENSTIVITY (Cell mediated reaction)</p>
<p>Type IV: e.g. T cell granulomas
Antigen <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Humoral immunity</p>
<p>Cell meditated immunity</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-antigens">TYPES OF ANTIGENS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-antigens" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Foreign antigen <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Hypersensitivity &amp; Graft rejection.
Self antigen <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Autoimmune disease e.g. connective tissue disease.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="type-i-hypersensitivity">TYPE I HYPERSENSITIVITY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#type-i-hypersensitivity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Type I reactions involve immunoglobulin E (lgE)-mediated release of histamine and other mediators from mast cells and basophils.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism">Mechanism:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>1</mn><mtext>st&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">1^{\text {st }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7936em;"></span><span class="mord"><span class="mord">1</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7936em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">st&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> exposure Antigen <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> causes tissue B lymphocytes &amp; plasma cells to produce IgE which attaches on surface of Mast cells/basophils (sensitized cell)
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>2</mn><mtext>nd&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">2^{\text {nd }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8491em;"></span><span class="mord"><span class="mord">2</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8491em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">nd&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> exposure Antigen <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> antigen attaches to Fab fragment of antibody and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> degranulation of mast cell or basophil---&gt;release of vasoactive amines or chemical mediators (chemotactic to eosinophils &amp; neutrophils). It is an acute inflammation rich in eosinophils.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples">Examples<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th style="text-align: center;">ANAPHYLAXIS &lt;br&gt; Systemic reaction &lt;br&gt; In blood stream (injection)</th><th style="text-align: center;">ATOPY &lt;br&gt; Local reaction &lt;br&gt; Hay fever &lt;br&gt; Bronchial asthma &lt;br&gt; grass -pollen &lt;br&gt; mite dust &lt;br&gt; animal fur &lt;br&gt; Wide spread reaction</th><th style="text-align: center;">localized at site of IgE production</th></tr></thead><tbody><tr><td style="text-align: center;">Basophils are in circulation</td><td style="text-align: center;">It has a genetic predisposition. Mast cells are involved</td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Edema larynx <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> death &lt;br&gt; Bronchospasm &lt;br&gt; Skin rash(urticaria) &lt;br&gt; Hypotension &lt;br&gt; Vomiting &amp; diarrhea</td><td style="text-align: center;">local sensitization &lt;br&gt; - conjunctiva &lt;br&gt; - nasal passages &lt;br&gt; - upper resp tract &lt;br&gt; bronchospasm &lt;br&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> mucus secretions &lt;br&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↓</mo></mrow><annotation encoding="application/x-tex">\downarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↓</span></span></span></span></span> &lt;br&gt; difficult breathing wheezing.</td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Shock</td><td style="text-align: center;">Acute catarrhal Inflammation</td><td style="text-align: center;"></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-picture-of-acute-inflammation">Gross: Picture of acute inflammation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-picture-of-acute-inflammation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic">Microscopic:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Many eosinophils + macrophages + some PNL+ lymphocytes &amp; plasma cells + vasodilatation + marked edema.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="other-examples-of-type-i-hypersensitivity">Other Examples of Type I hypersensitivity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-examples-of-type-i-hypersensitivity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Allergic rhinitis &amp; Nasal polyp (see special)
TYPE II HYPERSENSITIVITY antibody dependant cell mediated cytotoxicty ( ADCC)</p>
<p>Type II reactions (ie, cytotoxic hypersensitivity reactions) involve immunoglobulin G or immunoglobulin M antibodies bound to cell surface antigens, with subsequent complement fixation.</p>
<ul>
<li>The antigens are normally endogenous, although exogenous chemicals can attach to cell membranes.</li>
<li>Cytolysis (cell lysis) is primarily mediated by antibodies of the IgM or IgG classes and complement. Phagocytes and K cells may also playa role (ADCC).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples">Examples:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Hemolytic anemia</li>
<li>Incompatible blood transfusion reactions</li>
<li>Rh incompatibility (erythroblastosis fetalis)</li>
</ul>
<p>Microscopic (BR): <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> eosinophils + macrophages + some PNL, lymphocytes &amp; plasma cells + vasodilatation <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>+</mo><mo>↑</mo></mrow><annotation encoding="application/x-tex">+\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord">+</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">↑</span></span></span></span></span> edema</p>
<p>TYPE III HYPERSENSITIVITY-IMMUNE COMPLEX DISORDERS (Arthu5 type)
Type III reactions involve circulating antigen-antibody immune complexes that deposit in postcapillary venules, with subsequent complement fixation.</p>
<p>Mechanism: Antigen + Antibody (lgG/lgM) (Immune complex), circulate in blood then get trapped in blood vessel basement membrane &amp; activate the complement (anaphylatoxin &amp; PNL chemotaxis) resulting in VASCULITIS. This produces damage to endothelium with platelet aggregation &amp; THROMBOSIS. Ischemia occurs ending in NECROSIS of surrounding tissue</p>
<p>Examples:</p>
<ul>
<li>Post streptococcal glomerulonephritis-Rheumatic fever</li>
<li>Acute serum sickness</li>
</ul>
<p>1 dose of serum injected produces slow release of antigenic proteins (long exposure) produces urticaria-fever-glomerulonephritis-joint pains-lymph node enlargement.</p>
<ul>
<li>Arthus reaction</li>
</ul>
<p>Repeated injections e.g. insulin causes vasculitis-necrosis-edema &amp; hemorrhage.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="parasitic-infestation">- Parasitic infestation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#parasitic-infestation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Microscopic picture: plasma cells &amp; B lymphocytes + macrophages + vasodilatation + edema.</p>
<p>TYPE IV HYPERSENSITIVITY - CELL MEDIATED HYPERSENSITIVITY
Type IV reactions (i.e. delayed hypersensitivity reactions, cell-mediated immunity) are mediated by T cells rather than by antibodies. The term delayed is used to differentiate a secondary cellular response, which appears 48-72 hours after antigen exposure, from an immediate hypersensitivity response, which generally appears within 12 minutes of an antigen challenge. These reactions are mediated by T cells and monocytes/macrophages rather than by antibodies.</p>
<p>MECHANISM: Dendritic cells at site of entry in draining LN, process antigen &amp; present it to T lymphocytes. These become activated T lymphoblasts and divide producing memory cells &amp; sensitized T cells. Sensitized T lymphocytes migrate to the affected area where they recruit other cells (lymphocytes, macrophages, fibroblasts), sensitize local lymphocytes &amp; produce more Iymphokines as well as cause antigen destruction.</p>
<p>Sensitized T lymphocyte subtypes &amp; their functions:</p>
<ul>
<li>cvtotoxic cells CD8+ cause direct cytotoxicity with lysis of cell surface antigens</li>
<li>T helper cells CD4+: these cells produce lymphokine. Lymphotoxin is one of the Iymphokines which destroys antigen, but mostly Iymphokines are geared to recruit other lymphocytes, macrophages &amp; fibroblasts to the area (BR).</li>
</ul>
<p>Microscopic picture: Vasculitis(Fibrinoid Necrosis of blood vessel wall + Acute inflammation of wall with PNLs &amp; macrophages) &amp; Necrosis with acute inflammation of tissue (PNLs -macrophages -vasodilatation- edema).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples">Examples:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Granulomas e.g. TB &amp; sarcoidosis</li>
<li>Viral infection with intracellular organism</li>
<li>Contact dermatitis</li>
<li>Insect bite</li>
<li>Parasitic infestation</li>
</ul>
<p>Viral infection: Virus enters cell as an obligate nuclear parasite, replicates &amp; change the DNA sequence of the cell producing a foreign protein. This induces a T cell reaction with killing of virus &amp; the cell containing the virus.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="granuloma">Granuloma<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#granuloma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A. Bacterial e.g. TB: Bacteria living inside macrophage (e.g. TB bacilli) produce antigens, which is processed in the dendritic macrophages of regional LN. These present the processed antigen to the T lymphocytes to transform them into T lymphoblasts. These cells divide &amp; produce memory T &amp; sensitized T cells. On arrival of the sensitized T cells at site of antigen, they produce lymphokines (MAF, MF&amp; others) which lead to further accumulation &amp; activation of macrophages, lymphocytes, and fibroblasts as well as synthesis of collagen. The TB or any type of granuloma is thus formed with central destruction due to cytotoxic lymphokines released from CD4+ cells or the direct cytotoxicity of CD8 + T lymphocyte subsets.
B. Sarcoidosis: Sarcoidosis is an immune system disorder of unknown cause. It is characterized by multisystemic affection that involves lung in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>90</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">90 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">90%</span></span></span></span></span> of cases. Usually occurs in 20-40 year old males and females, but it is more common in females.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="patholgical-lesions">Patholgical lesions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#patholgical-lesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Sarcoidosis is characterized by non-caseating granulomas . Virtually any organ can be affected; however, granulomas most often appear in the lungs or the lymph nodes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gaft-rejection-pathology-of-transplantation">Gaft rejection (pathology of transplantation)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gaft-rejection-pathology-of-transplantation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Tissue cells carry specific surface antigens, called Major Histocompatibility Antigens) MHC). These can evoke Type IV reactions also the RBC content with its ABO system can evoke in addition a Humoral type II reaction &amp; type III reactions to any complexes in blood.</p>
<p>This rejection can be suppressed by -cyclosporins (drugs), Irradiation or surgical removal of thymus (source of T cells)</p>
<p>Microscopic: T Cytotoxic (CD8+), T helper (CD4+ which attack graft cells) + B cells (antibodies) + macrophages</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="general-reaction-in-t-cell-responses">GENERAL REACTION IN T CELL responses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-reaction-in-t-cell-responses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Granulomatous: Lymphocytes + epithelioid macrophages + giant cells + FT &amp; endarteritis oblterans. OR
B. Diffuse reaction e.g. in graft rejection &amp; contact dermatitis Perivascular lymphocytes &amp; edema.
C. Patchy e.g. in insect bites</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="autoimmune-disorders">AUTOIMMUNE DISORDERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#autoimmune-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: Immune system of the host reacts against its own cells i.e. against selfantigens.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples">Examples:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Autoimmune hemolytic anemia. Type II</li>
<li>Connective tissue diseases: Autoimmune diseases characterized by injury to collagen especially in blood vessels and tissues around them.</li>
<li>Systemic lupus erythematosus (SLE) Rheumatic fever-Rheumatoid arthritisPolyarteritis nodosa-scleroderma-polymyositis/dermatomyositis mostly Type III.</li>
</ul>
<p>Microscopic: Fragmentation of collagen producing a fibrin-like, pink mass of Fibrinoid necrosis with Inflammation followed by fibrosis.</p>
<ul>
<li>Graves disease Type V IgG, long acting thyroid stimulator (LATS) attaches to TSH surface receptor on thyroid follicle cell &amp; it takes the place of TSH, stimulating the receptor &amp; escaping the control feedback mechanism. This results in the clinical condition thyrotoxicosis</li>
<li>Others (ulcerative colitis-1ry biliary cirrhosis-some types of male infertilityHashimoto thyroiditis Type IV NB see special for disease details.
N.B.: GRAFT VERSUS HOST reaction (GVH): It is a reaction which occurs in immunosuppressed patients where graft lymphocytes evoke an immune response to patient (host) tissue i.e. lymphocytes attacks the host &amp; produces disease.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="tolerance">TOLERANCE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tolerance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="natural-tolerance-self-tolerance">Natural tolerance (self tolerance)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#natural-tolerance-self-tolerance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is a process by which the body's immune system prevents itself from reacting to the body's own antigens.</p>
<p>Acquired tolerance: Occurs after neonatal period &amp; throughout adult life when very small doses of foreign antigen are introduced over a long period. This may induce tolerance in an adult &amp; is the basis of desensitization treatments in allergy.</p>
<p>Mechanism of tolerance (not yet well understood) possible hypotheses:</p>
<ol>
<li>Burnet's Forbidden clone theory (clonal selection):</li>
</ol>
<ul>
<li>clonal deletion:In fetal life all lymphoid cells, which could respond immunologically to selfantigens, are eliminated. Self-reactive T lymphocytes are eliminated in the thymus by apoptosis</li>
<li>
<div data-testid="stMarkdownPre" class="st-emotion-cache-acwcvw e1icttdg5"><div class="stCode st-emotion-cache-6ml83 e1xss9yb4" data-testid="stCode"><pre class="st-emotion-cache-1nqbjoj e1xss9yb2"><div style="background-color: transparent;"><code style="white-space: pre;"><span>- clonal anergy:ls the process of inactivation of some of the self-reactive T lymphocytes which have escaped death by apoptosis in the thymus</span></code></div></pre><div class="st-emotion-cache-chk1w8 e1xss9yb3"><button data-testid="stCodeCopyButton" title="Copy to clipboard" data-clipboard-text="- clonal anergy:ls the process of inactivation of some of the self-reactive T lymphocytes which have escaped death by apoptosis in the thymus" style="top: 0px; right: 0px;" class="st-emotion-cache-1lyayqq e1xss9yb5"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><rect x="9" y="9" width="13" height="13" rx="2" ry="2"></rect><path d="M5 15H4a2 2 0 0 1-2-2V4a2 2 0 0 1 2-2h9a2 2 0 0 1 2 2v1"></path></svg></button></div></div></div>
</li>
</ul>
<ol start="2">
<li>Peripheral T suppressor cell activity: In adults, acquired tolerance is associated with specific antibodies, which inhibit both helper T cells &amp; B cells</li>
</ol>
<p>TOLERANCE thus protects our bodies from developing autoimmune disorders</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-autoimmunity">MECHANISM OF AUTOIMMUNITY:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-autoimmunity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Genetic or familial defect.</li>
<li>Instability of tolerance mechanism.</li>
<li>Cross reactivity:
a) Foreign antigen may be similar to a body antigen.
b) Antibody produced against a foreign antigen may also react with certain body antigens.</li>
<li>Uncovering of sequestrated (hidden) antigens. Chronic tissue destruction results in:
a) Release of hidden proteins (thyroglobulin or semen or even intracytoplasmic proteins) thereby presenting the immune system with a new antigen.
b)Alteration of surface antigen Altered antigen thereby presenting the immune system with a new antigen.</li>
<li>Absence of T suppressor cell activity</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="immunodeficiencystates">IMMUNODEFICIENCYSTATES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunodeficiencystates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Failure in either the specific immune response (Humoral/cell mediated) or the nonspecific system (phagocytes-complement) may result in alteration of the immune response, which may be quantitative or qualitative.</p>
<ul>
<li>Primary genetic</li>
<li>Secondary to disease</li>
</ul>
<ol>
<li>
<p>Humoral system (Lack of B cells - inability to secrete Ig - activation of suppressors)</p>
</li>
<li>
<p>Cell mediated (Di George's syndrome-AIDS)</p>
</li>
<li>
<p>Phagocytic cell deficiencies (Chronic granulomatous disease-Lazy leukocyte syndrome)</p>
</li>
<li>
<p>Complement deficiencies
a) Primary or inherited deficiencies of B or T cells resulting in recurrent respiratory or alimentary tract infections
b) Secondary deficiencies e.g.</p>
</li>
</ol>
<ul>
<li>Infections: Acute viral-chronic bacterial-chronic protozoal (malaria)</li>
<li>AIDS or acquired immune deficiency syndrome (HIV virus)</li>
<li>Malnutrition particularly protein deficiency</li>
<li>Drug induced e.g. corticosteroids &amp; Cytotoxic drugs which cause immunosuppression</li>
<li>Malignant disease e.g. advanced cancer of lymph nodes (lymphoma/Hodgkin disease)</li>
</ul>
<p>All the above cause impaired immunity which results in intercurrent infection particularly:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="oportunistic-infections">OPORTUNISTIC INFECTIONS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oportunistic-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>DEFINITION: These are diseases caused by non pathogenic or low virulence organisms with an impaired immune system and which usually cause death.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Congenital immunodeficiencies</li>
<li>Acquired
a) Result of disease e.g. HIV (human Immunodeficiency virus) ( see viral infection) causes the acquired Immunodeficiency disorder AIDS or malignancy (lymphoma).
b) b) 2 ry to treatment in patients on immunosuppressives as cyclosporins or antibiotics which may change intestinal flora.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-manifestations">Types &amp; manifestations:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Bacteria: Low virulence Strept epidermidis or viridans is responsible for bacterial endocarditis &amp; low-grade septicemia.</li>
<li>Protozoa: Pneumocystis carinii pneumonia with a foamy (frothy pink) alveolar exudates Toxoplasmosis produces pneumonia or CNS damage</li>
<li>Viruses: cause a generalized infection, severe organ damage e.g.: Herpes encephalitis &amp; cytomegaloviral infection, Aquired immunodeficiency syndrome (AIDS)( see viral infections).</li>
<li>Fungi: Monilia (candidiasis) of GIT-systemic fungemia-endocarditis Aspergillosis: granulomas in lung - systemic fungemia.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="immunology-cancer">IMMUNOLOGY &amp; CANCER<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunology-cancer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Cancers stimulate immunological reactions since tumor cells have altered genes, which produce altered proteins. On the cell surface, these proteins are considered foreign by the body (tumor associated antigens TAA).</p>
<p>The involvement of the immune mechanism has been recognized since some cancers</p>
<ol>
<li>Tend to regress in some patients</li>
<li>Secondaries are relatively rare in spleen, probably due to the spleen's ability to destroy abnormal cells in the circulation.</li>
<li>In some tumors the presence of lymphocytic response around the tumor is associated with a favorable prognosis</li>
<li>BCG is given in some treatment protocols to increase cell mediated immunity in general i.e. nonspecific boost of immune system</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="applied-immunology">APPLIED IMMUNOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#applied-immunology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-diagnosis">A. DIAGNOSIS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-diagnosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- SEROLOGIC ANTIBODY DETECTION METHODS: by detection of circulating specific antibodies using specific antigens.</p>
<p>2- 2-IMMUNOHISTOCHEMISTRY &amp;TUMOR MARKERS (tissue &amp;serum).
Rabbit/mouse is injected with specific antigen e.g. TAA. The animal is left to live long enough to form antibodies against the antigen, then it is bled &amp; the blood containing the specific antibodies is tagged (i.e. labeled) with several dyes as: fluorescine (a fluorescent dye) or with peroxidase (dye with a brown color in tissue) or alkaline phosphatase (red color). Only cells containing the specific tumor antigen will react with the labeled antibody and staining only of the specific tumor cells will occur.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-prophylaxis-treatment-vaccines-organ-transplantationblood">B. PROPHYLAXIS &amp; TREATMENT VACCINES- ORGAN TRANSPLANTATIONBLOOD<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-prophylaxis-treatment-vaccines-organ-transplantationblood" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="transfusion-desensitization">TRANSFUSION- DESENSITIZATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#transfusion-desensitization" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Vaccination.
a. Passive: Injection sera containing Immunoglobulins specific or non-specific to bacteria or their products e.g. toxins. An important complication is serum sickness or anaphylaxis &amp; shock.
b. Active(modified antigen vaccine)</p>
</li>
<li>
<p>Killed <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> typhoid</p>
</li>
<li>
<p>Toxoid <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> tetanus</p>
</li>
<li>
<p>Attenuated or weakened e.g. viral vaccines of polio &amp; measles.</p>
</li>
<li>
<p>Organ transplantation-blood transfusion: Proper matching is mandatory to avoid incompatibility reactions.</p>
</li>
<li>
<p>Desensitization: Introduction of small gradually increasing doses of a specific antigen, which is responsible for a certain allergy, may result in tolerance to this antigen. This is a good method of treatment of atopic disorders (Type I hypersensitivity).</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Basic reactions</td><td style="text-align: left;">All &lt;br&gt; Immunity &lt;br&gt; Types of immune disorders: &lt;br&gt; Hypersensitivity &lt;br&gt; Autoimmune disorders (lmechanism of &lt;br&gt; tolerance) &lt;br&gt; Graft rejection &amp;GVH &lt;br&gt; Immunodeficiency &lt;br&gt; Opportunistic infections &lt;br&gt; Immunology &amp;cancer &lt;br&gt; Applied immunology</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="bacterial-infections">BACTERIAL INFECTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#bacterial-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="infection">INFECTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Is a form of injury, where the injurious agent is a pathogenic (harmful) organism.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="infectious-disease">INFECTIOUS DISEASE:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#infectious-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Is the clinical manifestation resulting from tissue damage + reactions as a result of exposure to pathogenic organism
<img src="assets/images/image-20251212-5a150ede.jpeg" alt="img-37.jpeg"></p>
<p>TYPES OF INFECTIONS</p>
<ol>
<li>
<p>Pyogenic infection <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mspace width="1em"></mspace></mrow><annotation encoding="application/x-tex">\quad</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0em;"></span><span class="mspace" style="margin-right: 1em;"></span></span></span></span></span>| Localized (abscess) |
| :-- |
| Diffuse(acute diffuse suppurative appendicitis) |</p>
</li>
<li>
<p>Putrefaction: area of necrosis + saprophytic bacteria (putrefaction) = gangrene</p>
</li>
<li>
<p>Toxic infections Endotoxin (endotoxic shock)</p>
</li>
</ol>
<p>Exotoxin (bacillary dysentery-cholera-tetanus-diphtheria)
4. Opportunistic infection: low body resistance (defective immune response) will encourage commensals to become pathogenic e.g. E.coli &amp; fungal infections which are common particularly in AIDS patients.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a-acute-bacterial-infections">A) ACUTE BACTERIAL INFECTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-acute-bacterial-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-acute-suppurative">1- Acute suppurative.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-acute-suppurative" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Localized e.g. Staph aureus e.g. subcutaneous abscess
Diffuse e.g. Strept pyogenes causing cellulitis or acute diffuse suppurative appendicitis also serous membrane suppuration as empyema (sac full of pus) &amp; septic peritonitis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-acute-non-suppurative">2- Acute non -suppurative<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-acute-non-suppurative" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Fibrinous</li>
<li>Serofibrinous</li>
<li>Serous inflammation</li>
<li>Pseudomembranous e.g. Diphtheria &amp; Bacillary dysentery</li>
<li>Hemorrhagic e.g. small pox &amp; necrotizing e.g. Hemophilus influenza</li>
<li>Putrefactive e.g. gas gangrene caused by Clostridia organisms</li>
<li>Allergic hypersensitivity to Typhoid (Salmonella) see later</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-chronic-bacterial-infections">B) CHRONIC BACTERIAL INFECTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-chronic-bacterial-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="non-specific">- Non specific<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#non-specific" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Specific (granulomas)</li>
</ul>
<ol>
<li>Tuberculosis (TB) and atypical mycobacteria</li>
<li>Leprosy: caused by Mycobacterium leprae</li>
<li>Syphilis: caused by Treponema pallidum</li>
<li>Rhinoscleroma: caused by Klebsiella rhinoscleromatis</li>
<li>Actinomycosis: caused by Actinomycetes israeli</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanisms-etiology">- Mechanisms-Etiology:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanisms-etiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A- The injurious agent is bacteria: Saprophytes + necrosis in tissue <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mspace width="2em"></mspace></mrow><annotation encoding="application/x-tex">\qquad</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0em;"></span><span class="mspace" style="margin-right: 2em;"></span></span></span></span></span>
Commensal + low immunity
Pathogenic
disease
B- Route of infection
Inhalation e.g. TB, pneumonia
Ingestion e.g. Typhoid
Contact or direct e.g. venereal diseases as gonorrhea or syphilis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="factors-related-to-both-organism-host">Factors related to both organism &amp; host<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-related-to-both-organism-host" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-host-organism-interaction">1. Host organism interaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-host-organism-interaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251212-b3a4329c.jpeg" alt="img-38.jpeg">
2. Host resistance Natural mechanisms
immunopathology)
Induced immune mechanisms (see immunopath)
3. Factors depending on organism:</p>
<p>Dose i.e. quantity
Virulence i.e. strength or ability to produce disease
This depends on:
a. Ability to resist phagocytosis &amp; attack of enzymes
b. Adhesive properties of organism to cell wall
c. Toxin production
<img src="assets/images/image-20251212-bffce5a9.jpeg" alt="img-39.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="course-fate-of-any-infection">COURSE &amp; FATE OF ANY INFECTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#course-fate-of-any-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A)Inflammatory reaction:
<img src="assets/images/image-20251212-1c96b1a1.jpeg" alt="img-40.jpeg">
B)Immune response (humoral or cell mediated) attacks organism &amp; prepares for healing.
C) Gamma Interferon is important in viral infections
D) Phagocytic activity removes debris &amp; organism to make way for healing
E) Failure of protective mechanisms <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> SPREAD of infection
1.Direct spread
2.Distant spread:
a) Lymphangitis <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> regionallymphadenitis <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> generalized lymphadenitis <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> thoracic duct to reach blood stream.
b) Blood stream spread leads to:
<img src="assets/images/image-20251212-dfc5cf74.jpeg" alt="img-41.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="manifestations-of-distant-blood-stream-spread-of-infection">MANIFESTATIONS of distant blood stream spread of infection<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#manifestations-of-distant-blood-stream-spread-of-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Bacteraemia: circulation of low doses or low virulence organisms in the blood stream may cause no disease or just fever (symptoms only with no lesions) except if there is already an abnormality e.g. diseased heart valves or congenital heart disease, where it produces lesions of subacute infective endocarditis) NB in viral infection it is called viraemia.
b) Toxemia: Organismal toxins in the circulation</p>
<p>Endotoxin: gram negative bacteria release toxins when they die &amp; produce endotoxic shock (see shock)</p>
<p>Exotoxin: gram positive bacteria produce toxins which act on specific sites e.g.</p>
<ol>
<li>Tetanus (clostridium tetani acts on presynaptic junctions locally at site + away from site of infection, producing severe contraction of muscle i.e.spasm)</li>
<li>Diphtheria toxins result in neural malfunction (neuritis) +myocarditis + fibrinoid necrosis of abdominal wall muscle (dark pink coagulated mass of necrotic muscle). Shock (acute circulatory failure) may also occur. Death occurs due to acute heart failure as a result of toxic myocarditis.</li>
<li>Bacillary dysentery i.e. Shigella: like diphtheria it is another pseudomembranous type of inflammation where the organism cannot penetrate the tissue but sends its toxins to the submucosal BV and produces the same picture. Toxins produce shock + degeneration &amp; necrosis + acute inflammation</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="common-features-of-toxemia">Common features of toxemia:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#common-features-of-toxemia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Effect of toxins on nerves &amp; muscles (fibrinoid necrosis &amp; toxic myocarditis)</li>
<li>Toxic injury to liver &amp; kidneys in the form of fatty change up to necrosis</li>
<li>Bone marrow depression</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-pyaemia">c) Pyaemia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-pyaemia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Circulation of insoluble necrotic material containing pyogenic organisms. These circulating insoluble substances are called septic emboli and will circulate until they reach a BV with a small lumen, where they get impacted and an abscess is formed, named.</p>
<p>PYAEMIC ABSCESS</p>
<table><thead><tr><th style="text-align: left;">GROSS</th><th style="text-align: left;">MICROSCOPIC</th></tr></thead><tbody><tr><td style="text-align: left;">Multiple, small, yellow abscesses</td><td style="text-align: left;">BV with nearby focus of suppuration &lt;br&gt; (describe pus) and surrounded by &lt;br&gt; pyogenic membrane (structure of abscess, &lt;br&gt; see acute inflammation).</td></tr><tr><td style="text-align: left;">surrounded by a zone of congestion &lt;br&gt; related to a BV.</td><td style="text-align: left;"></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types">TYPES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th style="text-align: center;">1) Pulmonary pyaemia</th><th style="text-align: center;">2) Systemic pyaemia</th><th style="text-align: center;">3) Portal pyaemia</th></tr></thead><tbody><tr><td style="text-align: center;">Couses: &lt;br&gt; a. Cellulitis/abscess &lt;br&gt; b. Septic thrombophlebitis of any systemic vein</td><td style="text-align: center;">a. Pulmonary vein Septic thrombophlebitis &lt;br&gt; b. Lt.heart vegetations (acute infective endocarditis) &lt;br&gt; c. Very small emboli which by pass lungs &amp; reach pulmonary Veins &lt;br&gt; d. Emboli which by pass lung through a congenital defect in Rt atrium or Rt Ventricle (ASD &amp; VSD)</td><td style="text-align: center;">septic thrombo phlebitis of GIT veins &lt;br&gt; (tributaries of portal vein)</td></tr><tr><td style="text-align: center;">Mechanism: &lt;br&gt; Emboli reach Rt. Heart to Pulmonary artery &amp; then impact in lung BV</td><td style="text-align: center;">Emboli are distributed to all organs by the aorta.</td><td style="text-align: center;">Emboli reach portal veins to liver.</td></tr><tr><td style="text-align: center;">Fate &lt;br&gt; Pyaemic abscesses In LUNG</td><td style="text-align: center;">Pyaemic abscesses in BRAIN-KIDNEYS etc ...</td><td style="text-align: center;">Pyaemic abscesses in LIVER.</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="n-b">N.B.:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The gross &amp; microscopic picture of pyaemic abscesses is similar to that of acute abscess but they are small, multiple &amp; always related to a BV.</p>
<p>If the septic embolus is LARGE it doesn't produce an abscess, it produces SEPTIC INFARCTION (see circulatory).
d) Septicemia (usually fatal): Circulation of large numbers of bacteria, which are multiplying, in the blood stream &amp; releasing their toxins.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="etiology">Etiology:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#etiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Severe infections i.e. high virulence organisms e.g. meningococcal meningitis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="or">Or<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#or" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>2- Ordinary infection with a lowered body resistance e.g. E.coli, abscess, cellulitis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="manifestations">Manifestations:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#manifestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Bacteria + Toxins in large doses produce: shock + necrosis + acute inflammation + Toxaemia</p>
<ul>
<li>Septic shock (see circulatory)</li>
<li>Septic inflammation of serous membranes (septic peritonitis etc ... )</li>
<li>Acute splenic swelling: large, soft friable &amp; necrotic spleen (inflammed + necrotic)</li>
<li>Waterhouse-Fridriechsen syndrome: haemorrhagic necrotic adrenals</li>
<li>Toxic injury(toxemia): toxic myocarditis-toxic injury to liver &amp; kidneys-bone marrow depression</li>
<li>Damage to alveoli (DAD) ending in acute respiratory distress syndrome</li>
<li>Disseminated intravascular coagulopathy (DIG): thrombosis in small vessels &amp; capillary hemorrhages (see circulatory)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="examples-of-chronic-bacterial-infections">EXAMPLES OF CHRONIC BACTERIAL INFECTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-of-chronic-bacterial-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-tuberculosis">1. TUBERCULOSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-tuberculosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Tuberculosis is an infectious granuloma caused by Mycobacterium tuberculosis.</p>
<p>The disease is common is communities with low standards of health.
Methods of infection are: inhalation, ingestion and skin inoculation</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="primary-sites-of-infection">Primary Sites of Infection<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#primary-sites-of-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Lungs: Inhalation of human tubercle bacilli.</li>
<li>Intestine: Ingestion of milk containing bovine tubercle bacilli.</li>
<li>Tonsils: Ingestion of milk containing bovine tubercle bacilli.</li>
<li>Skin By contact.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="tissue-reaction-in-tuberculosis">Tissue Reaction In Tuberculosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tissue-reaction-in-tuberculosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Two types of tissue reaction occurs; I-Tubercle (proliferative tissue reaction) IIExudative tissue reaction</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-tubercle-proliferative-tissue-reaction">I) Tubercle (Proliferative Tissue Reaction):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-tubercle-proliferative-tissue-reaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The tubercle is the basic unit of tuberculosis. It is collection of epithelioid cells, Langhans giant cells and lymphocytes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mode-of-tubercle-formation">Mode of tubercle formation:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mode-of-tubercle-formation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>The polysaccharide fraction of tubercle bacilli attracts the neutrophils within few hours. They phagocytose the bacteria but unable to destroy them as the bacteria are protected by lipid cell wall and the neutrophils do not contain the lipase enzyme.</li>
<li>The lipid fraction of the cell wall attracts the macrophages after the first day. They collect and phagocytose the free bacilli and those inside the neutrophils and are now called epithelioid cells. The bacilli are partially digested with the release of</li>
</ol>
<p>tuberculoprotein. The tuberculoprotein stimulate a cell mediated immune response (delayed hypersensitivity) within 10 days. Sensitized T-lymphocytes appear and surround the epithelioid cells.
3) The sensitized lymphocytes release various lymphokines which have the following actions:
a) Chemotactic factor:Attracts more nmacrophages to the area of inflammation.
b) Migration inhibition factor (MIF): Inhibits migration of macrophages from Inflamed area.
c) Mitogenic factor: Stimulates proliferation of lymphocytes.
d) Transfer factor: Transfer sensitization to new lymphocytes.
e) Cytotoxic factor: Causes caseating necrosis.
f) Skin reactive factor: Responsible for positive skin test (tuberculin test).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="gross-picture">Gross Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The tubercle is of microscopic size. Number of tubercles fuse together to form small rounded grossly seen grey follicles 1-2 millimeters in diameter. When caseation occurs the lesion appears pale yellow and cheesy in consistency.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic-picture">Microscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is collection of many epithelioid cells, Langhans giant cells and lymphocytes.</p>
<ol>
<li>Epithelioid cells derived from macrophages which have phagocytosed the tubercle bacilli and became altered by their lipid fraction. They have an epithelial like shape. The cytoplasm is abundant and pale red.The borders are indistinct.</li>
</ol>
<p>The nuclei are large, oval or comma-shaped and vesicular.
2. Lymphocytes at periphery of tubercle.
3. Langhans giant cell: Formed by fusion of a number of epithelioid cells or repeated division of its nucleus. They have abundant cytoplasm and multiple rounded nuclei arranged around the periphery in a circle.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="subsequent-change-in-tubercle-caseation">Subsequent change in Tubercle (caseation):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#subsequent-change-in-tubercle-caseation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>With the development of hypersensitivity the centre of the tubercle undergoes caseation by partial liquefaction forming yellow ,pasty like material which appears microscopically as a homogenous, structureless and stains pink with eosin.</p>
<p>Caseation occurs when hypersensitivity to tuberculoproteins of bacilli is developed and it is due to lymphotoxins from sensitized T lymphocytes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="fate-of-tubercle">Fate of Tubercle:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fate-of-tubercle" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>High immunity:
a) Small lesions are completely fibrosed
b) Large caseous lesions are encapsulated and may be followed dystrophic calcification. Living bacteria may remain in the lesion.</li>
<li>Low immunity: The lesion spreads.( describe).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-exudative-tissue-reaction">II) Exudative Tissue Reaction:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-exudative-tissue-reaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Occurs when large number of tubercle bacilli reach the lung and serous membranes of sensitized individual (high hypersensitivity) and low immunity.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-reaction-is-characterized-by">The reaction is characterized by:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-reaction-is-characterized-by" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Excess serous inflammatory fluid exudate reach in fibrinogen</li>
<li>The exudate contains large number of neutrophils and lymphocytes and small number of epithelioid cells and Langhans giant cells.</li>
<li>Caseation is rapid and extensive, may undergo liquefaction by the enzymes of neutrophils.
<img src="assets/images/image-20251212-54e7b98c.jpeg" alt="img-42.jpeg"></li>
</ol>
<p>Fig. 2 - Microscopic features of tubercle and its fate.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spread-of-tuberculous-infection">Spread of Tuberculous Infection<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spread-of-tuberculous-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Direct spread: Macrophages and tissue fluid carry the bacilli to the surrounding tissues.</p>
</li>
<li>
<p>Lymphatic spread: Bacilli free or carried by macrophages pass along ymphatics to regional lymph nodes.</p>
</li>
<li>
<p>Blood spread: Occurs when caseous focus breaks through the wall of blood vessel.</p>
</li>
<li>
<p>Intracanalicular spread: Spread through the lumen of natural tubes e.g. spread through the bronchi or the ureter.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="immunity-and-hypersensitivity-in-tuberculosis">Immunity and Hypersensitivity in Tuberculosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunity-and-hypersensitivity-in-tuberculosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>When the infection by tubercle bacilli occurs, tuberculoprotein is released and stimulates the body to produce both immunity and hypersensitivity.</p>
<p>Immunity: Is the ability of the body to overcome the infection by pathogenic bacteria. It occurs after exposure (sensitization). The reaction is beneficial as it localizes and destroys the antigen without disease production. If the bacilli overcome the immunity, it will multiply resulting in progression from tuberculous infection to tuberculous disease.</p>
<p>Hypersensitivity: Is the change in reaction following re-exposure to the same antigen. When an antigen enters the body for the first time no harmful effect occurs. If the same antigen is reintroduced into the body, cellular damage with sever inflammatory reaction occurs called hypersensitivity. In tuberculous infection a delayed type of hypersensitivity (cell mediated immune reaction) develops within 10 days of first infection with tubercle bacilli. Hypersensitivity decrease with time. It is detected by tuberculin test.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cell-mediated-delayed-br-hypersensitivity-reaction-in-tuberculosis">Cell Mediated (Delayed) &lt;br&gt; Hypersensitivity Reaction in Tuberculosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cell-mediated-delayed-br-hypersensitivity-reaction-in-tuberculosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is an exaggerated cell mediated immune response that damages the host cells. The main cell involved is the activated T-Lymphocyte T helper 1 cell (Th1 ).Antibody and histamine play no role in this type. The response is delayed, it starts hours or days after contact with the antigen.</p>
<p>The Th1 cell recognize the antigen and release the cytokines (lymphokines) that result in the accumulation of large number of activated macrophages and tubercle formation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites-of-secondary-tuberculous-lesions">Sites of Secondary Tuberculous Lesions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites-of-secondary-tuberculous-lesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Primary sites of infection can develop secondary lesions after reinfection or reactivation of the primary lesion.</li>
<li>Other organs of the body can develop secondary tuberculous infection through:
a) Direct extension of infection from primary lesion.
b) Blood borne infection.
E.g.: Pleura, peritoneum, pericardium, heart, lymph nodes, brain, bones, kidney, bladder, etc....</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pulmonary-tuberculosis-br-i-primary-pulmonary-tuberculosis-figs-3-4">Pulmonary Tuberculosis &lt;br&gt; I) Primary Pulmonary Tuberculosis (Figs. 3&amp;4)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pulmonary-tuberculosis-br-i-primary-pulmonary-tuberculosis-figs-3-4" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Primary pulmonary tuberculosis follows the first infection of the lung with tubercle bacilli by inhalation, usually in young age "childhood type". Three lesions develop: "primary pulmonary complex".</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-features">Pathological Features<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Ghon's focus: A small caseous focus develops underneath the pleura in the base of upper lobe or apex of lower lobe. Microscopically the lesion consists of tubercles showing caseation. (describe)</li>
<li>Tuberculous lymphangitis: A chain of tubercles develop in walls of draining lymphatics.</li>
<li>Tuberculous lymphadenitis: The tracheobronchial lymph nodes are enlarged and caseous. They are larger in size than the Ghons focus, by the time the infection reaches the draining lymph nodes, the cell mediated immunity ( CMI ) had developed (within a period of about 10 days) this feature is present in primary infections in other sites.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fate-of-primary-complex">Fate of Primary Complex<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fate-of-primary-complex" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I) Healing: Majority of patients do not develop signs or symptoms. The lesions heal by fibrosis or become encapsulated with or without calcification.
II) Spread (post 1ry complications): Occurs in a minority of cases with low body resistance.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-direct-spread">1) Direct spread:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-direct-spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Direct spread of Gohn's focus in the lung tissue causing tuberculous pneumonia.
b) Direct spread of Gohn's focus to the pleura causing tuberculous pleurisy.</p>
<p>The reaction is of the exudative type. Serous exudate collects in the sac and scanty fibrin deposits on the pleural surfaces. Healing occurs by organization forming adhesions.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-blood-spread">2) Blood spread:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-blood-spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Small number of bacilli: Removed by cells of reticulo-endothelial system.
b) Moderate number of bacilli: Settle in one of the favorable sites as brain, meninges, bone or kidney and form tuberculous lesions. Such lesions may be arrested or progress causing isolated organ tuberculosis.</p>
<p>c) Large number of bacilli: Usually results from opening of a caseous focus through large vessel. The bacilli spread with blood to large number of organs forming small uniform tuberculous lesions about 1-2 millimeters .The condition is known as miliary tuberculosis. It is rapidly fatal.
3) Bronchial spread: Gohn's focus or nodal lesion open in a bronchus and the caseous material is aspirated into the adjacent lung tissue causing tuberculous bronchopneumonia.
III) Encapsulation and reactivation: The lung and nodal lesion get capsulated, but with lowering of body resistance the lesion gets reactivated and spread. The spread is either direct, through bronchi or blood spread.
<img src="assets/images/image-20251212-1326fee9.jpeg" alt="img-43.jpeg"></p>
<p>Fig. 3 - Primary pulmonary tuberculosis in upper lobe progressed to tuberculous pneumonia in middle and lower lobes.
<img src="assets/images/image-20251212-ac24643c.jpeg" alt="img-44.jpeg"></p>
<p>Fig. 4 - Primary pulmonary tuberculosis in upper lobe progressed to tuberculous pleurisy with effusion.</p>
<p>Second infection of the lung after recovery from primary one, commonly occurs in adult (adult type)</p>
<p>The second infection may be:</p>
<ol>
<li>
<p>Exogenous: Inhalation of human bacilli.</p>
</li>
<li>
<p>Endogenous: Reactivated primary lesion.</p>
</li>
</ol>
<p>The post-primary lesion starts always at the apex of the lung (less blood supply and more aeration). The course of the disease depends on the dose of the bacilli and the state of immunity.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="course">Course:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#course" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Regression: Occurs with small number of bacilli and high immunity. Heals by fibrosis forming apical scar.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-progresion">2. Progresion:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-progresion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Moderate number of bacilli and moderate immunity causes chronic fibrocaseous pulmonary tuberculosis.
b) Large number of bacilli and low immunity causes tuberculous bronchopneumonia and acute caseous tuberculous pneumonia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-chronic-fibro-caseous-pulmonary-tuberculosis-fig-5">1. Chronic Fibro-caseous Pulmonary Tuberculosis (Fig.5)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-chronic-fibro-caseous-pulmonary-tuberculosis-fig-5" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="this-is-characterized-by">This is characterized by:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#this-is-characterized-by" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>A slow course which spreads over years.</li>
<li>Repeated attempts to check and encapsulate the lesion by fibrosis.</li>
<li>Lymph nodes lesions are insignificant in comparison to those of primary Pulmonary tuberculosis.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="macroscopic-picture">Macroscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#macroscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Apical Cavity: The apical lesion progresses forming an area of caseation surrounded by tuberculous granulation tissue and fibrosis. When caseation involves a bronchus, the caseous material is evacuated and a cavity is left. The cavity lining is at first yellow irregular and caseating but later it becomes smooth due to fibrosis.</li>
</ol>
<p>The blood vessels in the wall are thickened due to endarteritis. The bronchi and blood vessels are more resistant to caseation so they appear as cords or ridges in the wall. The fibrous wall of the cavity is progressively destroyed by caseation but it reforms again a little further out and in this way the cavity enlarges gradually.
2. Acinar lesions: Part of caseous material is aspirated in distal bronchioles leading to small caseating lesions of clover leaf shape (acinar lesion) mainly at the base of the lung.
3. Nodal lesion: Lymph nodes involvement is insignificant as the bacilli reaching the nodes inside the macrophages are few because of the presence of the migration inhibition factor (MIF).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="microscopic-picture">Microscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Large areas of homogenous pink caseation surrounded by fibrous tissue. Recent tubercles are present. (describe tubercle)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Haemoptysis from tuberculous granulation tissue or eroded blood vessel</li>
<li>Spread of infection:
a. Blood causing isolated organ tuberculosis or miliary tuberculosis.
b. Direct to pericardium and mediastinum.
c. Direct to the pleura causing sero-fibrinous pleurisy or empyema.</li>
<li>Rupture cavity causing pneumothorax or pyopneumothorax.</li>
<li>Infected sputum causes infection of other lung, tonsils, larynx, or tongue</li>
<li>Swallowing of infected sputum causing intestinal tuberculosis.</li>
<li>Lung fibrosis and right sided heart failure.</li>
<li>Secondary amyloidosis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="signs-and-symptoms">Signs and Symptoms:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#signs-and-symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Loss of weight, sweating and night fever due to toxemia.</li>
<li>Chest pain due to pleurisy and dyspnea due to pleural effusion.</li>
<li>Haemoptysis.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-tuberculous-bronchopneumonia">2. Tuberculous Bronchopneumonia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-tuberculous-bronchopneumonia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Rare fatal condition develops as a complication of primary or secondary pulmonary tuberculosis. The lesion is caused by large dose of bacilli in a patient with high hypersensitivity and low immunity.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-features">Pathological features:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>The tuberculous lesion progress rapidly by direct extension or by bronchial aspiration.</li>
<li>Tracheobrobchial lymph nodes are caseous and enlarged.</li>
<li>The course is rapidly fatal with or without miliary tuberculosis.</li>
</ol>
<p><img src="assets/images/image-20251212-81b1a349.jpeg" alt="img-45.jpeg"></p>
<p>APICAL LESION TRACHEDBRONCH. NODES FREE
<img src="assets/images/image-20251212-847d689f.jpeg" alt="img-46.jpeg"></p>
<p>APICAL CAVITY DISTAL BRONCHOPNEUMONIC LESIONS</p>
<p>Fig. 5 - Chronic fibrocaseous pulmonary tuberculosis</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="complications-of-pulmonary-tb">COMPLICATIONS OF PULMONARY TB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications-of-pulmonary-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Chronic destruction + Healing (Chronic inflammation)</p>
<ol>
<li>Hemoptysis i.e. coughing of blood due to hemorrhage into bronchus</li>
<li>Alveolar or bronchial rupture into pleura---bronchopleural fistula or pneumothorax (air in pleural cavity)</li>
<li>Respiratory failure in diffuse caseous pneumonia or miliary TB</li>
<li>Right sided heart failure secondary to diffuse lung fibrosis, since this would elevate he pressure in the pulmonary artery producing corpulmonale (right sided heart failure 2 ry to lung disease)</li>
<li>2ry or systemic amyloidosis &amp; dystrophic calcification (see cell injury)</li>
<li>Bronchieclasis i.e. dilatation of bronchi</li>
<li>Apical fibrosis may produce Horner's syndrome due to affection of peripheral nerves and blood vessels of the region.</li>
<li>Spread</li>
</ol>
<p>Direct Lung: confluence of acinar lesions produces confluent pneumonia Pleura: 1ry effusion (no Caseation)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="caseous-empyema-br-dense-adhesions">Caseous empyema &lt;br&gt; Dense adhesions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#caseous-empyema-br-dense-adhesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Spread to pericardium &amp; mediastinum leading to adhesive mediastinopericarditis
Transbronchial spread: Caseous material if aspirated. Producing TB bronchopneumonia in one or both lungs &amp; if swallowed in sputum it may lead to intestinal, tonsillar or laryngeal TB</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="distant">Distant:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#distant" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Generalized lymphadenopathy
Blood stream: Isolated organ TB or Miliary TB</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="tuberculous-lesions-in-other-organs">Tuberculous Lesions in Other Organs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tuberculous-lesions-in-other-organs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-intestinal-tb-lesious-in-other-ovsams">1. INTESTINAL TB lesious in other ovsams<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-intestinal-tb-lesious-in-other-ovsams" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. 1ry complex:</p>
<ul>
<li>Small intestinal tubercle formation in Peyer's patches of terminal ileum. The tubercles coalesce forming 1 small nodule (granuloma) which may ulcerate on the mucosa resulting in a single tuberculous ulcer.</li>
<li>Lymphangitis: tiny tubercles along the course of the lymphatics.</li>
<li>Mesenteric draining lymph nodes are studded with multiple small tubercles.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="post-primary-spread">Post primary spread:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#post-primary-spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Mesenteric lymph nodes are enlarged, undergo caseation and fuse, forming a yellowish amalgamated mass with central caseation (Tabes mesenterica).
Blood spread lesions of Miliary TB in intestine</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="secondary-intestinal-tb">Secondary intestinal TB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#secondary-intestinal-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Small intestine is studded with multiple TB ulcers secondary to swallowing infected sputum or 2 ry to lymphatic or blood stream spread or reinfection with infected milk.</p>
<p>Gross:
Multiple, transverse ulcers (since spread occurs along lymphatics of Peyer's patches)
Edges: undermined i.e. hang over the defect in the underlying tissue since there is more submucosal destruction than mucosal.</p>
<p>Floor: yellow caseous material
Base: tuberculous granulation tissue</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications-of-intestinal-tb">COMPLICATIONS OF INTESTINAL TB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications-of-intestinal-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Hemorrhage: altered blood in stools (Melena)</li>
<li>Stenosis of lumen &amp; intestinal obstruction</li>
<li>Fistulae between adjacent intestinal loops</li>
<li>Ulcer perforation leading to TB peritonitis</li>
<li>Secondary amyloidosis 2ry</li>
<li>Spread: Direct to peritoneum (TB peritonitis) &amp; or pelvic organs Distant same as before</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-tonsillar-tb">2. TONSILLAR TB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-tonsillar-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1ry TB primary tonsillar complex: granuloma in tonsil (describe) + lymphangitis + cervical lymphadenitis.</p>
<p>2ry Tonsillar TB from swallowing infected sputum or reinfection by contaminated milk.</p>
<p>Marked caseation of the tonsil, which may present with TB ulcer or a cold abscess containing, liquefied caseous material, which simulates pus. A cold abscess is not a true abscess since it is not hot, nor does it contain pus cells (dead PNL's).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="complications-of-tonsillar-tb">COMPLICATIONS OF TONSILLAR TB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications-of-tonsillar-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Hemorrhage: blood tinged sputum</li>
<li>Dysphagia: inability to swallow due to obstruction</li>
<li>Cold abscess in cervical LN which may result in skin sinus formation</li>
<li>Secondary amyloidosis</li>
<li>Spread (see before local &amp; distant, blood &amp; lymphatic): Infected material if swallowed may produce intestinal TB &amp; if aspirated may produce pulmonary TB lesions.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-tuberculous-lymphadenopathy">3. Tuberculous lymphadenopathy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-tuberculous-lymphadenopathy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1ry TB: as part of the primary complex only regional lymph nodes (hilar, cervical or mesenteric) are affected in the form of tiny tubercles which coalesce &amp; cause LN enlargement.</p>
<p>Post primary lymphatic spread results in generalized tuberculous lymphadenopathy. E.g. Tabes mesenterica: grossly: matted (fused) LN with extensive caseation.</p>
<p>Microscopically: a homogenous structureless (no ghosts of tissue or nuclear debris) pink area of granular caseation surrounded by epithelioid cells, some Langhan's giant cells &amp; an outer layer of lymphoid cells &amp; the LN capsule.</p>
<p>In <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>2</mn><mtext>nd&nbsp;</mtext></msup><mrow><mi mathvariant="bold">T</mi><mi mathvariant="bold">B</mi></mrow></mrow><annotation encoding="application/x-tex">2^{\text {nd }} \mathbf{T B}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8491em;"></span><span class="mord"><span class="mord">2</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8491em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">nd&nbsp;</span></span></span></span></span></span></span></span></span></span><span class="mord"><span class="mord mathbf">TB</span></span></span></span></span></span>, there is no <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="bold">L</mi><mi mathvariant="bold">N</mi></mrow><annotation encoding="application/x-tex">\mathbf{L N}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6861em;"></span><span class="mord"><span class="mord mathbf">LN</span></span></span></span></span></span> enlargement: These reactions are due hypersensitivity. They will they become large only if the lymph nodes are the source of reactivation or they are draining diffuse caseous TB (the amount of destruction is more than the drainage ability or immunity is low) (gross &amp; microscopic see before)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">COMPLICATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cold abscess (cold since no hyperemia to cause heat- abscess since contents are yellow and liquefied by -enzymes released in large areas of necrosis Le. similar to pus) Sinus draining on the skin Spread (direct, lymphatic &amp; blood).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-tb-of-skin">4. TB OF SKIN<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-tb-of-skin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1ry TB: rare usually in laboratory workers handling infected material
1ry complex: skin tubercles form a skin nodule + lymphangitis + regional (axillary lymphadenitis)
2ry TB skin also called Lupus vulgaris
Consists of a nodule, which may ulcerate producing a tuberculous skin ulcer. This condition is precancerous and may cause squamous cell carcinoma.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="tb-in-any-other-site-other-than-1-5-lis-secondary-tb">TB in ANY OTHER SITE (OTHER THAN 1-5 lis secondary TB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tb-in-any-other-site-other-than-1-5-lis-secondary-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-genito-urinary-tb">5. GENITO-URINARY TB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-genito-urinary-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Source of infection: direct, Transcanalicular or blood stream spread</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="renal-tuberculosis">RENAL TUBERCULOSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#renal-tuberculosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Lesions (2ry TB) &amp; Post 1ry or complicated 2ry TB</p>
<ol>
<li>Fibrocaseous or fibro-cavitary renal TB (similar to fibrocaseous lesion of lung)</li>
<li>Diffuse caseation of kidney tissue</li>
<li>TB pyonephrosis: direct spread of caseation from kidney tissue to pelvicalyceal system &amp; ureter, which becomes stenotic causing proximal dilatation. The pelvicalyceal system and part of ureter above obstruction becomes swollen and transformed into a sac full of caseous material.</li>
<li>Tuberculoma of kidney as a part of isolated organ TB resulting from blood spread</li>
<li>Miliary TB from blood spread (describe)</li>
<li>Kidney fibrosis (fibrotic type) resulting in shrunken kidney</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications-of-renal-tb">Complications of renal TB:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications-of-renal-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Hemorrhage into pelvicalyceal system producing hematuria (blood in urine)</li>
<li>Organ damage and fibrosis resulting in chronic renal failure &amp; 2ry hypertension</li>
<li>Spread: Direct mostly transcanalicular, through ureters to urinary bladder Distant blood stream: isolated organ TB or Miliary TB</li>
<li>Complications of chronic tissue damage e.g. 2ry amyloidosis etc ... (see before) &amp; complications of healing by fibrosis as urinary tract obstruction due to stenosis (TB pyonephrosis) &amp; vesico-rectal or vesico-vaginal fistulae.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="urinary-bladder-ub">URINARY BLADDER (UB)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#urinary-bladder-ub" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Same source as kidneys but mostly direct spread from renal TB (descending infection)
Lesion: Fibrosis
TB ulcers</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1-Hemorrhage <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> Hematuria
2-Fibrosis <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> Contracted UB
3-Spread of infection:
a) blood spread
b) ascending spread to kidneys through ureters</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="epididymis-testis">EPIDIDYMIS &amp; TESTIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#epididymis-testis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Source: blood spread
Lesion: Fibrotic lesion, fibrocaseous or caseous types
Caseous necrosis of epididymis produces a sinus on posterior aspect of scrotum</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Hemorrhage hemospermia (blood in seminal fluid)</li>
<li>Fibrosis results in Infertility (obstruction to the flow of semen)</li>
<li>Spread: a) direct to testis- extensive caseation with liquefaction producing: testicular cold abscess and scrotal sinus formation b) blood spread</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fallopian-tubes">FALLOPIAN TUBES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fallopian-tubes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Source mostly blood stream affecting both tubes
Lesion: TB pyosalpinx: tubes get obstructed with dilatation proximal to obstruction and both tubes become sacs full of caseous material</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Fibrosis leads to Infertility</li>
<li>Spread: Direct to peritoneum through tubal fimbria, endometrium &amp; cervix Blood.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-bones-joints">6. BONES &amp; JOINTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-bones-joints" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="joints">JOINTS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#joints" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Source: Direct from bone
Blood spread</p>
<p>Lesion: commonly occurs in knee joints or hip joints in the form of:</p>
<ul>
<li>joint effusion rich in lymphocytes.</li>
<li>Fragmented joint cartilage.</li>
<li>Fibrous adhesions in synovial membranes resulting in joint ankylosis and difficulty in movement i.e. loss of function.</li>
</ul>
<p>Complications: Fibrosis of joint with loss of function due to adhesions (Ankylosis)
Spread: Direct to ligaments causing their destruction
Blood spread
Cold abscess and sinus formation</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="bones">BONES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#bones" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Source: blood spread to long bones or vertebrae (Pott's disease of vertebral column)</p>
<ul>
<li>POTT'S disease of vertebrae: comprises a triad of Kyphosis, cold abscess &amp; paraplegia). Caseation of vertebrae (especially lower thoracic &amp;upper lumbar, followed by cervical) &amp;the intervening discs causes vertebral collapse &amp; deformity (kyphosis)</li>
</ul>
<p>Cold abscess: caseous material collects under the vertebral ligament &amp; is squeezed into different places according to site of accumulation a) TB of thoracic vertebrae: abscess in posterior mediastinum b) Lumbar vertebrae: caseous material reaches the sheath of the psoas muscle &amp; appears in femoral triangle (Psoas cold abscess) c) Cervical vertebrae: caseous material reaches retropharyngeal area &amp; appears at posterior border of sternomastoid. Pressure of caseous material on peripheral nerves &amp; on spinal cord producing paraplegia (paralysis lower limbs) this is accentuated by the associated endarteritis obliterans (little blood supply to area) &amp; easy fracture of the bones, also causing damage to nerves.</p>
<ul>
<li>Long bones (tuberculous osteomyelitis) bones undergo caseation and pathological fracture is common. Direct spread to the adjacent joint is also common. Such fractures undergo faulty union e.g. fibrosis or weak union.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-tb-peritonitis">7. TB PERITONITIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-tb-peritonitis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Source: Direct from genitourinary tract or caseous mesenteric lymph nodes Blood spread &amp; lymphatic spread from generalized lymphadenopathy</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types">Types:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Serous or wet type associated with peritoneal small tubercles and minimal adhesions.</p>
<p>b) Adhesive or dry type. The excess fibrosis causes omentum to roll on its self (frozen abdomen) causing intestinal obstruction or intestinal fistulae. Peritoneal fluid is caseous.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="8-tb-of-cns">8. TB OF CNS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-tb-of-cns" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Source: blood stream
Lesions: Tuberculoma = caseous necrotic mass in brain surrounded by gliosis
TB MENINGITIS= TUBERCLES ON MENINGES + MUCH EXUDATE rich in lymphocytes &amp; fibrin but poor in epithelioid cells &amp; Langhan's giant cells. CSF is under high pressure. The pia &amp; arachnoid mater are mainly affected as well as the lining of the ventricles.</p>
<p>Manifestations: Local:gross &amp; microscopic picture of lesions
General: e.g. fever &amp; blood changes i.e. clinical picture</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="progress-fate">Progress &amp; fate<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#progress-fate" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Recovery &amp; healing</li>
<li>Persistence of organism: Acute changes to chronic (chronicity</li>
<li>Complications:
a. Tissue damage &amp; necrosis with loss of function of organ.
b. Spread (no localization)</li>
</ol>
<p>Direct (local spread) Distant -Bloodstream
c. Complications of healing by fibrous tissue according to site</p>
<ol>
<li>Fibrosis with cranial nerve paralysis due to compression</li>
<li>Hydrocephalous due to obstruction of CSF flow</li>
<li>Spread mostly direct producing encephalitis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-tb-summary">1) TB SUMMARY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-tb-summary" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1ry-tb-complex">1RY TB COMPLEX<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1ry-tb-complex" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Proliferative lesion (granuloma) with minimal exudative reaction (late in the disease with onset of hypersensitivity)</li>
<li>Lymphangitis</li>
<li>Regional lymphadenitis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2ry-tb">2RY TB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2ry-tb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Exudative (hypersensitivity reaction) characterized by caseous necrosis (no lymph node enlargement)</li>
<li>Minimal proliferative reaction</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="post-1ry-spread-or-complicated-2ry">POST 1RY spread or COMPLICATED 2RY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#post-1ry-spread-or-complicated-2ry" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Proliferative &amp; exudative reaction with generalized lymphadenopathy (enlargement) LESIONS</p>
<table><thead><tr><th style="text-align: center;">PROLIFERATIVE</th><th style="text-align: center;">EXUDATIVE</th><th style="text-align: center;">FIBROTIC</th></tr></thead><tbody><tr><td style="text-align: center;">Granuloma</td><td style="text-align: center;">Caseation or lymphocyte rich effusion.</td><td style="text-align: center;">FT/scar</td></tr><tr><td style="text-align: center;">C.inflam + immune reaction. (late)</td><td style="text-align: center;">Hypersensitivity reaction (harmful immune reaction)</td><td style="text-align: center;">Healing</td></tr><tr><td style="text-align: center;">1ry -post 1ry complications</td><td style="text-align: center;">2ry - post 1ry complications</td><td style="text-align: center;">1ry &amp; 2ry</td></tr><tr><td style="text-align: center;">Activated lymphocytes &amp; epithelioid cells.</td><td style="text-align: center;">Necrotic cheesy caseation</td><td style="text-align: center;">White -firm tissue that shrinks</td></tr><tr><td style="text-align: center;">1. Tubercles e.g.: &lt;br&gt; - Multiple Miliary TB &lt;br&gt; - Single Gohn's focus &lt;br&gt; 2. Tuberculoma (isolated organ TB) 1-5 cm formed of fused tubercles with central caseation.</td><td style="text-align: center;">1-TB pneumonia &lt;br&gt; 2-Serous effusions &lt;br&gt; 3-Cold abscess &lt;br&gt; 4-Caseous empyema &lt;br&gt; 5-Pott's disease</td><td style="text-align: center;">1ry-healed Gohn's &lt;br&gt; 2ry -apical fibrosis</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-syphylis">2) SYPHYLIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-syphylis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: infective granuloma caused by Treponema pallidum. It is one of the venereal diseases.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mode-of-infection">Mode of infection:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mode-of-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Direct method: during sexual contact. Bacteria can penetrate intact skin or mucous membranes.</p>
<p>Congenital method: bacteria can cross the placenta from the mother to her fetus.
It is important to mention that once the bacteria enter the body, they pass to the lymph vessels then lymph nodes and finally the blood stream before the development of any lesion at site of entry.</p>
<p>Tissue reaction: syphilitic granulation tissue [SGT] formed of dense perivascular infiltrate of plasma cells, lymphocytes and few giant cells. Characteristically there is prominent end arteritis obliterans while the reaction is still early and cellular [in other inflammations, end arteritis obliterans appear late when the reaction is fibrous].</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="lesions-or-stages">Lesions or Stages:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#lesions-or-stages" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="primary-stage-hard-chancre">Primary Stage <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> Hard Chancre:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#primary-stage-hard-chancre" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Appears 2 weeks after infection at site of entry of bacteria.</li>
<li>Site may be genital or extragenital [fingers, lip, tongue].</li>
<li>Grossly: single raised red papule which ulcerates after few days. The ulcer is rounded, superficial and has flat edgeshclean floor firm margin and firm base. The ulcer is painless &amp; very infective. It heals by thin atrop ic scar. The draining lymph nodes appear enlarged, separate, mobile and painless [lymphadenitis].</li>
<li>Microscopic: the covering epithelium is absent. The subepithelial tissues show syphilitic granulation tissue. The lymph nodes show reactive hyperplasia.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="secondary-stage">Secondary Stage:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#secondary-stage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Appears 2 months after the primary stage.</li>
<li>Affects mainly tissues of ectodermal origin.</li>
<li>Lesions are also very infective and are accompanied by fever, headache, weakness and joint pains.</li>
<li>Skin rash: painless rash formed of macules, papules and pustules all over the body. Micro: the usual SGT.</li>
<li>Condyloma lata (warts): bulky skin papules at areas of moist skin as axilla and under the breast.
Micro: the usual SGT with hyperplastic covering epithelium.</li>
<li>Scaly desquamation of palms and soles, leucoderma and alopecia</li>
<li>Mucous patches: lesions similar to skin rash on mucous membranes of mouth, pharynx, vagina, anus. They may ulcerate → snail track</li>
<li>Generalized lymphadenitis: especially epitrochlear &amp; posterior cervical.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="tertiary-stage">Tertiary Stage:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tertiary-stage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Appears 2 years after the primary stage.</li>
<li>Gumma: localized area of syphilitic granulation tissue which under-goes slow caseous necrosis. It can affect any organ as liver, heart, brain, bones &amp; tongue. Gross: single or multiple, small or large mass with yellow center [necrosis] &amp; gray periphery [fibrosIs]. Microscopic: three zones: central zone of necrOSIS, ouetr zone of fibrosIs and mid zone of sypnilitic granulation tissue formed of. Fate: gumma in solid organs heals by fibrosis. Gumma on surface epithelia [tongue] ulcerates resulting in gummatous ulcer with sharp edges and necrotic floor, it has a punched out appearance &amp; is pre-cancerous.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="examples-of-gumma">Examples of gumma<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-of-gumma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>In the liver: multiple foci of necrosis surrounded by radiating fibrotic scars causing lobulation of the surface (Hepar lobatum).</li>
<li>In the heart: gumma of the septum leading to heart block.</li>
<li>In the testis: testicular enlargement followed by fibrosis.</li>
<li>In the skull: worm eaten appearance of skull bones.</li>
<li>Perforated palate and saddle nose.</li>
<li>In the tongue: gummatous ulcer.</li>
</ol>
<ul>
<li>Diffuse syphilitic inflammation: there is diffuse infiltration by syphilitic granulation tissue with minimal necrOSIS, It leads to diffuse fibrous thickening ofthe affectea organ. It is more common and develops very slowly.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="congenital-syphilis">Congenital Syphilis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#congenital-syphilis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The untreated mother can transmit syphilis to her fetus especially after the 4th month of pregnancy [after disappearance of Langhan's layer of placenta]. Abortion may result, the infant may die soon after birth or the baby may survive and syphilitic lesions appear early or late in life. The placenta is large, heavy and firm. It shows SGT &amp; many microorganisms.</p>
<p>Early Manifestations: develop during the <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>1</mn><mtext>st&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">1^{\text {st }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7936em;"></span><span class="mord"><span class="mord">1</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7936em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">st&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> two years of life.</p>
<ul>
<li>Skin rash: painless rash formed of macules, papules and pustules all over the body. Micro: the usual syphilitic reaction.</li>
<li>Condyloma lata: bulky skin papules at areas of moist skin as axilla and under the breast. Micro: the usual SGT with hyperplastic covering epithelium.</li>
<li>Scaly desquamation of palms and soles, leucoderma and alopecia.</li>
<li>Mucous patches: lesions similar to skin rash on mucous membranes of mouth, pharynx, vagina &amp; anus. They may ulcerate <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> snail track.</li>
<li>Rhagades: radiating scars at angles of mouth &amp; anus.</li>
<li>Saddle nose: caused by gumma of the nasal septum.</li>
<li>Syphilitic osteomyelitis: involving epiphyseal lines <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> retardation of growth.</li>
<li>Syphilitic inflammation of internal organs as liver <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> cirrhosis and lung <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> pneumonia.</li>
</ul>
<p>Late Manifestations: develop within 2-30 years after birth.</p>
<ul>
<li>
<p>Gumma of bones [gummatous osteitis): skull, nose saddle nose and hard palate (perforate palate).</p>
</li>
<li>
<p>Diffuse syphilitic periostitis: Produces a square shaped skull &amp; saber tibia.</p>
</li>
<li>
<p>Effusions in big joints.</p>
</li>
<li>
<p>Hutchinson teeth: the permanent central incisors are small, peg-shaped, widely separated and notched.</p>
</li>
<li>
<p>Iritis, keratitis, retinitis results in blindness.</p>
</li>
<li>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>8</mn><mtext>th&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">8^{\text {th }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8491em;"></span><span class="mord"><span class="mord">8</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8491em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">th&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> cranial nerve affection causes deafness.</p>
</li>
<li>
<p>C.N.S. affection results in general paralysis of insane.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-rhinoscleroma">3) RHINOSCLEROMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-rhinoscleroma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Granulomatous inflammation of the nose (other sites: laryngeal scleroma, pharyngeal scleroma) caused by Klebsiella rhinoscleromatis bacteria which is endemic in Egypt &amp; which multiplies in the macrophages producing a foamy appearance (Mickulicz cells).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="morphology-plate-7">Morphology: plate (7)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphology-plate-7" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Gross: Rhinoscleroma usually affects the nasal cavity by forming a bulky grey, firm mass. Lesions associated with Rhinoscleroma may also affect the larynx; nasopharynx; oral cavity; paranasal sinuses; or soft tissues of the lips, nose, trachea, and bronchi..</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic">Microscopic<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Microscopically, the most conspicuous feature is the presence of histiocytic granulomas, with fibrosis and an abundant infiltrate of lymphocytes and plasma cells.</li>
<li>The mucosal surfaces display variable changes, ranging from squamous metaplasia to extreme pseudoepitheliomatous hyperplasia.</li>
<li>Large vacuolated, "foamy" histiocytes, known as Mikulicz cells (arrow) are characteristic of rhinoscleroma and are most numerous in the nodular stage as well as Russel bodies (arrow head) which are plasma cells distended with glassy pink flyaline appearing material( immunoglobulins).</li>
<li>Klebsiella organisms are seen within cells and in extracellular locations.
<img src="assets/images/image-20251212-04dffbac.jpeg" alt="img-47.jpeg"></li>
</ul>
<p>A
<img src="assets/images/image-20251212-91586369.jpeg" alt="img-48.jpeg"></p>
<p>Plate (7)</p>
<p>B</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-leprosy">4)LEPROSY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-leprosy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: Infective granuloma caused by Mycobacterium leprae.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="etiology-pathogenesis">Etiology &amp; pathogenesis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#etiology-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Organism: Mycobacterium leprae
Acid-alcohol fast bacillus
Source: prolonged close contact 5-10 yrs
Site: skin and nerves</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="manifestations-according-to-type">Manifestations according to type<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#manifestations-according-to-type" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th style="text-align: center;">1) Tuberculoid (mild) &lt;br&gt; Macula-anaesthetic leprosy &lt;br&gt; Good immunity</th><th style="text-align: center;">2) Lepromatous (severe) &lt;br&gt; Nodular leprosy-leonine facies &lt;br&gt; Low immunity</th></tr></thead><tbody><tr><td style="text-align: center;">Gross &lt;br&gt; Macules (flat hypopigmented patches) &lt;br&gt; + nerve Inflammation (thickening)</td><td style="text-align: center;">Nodules or erythematous macules &lt;br&gt; + nerve Inflammation (Thick, cord-like)</td></tr><tr><td style="text-align: center;">Microscopic &lt;br&gt; Granuloma (leproma) + few organisms</td><td style="text-align: center;">Granuloma + many organisms</td></tr><tr><td style="text-align: center;">Lymphocytes + plasma cells + foamy macrophages (clear cells or foam cells) called lepra cells</td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">CP: &lt;br&gt; loss of sensation &amp; sweating &lt;br&gt; Trophic changes (ulcers) &lt;br&gt; Deformities and loss of parts of limbs &lt;br&gt; (due to loss of sensation &amp; low blood supply)</td><td style="text-align: center;">leonine facial disfigurement &lt;br&gt; Severe trophic changes &lt;br&gt; Deformities and loss of parts limbs &lt;br&gt; Loss of sensation</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="n-b">N.B.:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Macule: nat area of discoloration of skin
Papule: slightly raised area
Nodule: raised mass
Polyp (wide CT core) I papilloma (thin CT core): finger like ro"ection from surface</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="5-actinomycosis">5) ACTINOMYCOSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-actinomycosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: infective granuloma caused by Actinomyces israeli. It is an anaerobic gram +ve bacteria. The organism is commensal in the mouth, carious teeth and intestine. Infection can be endogenous especially when the body immunity is lowered.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-features">Pathological features:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Gross: multiple intercommunicating abscesses opening to the surface by multiple sinuses discharging pus and yellow bacterial colonies [known as sulphur granules].</p>
<p>Microscopic: each abscess is formed of three zones: [Fig. 6]</p>
<ol>
<li>Central zone of pus containing rounded or oval bacterial colonies formed of thinfilaments surrounded by club-like swellings.</li>
<li>Mid zone of inflammatory cells including polymorphs, pus cells, lymphocytes, plasma cells, macrophages and giant cells.</li>
<li>Outer zone of fibrosis.
<img src="assets/images/image-20251212-20ec29af.jpeg" alt="img-49.jpeg"></li>
</ol>
<p>Fig. 6</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-actinomycosis-are">Types of Actinomycosis are:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-actinomycosis-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Cervicofacial Actinomycosis [60%]:</li>
</ol>
<ul>
<li>Affects the region of angle of mandible and adjacent parts of neck and face.</li>
<li>Micro-organism enter through buccal mucosa after minor trauma.</li>
<li>Gross and micro: describe.</li>
<li>Blood spread may occur. No lymphatic spread because of the large size of the filaments.</li>
</ul>
<ol start="2">
<li>Intestinal Actinomycosis [20%].</li>
<li>Pulmonary Actinomycosis [15%].</li>
<li>Skin Actinomycosis [5%].</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="summaryof-bacterial-infections">SUMMARYOF BACTERIAL INFECTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#summaryof-bacterial-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>ACUTE inflammation
a. Suppurative
b. Non- suppurative</p>
<p>CHRONIC inflammation
a. Non -specific
b. Specific (granuloma)
c. Infl. + Immune reaction
<img src="assets/images/image-20251212-b348f4aa.jpeg" alt="img-50.jpeg"></p>
<p>Any infectious disease whether acute or chronic should be described in the following manner:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="etiology-pathogenesis">Etiology &amp; pathogenesis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#etiology-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Organism &amp; its description</li>
<li>Route of infection</li>
<li>Site of lesions</li>
<li>Mechanism of lesion production</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Basic reactions.</td><td style="text-align: left;">ALL</td></tr><tr><td style="text-align: left;">Bacterial infections.</td><td style="text-align: left;">Toxemia-bacteremia-septicimia-pyemia</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">T8</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Leprosy</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Syphilis.</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Actinomycosis.</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Rhinoscleroma.</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="viral-diseases">VIRAL DISEASES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#viral-diseases" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Viruses are the smallest known infective agents. All viruses depend on host cell metabolism for their replication, they are obligate intracellular parasites. Viruses vary greatly in size from 20-300 nm. Viruses are either spherical or cylindrical in shape. A single virus particle, called virion is made up of a core consisting of a single molecule of nucleic acid either DNA or RNA and a surrounding protein shell called a capsid. Diseases caused by viruses are either:</p>
<ol>
<li>Acute illness: e.g. common cold and influenza.</li>
<li>Lifelong latency and long-term reactivation: e.g. herpes viruses.</li>
<li>Chronic disease: e.g. HBV, HCV and HIV.</li>
<li>Neoplasia.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mode-of-infection">Mode of Infection:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mode-of-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Inhalation: e.g. Influenza and measles.</li>
<li>Ingestion: e.g. poliomyelitis and viral hepatitis.</li>
<li>Inoculation: e.g. trachoma.</li>
<li>Bite of a vector: e.g . yellow fever.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="disease-spectrum-and-pathological-changes-associated-with-viral-infections">Disease spectrum and pathological changes associated with viral infections:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disease-spectrum-and-pathological-changes-associated-with-viral-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>There are several possible consequences to a cell that is infected by a virus, and ultimately this may determine the pathology of a disease caused by the virus.</p>
<ol>
<li>host Lytic infections result in the destruction of the.</li>
<li>Abortive infection: in which the virus couldn't complete its replication, due to lack of essential factors needed for replication or due to action of host immune mechanisms.</li>
<li>Persistent infections: Symptoms and signs remain over relatively long periods of time due to slow viral release.</li>
<li>Latent infections: there is a delay between the infection by the virus and the appearance of symptoms. Fever blisters (cold sores) caused by herpes simplex type 1 result from a latent infection; they appear sporadically as the virus emerges from latency, usually triggered by some sort of stress in the host.</li>
<li>Transformation: Some viruses have the potential to change a cell from a normal cell into a tumor cell. These viruses are referred to as oncogenic viruses.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-changes">Pathological Changes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-changes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Cellular changes: include:
a) Cellular proliferation as in warts.
b) Cellular degeneration and necrosis as in poliomyelitis and viral hepatitis.</li>
</ol>
<p>c) Appearance of inclusion bodies as in rabies and smallpox.
2) Inflammatory cellular exudate: Mainly perivascular and consists lymphocytes and macrophages.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="acquired-immuno-deficiency-syndrome-aids">Acquired Immuno-Deficiency Syndrome: AIDS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acquired-immuno-deficiency-syndrome-aids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The causative organism is the human immunodeficiency virus (HIV) which is a retrovirus (RNA virus containing the enzyme reverse transcriptase), 2 types are known: HIV-1 &amp; HIV-2.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="transmission-of-the-virus-occurs-through">Transmission of the virus occurs through<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#transmission-of-the-virus-occurs-through" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Sexual contact.</li>
<li>Parentral inoculation</li>
<li>From infected mothers to their newborns.</li>
</ol>
<p>The persons at high risk for developing AIDS are Promiscuous homosexuals, intravenous drug abusers, hemophiliacs, blood recipients and sexual partners or children of any individual with the disease. Only small numbers of cases have been free from all risk factors._N.B. The virus may produce asymptomatic infection for many years.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism">Mechanism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Lymphopenia: mainly due to selective loss of CD4 + helper T-cell together with impairment in the function of the surviving helperT cells. The total leucocytic count is low (less than 2000) and the CD4 + T cell count is below 200. The CD4/CD8 ratio is inverted, normally it is 2 while in AIDS it is 0.5 .</li>
<li>Decreased and altered T cell functions: increased susceptibility to opportunistic infections and malignant neoplasms.</li>
<li>Decreased delayed tyge hapersensitivity, decreased proliferative response to antigens, decreased specIfic c OtOXIClty &amp; ecreased production of IL-2 &amp;IL-8.</li>
<li>Polyclonal B cell activation: hypergammaglobulinemia and inability to mount de novo antibody response to new antigens.</li>
<li>Altered Monocyte/Macrophage functions: decreased chemotaxis and phagocytosis.</li>
</ol>
<p>The phases of HIV infection and their corresponding clinical features</p>
<ul>
<li>
<p>Early acute (Unitial) phase (group I) Self limiting acute illness (acute infection) consisting of non specific symptoms such as: sore throat, muscle pain, fever and skin rash. There is high level of virus replication with antiviral response.</p>
</li>
<li>
<p>Middle ( Latent ichronic phase (group II) .There is low level of HIV replication which may last for several years. Patients may be asymptomatic (group II) or develop persistent generalized lymphadenopathy. Most if not all patients with HIV infection will progress to AIDS after a chronic phase lasting from 7 to 10 years.</p>
</li>
<li>
<p>Final crisis (opportunistic infection &amp; tumours) phase (group III): There is breakdown of host defense with recrudescence of viral replication, this phase comprises.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a-opportunistic-infections-such-as">A. opportunistic infections such as<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-opportunistic-infections-such-as" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Protozoal and Helminthic infections: toxoplasmosis, - strongyloidosis, pneumocystosis.</li>
<li>Fungal infections: candidiasis, histoplasmosis and cryptococcosis.</li>
<li>Bacterial infections: tuberculosis, atypical mycobacteriosis, salmonella and shigella infections.</li>
<li>Viral infections: cytomegalovirus, herpes simplex virus and Varicella - Zoster virus.
B. Malignant neoplasms, such as non Hodgkin's lymphoma, Burkitt's lymphoma and Kaposi's sarcoma</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="epstein-barr-virus">Epstein-Barr virus<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#epstein-barr-virus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Epstein- Barr Virus (EBV) is a herpes virus and is the causative agent of Burkitt's lymphoma in Africa, nasopharyngeal cancer in the orient and infectious mononucleosis.</p>
<p>Mode of transmission: The virus is spread by close contact (kissing). The virus can also be spread by blood transfusion.</p>
<p>Pathogenesis: EBV only infects a small number of cell types that express the receptor for complement C3d component (CR2 or CD21). These are certain epithelial cells (oro &amp; naso-pharynx) and B lymphocytes. This explains the cellular tropism of the virus. The virus is replicated in pharyngeal epithelial cells, shed into the saliva and is taken up by B lymphocytes. As a result of EBV infection, these lymphocytes become stimulated to divide and are protected from undergoing apoptosis (cell death). They become transformed cells and they begin to appear in high levels in the bloodstream.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="diseases-caused-by-ebv">Diseases caused by EBV:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diseases-caused-by-ebv" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Infectious mononucleosis: This disease is characterized by non specific symptoms and signs, including malaise, generalized lymphadenopathy, tonsillitis, enlarged spleen and liver, and fever. The disease usually runs a benign course.</p>
</li>
<li>
<p>Burkitt's lymphoma: A type of malignant tumor of B lymphocytes, affecting jaw and face of young children. Tumor cells show evidence of EBV DNA.</p>
</li>
<li>
<p>Nasopharyngeal cancer: The disease is a malignant tumor of the epithelium of the upper respiratory tract and the tumor cells contain EBV DNA.</p>
</li>
<li>
<p>The association between EBV and a number of other tumors has only come to light in more recent years, indicating that the oncogenic effects of the viruses may be evident when infecting other cell types. The best known of these examples is Hodgkin's disease, which another type of malignant lymphoma.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="human-papilloma-virus">Human Papilloma virus<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#human-papilloma-virus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: Human papilloma virusHPV) is a family of over 100 viruses including those which cause) warts and are transmitted by contact. Some types of HPV are associated with tumors of the genital .tract including cancer of the cervix</p>
<p>Types of HPVs: The strains of HPV may be divided into two major groups</p>
<ol>
<li>Low-risk groups: these are the strains which produce raised warts, namely HPV<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>6</mn><mi mathvariant="normal">&amp;</mi></mrow><annotation encoding="application/x-tex">6 \&amp;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord">6&amp;</span></span></span></span></span> HPV-11.</li>
<li>
<ol start="2">
<li>High-risk groups are more likely to lead to the development of cancer. These high-risk types cause growths that are usually flat and nearly invisible. Examples include HPV-16 8. HPV-18</li>
</ol>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="diseases-caused-by-hpv">Diseases caused by HPV:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diseases-caused-by-hpv" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Common warts: The majority of HPVs produce warts on the hands, fingers, and even the face. Most of these viruses are thus innocuous, causing nothing more than cosmetic concerns.</li>
<li>Genital warts (Condylomata acuminatum), sexually transmitted, and most commonly caused by two HPV strains, HPV-6 and HPV-11.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cytomegalic-inclusion-disease-cid">Cytomegalic Inclusion Disease (CID)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cytomegalic-inclusion-disease-cid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The modes of transmission of the cytomegalovirus include
A. Intra-uterine transplacental transmission. from newly infected or asymptomatic mother to her fetus leading to</p>
<ul>
<li>
<p>Abortion, stillbirth or premature baby.</p>
</li>
<li>
<p>Severe multisystem disease in the form of anemia, purpura, thrombocytopenia jaundice, hepato-splenomegaly, pneumonia, hepatitis, encephalitis and mental retardation. Most of these patients die.</p>
</li>
<li>
<p>Mild multisystem disease in the form of pneumonitis, hepatitis and encephalitis. Most of these patients recover but many may develop mental retardation</p>
</li>
<li>
<p>Asymptomatic infection, but few patients may develop hearing defects or mental retardation.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="b-acquired-transmission">B. Acquired transmission<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-acquired-transmission" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Respiratory droplet transmission .</li>
<li>Blood transfusions and organ transplantions.</li>
<li>Venereal transmission .</li>
<li>Transmission through mother's milk to her baby.</li>
</ul>
<p>The clinical picture ranged from an asymptomatic illness to serious multisystem affection in immunosuppressed persons. The manifestations include pneumonitis, hepatitis, enterocolitis, and retinochoroiditis. eNS involvement in adults is rare.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Viral infections</td><td style="text-align: left;">Acquired Immuno-Deficiency Syndrome: AIDS &lt;br&gt; HPV &lt;br&gt; EBV &lt;br&gt; Cytomegalovirus</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathology-of-fungal-infection">PATHOLOGY OF FUNGAL INFECTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathology-of-fungal-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition">Definition:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Fungi are microscopic plant single-celled or multicellular organism. They are not always pathogenic. Many fungi are saprophytes (living on dead organic matter). Fungi can be true pathogens that cause infections in healthy persons or they can be opportunistic pathogens that cause infections in immunocompromised persons. Others are used for the development of antibiotics, antitoxins, and other drugs used to control various human diseases.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="diseases-caused-by-fungi">Diseases Caused by Fungi<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diseases-caused-by-fungi" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Fungal infections or mycoses can be classified depending on the degree of tissue involvement and mode of entry into the host. These are:</p>
<ol>
<li>Superficial &amp; cutaneous: localized to the skin, hair, nails&amp; mucosa. Examples include oral candidiasis (thrush), vaginal candidiasis, athlete's foot (tinea pedis), and diaper fungal infections of babies.</li>
<li>Subcutaneous infection: Are rare conditions, in which Infection may arise following the wounding of the skin and the introduction of soil saprophytes. The infection is chronic, localized, confined to the dermis, subcutaneous tissue or adjacent structures, leading to ulcerative lesion. Madura foot is an example of this type of affection.</li>
<li>Systemic Mycoses: These are invasive infections of the internal organs. They are uncommon in normally healthy persons. They may be caused by:</li>
</ol>
<ul>
<li>Primary pathogenic fungi: These are fungal infections of the body caused by fungal pathogens which can overcome the physiological and cellular defenses of the normal human host by changing their morphological form. The primary site of infection is usually pulmonary. Infection by Histoplasma capsulatum (histoplasmosis) is an example of this type of affection.</li>
<li>Opportunistic fungi that are of marginal pathogenicity (non pathogenic or of low virulence) but can infect the immunocompromised host causing potentially fatal infections. Examples include systemic Candidiasis. In this condition candida albicans - which is part of the normal human flora - can proliferate and disseminate throughout the body of severely immunocompromized host.</li>
</ul>
<p>Pathogenesis of fungal infections: Fungi produce their pathological effects through the following mechanisms.
A. Surface factors that help in adherence to host tissue.
B. Enzymes which facilitate tissue invasion</p>
<p>Immunological response against fungi: immunological reaction against pathogenic fungi may be mediated By:</p>
<ol>
<li>Cell mediated immunity.</li>
<li>Humoral immunity against cell membrane antigens.</li>
</ol>
<p>Spectrum of inflammatory responses: Tissue reaction to pathogenic fungi may be extremely variable, depending on the type of invading fungus and the host immune response. we can find any of the following inflammatory responses.</p>
<ol>
<li>Acute and chronic suppurative inflammation.</li>
<li>Chronic inflammation with mononuclear inflammatory infiltrate.</li>
<li>Granulomatous inflammation.</li>
<li>Necrotizing inflammation.</li>
</ol>
<p>Any form of tissue reaction certainly may be associated with necrosis and scarring.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="candida-albicans">Candida albicans<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#candida-albicans" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Candida albicans (also called Monilia is the (most common fungal pathogens of mankind. These are normal inhabitants of oral cavity, GI tract, &amp; vagina. Fungi are yeast-like cell with pseudohyphae &amp; hyphae.
<img src="assets/images/image-20251212-99f259ae.jpeg" alt="img-51.jpeg"></p>
<p>Disease spectrum of Candida albicans: Depending on the immunological status of the host, Candida can cause superficial &amp; cutaneous affection in healthy individuals, and can cause systemic opportunistic affection in immunocompromised patients. The infection is endogenous as the organism is a commensal.</p>
<ol>
<li>Superficial &amp; cutaneous candidiasis: may occur in healthy individuals. The normal flora starts to invade mucosal surfaces and skin. Predisposing factors include pregnancy, with oral contaceptives, diabetes, and prolonged antibiotic intake.</li>
</ol>
<p>Sites: Oral candidiasis (thrush), vulvovaginal candidiasis, skin &amp; nail bed (paronychia) and esophagus &amp; intestine.</p>
<p>Gross: Mucosal surfaces showed superficial white friable patches composed of organisms and inflammatory debris. When detached, it leaves red inflamed surface and in severe cases there is surface ulceration.
<img src="assets/images/image-20251212-61e511cf.jpeg" alt="img-52.jpeg"></p>
<p>Fig 7 Oral candidiasis</p>
<p>Microscopic: Ranges from acute diffuse neutrophilic infiltration with microabscesses within the epithelium, to chronic granulomatous inflammation. Fungal bodies, hyphae and spores may be detected by PAS stain.
2. Systemic Candidiasis: is a form of opportunistic infection, occurs in immunocompromised patients.</p>
<p>Sites: Urinary tract (kidney &amp; urinary bladder), GIT (oesophagus &amp; stomach), Heart, Lung, CNS</p>
<p>Gross: Wide spread necrotizing lesion within the affected organ.
Microscopic: Multiple microabscesses, in which the fungal colonies occupy the center of the lesion. They are surrounded by necrosis and neutrophilic infiltrate. Fungal bodies, hyphae and spores may be detected by PAS stain.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mycetoma-madura-foot-nocardiasis">Mycetoma (Madura Foot/Nocardiasis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mycetoma-madura-foot-nocardiasis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: Madura foot or mycetoma (named because of the tumour-like mass it forms) is a chronic granulomatous infection involving the subcutaneous tissue and bone of feet and characterized by the formation of localized lesions with multiple draining sinuses. The exudates contains granules that may be yellow, white, red, brown, or black, depending upon the causative agent.</p>
<p>Aetiology: Mycetoma can be divided into two major categories according to the causative organism.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causative-agent">Causative agent:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causative-agent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Eumycetoma: which is caused by true fungi, in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>40</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">40 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">40%</span></span></span></span></span> of cases, which represent a form of subcutaneous fungal infection.</li>
<li>Actinomycetoma: which is caused by filamentous bacteria, and represent <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>60</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">60 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">60%</span></span></span></span></span> of cases.</li>
</ol>
<p>Both forms have similar gross and microscopic appearance.
Mode of infection: Organisms are normally present in environment (soil &amp; dust). Infection occurs in bare-footed persons after minor penetrating skin injury inoculating soil organisms, occurring preferentially in rural areas, usually among agricultural workers who work barefoot. The disease is endemic in the tropics and subtropics.</p>
<p>Risk factors: Mycetoma typically presents in agricultural workers (hands, shoulders and back - from carrying contaminated vegetation and other burdens), or in individuals who walk barefoot in dry, dusty conditions. Minor trauma allows pathogens from the soil to enter the skin.
<img src="assets/images/image-20251212-c67298e2.jpeg" alt="img-53.jpeg"></p>
<p>Gross: Both forms of mycetoma present as a progressive, cutaneous and subcutaneous swelling. Multiple nodules develop which may suppurate and drain through multiple sinus tracts that usually discharge serosanguinous fluid and, at times, grossly visible granules of various colours depending on the agent involved.
<img src="assets/images/image-20251212-b1cfe78f.jpeg" alt="img-54.jpeg"></p>
<p>Microscopically: the dermis and subcutaneous tissue contain localized abscesses, each of which contains one or more granules in its centre. Eosinophilic, club like material may border the granules. Between abscesses, there is extensive formation of septic granulation tissue and scarring. Infection often involve contiguous bone, resulting in destructive osteomyelitis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Fungal</td><td style="text-align: left;">Madura foot</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Candida</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">Rest category C</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="parasitic-infestations">PARASITIC INFESTATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#parasitic-infestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="parasitic-infestations">PARASITIC INFESTATIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#parasitic-infestations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Bilharziasis or schistosomiasis</li>
<li>Hydatid disease</li>
<li>Amoebiasis (see special colon)</li>
<li>Malaria</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="schistosomiasis-bilharziasis">SCHISTOSOMIASIS (Bilharziasis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#schistosomiasis-bilharziasis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>DEFINITION: Parasitic allergic granulomatous disease caused by Schistosoma mansoni or hematobium.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="aetiology-pathogenesis">AETIOLOGY &amp; PATHOGENESIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aetiology-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Schistosoma mansoni affects GIT. Schistosoma hematobium affects urogenital tract.
Pathogenesis: The bilharzial lesions are allergic ( type I -type IV hypersensitivity) to antigens produced by cercaria, adult worms and ova.</p>
<ol>
<li>Cercaria: Skin penetration by cercaria in swimming water resulting in allergic dermatitis or bathers itch (acute allergic inflammation) itchy macules or papules rich in eosinophils, some PNLs, macrophages &amp; dilated congested blood vessels</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-adult-worms">2. Adult worms:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-adult-worms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Living: Adult worm lives in veins of GIT (S.mansoni) or urogenital system (S.haematobium)
B. Dead: Severe allergic inflammation to its antigens causes tissue necrosis and dense inflammation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-ova">3. Ova:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-ova" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Trapped eggs mature normally, secreting antigens that elicit a vigorous immune response.</li>
<li>The egg induced granuloma formation is a delayed Type Hypersensitivity reaction, and, although eventually resulting in severe pathology classically associated with schistosomiasis, appears to be a necessary protective host response against hepatotoxic components of Soluble Egg Antigen.</li>
<li>The granuloma that forms around the egg consists mainly of a number of different type of immune cells, including both T and B cells, macrophages, giant cells, epitheloid cells, mast cells, plasma cells, fibroblasts and eosinophils, with subsequent fibrosis and ova calcification.</li>
</ul>
<p><img src="assets/images/image-20251212-65bb1d92.jpeg" alt="img-55.jpeg"></p>
<p>Severe acute allergic inflammation in BV wall(thrombophlebitis) Necrosis + A.lnfl. rich in eosinophils</p>
<p>Mechanical irritation in submucosa (highly vascular)</p>
<p>Some trapped in submucosa
Forming granuloma</p>
<p>Released in lumen come out in urine or stools</p>
<p>Some carried by blood to liver or lungs (emboli) forming granulomas + REG hyperplasia
reticuloendothelial system hyperplasia
(lymphadenopathy
&amp;
splenomegaly)</p>
<p>Ova &amp; worms produce mechanical irritation at site resulting in bilharzial granulomas &amp; release antigens which stimulate the immune system types 1,11,111 &amp; IV hypersensitivity reactions with an associated enlargement of LN &amp; spleen which are organs of the reticuloendothelial syster (RES)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="microscopic">MICROSCOPIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A. Granuloma</p>
<p>Early granulomas are cellular (many cells + GT &amp; Bilharzial granulation tissue
Later <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span>
Very late <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span>
fibrocellular(cells + FT)
fibrotic or healed (FT or scar tissue)</p>
<p>B. Generalized lymphadenopathy &amp; splenomegaly: antigenic stimulation of REG in LN &amp; spleen result in their proliferation (hyperplasia) with increase in the size of these organs.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="granuloma-basic-reaction-br-plate-6">Granuloma basic reaction (BR): (plate 6)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#granuloma-basic-reaction-br-plate-6" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Central zone contains ovum (oval structures) with a refractile shell. Ova may contain a living miracidium which is pink &amp; nucleated or a dead miracidium which is pink but with no nuclei. Dead ova in long standing infestations become dystrophicaly calcified &amp; appear blue (H&amp;E stain).</li>
<li>Ova are surrounded by many eosinophils, macrophages, lymphocytes, plasma cells, PNLs &amp; giant cells (this is a mixture of 4 different hypersensitivity reactions).
C. EPITHELIAL or mucosal changes (basic reaction)
N.B.: ova are deposited in the most vascular parts as submucosa, but may also be deposited elsewhere.</li>
</ol>
<p>GROSS
MICROSCOPIC</p>
<ol>
<li>Epithelial changes</li>
</ol>
<p>Thinning (transparent
Thick mucosa
Cysts
Mass (complication)
Atrophic epithelium
Hyperplasia of cells or Metaplasia
Cystitis cystica /glandularis (US)
Neoplasia (carcinoma US)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-sandy-patches">2. Sandy patches<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-sandy-patches" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Yellowish granular area calcified ova+dense FT seen causing mucosal roughening through atrophic mucosa
Occurs due to a massive oviposition at the same time.The ova die become calcified &amp;surrounded by FT and covered by a thin transparent mucosa.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-polyp">3. Polyp<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-polyp" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Surface protrusion of mucosa + submucosa with Silh. granulation tissue</p>
<p>Cellular + fibrocellular + fibrotic granulomas in mucosa &amp; polyp core. Ova are both fresh &amp; calcified in same lesion
Occurs due to a repeated oviposition of small numbers of ova at the same site over a long period of time. This produces a slow rise of mucosa until a fingerlike projection or polyp is formed.</p>
<table><thead><tr><th style="text-align: left;">GROSS</th><th style="text-align: left;">MICROSCOPIC</th></tr></thead><tbody><tr><td style="text-align: left;">4. Fibrotic lesions &lt;br&gt; White firm + shrinkage</td><td style="text-align: left;">Fibroblasts + collagen fibers &lt;br&gt; Few trapped dead ova (mostly &lt;br&gt; Calcified)</td></tr><tr><td style="text-align: left;">5. Bilh. Ulcers &lt;br&gt; Superficial (shallow) &lt;br&gt; Saucer shaped small &lt;br&gt; deep ulcers rare</td><td style="text-align: left;">Simple ulcer edges &amp; floor contain Bil.GT</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="caused-by">Caused by:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#caused-by" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>falling of a polyp</li>
<li>of ova penetrating mucosa</li>
<li>mucosal ischemia due to pressure atrophy of sandy patches fissure (tear in UB mucosa) which occurs as a result of over distention of bladder with urine, in the presence of 2 fixed fibrotic areas along which a tear of mucosa occurs.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clinical-picture">CLINICAL PICTURE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251212-46495308.jpeg" alt="img-56.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="urinary-bladder-ub-schistosomiasis-bilharzial-cystitis">URINARY BLADDER (UB) SCHISTOSOMIASIS (BILHARZIAL CYSTITIS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#urinary-bladder-ub-schistosomiasis-bilharzial-cystitis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>SITE: submucosa of trigone, posterior &amp; lateral walls</p>
<p><img src="assets/images/image-20251212-cd008b3c.jpeg" alt="img-57.jpeg"></p>
<p>Bilharzial granuloma
<img src="assets/images/image-20251212-c2b0881c.jpeg" alt="img-58.jpeg"></p>
<p>Large intestine with submucosal ova
<img src="assets/images/image-20251212-cb47adba.jpeg" alt="img-59.jpeg"></p>
<p>Large intestine polyps
<img src="assets/images/image-20251212-a7080917.jpeg" alt="img-60.jpeg"></p>
<p>Sandy patch in urinary bladder
<img src="assets/images/image-20251212-3075909c.jpeg" alt="img-61.jpeg"></p>
<p>Urinary bladder. Brunns nest arrow head &amp; early cystitis cystic arrow
<img src="assets/images/image-20251212-a0fdbd2f.jpeg" alt="img-62.jpeg">
<img src="assets/images/image-20251212-c7cc93da.jpeg" alt="img-63.jpeg"></p>
<p>Liver fibrosis</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="morphology">MORPHOLOGY:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="urothelial-epithelial-lesions-plate-6">Urothelial epithelial lesions:(plate 6)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#urothelial-epithelial-lesions-plate-6" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Transitional cell hyperplasia: this will cause thickening of mucosa. With more proliferation of the cells, the epithelium will send downgrowths in the form of downward projections. When these separate from the surface, they produce transitional cell islands called Brunn's nests. Central degeneration with loss of cells will result in transitionally lined cysts called cystitis cystica.</li>
<li>Transitional cell atrophy: reduction of cell layers to 1-2 layers due to ischemia from the pressure of ova on BVs &amp; the endarteritis obliterans associated with the inflammatory reaction.</li>
<li>Squamous metaplasia: chronic irritation by the ova will produce change in type of cover from a weaker transitional to a stronger squamous type of epithelium. With more irritation, this layer may start to produce surface keratin like skin &amp; is termed leukoplakia (grossly appears as a white patch).</li>
<li>Glandular metaplasia in Brunn's nests: whereby the transitional lining changes to mucous secreting intestinal type cells, it is called cystitis glandularis.
N.B.: cystitis glandularis &amp; leukoplakia are considered precancerous i.e. they may lead to UB carcinoma.</li>
<li>Sandy patches see above</li>
<li>Polyps see above</li>
<li>Ulcers see above</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">COMPLICATIONS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Terminal hematuria: Hemorrhage into lumen at end of micturition due to squeezing out of ova during bladder contraction.
2- Ulcers get 2ry infected by pyogenic organisms <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Fistulae (vesico-rectal or vesicovaginal) &amp; ascending infection to kidney ending in renal failure
3- Malignant transformation (squamous cell carcinoma/transitional cell carcinoma/adenocarcinoma) see tumors</p>
<p>4- Fibrosis: Contracted UB which has a small capacity
Bladder neck obstruction resulting in obstructive uropathy (see special)
Urinary tract obstruction causes pressure on both kidneys and eventually chronic renal failure.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="urogenital-bilharziasis">UROGENITAL BILHARZIASIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#urogenital-bilharziasis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Ureters: Lesions occur in submucosa of lower third &amp; are similar to those of UB Complications:-Fibrosis of a hollow organ leads to obstruction (see repair)
A) Stenosis causing hydroureter &amp; hydronephrosis but if 2ry infection occurs, this condition changes fo pyoureter &amp; pyonephrosis
B) Obstructive uropathy results in back pressure on kidney &amp; chronic renal failure</p>
<p>Seminal vesicles-prostate-epidydimis- rarely testis: granulomatous inflammation
Vulva - vagina- endocervix- urethra: fibrosis of these narrow structures results in stenosis &amp; obstructive complications &amp; infertility</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="bilharziasis-of-large-intestine-plate-6">BILHARZIASIS OF LARGE INTESTINE (plate 6)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#bilharziasis-of-large-intestine-plate-6" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Sites: lesions occur in submucosa &amp; lamina propria of rectosigmoid
Lesions: similar to US but polyps are more common than sandy patches &amp; ulcers. There is no predisposition to cancer. Finally, a feature of colonic bilharziasis in cases of whole wall fibrosis is that ova are deposited outside the colonic wall in the form of a tumor-like mass of bilharzial GT attached to the outer aspect of colon (Bilharzioma). In such cases, there will be no ova in stools since ova have no way of reaching the lumen (closed intestinal bilharziasis)</p>
<p>Complications: same as US
1- Hemorrhage: fresh blood in stools since lesions are rectosigmoidal and lower down the tract.</p>
<p>2-2ry infection of ulcers resulting in dysentery (diarrhea, blood, mucus &amp; tenesmus)</p>
<p>3- Fibrosis causing stenosis &amp; intestinal obstruction is rare since colon is wide &amp; lesions generally superficial. Nevertheless, submucosal fibrosis may result in Silharzioma</p>
<p>4- Spread to liver &amp; lungs</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="bilharziasis-of-liver">BILHARZIASIS OF LIVER<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#bilharziasis-of-liver" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>MORPHOLOGY
GROSS
Early: Increase in liver size (Hepatomegaly) due to REC hyperplasia ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> Kupffer cells) Late: shrinkage of liver due to fibrosis</p>
<ol>
<li>
<p>Surface irregular due to FT retraction or shrinkage</p>
</li>
<li>
<p>Size: small shrunken</p>
</li>
<li>
<p>Cut section: liver parenchyma appears normal, but portal tracts are widened, due to fibrosis and appear as white thickbanas (pipe stem fibrosis). The smaller portal tracts when affected only appear as fine white lines.</p>
</li>
<li>
<p>Consistency: firm (FT)</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="microscopic">MICROSCOPIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Liver cells &amp; lobules are not affected; only the sinusoids show increased number of Kupffer cells containing hematin pigment.</li>
<li>Portal tracts:</li>
</ol>
<ul>
<li>Widened by fibrosis</li>
<li>Ova + bilharzial granulomas (cellular-fibrocellular-fibrotic)</li>
<li>Dead worms producing an allergic thrombophlebitis may be present</li>
<li>Angiomatoid formation: They are dilated congested anastomotic collateral channels opening between branches of hepatic artery and portal vein (PV) to by pass the fibrotic obstruction of portal tracts</li>
</ul>
<p>COMPLICATIONS of schistosomalliver fibrosis</p>
<ol>
<li>Portal hypertension:
<img src="assets/images/image-20251212-a9c16dd1.jpeg" alt="img-64.jpeg"></li>
</ol>
<ul>
<li>Ascitis</li>
<li>Congestive splenomegaly</li>
<li>Porto-systemic anastomosis open producing dilated tortuous BVs: e.g. esophageal varices-piles- caput medusa (periumblical dilated tortuous veins)</li>
</ul>
<ol start="2">
<li>Portal vein thrombosis resulting from slowing of the portal blood flow</li>
<li>Ammonia encephalopathy</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="bilharzial-or-egyptian-or-congestive-splenomegaly-morphology">BILHARZIAL OR EGYPTIAN OR CONGESTIVE SPLENOMEGALY MORPHOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#bilharzial-or-egyptian-or-congestive-splenomegaly-morphology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>GROSS
Early: mild enlargement due to antigenic stimulation of REC (littoral cells &amp; white pulp cells) hyperplasia
Late: marked enlargement due to congestion from portal hypertension (high portal venous pressure) congestion of red pulp</p>
<ul>
<li>Size: large</li>
<li>Surface: shows perisplenitis as ruptured vessels lead to subcapsular hemorrhage causing irritation &amp; perisplenitis (serofibrinous inflammation)</li>
<li>Cut section:</li>
</ul>
<p>Dark reddish brown (congestion of red pulp sinusoids)
Dark grayish brown nodules called fibrosiderotic nodules may be seen due to hemorrhages in red pulp. RECS engulf RBC and carry hemosiderin pigment. Many die releasing the hemosiderin, this excites a fibrotic reaction around it.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic">MICROSCOPIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Early: white pulp increased in size &amp; littoral cells containing bilharzial pigment hematin are increased in the sinusoids of red pulp</p>
<p>Late: congestive spleen:</p>
<ul>
<li>White pulp is atrophic due to pressure atrophy by the congested red pulp.</li>
<li>Red pulp sinusoids dilated &amp; full of RBCs. Sinusoids contain many littoral cells filled with hemosiderin.</li>
<li>Scattered foci of fibrous tissue containing free hemosiderin (fibrosiderotic nodules)(+ve Prussian blue reaction).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pulmonary-bilharziasis">PULMONARY BILHARZIASIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pulmonary-bilharziasis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Ova <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> endarteritis obliterans <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> necrotizing arteriolitis which heals by FT</li>
</ul>
<p>Bilharzioma</p>
<ul>
<li>Dead worms <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟶</mo></mrow><annotation encoding="application/x-tex">\longrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟶</span></span></span></span></span> verminous pneumonia</li>
</ul>
<p>May reach lungs through:
1- Opening of porto-systemic anastomosis and passage of mansoni ova from GIT
2- Vesical plexus ,internal iliac veins &amp; inferior vena cava to lungs in hematobium infestation
3- Diffuse fibrosis of lung granulomas may result in interstitial fibrosis of lung</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="malaria">Malaria<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#malaria" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Malaria is an infectious disease caused by the parasite called Plasmodia. There are four identified species of this parasite causing human malaria, namely, Plasmodium vivax, P. falciparum, P. ovale and P. malariae. It is transmitted by the female anopheles mosquito.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathology-of-malaria">Pathology of Malaria:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathology-of-malaria" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Anaemia: Red blood cells are the principal sites of infection in malaria. All the clinical manifestations are primarily due to the involvement of red blood cells. Anemia is caused mainly by repeated hemolysis of infected red cells. The bone marrow shows marked normoblastic hyperplasia</li>
<li>Spleen: Spleen plays an important role in the immune response against malarial infection. Splenic enlargement is one of the early and constant signs of malarial infection. Spleen may become palpable as early as the first paroxysm. The early enlargement of the spleen is due to congestion and oedema of the pulp. Later it is due to lymphoid and reticulo-endothelial hyperplasia with an increased hemolytic and phagocytic function of the organ. Frequent relapses and reinfections lead to pulp sclerosis and dilated sinuses. Rapid and considerable enlargement of spleen may sometimes result in splenic rupture, which is a serious complication of malaria</li>
<li>Liver: Enlargement of the liver also occurs early in malaria. The liver is enlarged after the first paroxysms, it is usually firm and may be tender. It is oedematous, coloured brown, grey or even black as a result of deposition of malaria pigment. In patients with repeated attacks of malaria, liver also enlarges significantly along with a large and hard spleen. However, there is no functional abnormality of the liver in these patients.</li>
<li>kidneys: In falciparum malaria an acute and transient self-limiting glomerulonephritis is common, whereas in P.malariae a chronic glomerulonephritis presents as nephrotic syndrome.</li>
<li>Nervous system gets involved predominantly in P. falciparum malaria and only very rarely in the other forms. Increased cytoadherence and rosetting of red cells, occlusion of the microcirculation by the red cell rosettes and their thrombosis all result in cerebral anoxia, development of malaria granulomas and punctate haemorrhages leading to malarial encephalitis and meningoencephalitis.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="summaryof-bilharziasis">SUMMARYOF BILHARZIASIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#summaryof-bilharziasis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="basic-reaction">Basic reaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#basic-reaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>MICROSCOPIC: granuloma: ovum + many eosinophils + lymphocytes, plasma cells, macrophages, few giant cells &amp; PNLs</p>
<p>GROSS:</p>
<table><thead><tr><th style="text-align: center;">1. Hollow structures</th><th style="text-align: center;">Urinary bladder</th><th style="text-align: center;">Large Intestine</th></tr></thead><tbody><tr><td style="text-align: center;">A- Epithelial changes</td><td style="text-align: center;">Atrophy &lt;br&gt; Ulcer &lt;br&gt; Hyperplasia &lt;br&gt; - Von Brunn's nests &lt;br&gt; - Cystitis cystica</td><td style="text-align: center;">Atrophy &lt;br&gt; Ulcer &lt;br&gt; Hyperplasia</td></tr><tr><td style="text-align: center;"></td><td style="text-align: center;">Metaplasia &lt;br&gt; - Squamous metaplasia &lt;br&gt; - Leukoplakia &lt;br&gt; Cystitis glandularis &lt;br&gt; Neoplasia (carcinoma)</td><td style="text-align: center;">Metaplasia &lt;br&gt; Sq. metaplasia</td></tr><tr><td style="text-align: center;">B- Polyps &lt;br&gt; C- Sandy patches &lt;br&gt; D- Fibrosis</td><td style="text-align: center;">Less common &lt;br&gt; Common &lt;br&gt; Diffuse</td><td style="text-align: center;">Common &lt;br&gt; Less common &lt;br&gt; Bilharzioma</td></tr><tr><td style="text-align: center;">2. Solid organs</td><td style="text-align: center;">Liver &lt;br&gt; Granulomas &lt;br&gt; Fibrosis</td><td style="text-align: center;">Lung &lt;br&gt; Granulomas &lt;br&gt; Fibrosis &lt;br&gt; Thrombophlebitis &lt;br&gt; Eosinophilic abscess</td></tr></tbody></table>
<ol start="3">
<li>Surface: skin allergic dermatitis at site of skin penetration by cercaria</li>
<li>Reticuloendothelial system: lymph nodes &amp; spleen</li>
<li>Hyperplasia of REC--+enlargement</li>
<li>Pigment in REC</li>
<li>Chronic venous congestion spleen</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hydatid-disease-echinococcosis">Hydatid disease (echinococcosis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hydatid-disease-echinococcosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="infectious-agent">Infectious agent<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#infectious-agent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The causative agent is Echinococcus granulosus (dog tapeworm).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mode-oftransmission">Mode oftransmission:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mode-oftransmission" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Human infection occurs by hand-to-mouth transfer of tapeworm eggs from dog faeces. The larvae penetrate the intestinal mucosa, enter the portal system and are carried to various organs where they produce cysts in which infectious protoscoleces develop called hydatid cysts.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-features">Pathological features:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Symptoms depend on the location of the cyst within the body The most common site for the cysts is the liver. Less commonly brain, lungs and kidneys are affected.</p>
<p>The wall of the cyst is formed of the following layers:</p>
<ol>
<li>Ectocyst: fibrous advential layer due to host response</li>
<li>Middle layer: laminated membrane of proteinaceous material</li>
<li>Endocyst: inner germinal layer from which the scolices may be detached</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="effects">Effects:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Pressure atrophy on the surrounding structures.</li>
<li>Leakage: Allergic reaction.</li>
<li>Rupture: Sudden rupture of the brood capsules and liberation of the daughter cysts and formation of secondary cysts. Rupture may also cause fatal anaphylaxis.</li>
<li>Secondary infection and abscess formation.</li>
<li>Cysts in the body may remain viable or die and calcify. They may be detected on routine X-rays.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Category A 80% of exam
Category B 15% of exam
Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Parasitic</td><td style="text-align: left;">Bilharziasis &lt;br&gt; Hydatid &lt;br&gt; Rest category c</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="circulatory-disturbances">CIRCULATORY DISTURBANCES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#circulatory-disturbances" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-hyperemia-congestion">1- HYPEREMIA&amp; CONGESTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-hyperemia-congestion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>They are two reasons for increased blood volume in a particular part of the body.</p>
<p>Hyperemia is increased blood flow to an organ, resulting in increased blood content. It is due to active vasodilatation of its arterioles and capillaries.</p>
<p>Examples are blushing, and rubor of acute inflammation.
Congestion is decreased blood flow from an organ, resulting in increased blood content. It is due to obstruction to the venous outflow.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-congestion">Types of Congestion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-congestion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251212-c4d4c00c.jpeg" alt="img-65.jpeg"></p>
<p>1- Local:
a. Acute local venous congestion:</p>
<p>Aetiology: Sudden occlusion of a vein by thrombus, ligature, strangulation ecl.. Effects: Sudden congestion associated with edema and hemorrhage</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-chronic-local-venous-congestion">b. Chronic local venous congestion:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-chronic-local-venous-congestion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Aetiology: Gradual incomplete occlusion of a vein by</p>
<ul>
<li>Pregnancy ( compress iliac veins) Leading to congested leg veins.</li>
<li>Cirrhosis or portal fibrosis ( compress portal vein radicals),) leading to mesentric and splenic veins congestion causing ascitis, splenomegaly and esophageal varices).</li>
<li>Mitral stenosis ( blood stasis in left atrium) leading to pulmonary venous congestion.</li>
</ul>
<p>Effects: Gradual congestion associated with edema, hemorrhage, opening of the collaterals and formation of varicosities (dilatation, elongation, thickening and tortousity of the chronically congested veins) and may be thrombosis due to stasis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-generalized">2- Generalized:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-generalized" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a. Acute general venous congestion:</p>
<p>Aetiology: Acute heart failure.
Effects: Sudden generalized congestion of organs associated with generalized edema.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="b-chronic-general-venous-congestion">b. Chronic general venous congestion:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-chronic-general-venous-congestion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: Gradual congestion of the systemic veins and their tributaries with or without congestion of pulmonary veins.
Aetiology: 1-Left sided failure 2- Rt sided failure. 3- Congenital heart disease.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples">EXAMPLES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Lung congestion: It occures in mitral stenosis or left sided hairt failure</li>
</ul>
<p>Gross: Early the lungs are dark red, moist and heavy, later they appear brown and indurated.</p>
<p>Microscopic: (Fig. 11) The alveolar walls showed congested capillaries, edema and hemorrhage. Intraalveolar heart failure cells ( macrophages engulfing hemosiderin) which may migrate to the draining lymph nodes. Later the libarated hemosiderine surrounded by fibrosis (brown induration).</p>
<p>CP: Dyspnea, hemoptysis and pulmonary hypertension ending in right ventricular failure. The right ventricular failure results in chronic generalized venous congestion.
<img src="assets/images/image-20251212-da9579ee.jpeg" alt="img-66.jpeg">
(Fig. 11) Lung congestion</p>
<ul>
<li>Liver congestion (Nutmeg liver): It occures in chronic generalized venous congestion.</li>
</ul>
<p>Gross: (Fig. 12) Early the liver is enlarged and heavy, cut section showed dark red spots of congested centrilobular areas against a yellow background of fatty change (nut meg apearance). Later, the liver become shrunken with irregular surface due to fibrosis around central areas.</p>
<p>Microscopic: Congestion of the central veins and central parts of the sinusoids. These associated with pressure atrophy of the centilobular hepatocytes and steatosis of the periphrall hepatocytes. Later, fibrosis around the central areas occur.
<img src="assets/images/image-20251212-9df19cb4.jpeg" alt="img-67.jpeg">
(Fig. 12) Nut meg liver: left (gross) and right (microscopic)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="spleen-congestion">- Spleen congestion:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spleen-congestion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Gross: Enlarged heavy spleen with dark congested cut section.
Microscopic: Congested sinusoids and atrophic follicles. Later hemosiderin leak associated with fibrosis leading to fibrosiderotic nodules.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-edema">2- EDEMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-edema" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Pathological accumulation of excess fluids [transudate or exudate) in the interstitial tissue spaces and serous sacs.</p>
<table><thead><tr><th style="text-align: left;">Exudate</th><th style="text-align: left;">Transudate</th></tr></thead><tbody><tr><td style="text-align: left;">High protein content&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>3</mn><mrow><mi mathvariant="normal">g</mi><mi mathvariant="normal">m</mi></mrow><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">3 \mathrm{gm} \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.9444em; vertical-align: -0.1944em;"></span><span class="mord">3</span><span class="mord"><span class="mord mathrm">gm</span></span><span class="mord">%</span></span></span></span></span>.</td><td style="text-align: left;">Low protein content &lt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>3</mn><mrow><mi mathvariant="normal">g</mi><mi mathvariant="normal">m</mi></mrow><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">3 \mathrm{gm} \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.9444em; vertical-align: -0.1944em;"></span><span class="mord">3</span><span class="mord"><span class="mord mathrm">gm</span></span><span class="mord">%</span></span></span></span></span>.</td></tr><tr><td style="text-align: left;">High specific gravity&gt; 1015.</td><td style="text-align: left;">Low specific gravity &lt; 1015.</td></tr><tr><td style="text-align: left;">High fibrinogen content [clots].</td><td style="text-align: left;">No fibrinogen [does not clot].</td></tr><tr><td style="text-align: left;">Rich in inflammatory cells.</td><td style="text-align: left;">Low cellularity.</td></tr><tr><td style="text-align: left;">Result when vessels leak protein (which</td><td style="text-align: left;">They result when hydrostatic pressure</td></tr><tr><td style="text-align: left;">carries water) which may be due either to</td><td style="text-align: left;">pusing salt and water out of normal</td></tr><tr><td style="text-align: left;">inflammation or to mild vascular injury.</td><td style="text-align: left;">vessels.</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes-of-edema">Causes of edema:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes-of-edema" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Increased capillary hydrostatic pressure: may be localized due to vein obstruction or generalized in congestive heart failure.</p>
<p>2- Sodium and water retention: due to excess aldosterone (tumor, liver failure, other), kidney failure, glomerulonephritis urinary obstruction.
3- Decreased osmotic pressure: When the total plasma proteins drops below <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>2.5</mn><mrow><mi mathvariant="normal">g</mi><mi mathvariant="normal">m</mi></mrow><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">2.5 \mathrm{gm} \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.9444em; vertical-align: -0.1944em;"></span><span class="mord">2.5</span><span class="mord"><span class="mord mathrm">gm</span></span><span class="mord">%</span></span></span></span></span> or when the albumin drops below <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1.5</mn><mrow><mi mathvariant="normal">g</mi><mi mathvariant="normal">m</mi></mrow><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">1.5 \mathrm{gm} \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.9444em; vertical-align: -0.1944em;"></span><span class="mord">1.5</span><span class="mord"><span class="mord mathrm">gm</span></span><span class="mord">%</span></span></span></span></span> lead to excess fluid accumulation in the tissue spaces and serous sacs causing generalized edema.
4- Increased capillary permeability: due to toxins, chemicals as histamine and serotonin in acute inflammation.
5- Lymphatic obstruction: causes local edema.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-edema">Classification of edema:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-edema" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1- Generalized edema is usually due to heart failure, cirrhosis of the liver, nephrotic syndrome, nutritional, malabsorption / protein losing enteropathies The worst generalized edema is seen in hypoproteinemia from many causes. Bad generalized edema called anasarca.
2- Localized: caused by obstruction of veins or lymphatics and inflammation.
Examples of edema due to venous obstruction:
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">✓</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">✓</span></span></span></span></span> Pulmonary veins in left-sided heart failure
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">✓</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">✓</span></span></span></span></span> Leg veins due to thrombosis or Pregnancy ("pressure of the uterus", estrogen)
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">✓</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">✓</span></span></span></span></span> Portal vein: in Cirrhosis and certain other liver diseases
Examples of edema due to lymphatic obstruction:
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">✓</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">✓</span></span></span></span></span> When lymphedema involves the extremities, it can be producing elephantiasis caused by filarial worms.
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">✓</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">✓</span></span></span></span></span> Obstruction of the pulmonary lymphatics by cancer is a common mechanism of death in cancer patients. Obstruction of lymphatics in the breast by a cancer produces "orangepeel skin", an ominous sign.
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">✓</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">✓</span></span></span></span></span> After surgery and after irradiation Chylous effusions result from leaking lymphatics, usually from trauma or cancer involving the thoracic duct.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-thrombosis">3- THROMBOSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-thrombosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: The formation of a solid compact mass inside the cardiovascular system during life from the circulating blood constituents. It mainly consists of platelets and clotted blood( fibrin entangling blood cells).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="three-conditions-predispose-to-thrombus-formation">Three conditions predispose to thrombus formation:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#three-conditions-predispose-to-thrombus-formation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>(1) injured endothelium.
(2) alterations in normal blood flow
(3) hypercoagulable blood. These are Virchow's triad.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="causes-of-thrombosis">Causes of thrombosis:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes-of-thrombosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1-Injured endothelium: as in myocardial infarcts, myocarditis sites ,cardiac jet lesions (abnormal flow), inflamed or prosthetic cardiac valves, ruptured atherosclerotic plaques, vasculitis syndromes and radiation injury.</p>
<p>2- Altered blood flow ("turbulence and stasis"): Blood physics keeps the formed elements, including the platelets, away from the endothelial surface. When the flow is turbulent, the platelets meet the endothelium. Activated coagulation factors, which are ordinarily cleared by the onward flow of blood,probably accumulate in pockets of turbulence, while sufficiently anti-clotting proteins probably cannot reach these pockets. Finally, turbulence itself might physically damage endothelium. As in myocardial infarcts, fibrillating cardiac atria, in dilated cardiac chambers (valve or muscle disease) and aneurysms.</p>
<p>3- Hypercoagulable blood: Congenital factor deficiencies, increase in number of platelates [after operations], fibrinogen [during pregnancy], RBCs [polycythaemia], WBCs [leukaemia] &amp; decrease plasma volume [dehydration].</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism-of-thrombosis">Mechanism of thrombosis:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-thrombosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="endothelial-injury-leading-to">Endothelial injury leading to<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#endothelial-injury-leading-to" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Exposure of subendothelial collagen which is highly thrombogenic and release of endothelial thrombotic and antithrombotic factors.</li>
<li>Adhesion of the platelets to the exposed collagen which is mediated by factor VIII. This factor is produced by the endothelial cells. The initial thrombus is formed of platelets only. They adhere to exposed collagen at site of endothelial injury. The platelets release ADP which promotes further aggregation of more platelets. This thrombus is pale, fragile and can be washed out.</li>
<li>The platelets derived thromboxane A2 causes platelet contraction and platelet factor 3 is involved in formation of thrombin from prothrombin.</li>
<li>Thrombin leads to transformation of fibrinogen into fibrin. These fibrin threads which deposit on the platelet thrombus and encourage further deposit in of platelets. Platelets depoist in layers at right angles to the blood stream. Between this layers blood stasis allows deposition of fibrin threads entangling red and white cells. The thrombus is now formed of all blood elements [mixed thrombus] &amp; shows homo-genous pink lines [aggregated platelets] known as lines of Zahn.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="morphology-of-the-thrombus">Morphology of the thrombus:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphology-of-the-thrombus" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Thrombi generally have formed in irregular, swirling layers with more or fewer red cells and/or platelets Includecf. (When flow is laminar, fewer red cells are</p>
<p>incorporated; when flow is turbulent more red cells are incorporated.) These are the lines of Zahn. The thrombi tend to be rather hard and friable.</p>
<p>Rule: When thrombi form in fast-moving blood (heart, arteries), fibrin and platelets will predominate (pale thrombus). When thrombi form in slow-moving blood (veins, sites of turbulence and stasis), they will contain areas which are rich in red blood cells (red thrombus).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="special-thrombi">Special thrombi:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#special-thrombi" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Mural thrombi form on the walls of the cardiac chambers and aorta. As a rule, they do not occlude the lumen.</p>
<p>Arterial thrombi usually occur over ruptured atherosclerotic plaques, less often at sites of other vascular disease or old surgery. Except in the aorta, arterial thrombi generally occlude the artery, adhering tightly to the wall, and seldom embolize. Thrombi that form in the aorta, however, are notorious for embolizing.</p>
<p>Vegetations are thrombi which occur on cardiac valves. They may be loaded with bacteria ("bacterial endocarditis"), or sterile (the thrombi of acute rheumatic fever).</p>
<p>Venous thrombi almost always occlude the vein &amp; easily embolize. Thrombosis in veins more common because veins are thin-walled, superficial [easily injured) and blood flow is slow. They are of 2 types:</p>
<ol>
<li>Thrombophlebitis: thrombosis initiated by inflammation. It may be septic [in veins draining areas of acute suppuration) or aseptic [in veins exposed to trauma or radiation).</li>
<li>Phlebothrombosis: thrombosis initiated by factors other than inflammation. It occurs in veins of feet and calf in cardiac patients due to stasis and compression of veins against matress; or in femoral and pelvic veins after labour or operations due to increase in number of platelets, stasis and mild inflammation.</li>
</ol>
<p>Venous thrombi are likely to be symptomatic. Deep leg vein thrombi are usually asymptomatic, but often cause pain and edema. Even thrombosis of superficial (varicose) veins can be painful.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="effects-and-fate-of-thrombi-fig-13">Effects and Fate of thrombi: (Fig. 13)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#effects-and-fate-of-thrombi-fig-13" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Fragmentation: Thrombi may fragment or break free, producing thromboemboli. It produce septic emboli and pyaemia if the thrombus is infected.</p>
<p>2- Occlusion of an artery will result in ischemia and of a vein will lead to congestion and edema.</p>
<p>3- Organization :Since thrombi are composed of fibrin, they are simultaneously attacked by plasmin (to break them up) and invaded by fibroblasts and</p>
<p>angioblasts i.e granulation tissue which coverts into scar (organization). Mural thrombi generally take a long time to organize, incorporate into the lumen and they even calcify.</p>
<p>4- Organization and canalization: As the thrombus turns, over a few weeks, into vascular granulation tissue, it recanalizes. Ultimately, an occluded vessel which once had a single large lumen ends up with many tiny lumens.</p>
<p>5- Propagation: when a thrombus occludes a vein completely, the proximal column of blood clots till the next tributary. Opposite the tributary another thrombus is formed [the blood is moving) and when it occludes the lumen completely it results in the formation of another clot proximal to it. The process may be repeated several times [resulting in alternating thrombi and clots) and may even reach the heart [fatal].</p>
<p>6- Lnfection: very large thrombi become infected with bacteria, producing an intractable infection which .ultimately turns the thrombus into pus
<img src="assets/images/image-20251212-716f389e.jpeg" alt="img-68.jpeg">
(Fig. 13) Effects and Fate of thrombi</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-embolism">4- EMBOLISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-embolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: embolus is an insoluble mass circulating in the blood stream. Embolism is the process of impaction of embolus in a narrow vessel.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-emboli">Types of emboli:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-emboli" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Most emboli are dislodged or fragmented thrombi (thromboemboli).</p>
</li>
<li>
<p>Tumor emboli.</p>
</li>
<li>
<p>Parasitic emboli.</p>
</li>
<li>
<p>Air emboli.</p>
</li>
<li>
<p>Fat emboli.</p>
</li>
<li>
<p>Amniotic fluid emboli.</p>
</li>
</ol>
<p>Sites of embolism: systemic arteries, pulmonary arteries and portal vein.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="course-of-emboli-of-thrombotic-origin">Course of emboli of thrombotic origin:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#course-of-emboli-of-thrombotic-origin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Emboli from systemic vein or right side of heart impact in lungs.</li>
<li>Emboli form aorta or left side of heart impact in any organ [cerebral, renal, splenic].</li>
<li>Emboli form portal vein impact in liver.</li>
<li>Emboli form systemic vein may by-pass the lungs through septal defect in the heart &amp; impact in any organ. This is called paradoxical embolism.</li>
</ul>
<p>Effect of thromboembolism: Depends on size of the embolus, Nature (septic or aseptic) and state of collateral circulation.</p>
<p>A- Aseptic embolus: Produces transient ischemia if the collateral circulation is good and infarction when poor.
B- Septic embolus: Produce pyaemic abscess at the site of its impaction.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pulmonary-embolism">PULMONARY EMBOLISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pulmonary-embolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Source: The large majority of pulmonary emboli come from the deep leg veins and may be from thrombi in iliac and pelvic veins or right side of the heart..</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="effects">Effects:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Big embolus: occluding the pulmonary trunk or one of its main branches <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> release of excessive amounts of serotonin from the platelets <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> bilateral pulmonary artery vasoconstriction <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> sudden death due to acute right sided heart failure. No infarction [no time].</li>
<li>Medium-sized embolus in healthy lung <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> no effect because the lung has double blood supply [bronchial and pulmonary).</li>
<li>Medium-sized embolus In systemic hypotension, when the bronchial arteries are poorly perfused <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> haemorrhagic lung infarct.</li>
<li>Patients may have several episodes of embolization, leading to permanent high pulmonary vascular resistance.</li>
<li>Small-sized embolus <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> no effect.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="systemic-embolization">Systemic embolization<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#systemic-embolization" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>It is an embolization down a systemic artery. Most come from the heart (75%) e.g mural thrombi from myocardial infarcts and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>25</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">25 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">25%</span></span></span></span></span> are others, e.g aortic aneurysms, and ulcerated atherosclerotic plaques</p>
<p>Rule: In contrast to pulmonary emboli, systemic emboli almost always produce infarcts. No artery is immune, though the majority probably go to the lower extremities.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="amniotic-fluid-embolism-amniotic-fluid-infusion-fig-14">AMNIOTIC FLUID EMBOLISM ("Amniotic Fluid Infusion") [Fig. 14]<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#amniotic-fluid-embolism-amniotic-fluid-infusion-fig-14" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>This very lethal event occurs in 1 out of 50,000 deliveries.</li>
<li>Amniotic fluid, which is full of baby's debris, enters the maternal circulation.</li>
<li>Respiratory difficulty and shock are followed by DIC (Disseminated intravascular coagulopathy).</li>
<li>The mechanism may be: the amniotic fluid vasoactive substances cause pulmonary vasoconstriction or its thrombogenic factors causing intravasular coagulation.</li>
<li>The pathologist finds squamous cells and other debris in the pulmonary vasculature.
<img src="assets/images/image-20251212-62998503.jpeg" alt="img-69.jpeg">
(Fig. 14) Amniotic fluid pulmonary embolism</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="air-embolism">Air Embolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#air-embolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Injury to large neck veins
2- Ruptured chest veins due to chest trauma
3- Decompression sickness ("caisson disease") : Results when a pressurized underwater worker or scuba diver surfaces too fast, or when a high-flying plane's cabin depressurizes. The dissolved gases in the tissue escapes into the circulation as bubbles. The acute form causes agonizing pain and brain damage because nitrogen is very soluble in myelin. The chronic form ("caisson disease") causes ischemic necrosis of parts of the skeleton and the mechanism is poorly understood.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="effects">Effects:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Wherever the gas lodges, it interferes with blood flow. Large amounts of gas in the heart render pumping ineffective.</p>
<p>2- The few bubbles introduced into the blood during intravenous therapy seem to be harmless. It takes maybe 100 mL of gas to harm a grown-up.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-ischemia">5- ISCHEMIA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-ischemia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: decrease of arterial blood supply to organ or tissue due to occlusion of its artery.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types">Types:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Acute Ischemia sudden complete arterial occlusion:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Thrombus or embolus.
2- Strangulation of vessels as occlusion of intestinal vessels in strangulated hernia, intussusception and volvulus.
3- Twisting of pedicle of movable organ, e.g. ovarian cyst.
4- Surgical ligature of artery.
5- Severe arterial spasm as in ergot poisoning.
6- Extensive venous obstruction as in case of mesentric venous thrombosis ( marked venous engorgment, this impedes the arterial blood flow leading to ischemia).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="effects">Effects:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Sudden occlusion of arteries with poor collaterals [end arteries] <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> infarction or gangrene.</li>
<li>Sudden occlusion of arteries with good collaterals <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> no effect.</li>
<li>Gradual <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> Chronic Ischaemia:</li>
</ul>
<p>B. Chronic ischemia (gradual incomplete arterial occlusion):</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="causes">Causes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Atherosclerosis.</li>
<li>Arteritis as in marked endartitis oblitrans as in syphilis.</li>
<li>Artery compression as by tumour.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="effects">Effects:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>With poor collaterals <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> ischaemic atrophy and fibrous replacement as in myocardial fibrosis due to coronray atherosclerosis.</li>
<li>With good collaterals <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> no effect.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-infarction">6- INFARCTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-infarction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: An infarct is a localized area of necrosis due to sudden ischemia produced by occlusion of either arterial supply or venous drainage. 99% results from arterial occlusion caused mainly by thrombosis or embolism.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Arterial infarcts, the most common situation, usually result from:</p>
<ul>
<li>thromboemboli or in-situ thrombus formation.</li>
<li>The next most common cause is spasm (Prinzmetal's angina).</li>
<li>Much less common are extrinsic compression from adhesions or tumors.</li>
</ul>
<p>2- Venous infarcts result when veins are compressed and deoxygenated blood cannot leave the organ.</p>
<ul>
<li>The classic examples involve the bowel (strangulated hernias, torsion of the testis, fibrous adhesions), and even tumors or</li>
<li>extrinsic pressure can impinge on outflow.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-infarcts">Types of infarcts:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-infarcts" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Pale infarcts are usual when arteries are occluded in solid organs. Bleeding is minimal, cloudy swelling of cells pushes blood back out, and the red cells lyse and disperse their hemoglobin.</li>
<li>Red infarcts ("hemorrhagic infarcts", ) result when veins are occluded, or when arteries are occluded in loose tissues (bowel) or with a dual blood supply, or when the organ was already very congested. Infarcts of the lung and small bowel from any cause tend to be hemorrhagic, and many brain infarcts (especially the embolic ones, where collateral circulation is good) are hemorrhagic from reperfusion.</li>
</ol>
<p>KEY: If the artery (rather than the vein) is occluded, and there is no reperfusion from removal of the occlusion, and the organ possesses only a single blood supply, then the infarct will be white. Otherwise it will be red.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="morphology-of-infarcts">Morphology of infarcts:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphology-of-infarcts" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Gross: All infarcts tend to be wedge-shaped" ( pyramidal), with the apex pointed at the focus of arterial occlusion in lung, spleen, and kidney infarcts. The infarction is surrounded by a zone of hyperemia, its base is raised when recent (edema), covered by fibrinous exudate and depressed when old (fibrosed). Venous infarcts, watershed infarcts, cerebral infarcts, or myocardial infarcts are not wedge shaped.</p>
<p>Microscopic picture is coagulatire necrosis or liquefactive necrosis if there is bacterial infection, or the infarct has caused necrosis of all the cells in a portion of the brain. Inflammatory cells enter the infarct by the first day, and become plentiful over the next several days. (see BR for necrosis).</p>
<p>Fate of infarcts: Healing by fibrosis may followed by dystrophic calcification.
Remark: General reaction: fever, leucocytosis, increased sedimentation rate and elevation of certain serum enzymes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-gangrene">7- GANGRENE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-gangrene" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: massive tissue necrosis followed by putrefaction.</p>
<ul>
<li>Necrosis is caused by: sudden ischaemia or bacterial toxins.</li>
<li>Putrefaction is caused by: saprophytic bacteria which breaks down proteins and produces hydrogen sulphide [bad odour]. The latter reacts with iron of haemoglobin forming iron sulphide [black In colour].</li>
</ul>
<p>Types are: classified according to amount of blood and tissue fluids in the affected part at the time of its death .</p>
<ol>
<li>Dry gangrene. (fig. 15)</li>
<li>Moist gangrene.</li>
<li>Infective gangrene.</li>
</ol>
<p>Fig. 15 Dry gangrene
4. Gas gangrene.
<img src="assets/images/image-20251212-7e1fc873.jpeg" alt="img-70.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-dry-gangrene">1- Dry Gangrene<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-dry-gangrene" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It occurs due to cut of arterial blood supply alone while the venous drainage and surface evaporation are normal.</li>
<li>Caused by thrombosis, embolism, surgical ligature, arterial spasm etc.... But the commonest example is senile gangrene.</li>
</ul>
<p>Senile gangrene: usually affects old males.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="predisposing-factors">Predisposing factors:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#predisposing-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Atherosclerosis which affects the main artery as well as the collaterals.</li>
<li>Weak cardiac action helps vascular stasis leading to thrombus formation either spontaneously or after minor injury by e.g. wearing tight shoes.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-features">Pathological features:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It is important to mention the fact that healthy tissues respond to irritation by inflammation, while ischaemic tissues respond to irritation by necrosis.</li>
<li>The condition usually begins in the tip of big toe.</li>
<li>Cut of blood supply will result in a small area of necrosis, which is rapidly invaded by saprophytic bacteria resulting in gangrene.</li>
<li>The necrotic part appears pale and cold at first, but as gangrene develops it becomes black, shrunken and mummified and has a bad odour.</li>
<li>Putrefaction of the gangrenous part produces small amounts of toxins that irritate the adjacent ischaemic tissues which respond to irritation by necrosis. The necrotic tissues then undergo putrefaction and become gangrenous.</li>
<li>The gangrenous process spreads proximally until it reaches an area of good blood supply, where the tissues respond to irritation by inflammation.</li>
<li>Now the gangrenous process stops and a red line of acute inflammation, known as line of demarcation, appears separating the healthy skin above from the gangrenous skin below.</li>
<li>A groove, known as line of separation, formed by granulation tissue separates the healthy tissues above from the gangrenous tissues below.</li>
<li>This groove may gradually deepens until it separates the gangrenous part [natural amputation], leaving a conical stump. The conical shape of the stump is due to variation of blood supply.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-moist-gangrene-fig-16">2- Moist Gangrene (Fig. 16)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-moist-gangrene-fig-16" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Moist gangrene caused by occlusion of both arterial and venous blood supply and usually affects internal organs. Putrefaction is rapid and toxaemia is severe [fatal]. The line of demarcation is poorly developed and spontaneous separation doesn't occur. Examples: Diabetic gangrene and intestinal gangrene.
<img src="assets/images/image-20251212-52f4573d.jpeg" alt="img-71.jpeg"></p>
<p>Fig. 16 Moist gangrene</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="dry-gangrene">Dry GANGRENE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dry-gangrene" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Caused by occlusion of arterial blood supply alone.</li>
<li>Usually affects exposed limbs.</li>
<li>Putrefaction is slow.</li>
<li>Spread is slow.</li>
<li>Toxins are minimal in amount.</li>
<li>Toxaemia is mild [not fatal].</li>
<li>Line of demarcation is well developed</li>
<li>Line of separation is well developed.</li>
<li>Natural amputation can occur.</li>
</ul>
<ol>
<li>Affected part is shrunken &amp; black.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="moist-gangrene">Moist Gangrene<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#moist-gangrene" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Caused by occlusion of both arterial and venous blood supply.</li>
<li>Usually affects internal organs.</li>
<li>Putrefaction is rapid.</li>
<li>Spread is rapid.</li>
<li>Toxins are maximal in amount.</li>
<li>Toxaemia is severe [fatal].</li>
<li>Line of demarcation is poorly developed</li>
<li>Line of separation is absent.</li>
<li>Natural amputation cannot occur. Affected part is swollen and brown.</li>
</ul>
<p>Diabetic gangrene: more common in diabetic females after the age of 45 years. Uncontrolled diabetes results in hyperlipaemia which leads to atherosclerosis at an earlier age. It begins in the tip of the big toe or in the sole of the foot. The gangrene starts dry but rapidly becomes moist because low body resistance and excess sugars in the tissues help putrefaction and lead to rapid occlusion of the venous drainage. It is characterized by rapid putrefaction, rapid spread, excess toxins, severe toxaemia, poorly developed line of demarcation, no line of separation and no natural amputation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-infective-gangrene">3- Infective gangrene<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-infective-gangrene" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>It is a subtype of moist gangrene in which bacteria cause both tissue necrosis and putrefaction.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples">Examples:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Lung gangrene: putrefaction of lung abscess.</li>
<li>Cancrum oris: oral gangrene caused by treponema vincenti &amp; Bacillus fusiform in debilitated children.</li>
<li>Bed sores: Skin ulcer over bony prominence due to prolonged recumbence. They are due to blood stagnation &amp; thrombosis of the vessels followed by bacterial infections.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-gas-gangrene">4- Gas gangrene:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-gas-gangrene" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is a subtype of infective gangrene characterized by elaboration of several gases which is very serious and commonly fatal due to toxemia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes-and-pathogenesis">Causes and pathogenesis:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes-and-pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It occurs in deep ischemic wounds contaminated by soil containing anaerobic spores (contaminated by animal fecal material) as in agricultural accidents.</li>
<li>Tissue destruction including vascular damage causes local ischemia and germination of spores.</li>
<li>The organisms are of 2 types of clostridia.</li>
</ul>
<ol>
<li>Saccharolytic group (CI. welchii) produces;
a) Powerful exotoxin causing muscle necrosis.
b) Hyaluronidase causing rapid spread of infection resulting in progressive muscle necrosis.
c) Fermentation of muscle carbohydrates resulting in production of carbon dioxide and hydrogen gases.</li>
<li>Proteolytic group (CI. Histolyticum);</li>
</ol>
<p>They cause putrefaction of the necrotic muscle resulting in hydrogen sulfide gas which is responsible for the foul odour of the gangrenous part.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-hemorrhage">8- HEMORRHAGE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-hemorrhage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Escape of blood outside the cardiovascular system</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes-of-hemorrhage">Causes of hemorrhage:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes-of-hemorrhage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Trauma.
2- Diseases of blood vessels themselves (from the petechiae of scurvy to the rupture of a syphilitic aortic aneurysm into the throat).</p>
<p>3- Diseases around blood vessels (infections, cancers)
4- Lack of clotting factors (congenital, acquired, DIC), lack of platelets,.
5- High blood pressure.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types-of-hemorrhage">Types of hemorrhage:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-hemorrhage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-internal">1- Internal:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-internal" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Hemopericardium: in the pericardial cavity.</li>
<li>Hemoperitoneum: Blood in the peritoneal cavity.</li>
<li>Hemarthrosis: Bleeding into a joint.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-external">2- External:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-external" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Hemoptysis: Bleeding from the trachea. Coughing of blood.</li>
<li>Hematemesis: Vomiting blood.</li>
<li>Hematochezia: Bright red blood out the rectum. Bleeding per rectum From lower GI bleeding.</li>
<li>Melena: Black, tarry, partially-digested blood out the rectum. From upper GI bleeding</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-interstitial">3- Interstitial:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-interstitial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Hematomas: Enough blood in the tissues to create a palpable mass,</li>
<li>Petechiae: Little hemorrhages in the tissues, generally defined to be under 3 mm across.</li>
<li>Purpura: Hemorrhages in the tissues defined to range from 3-10 mm.</li>
<li>Ecchymoses: A bigger part of hemorrhage in the tissues defined to be above 10 mm .</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-effects-of-hemorrhage-depends-on-where-and-how-much">The Effects of hemorrhage depends on "where" and "how much".<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-effects-of-hemorrhage-depends-on-where-and-how-much" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="where">Where:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#where" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Bleeding into the brain are devastating.</li>
<li>A few cc of blood forced into the pericardial sac under left-heart pressures causes instant death by occluding the return of blood to the right side of the heart.</li>
<li>Bleeds into the vitreous lead to blindness.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="how-much">How much:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#how-much" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Loss of <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>10</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">10 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">10%</span></span></span></span></span> of blood volume: No effect.</li>
<li>Loss of <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>20</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">20 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">20%</span></span></span></span></span> : can be compensated by release of catecholamines, renin and antidiuretic hormones which cause restoration of blood pressure.</li>
<li>Loss of <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>40</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">40 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">40%</span></span></span></span></span> : Leads to hypovolemic shock.</li>
<li>Chronic blood loss: as in case of bilharziasis leading to iron deficiency anemia.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="9-shock">9- SHOCK<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#9-shock" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: Widespread hypoperfusion of the tissues.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clinical-picture-cp">Clinical picture (CP):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-picture-cp" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Skin pallor and sensation of cold that indicate under perfusion of the skin as blood is shunted to the vital organs.</li>
<li>Weak rapid pulse and shallow respiration</li>
<li>Oliguria or anuria</li>
<li>Hypotension.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-and-causes-of-shock">Types and Causes of shock<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-and-causes-of-shock" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I) Cardiogenic (pump failure):Causes :</p>
<p>1- Massive myocardial infarct.
2- Rupture (ventricle, or valve).
3- Massive pulmonary embolism.
4- Severe arrhythmias.
5- Cardiac tamponade.
II) Hypovolemic shock:</p>
<p>1- Heavy bleeding: Externally or Internally ( Trauma, surgery and blood diseases).
2- Other fluid loss e.g Vomiting, Burns and Diarrhea.
III) Peripheral pooling of blood:</p>
<p>Peripheral pooling of blood in capillary bed due to periphral vasodilation resulting in reduction of blood volume and cardiac output as:</p>
<p>1- Septic shock as in septicemia (from bacterial breakdown products and especially cytokine production by way of nitric oxides.</p>
<p>2- Anaphylactic shock (generalized mast-cell degranulation, type I hypersensitivity): leading to loss of vascular tone.</p>
<p>3- Neurogenic: Certain poisons (notably war gases), Profound anaesthesia, Spinal cord injury and Vasovagal (i.e., extreme pain, emotion) leading to neurogenic vasodilatation and hyotension.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathogenesis">Pathogenesis:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathogenesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>With widespread anaerobiosis, lactic acidosis is likely to develop, and pH goes way down resulting in arteiolar vasodilataion and periphral pooling of blood in the microcirculation.</li>
<li>A variety of other secondary mediators of shock are produced by hypoperfused tissues. Histamine, serotonin, leukotrienes, cachectin, interleukin 1, C3a, C5a, and</li>
</ol>
<p>many other substances dilate vessels, inviting blood to pool in venules (congestion), and/or make small vessels permeable, causing blood to leak out.
3. When endothelial cells are damaged or thromboplastin enters the circulation, DIC may result.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="stages-of-shock">Stages of shock:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stages-of-shock" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Compensated shock, periphral vasoconstriction by released catecholamines and activation of renninangiotensin system). The blood is shunted away from the kidneys, salivary glands, gut, skin, and muscles in order to perfuse the brain and heart. Blood pressure is maintained. Patients may be oliguric from reduced blood flow to the kidneys and have dry mouth and skin from reduced blood flow to these organs.</li>
<li>Progressive shock ("decompensated shocl('), blood pressure and cardiac output decline and he vital organs experience severe hypoxia. All these patients have the lactic acidosis.</li>
<li>Irreversible phase: Multi organ failure ( renal, cardiac, cerebral, respiratory).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-changes">Pathological changes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-changes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Survivors typically have reversible necrosis of the renal tubules, which don't grow back for a few weeks. Until this time, patients are oliguric, and accumulate toxic products that are ordinarily excreted in the urine. This is not a lethal problem with today's fluid management. Tough cases can be dialyzed.</p>
<p>2- In worse cases, the lungs are damaged, and after a few weeks, patients die of pulmonary exudates, fibrin deposition "hyaline membranes" and fibrosis "adult respiratory distress syndrome, (ARDS)".</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="postmortem-picture-of-shock">Postmortem picture of shock:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#postmortem-picture-of-shock" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Brain: Diffuse hypoxic injury ("respirator brain") and may be infarcts.</p>
</li>
<li>
<p>Heart: Subendocardial necrosis (the subendocardium is the least-well oxygenated part of the heart) and widespread contraction band necrosis in the heart.</p>
</li>
<li>
<p>Lung: diffuse arteriolar damage ( ARDS).</p>
</li>
<li>
<p>Kidney: Acute tubular necrosis of the kidneys (shock kidneys are heavy, since lack of tubular integrity promotes backleak of glomerular filtrate into the interstitium)</p>
</li>
<li>
<p>Adrenals: stressed adrenals, i.e., cortical hyperplasia, lipid depletion</p>
</li>
<li>
<p>GIT: bleeding points ("stress ulcers") in the stomach and duodenum. Necrosis of, and bleeding into, portions of the small intestine.</p>
</li>
<li>
<p>Liver: fatty change of the liver and centrilobular necrosis.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Category A 80% of exam
Category B 15% of exam
Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Circulatory disturbances</td><td style="text-align: left;">Hyperemia &lt;br&gt; Venous congestion &lt;br&gt; Edema &lt;br&gt; Thrombosis &lt;br&gt; Embolism &lt;br&gt; ischemia &amp; infarction &lt;br&gt; Gangrene &lt;br&gt; Types of hemorrhage &lt;br&gt; Shock</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="disturbances-of-growth">DISTURBANCES OF GROWTH<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disturbances-of-growth" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="any-growth-entails">Any growth entails:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#any-growth-entails" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cell proliferation or division with an Increase in number of cells
Cell maturation and differentiation is the change in appearance and function
Any growth may be:
Normal or physiologic (controlled)
Abnormal or Pathologic (controlled or uncontrolled)
<img src="assets/images/image-20251212-d6b8d6ab.jpeg" alt="img-72.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="decreased-growth">Decreased growth<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#decreased-growth" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A) Developmental or congenital
B) Non Developmental - atrophy</p>
<p>Increased growth
A) Non Neoplastic: atrophy-hypertrophy-hyperplasia-metaplasia- dysplasia (adaptations &amp; controlled growths )
B) Neoplastic (uncontrolled growths or tumours)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="decreased-growth">Decreased growth<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#decreased-growth" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-developmental-or-congenital">A- Developmental or congenital<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-developmental-or-congenital" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Agnesia: Means complete absence of an organ e.g. absence of a whole kidney.
Aplasia: Means complete failure of cell growth of an organ( severe from of hypoplasia) e.g. a kidney.
Hypoplasia: Means failure to reach full-sized development e.g. infantile uterus.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-non-developmental">B- Non Developmental<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-non-developmental" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Atrophy (see before)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="increased-growth">Increased growth<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#increased-growth" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A-Non Neoplastic (adaptations &amp; controlled growths - see before)</p>
<ol>
<li>Hypertrophy</li>
<li>Hyperplasia</li>
<li>Metaplasia</li>
<li>Dysplasia</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="dysplasia-fig-17">DYSPLASIA (Fig 17)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dysplasia-fig-17" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: A non neoplastic disordered cellular proliferation, maturation and differentiation of cells usually in association with chronic irritation &amp; chronic inflammation</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>(1) Mucous membranes of the cervix uteri, bronchi, oral cavity, urinary bladder, colon and gall bladder.
(2) Skin epidermis.
(3) Liver.</p>
<p>Gross: Nonspecific gross appearance</p>
<p>Microscopic Picture: is characterized by
(1) Loss of cell pattern i.e. normal orderly arrangement (polarity) with increase in layers of immature cells
(2) The dysplastic cells show mild atypia (cellular abnormalities in appearance) as pleomorphism (different shapes &amp; sizes) and hyperchromasia (increased nuclear colour)
(3) Increased mitosis
(4) Dysplasia may be low grade or high grade depending on the degree of cellular atypia.</p>
<p>Low grade dysplasia affects the basal third of the epithelium.
High grade dysplasia affects the lower two-thirds up to the whole thickness.
Prognosis &amp; clinical significance: low grade dysplasia is commonly reversible when the irritating cause is removed. High grade dysplasia and carcinoma in situ (intra epithelial malignancy not invading the basement membrane) are difficult to differentiate from one another microscopically, hence are grouped together and considered as a pre-invasive phase of malignancy</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="n-b">N.B.:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#n-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Dysplasia literally means any abnormal growth. Therefore the term is sometimes used to describe certain congenital defects, such as fibrous dysplasia of bone and renal dysplasia. These types of dysplasia are not related to the conventional epithelial dysplasia described above.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="carcinoma-in-situ">CARCINOMA IN SITU<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#carcinoma-in-situ" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>(Intraepithelial Neoplasia, Intraepithelial Carcinoma, Pre-invasive Carcinoma)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition">Definition:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Carcinoma in situ (CIS) represents a pre-invasive stage of cancer &amp; is characterized by severe epithelial atypia (severe dysplasia) without invasion of the basement membrane. CIS is essentially a microscopic change. Once the basement membrane is invaded the CIS phase ends and actual malignant tumor starts.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-features">Pathological Features:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-features">Gross features:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>CIS may be difficult to detect grossly.</p>
</li>
<li>
<p>However some cases may cause a thick indurated patch (as CIS of cervix or bladder).</p>
</li>
<li>
<p>Rarely CIS may cause a mass as in cases of CIS of mammary ducts.</p>
</li>
</ul>
<p>Microscopic features: CIS is essentially a microscopic change characterized by:</p>
<ul>
<li>Diffuse cellular atypia involving the whole thickness of the affected epithelium. The cells are pleomorphic with dark nuclei and numerous mitoses i.e. cytologically malignant. Their architectural orientation (polarity) is disturbed.</li>
<li>No invasion of basement membrane.</li>
</ul>
<p>Fate: Progression into invasive carcinoma occurs after a variable time (usually years).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="examples-of-common-sites-of-cis">Examples of common sites of CIS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-of-common-sites-of-cis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Bladder</li>
<li>Cervix &amp; endometrium</li>
<li>GIT</li>
<li>Mammary gland</li>
<li>Skin</li>
</ol>
<p>B- Neoplastic (uncontrolled growths or tumours)
<img src="assets/images/image-20251212-a8394693.jpeg" alt="img-73.jpeg"></p>
<p>Fig. 17 High grade dysplasia/CIS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="neoplasia">NEOPLASIA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neoplasia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition">DEFINITION:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A neoplasm (tumor) is a new growth forming an abnormal mass, caused by autonomous self controlling proliferation of cells. It is characterized by being a pathologic proliferation of any cell type which is Irreversible, uncontrolled, unlimited, progressive &amp; purposeless.</p>
<p>The study of tumors is referred to as oncology.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="aeiiological-aspects-of-neoplasia">AEIIOLOGICAL ASPECTS OF NEOPLASIA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aeiiological-aspects-of-neoplasia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A)PREDISPOSING FACTORS,: Co-carcinogens &amp; Precancerous factors: These are nonspecific promoting or helping factors which may transform the latent tumour cells to frank malignant cells.</p>
<ol>
<li>Aging increases the risk of some types of cancer (prolonged exposure to carcinogens), e.g prostatic cancer is almost present in every male above the age of 100 years..</li>
<li>Sex: Males are generally more susceptible to cancer, however some carcinomas predominate in females as breast carcinoma (very rare in males) &amp; thyroid carcinoma.</li>
<li>Diet: Diet rich in fat is related to colorectal cancer, while smoked fish is related to gastric cancer.</li>
<li>Environmental Factors: e.g air pollution (lung cancer), farmers (skin cancer due to prolonged exposure to sun).</li>
<li>Trauma: It may be related to some types of cancer as osteosarcoma.</li>
<li>Histocomaptibility type &amp; blood group: e.g gastric carcinoma is more common in blood group A persons.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-hormonal-sex-factors">7. Hormonal/sex factors:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-hormonal-sex-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> oestrogen is responsible for breast cancer or uterine cancer
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>↑</mo></mrow><annotation encoding="application/x-tex">\uparrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mrel">↑</span></span></span></span></span> testosterone is responsible for prostate cancer
8. Chronic irritation at sites where cells are known to divide rapidly(labile) &amp; Chronic diseases (PRECANCEROUS FACTORS) Examples include:</p>
<ul>
<li>
<p>Chronic Inflammatory Diseases as: a-Bilharziasis of the urinary bladder. b-Ulcerative colitis. c -Atrophic gastritis d-Radiodermatitis e-Peptic ulcer of the stomach. f-Tertiary syphilis of tongue -Lupus vulgaris (cutaneous T.B)</p>
</li>
<li>
<p>Gall stones and urinary stones</p>
</li>
<li>
<p>Hyperplastic and metaplastic lesions as leukoplakia, endometrial hyperplasia, mammary hyperplasia.</p>
</li>
<li>
<p>Some Benign Tumors e.g villous bladder papilloma, adenomatous polyps, some nevi. .. etc</p>
</li>
<li>
<p>Others as liver cirrhosis, varicose ulcers, Paget's disease of bone, undescended testis.</p>
</li>
</ul>
<ol start="9">
<li>Trauma Unknown effect but is suspected to play a role.
B) AGENTS CAUSING CANCER: Carcinogens &amp; Oncogenes</li>
</ol>
<p>The process of neoplasia begins with cell transformation (DNA damage &amp; genetic mutation). A variety of a) chemical carcinogens as benzene, cigarette smoke &amp; nitrites can initiate &amp; or promote this process b) Radiation, either as low level, long-term environmental gamma rays or as higher, therapeutic irradiation, can also produce genetic mutations. c) Infections particularly viral e.g. human papilloma virus (HPV) are also important agents ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">a</mi><mi mathvariant="normal">&amp;</mi><mrow><mtext>&nbsp;</mtext><mi mathvariant="normal">b</mi></mrow><mi mathvariant="normal">&amp;</mi><mi mathvariant="normal">c</mi></mrow><annotation encoding="application/x-tex">\mathrm{a} \&amp; \mathrm{~b} \&amp; \mathrm{c}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathrm">a</span><span class="mord">&amp;</span><span class="mord"><span class="mspace nobreak">&nbsp;</span><span class="mord mathrm">b</span></span><span class="mord">&amp;</span><span class="mord mathrm">c</span></span></span></span></span> are called carcinogens. They are external agents that can cause DNA damage <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn mathvariant="bold">1</mn></msup></mrow><annotation encoding="application/x-tex">{ }^{\mathbf{1}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8141em;"></span><span class="mord"><span class="mord"></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8141em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathbf mtight">1</span></span></span></span></span></span></span></span></span></span></span></span></span> )</p>
<p>Genetic damage with DNA alterations leads to a) point mutations, b) translocation of genetic material from one chromosome to another, c) gene reduplication with amplification. These alterations transform proto-oncogenes (genes which are responsible for promotion &amp; regulation of growth in embryogenesis or normal growth but are suppressed or "turned off' in adult life) into oncogenes (are "turned on" or activated proto-oncogenes).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="important-definitions">Important definitions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#important-definitions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>a- Carcinogen: external agents, which can cause DNA damage &amp; point mutations. Carcinogens are also called teratogens if they produce neoplasia during pregnancy.
b-Proto-oncogenes: Are normal genes that promote &amp; regulate growth i.e. expressing growth factors e.g. EGF -PDGF .... etc ... and may become mutated or activated into an oncogene. These protooncogenes are inhibited or regulated during normal growth by anti - oncogenes
c- Anti-oncogenes which are like proto-oncogenes but express growth inhibitory effects e.g. TGF B &amp; P53, &amp; are also called tumor suppressor factors.
d- Oncogene: is a suppressed anti-oncogene or an activated proto-oncogene (activated by change in gene structure or in gene expression i.e. functions) They are no longer sensitive to growth regulatory stimuli e.g. c- oncogene or cellular oncogene &amp; v-oncogene or viral oncogene. An oncogene can be considered as a cancer inducing gene.</p>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup></mrow><annotation encoding="application/x-tex">{ }^{1}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8141em;"></span><span class="mord"><span class="mord"></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8141em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span></span></span></span></span></span> Examples: c-erb-B2 in breast carcinoma, ras found in many carcinomas &amp; leukemias, BRCA-1 in breast &amp; ovarian carcinomas, Rb in retinoblastoma &amp; mutations in p53 gene in many carcinomas</p>
<p>The Transformation Of Proto-Oncogenes Into Oncogenes occurs by one of three mechanisms:</p>
<p>1- Point mutations, possibly due to exposure to cancer-causing chemicals.
2- Chromosomal translocations, where during cell divisions, a part of a certain chromosome (with its genes) is relocated into another chromosome leading to gene fusion or change in the sequence of genes, finally resulting in activation and transformation of proto-oncogenes.</p>
<p>3- Gene amplification: this is reduplication of proto-oncogenes.</p>
<p>Oncogenes encode synthesis of proteins called oncoproteins. These oncoproteins differ from the normal products of proto-oncogenes in that they are devoid of important regulatory elements and that their production in the transformed (neoplastic) cells is not dependent on growth factors or other external signals.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types-of-carcinogens">TYPES OF CARCINOGENS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-carcinogens" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>CHEMICAL CARCINOGENS e.g. Aromatic hydrocarbons as 3,4 benzpyrene (exist in cigarette smoke) <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> cancer lung and bacterial metabolites (as nitrosamines) <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> cause cancer stomach.</li>
<li>PHYSICAL CARCINOGENS: e.g polonged exposure to ultraviolet rays (sun ) can cause skin malignancy (basal cell carcinoma, squamous cell carcinoma &amp; melanoma).</li>
<li>VIRUSES: Some viruses are oncogenic, e.g.</li>
</ol>
<p>Hepatitis C or B virus <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> liver cancer
Ebstein Barr virus <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> nasopharyngeal carcinoma and Burkitt's lymphoma
Human papilloma virus <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> carcinoma of oral mucosa and cervix
4. HORMONES: They cannot cause tumor initiation but may act as promotors. Examples include</p>
<p>Oestrogen : High levels of oestrogen can promote endometrial carcinoma &amp; mammary carcinoma.
Androgens: Androgen in high levels can promote prostatic carcinoma.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-theories-of-origin">C) THEORIES OF ORIGIN<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-theories-of-origin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Most tumors arise from a single clone of cells (monoclonal), in response to an unknown or less commonly known stimulus.
Several theories have been put forward:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="multistep-theory">- Multistep theory<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#multistep-theory" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1- Stage of initiation---Exposure to carcinogen is followed by a latent stage where the affected cell remains dormant until it is acted upon by a carcinogen or non carcinogen(cocarcinogen).</p>
<p>2- Stage of promotion-carcinogen/non carcinogen (co-carcinogen) affect latent cell which proliferates by REVERSIBLE (hyperplasia-metaplasia -dysplasia) then IRREVERSIBLE (neoplasia) growths</p>
<p>3- Stage of neoplastic transformation/progression: Purposeless- uncontrolledprogressive cell proliferation IRREVERSIBLE</p>
<ul>
<li>Genetic mutation theory successive DNA mutations in a single cell cause cancer (somatic mutation theory)</li>
<li>Failure of immune surveillance: Failure of immune surveillance prevents removal of the new abnormal tumour cells which form during life. These cells if left in the body proliferate resulting in a neoplasm Failure of immune surveillance mechanisms: Neoplastic cells produce new or new oncoproteins or antigens (tumor associated antigens-TAA, which are considered foreign by the immune system. The immune system reacts by a cytotoxic immune response. If the immune system is defective or fails to recognize the new antigens as foreign, the cell escapes immune system &amp; a tumor is formed e.g. AIDS failure of immune system to recognize these new foreign antigens &amp; kill the cells carrying them results in tumor formation</li>
<li>Inhibition of apoptosis: it is now clear that some oncogenic mutations disrupt apoptosis, leading to tumor initiation, progression or metastasis</li>
<li>Virogene-oncogene theory Viruses may lead to development of cancer by:
integrating viral oncogenes into host DNA
producing proteins that inactivate products made by tumour suppressor genes
Some viruses that have been implicated in causing neoplasms:</li>
<li>Epstein-Barr virus e.g.
a. Burkitt's lymphoma
b. form of lymphoma derived from B cells)
c. Nasopharyngeal carcinoma
d. other B cell lymphomas and some cases of Hodgkin's disease</li>
<li>Hepatitis B causes hepato cellular carcinoma</li>
<li>Human papillomavirus causes cervical carcinoma and some forms of carcinoma of skin cancers</li>
<li>HTLV-1 causes T ceilleukaemia/lymphoma</li>
</ul>
<p>Viruses not only affect growth regulatory genes (proto-oncogenes) but also may cause loss of tumor suppressor gene function (anti-oncogenes) and cause limitation of apoptosis</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-characteristics-of-tumors">GENERAL CHARACTERISTICS OF TUMORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-characteristics-of-tumors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A) Structural
B) B) Behavioral including complications &amp; spread as well as causes of death</p>
<p>All tumours share certain structural &amp; behavioral features, such as:</p>
<ul>
<li>Tumor proliferation is due to genetic abnormalities (inherited or acquired).</li>
<li>Tumor proliferation does not respect the rules that control normal cell growth, e.g.:</li>
</ul>
<p>1- Tumors can be derived from any cells, even from permanent cells that do not normally divide (nerve cells and striated muscle cells).</p>
<p>2- Cell proliferation is irreversible and unlimited. Thus cell proliferation progresses even after Any tumor consists of proliferating cells and fibrovascular stroma.</p>
<table><thead><tr><th style="text-align: left;">HYPERPLASIA</th><th style="text-align: left;">NEOPLASIA</th></tr></thead><tbody><tr><td style="text-align: left;">- Excited by a stimulus</td><td style="text-align: left;">- A stimulus is not always detected.</td></tr><tr><td style="text-align: left;">- Reversible, i.e. pathological</td><td style="text-align: left;">- Irreversible, i.e. cell proliferation is</td></tr><tr><td style="text-align: left;">hyperplasia stops and disappears if the</td><td style="text-align: left;">unlimited and progresses independent</td></tr><tr><td style="text-align: left;">stimulus abates.</td><td style="text-align: left;">of any stimuli.</td></tr><tr><td style="text-align: left;">- Proliferated cells are normal-shaped</td><td style="text-align: left;">- Proliferated cells in case of malignant</td></tr><tr><td style="text-align: left;">- May be useful (e.g. compensatory</td><td style="text-align: left;">neoplasia are abnormal-shaped.</td></tr><tr><td style="text-align: left;">hyperplasia)</td><td style="text-align: left;">- Harmful</td></tr></tbody></table>
<ul>
<li>According to their behavior, tumors are classified into:
A. According to type of growth (Benign or malignant) Plate 9</li>
<li>Malignant tumours are further subdivided into: Insitu Intraepithelial and Invasive - There are 2 main types of invasive tumours:</li>
</ul>
<p>Locally malignant No metastasis and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>⟷</mo></mrow><annotation encoding="application/x-tex">\longleftrightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.522em; vertical-align: -0.011em;"></span><span class="mrel">⟷</span></span></span></span></span> frank Invasive with metastasis
N.B.: Invasive tumours are called:
a) Primary: original single tumour mass
b) Occult: Hidden primary
c) Secondaries (metastasis): spread, many masses.</p>
<p>B) According to histological origin of tumour (epithelial, mesenchymal or other)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="plate-9-benign-malignant-tumours">PLATE 9 Benign &amp; Malignant tumours<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#plate-9-benign-malignant-tumours" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251212-72c6c0a0.jpeg" alt="img-74.jpeg"></p>
<p>Benign tumour (lipoma)
<img src="assets/images/image-20251212-a225b23d.jpeg" alt="img-75.jpeg"></p>
<p>Benign tumour (chondroma)
<img src="assets/images/image-20251212-bb63128f.jpeg" alt="img-76.jpeg"></p>
<p>Malignant tumour (Osteosarcoma)</p>
<table><thead><tr><th style="text-align: center;">Tissue of Origin</th><th style="text-align: center;">Benign</th><th style="text-align: center;">Malignant</th></tr></thead><tbody><tr><td style="text-align: center;">A) EPITHELIUM:</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">1. SURFACE EPITHELIUM.</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">a) Stratiffed squamous</td><td style="text-align: center;">Squamous cell papilloma</td><td style="text-align: center;">Squamous cell carcinoma</td></tr><tr><td style="text-align: center;">b) Transilional</td><td style="text-align: center;">Transilional cell papilloma</td><td style="text-align: center;">Transilional cell carcinoma</td></tr><tr><td style="text-align: center;">c) Ducts of glands</td><td style="text-align: center;">Duct papilloma</td><td style="text-align: center;">Duct carcinoma</td></tr><tr><td style="text-align: center;">d) Mucosa of GIT</td><td style="text-align: center;">Adenomalous polyp</td><td style="text-align: center;">Adenocarcinoma</td></tr><tr><td style="text-align: center;">2. GLANDULAR EPITHELIUM</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">Endocrine &amp; Exocrine glands</td><td style="text-align: center;">Adenoma</td><td style="text-align: center;">Adenocarcinoma</td></tr><tr><td style="text-align: center;">B) MESENCHYME</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">1- CONNECTIVE TISSUE</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">a) Fibrous</td><td style="text-align: center;">Fibroma</td><td style="text-align: center;">Fibrosarcoma</td></tr><tr><td style="text-align: center;">b) Adipose</td><td style="text-align: center;">Lipoma</td><td style="text-align: center;">Liposarcoma</td></tr><tr><td style="text-align: center;">c) Primitive mesenchyme</td><td style="text-align: center;">Myxoma</td><td style="text-align: center;">?Myxosarcoma</td></tr><tr><td style="text-align: center;">d) Bone</td><td style="text-align: center;">Osleoma &amp; osleoblasloma</td><td style="text-align: center;">Osteosarcoma.</td></tr><tr><td style="text-align: center;">e) Cartilage</td><td style="text-align: center;">Chondroma, osteochondroma</td><td style="text-align: center;">Chondrosarcoma</td></tr><tr><td style="text-align: center;">2- SMOOTH MUSCLE</td><td style="text-align: center;">Leiomyoma</td><td style="text-align: center;">Leiomyosarcoma</td></tr><tr><td style="text-align: center;">3- STRIATED MUSCLE</td><td style="text-align: center;">Rhabdomyoma</td><td style="text-align: center;">Rhabdomyosarcoma</td></tr><tr><td style="text-align: center;">4- ENDOTHELIUM</td><td style="text-align: center;">Angioma</td><td style="text-align: center;">Angiosarcoma</td></tr><tr><td style="text-align: center;">5- MESOTHELIUM</td><td style="text-align: center;">Rare</td><td style="text-align: center;">Mesothelioma</td></tr><tr><td style="text-align: center;">6- Synovium</td><td style="text-align: center;"></td><td style="text-align: center;">Synovial sarcoma</td></tr><tr><td style="text-align: center;">C) OTHERS</td><td style="text-align: center;"></td><td style="text-align: center;"></td></tr><tr><td style="text-align: center;">1- Pigmenled cells</td><td style="text-align: center;">Nevus (benign melanoma)</td><td style="text-align: center;">Malignant melanoma</td></tr><tr><td style="text-align: center;">2- Totipotent cells</td><td style="text-align: center;">Teratoma ,malure (benign)</td><td style="text-align: center;">Terafoma,immalure (malign)</td></tr><tr><td style="text-align: center;">3- Embryonic cells</td><td style="text-align: center;"></td><td style="text-align: center;">Embryonic rumors</td></tr><tr><td style="text-align: center;">4- Lymphoid &amp; hemopoeitic</td><td style="text-align: center;"></td><td style="text-align: center;">Lymphoma &amp; leukemia</td></tr><tr><td style="text-align: center;">5- Schwann cells</td><td style="text-align: center;">Schwannoma</td><td style="text-align: center;">Malignant schwannoma</td></tr><tr><td style="text-align: center;">6- Trophoblast</td><td style="text-align: center;">Vesicular mole</td><td style="text-align: center;">Choriocarcinoma</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="characteristics-of-benign-and-malignant-neoplasms-br">CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS (BR)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#characteristics-of-benign-and-malignant-neoplasms-br" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th style="text-align: center;">BENIGN NEOPLASMS</th><th style="text-align: center;">MALIGNANT NEOPLASMS</th></tr></thead><tbody><tr><td style="text-align: center;">A. TUMOR STRUCTURE &lt;br&gt; 1-GROSS FEATURES: &lt;br&gt; Regular defined tumor &lt;br&gt; - In solid organs the tumor appears lobular and commonly capsulated &lt;br&gt; - Tumors arising from a surface (skin, &amp; mucous membranes) appear as a defined noncapsulated projection called papilloma</td><td style="text-align: center;">A. TUMOR STRUCTURE &lt;br&gt; 1-GROSS FEATURES: &lt;br&gt; Irregular ill-defined noncapsulated tumor with the cut section of the tumor often showing areas of Hge &amp; necrosis. &lt;br&gt; - A tumor inside a solid organ appears as an irregular mass. &lt;br&gt; - Tumors arising from surface epithelia appear are either: &lt;br&gt; 1- Polypoid fungating cauliflower mass &lt;br&gt; 2- Ulcerative pattern: with raised everted edges, rough necrotic floor &lt;br&gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">&amp;</mi></mrow><annotation encoding="application/x-tex">\&amp;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord">&amp;</span></span></span></span></span> &lt;br&gt; indurated base, &lt;br&gt; 3- Irregular infiltrative growth below the surface.</td></tr><tr><td style="text-align: center;">2-MICROSCOPIC FEATURES: &lt;br&gt; a)Cell Differentiation: Excellent The cells are perfectly differentiated i.e. closely mimic the corresponding normal cells. Rare mitoses.</td><td style="text-align: center;">2-MICROSCOPIC FEATURES: &lt;br&gt; a)Cellular Anaplasia (bad differentiation): &lt;br&gt; 1) Cellular pleomorphism. &lt;br&gt; 2) Nuclear pleomorphism: &lt;br&gt; 3)High N/C ratio and hyperchromatism &lt;br&gt; 4) Nucleoli may be prominent. &lt;br&gt; 5) Abundant mitoses &lt;br&gt; 6)Tumor giant cells containing a</td></tr><tr><td style="text-align: center;">b)Structural (histological) Differentiation: &lt;br&gt; This is the degree of resemblance of the structural pattern of the tumor to that of the normal tissue In benign tumors the tumor cells exhibit structural patterns similar to the normal tissue (perfectly differentiated</td><td style="text-align: center;">singleLarge &lt;br&gt; polypoid nucleus or multiple nuclei &lt;br&gt; b)Histological Differentiation: . &lt;br&gt; May be graded as well differentiated (grade I), moderately differentiated (grade II), poorly differentiated (grade III) &amp; undifferentiated (grade IV), according to the degree of differentiation</td></tr></tbody></table>
<table><thead><tr><th style="text-align: center;">BENIGN NEOPLASMS</th><th style="text-align: center;">MALIGNANT NEOPLASMS</th></tr></thead><tbody><tr><td style="text-align: center;">B. TUMOR BEHAVIOR &lt;br&gt; 1-Rate of Growth: Often slow. &lt;br&gt; 2-Mode of Growth: Expansile, compressing without invasion &lt;br&gt; 3- Prognosis: &lt;br&gt; a. Benign tumors do not spread &lt;br&gt; b. Benign tumors do not recur if well excised. &lt;br&gt; c. Benign tumors are not dangerous unless: &lt;br&gt; - They arise in vital organs as brain. &lt;br&gt; - They cause obstruction. &lt;br&gt; - They produce hormones &lt;br&gt; - They may change malignant</td><td style="text-align: center;">B. TUMOR BEHAVIOR &lt;br&gt; 1- Rate of Growth: Often rapid. &lt;br&gt; 2- Mode of growth: Invasive &lt;br&gt; 3- Prognosis: &lt;br&gt; a. Malignant tumors spread (local &amp; distant). &lt;br&gt; b. Recurrence is very common &lt;br&gt; c. Malignant tumors are serious &amp; cause death due to spread, cachexia, infections &amp; organ destruction &amp; failure (e.g. liver failure, respiratory failure, renal failure ... ) &lt;br&gt; d. Some malignant tumours may act as functioning tumours e.g. &lt;br&gt; - Endocrinal tumour may over secrete FUNCTIONING tumour. &lt;br&gt; - Non endocrinal ECTOPIC hormone or polypeptide production (e.g. Lung cancer may produce ACTH &amp; Cushing syndrome. Such non endocrinal tumours which produce signs and symptoms of a known endocrinal disorder are termed paraneoplastic syndromes. &lt;br&gt; e. Complications of any malignancy &lt;br&gt; - General complications: &lt;br&gt; 1. Cachexia 2. Anemia 3. Hemorrhages &lt;br&gt; 4- Severe infection &lt;br&gt; - Local complications of any malignancy: Organ failure due to destruction- Obstruction - Pressure &lt;br&gt; - Complications due to spread of tumour: &lt;br&gt; 1- Lymphatic spread &lt;br&gt; 2- Blood stream spread &lt;br&gt; 3- Transceolomic:Krukenberg T ovary &lt;br&gt; 4- Implantation &lt;br&gt; a) Transcanalicular &lt;br&gt; b) Direct implantation or inoculation</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="spread-of-malignant-tumors">SPREAD OF MALIGNANT TUMORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spread-of-malignant-tumors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>MECHANISM OF SPREAD</p>
<p>Malignant tumors spread locally to surrounding tissues and distantly to remote sites (metastases).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism">Mechanism:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Gene mutation: results in new tumour associated (TAA) antigens on surface of cell. This changes the surface molecule receptors with loosening of Intercellular junctions &amp; loss of contact inhibition: E Cadherin loss results in proliferation and invasion</p>
<ol>
<li>Invasion of Extracellular Matrix (ECM): The following steps are included:</li>
</ol>
<ul>
<li>Loss of cellular cohesion: Normal cells are glued together by molecules called cadherins. Tumor cells lose the normal cadherin expression, allowing them to detach (loosening up).</li>
<li>Attachment of tumor cells (through receptors) to matrix components; mainly to laminin of basement membrane and fibronectin of the interstitial tissue . Attachment to ECM promotes the next steps.</li>
<li>Degradation of the ECM by proteolytic enzymes secreted by the tumor cells or by stimulated host cells (fibroblasts &amp; macrophages). Several enzymes are released as type IV collagenase (causing lysis of basement membranes of epithelia and of vessels) and cathepsin D (causing degradation of interstitium). Degradation of ECM is very important for the tumor cells to create passage ways for their migration.</li>
<li>Migration (mobility) of tumor cells (by pseudopodia). This is mediated by tumor-derived cytokines (mobility factors) such as "autocrine mobility factor". The process may be helped by acquiring negative charges on surface of tumor cells causing their repulsion and loss of contact inhibition.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-vascular-dissemination-and-homing-of-tumor-cells">2) Vascular Dissemination and Homing of Tumor Cells:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-vascular-dissemination-and-homing-of-tumor-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Tumor mobility allows cells to come in contact with lymphatics, capillaries, venules or arterioles.</li>
<li>Tumor cell can penetrate lymphatics, capillaries &amp; venules, but rarely the thickwalled arterioles.</li>
<li>Once the tumor cells cross the vascular basement membranes, they reach circulation as tumor emboli, where most of them get destroyed by immune mechanisms. The surviving tumor cells adhere to platelets &amp; get impacted in small vessels, where they adhere to the endothelium, cross the basement membrane (by mechanisms similar to those described above) &amp; settle in the</li>
</ul>
<p>new site (homing). In their new sites, tumor cells proliferate forming metastatic deposits (metastasis, secondary tumors).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="routes-of-spread">ROUTES OF SPREAD<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#routes-of-spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>LOCAL (DIRECT) SPREAD Tumor cells invade adjacent structures in direct continuity e.g. cancer: tongue can directly spread to the floor of mouth</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="distant-spread-metastasis">DISTANT SPREAD (METASTASIS):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#distant-spread-metastasis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A) LYMPHATIC SPREAD: Occurs more commonly with carcinomas than sarcomas
i) Lymphatic embolism:</p>
<p>Malignant cells invade the wall of lymphatic vessels <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> tumor emboli <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> lymph node.</p>
<ul>
<li>Spread from one node to another may occur by efferent lymphatics.</li>
</ul>
<p>Grossly: The affected nodes are enlarged &amp; firm. They may become fused &amp; fixed.
Microscopically the metastatic deposit resembles the primary tumor from which it is derived.</p>
<ul>
<li>Progressive spread by the lymphatic route may ultimately lead to tumor emboli within the main lymphatic ducts (thoracic duct), from which tumor emboli reach the venous circulation causing hematogenous spread
ii) Lymphatic permeation <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> lymphatic obstruction <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> lymphatic oedema.</li>
</ul>
<p>Example: Breast carcinoma <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> permeation of axillary lymphatics <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> oedema of the whole arm</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-hematogenous-blood-spread-course">B) HEMATOGENOUS (BLOOD) SPREAD: COURSE:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-hematogenous-blood-spread-course" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Emboli derived from primary tumors of organs drained by systemic veins (vena cava) e.g. breast, and kidney <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> pulmonary arteries <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> lung metastases.</li>
<li>Emboli derived from tumors of lungs (whether primary or metastatic) are carried through pulmonary veins to left side of heart and systemic arterial and systemic arterial circulation <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> metastases in different organs as liver, bones, brain ... etc.</li>
<li>Emboli derived from tumors of organs drained by the portal vein (tumors of gastrointestinal tract) <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> liver metastases. Further spread from liver gives rise to emboli that reach the hepatic veins <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> inferior vena cava to lungs ... etc.</li>
<li>Emboli reaching the vertebral system of veins from tumours of pelvic, abdominal or thoracic organs lead to metastasis in brain, spinal cord &amp;</li>
</ul>
<p>vertebrae without causing lung metastasis since vertebral veins have wide anastmotic channels connecting them with lumbosacral, abdominal &amp; thoracic veins.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pathology-of-organ-metastases">PATHOLOGY OF ORGAN METASTASES:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathology-of-organ-metastases" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The most common sites of metastases include the liver, lungs, bones &amp; brain.
Metastases are rare in muscles ,spleen, pancreas &amp; intestine.
Gross picture Metastases appear as scattered round nodules of variable sizes:
Microscopic picture: Metastases resemble the primary tumor from which they are derived.</p>
<p>Bone metastases: May be osteolytic but in case of cancer prostate it may be osteosclerotic (new bone formation is stimulated around the metastatic deposit, since malignant cells of prostatic origin secrete phosphatase).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-spread-through-body-cavities-transcoelomic-spread">C) SPREAD THROUGH BODY CAVITIES (TRANSCOELOMIC SPREAD):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-spread-through-body-cavities-transcoelomic-spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>When the serosal covering of an organ is infiltrated by malignant cells of a tumor within this organ, some of these cells may detach and become implanted in other sites. This may be associated with hemorrhagic effusion. Transcoelomic spread includes:</p>
<p>1- Transperitoneal spread from carcinoma of stomach, colon, pancreas...etc cause metastatic peritoneal/ omental nodules accompanied by hemorrhagic ascites. In females, carcinoma of stomach (or colon) may be associated with bilateral ovarian metastases, termed "Krukenberg tumors" which were considered to represent transcoelomic spread. They are now believed to be due to retrograde lymphatic or blood spread, since Krukenberg tumors can also occur in case of cancers of breast, urinary bladder &amp; biliary tract.
2- Transpleural and transpericardial spread from lung or breast cancer resulting in metastases on the diaphragm accompanied by hemorrhagic pleural or pericardial effusion.</p>
<p>3- Malignant tumors of brain may give rise to tumor cells within the CSF leading to metastases within the lining of the ventricles, base of skull and spinal cord.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-other-methods-of-spread">D) OTHER METHODS OF SPREAD:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-other-methods-of-spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Transluminal spread: malignant cells detached from transitional carcinoma of the renal pelvis may become implanted in the mucosa of urinary bladder forming secondary deposits.</li>
<li>Surgical implantation/ Innocculation:</li>
</ol>
<p>a) Instruments contaminated with malignant cells during surgical management of a tumor may transfer tumor cells into the surgical wound causing secondary tumor deposits.
b) Implantation from carcinoma of lower lip may lead to a secondary tumor in the upper lip</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="causes-of-death-in-malignant-tumours">Causes of death In Malignant tumours<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes-of-death-in-malignant-tumours" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Malnutrition: obstruction-anorexia-Ioss of absorption- Macrophage TNF alpha &amp; toxic tumour metabolites(toxemia).Tumour interferes with food intake absorption &amp; digestion</li>
<li>Anemia due to:
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Hemorrhages: invasion of blood vessels
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Bone Marrow metastasis: causes destruction of marrow
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Hemolysis: is an immune reaction
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Folic acid def: due to malnutrition</li>
<li>Cachexia: severe form of protein calorie malnutrition causing wasting of body (loss of wt-anemiaweakness): Malnutrition-TNF alpha&amp; toxic metabolites-anorexia &amp; decrease Fat metabolism- low resistance to infection (malnutrition &amp; low immunity)</li>
</ul>
<p>CP: Wasting - Pallor- malaise &amp; fever +/- 2ry infections</p>
<ul>
<li>Local complications due to organ destruction or affection
A) Renal failure: obstruction &amp; local tissue destruction if metastatic &amp; bilateral
B) Hepatic failure &amp; obstructive jaundice
C) Increase intracranial tension &amp; pressure on vital centers</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-epithelial-tumours">1- Epithelial tumours<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-epithelial-tumours" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-benign-tumours-of-epithelial-origin">A) BENIGN TUMOURS OF EPITHELIAL ORIGIN<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-benign-tumours-of-epithelial-origin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-papilloma-a-benign-exophytic-tumor-of-surface-epithelium">(1)Papilloma: A benign exophytic tumor of surface epithelium.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-papilloma-a-benign-exophytic-tumor-of-surface-epithelium" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A benign noncapsulated tumor of surface epithelium. Papillomas are classically exophtic (projecting) papillary tumors, composed of proliferated epithelial cells resting on intact basement membranes, supported from below by connective tissue core; containing blood vessels. Papillomas are rarely inverted endophytic lesions (that push the basement membrane and grow inwards, pushing the subepithelial tissues; of course without invasion) e.g. inverted papillomas of urinary bladder and nose. Classical papilloma may be sessile or pedunculated, single or multiple, they are classifies (according to type of epithelium) into:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a-squamous-cell-papilloma">A) SQUAMOUS CELL PAPILLOMA:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-squamous-cell-papilloma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition &amp; origin: A benign tumor of stratified squamous epithelium
Sites: Skin, lip, tongue, oral mucosa, pharynx, larynx, oesophagus, cervix, vagina and anal canal.</p>
<p>Gross Picture: Small sessile or pedunculated projection.
Microscopic Picture: Connective tissue cores covered by thick proliferated stratified squamous epithelium</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-other-types-of-paplloma">B) OTHER TYPES OF PAPLLOMA:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-other-types-of-paplloma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="transitional-cell-papilloma-villous-papilloma">Transitional cell papilloma (villous papilloma):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#transitional-cell-papilloma-villous-papilloma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; origin: A benign tumor arising from urothelium (transitional mucosa of urinary tract). It is strongly pre-malignant.</p>
<p>Sites: urinary bladder, ureter or renal pelvis.
Gross Picture: The tumor appears as a noncapsulated velvety friable mass of delicate papillary processes.</p>
<p>Microscopic Picture: Delicate vascularized connective tissue cores covered by usually not more than six layers of regular transitional cells.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Bleeding (hematuria).</li>
<li>Malignant change into transitional cell carcinoma</li>
<li>Urethral or ureteric obstruction</li>
</ol>
<p>Columnar cell papilloma: A benign tumor arising from columnar cells e.g. duct papilloma of the breast &amp; mucous cell papilloma (Adenomatous Polyp): of gastrointestinal mucosa.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-duct-papilloma">1- DUCT PAPILLOMA:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-duct-papilloma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; origin: A benign tumor arising from the epithelium of major ducts; Sites: Major ducts, as those of breast (most common) or pancreas.</p>
<p>Gross Picture: It usually appears as a small complex papillary projection inside the duct lumen.</p>
<p>Microscopic Picture: Delicate vascular cores covered by regular ductal epithelial cells.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Bleeding per nipple 2) Malignant transformation into duct carcinoma.</p>
</li>
<li>
<p>MUCOUS CELL PAPILLOMA (Adenomatous Polyp, adenopapilloma, mucosal adenoma):</p>
</li>
</ol>
<p>Definition, origin and Sites: A benign tumor of mucosa. Sites: Gastrointestinal tract is the commonest site.</p>
<p>Gross Picture: It appears as a sessile, pedunculated or complex papillary projection. Microscopic Picture: Proliferated mucosal glands lined by columnar epithelium, supported by fibrovascular stroma.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="complications">Complications:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Gastrointestinal bleeding is common.</li>
<li>Malignant transformation into adenocarcinoma.</li>
<li>Obstruction (e.g. pyloric obstruction)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-adenoma">2- ADENOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-adenoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition, origin: A benign tumor arising from glandular epithelium</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Exocrine or endocrine glands (breast, ovary, salivary glands ,pancreas ,thyroid, etc)
2- Mucosal glands of GIT, endometrium ... etc (adenomatous polyp... see above)</p>
<p>Gross Picture: A capsulated globular or ovoid mass.
Microscopic Picture: Several Patterns:
1- Simple adenoma (tubular adenoma): proliferated glands separated by delicate fibrovascular stroma.</p>
<p>Remark: Mucous cell papilloma, is grossly a papilloma (arising from surface epithelium), but microscopically is an adenoma (composed of proliferated mucosal glands), Therefore it is called adenopapilloma or adenomatous polyp</p>
<p>2- Fibroadenoma : glandular as well as stromal proliferations. Breast is the main site.</p>
<p>3- Cystadenoma: Adenoma with retained secretions <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> cystic dilatation. Example: ovarian cystadenoma.</p>
<p>4- Papillary Cystadenoma: A cystadenoma with profound intracystic epithelial proliferation <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> papillae. Example: papillary cystadenoma of the ovary.</p>
<p>5- Special types of adenomas arising in salivary glands (salivary gland adenomas) e.g.
a. Pleomorphic adenoma: It is an adenoma with stroma rich In mucin and pseudocartilage foci
b. Warthin's tumor (papillary cystadenoma lymphomatosum): It is a special type of papillary cystadenoma in which the epithelial cells appear oncocytic (large eosinophilic cells) and the stroma is rich in Iymhocytes</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="complications">Complications:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>I) Adenoma of endocrine glands may be hormone secreting e.g. thyroid adenoma
II) May change to malignant</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="malignant-epithelial-tumors-carcinoma-plate-10">MALIGNANT EPITHELIAL TUMORS (CARCINOMA) (plate 10)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#malignant-epithelial-tumors-carcinoma-plate-10" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I) Carcinomas of Surface Epithelium:
(1)Squamous cell carcinoma.
(2) Basal cell carcinoma.
(3) Transitional cell carcinoma.
II) Glandular Carcinoma:
(1)Adenocarcinoma.
(2) Mucoid carcinoma.
(3) Carcinoma simplex</p>
<ol>
<li>TRANSITIONAL CELL CARCINOMA (TCC)</li>
</ol>
<p>Definition &amp; Origin: A malignant tumor of transitional epithelium. It arises de novo or on top of villous papilloma.</p>
<p>Sites: Urinary bladder, ureter and renal pelvis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-picture">Gross Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Papillary Type:_A villous papilliferous growth with broad infiltrating base.
2- Non-papillary Types:
a) Fungating polypoid mass.
b) Malignant ulcer.
c) Infiltrative pattern.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="microscopic-picture">Microscopic Picture<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1- Papillary TCC:Jhe malignant transitional cells overlie vascular connective tissue cores, usually more than 6 cell layers. Papillary TCC tends io invade less deeply than non-papillary TCC and hence has a better prognosis.
2- Nonpapiliarv TCC:Jhe malignant transitional cells form solid groups.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spread">Spread:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Local</li>
<li>Distant : mainly by lymphatics &amp; late by blood.</li>
<li>Transluminal implantation may occur</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-squamous-cell-carcinoma-epidermoid-carcinoma">2) SQUAMOUS CELL CARCINOMA (Epidermoid Carcinoma)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-squamous-cell-carcinoma-epidermoid-carcinoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: A malignant tumor of stratified squamous epithelium.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a. Skin
b. Squamous mucous membranes as lip, tongue, mouth, pharynx, larynx, oesophagus, cervix, vagina &amp; anal canal
c. Other mucous membranes on top of squamous metaplasia e.g. squamous cell carcinoma of urinary bladder on top of squamous metaplasia due to bilharziasis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="predisposing-factors">Predisposing factors:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#predisposing-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) prolonged exposure to sun. b) squamous metaplasia &amp; leukoplakia.</p>
<p>Gross Picture: Several patterns:
a) Fungating polypoid pattern.
b) Ulcerative pattern:</p>
<p>Irregular -Raised everted edges. - Rough necrotic floor.- Indurated base.-infiltrative pattern.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic-picture">Microscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The dermis or submucosa is infiltrated by malignant epithelial cells which in well differentiated neoplasms form "cell nests". These cell nests consist of malignant cells that replicate the organization of the normal epidermis i.e. the periphery of these nests shows basal cell differentiation, followed by prickle cells then granular cells with the center of the nests showing keratin. In less differentiated neoplasms fewer cell nests are formed &amp; in anaplastic carcinoma, no cell nests may be detected .
Broder's grading of squamous cell carcinoma:
Grade I: 75-100% of the tumor consists of cell nests.
Grade II: 50-75% cell nests.
Grade III: 25-50% cell nests.
Grade IV: 0-25% cell nests.</p>
<p>Spread: Local, lymphatic and by blood.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-basal-cell-carcinoma-rodent-ulcer">3) BASAL CELL CARCINOMA (Rodent Ulcer)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-basal-cell-carcinoma-rodent-ulcer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: A locally malignant tumor arising from basal layer of skin.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a. Skin exposed to sun, commonly that of face, particularly above an imaginary line drawn from the angle of the mouth to the lobule of ear, particularly at the inner and outer angles of eyes, side of nose and angie of mouth.
b. Skin of extensor surface of arms and legs is less commonly affected</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="predisposing-factors">Predisposing factors:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#predisposing-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Prolonged exposure to sun.</p>
<p>Gross Picture Starts as a red papule: <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>→</mo></mrow><annotation encoding="application/x-tex">\rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">→</span></span></span></span></span> ulcer which has the following features:
Irregular-Raised, rolled in, beaded edges. Rough floor. - Firm base.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic-picture">Microscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The dermis is infiltrated by masses of malignant epithelial cells, the peripheral cells are columnar basal cells with palisade (parallel) arrangement, while the central cells are polyhedral. There are several variants of basal cell carcinoma e.g. the pigmented, type, where tumor masses contain excessive melanin pigment.</p>
<p>Spread: only local. However basal cell carcinoma may change malignant (basosquamous or squamous cell carcinoma) leading to distant spread.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-carcinomas-of-glandular-origin">2) CARCINOMAS OF GLANDULAR ORIGIN<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-carcinomas-of-glandular-origin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition-origin-sites">DEFINITION &amp; ORIGIN &amp; SITES:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition-origin-sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These are malignant tumors arising from glandular epithelium:</p>
<ol>
<li>Of the mucosal surfaces (as gastrointestinal mucosa, endometrium or endocervix)</li>
<li>Glandular organs (endocrine or exocrine glands as prostate, ovary, mammary gland, salivary glands... etc)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-picture">GROSS PICTURE:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>In mucous surfaces the tumor pattern may be:
a) Fungating polypoid pattern.
b) Malignant ulcer type.
c) Infiltrative pattern (annular and diffuse subtypes).</li>
<li>In endocrine and exocrine glands, the tumor forms an irregular infiltrative growth.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spread">SPREAD:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Local</li>
<li>Distant spread by :
a) Lymphatics
b) blood (late)
c) transcoelomic</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic-types">MICROSCOPIC TYPES:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-types" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-adenocarcinoma">1) Adenocarcinoma:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-adenocarcinoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: A malignant tumor of glandular epithelium.
Sites:
1- Endocrine and exocrine glands as pancreas, prostate, salivary glands, breast, ovaries.
2- Mucous surfaces as GIT, gall bladder ,endometrium, cervix, bronchi.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-picture">Gross Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Ln endocrine and exocrine glands, the tumor forms an irregular infiltrative growth.
2- In mucinous surfaces the tumor pattern may be:
a) Fungating polypoid pattern.
b) Malignant ulcer type.
c) Infiltrative pattern (annular and diffuse subtypes).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="microscopic-picture">Microscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1- In well differentiated adenocarcinoma, the malignant cells show acinar arrangement. These malignant acini differ from the normal acini in several respects:</p>
<ul>
<li>They are irregular with no definite basement membranes.</li>
<li>Their lumens are irregular</li>
<li>The cells show malignant features (describe)</li>
<li>They exist in abnormal sites (as submucosa, musculosa or serosa) due to infiltration.</li>
<li>They may be cystically dilated (cystadenocarcinoma) if the malignant cell secretions are retained. Some malignant cells may show papillary proliferations (papillary adenocarcinoma or papillary cystadenocarcinoma).</li>
</ul>
<p>2- Less differentiated adenocarcinomas show less degrees of acinar differentiation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-mucin-secreting-carcinomas">2) Mucin secreting carcinomas:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-mucin-secreting-carcinomas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Two types:
a- Mucinous adenocarcinoma (mucoid or colloid Carcinoma): This is an adenocarcinoma with abundant extracellular mucin secretion
b- Signet Ring Cell Carcinoma The malignant cells show intracytoplasmic mucin that pushes the nuclei eccentrically. No acinar differentiation.
3) Carcinoma simplex (undifferentiated carcinoma, spheroidal cell carcinoma:These are malignant tumors of glandular origin, that neither exhibit acinar differentiation nor secrete mucin. Malignant cells form solid groups</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Most common in breast
2- Less common in other glandular sites mainly GIT.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-microscopic-features">Gross &amp; Microscopic Features<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-microscopic-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Scirrhous Carcinoma: Grossly the tumor is firm, gritty &amp; ill-defined. Microscopically malignant cells are rounded and form small-sized solid groups surrounded by dense stroma.
2- Medullary CarcinomaJencephaloid carcinoma): Grossly the tumor is more expansile and better defined than scirrhous carcinoma and appears relatively soft .Microscopically, malignant cells are rounded and form large-sized solid groups usually with more marked necrosis and little fibrous stroma.
Spread: As adenocarcinoma, describe (1- local spread 2-Distant spread).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-other-types-of-carcinoma">4) OTHER TYPES OF CARCINOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-other-types-of-carcinoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Urothelial carcinoma (transitional cell carcinoma): A malignant tumor of transitional epithelium occurring in the urinary tract; most commonly the urinary bladder. It is very common in Egypt due to bilharziasis</li>
<li>Hepatocellular carcinoma: A malignant tumor of liver arising from hepatocytes. It is common in Egypt due to chronic hepatitis</li>
<li>Choriocarcinoma: A rare malignant tumor of placenta</li>
<li>Salivary gland carcinomas as adenoid cystic carcinoma, mucoepidermoid carcinoma &amp; acinic cell carcinoma</li>
<li>Renal cell carcinoma</li>
<li>Other types</li>
</ul>
<p><img src="assets/images/image-20251212-35cb94f1.jpeg" alt="img-77.jpeg"></p>
<p>Squamous papilloma
<img src="assets/images/image-20251212-92e94205.jpeg" alt="img-78.jpeg"></p>
<p>Squamous cell carcinoma
<img src="assets/images/image-20251212-2beb483d.jpeg" alt="img-79.jpeg"></p>
<p>Adenoma
<img src="assets/images/image-20251212-a35a0e33.jpeg" alt="img-80.jpeg"></p>
<p>Basal cell carcinoma
<img src="assets/images/image-20251212-464abbc1.jpeg" alt="img-81.jpeg"></p>
<p>Adenocarcinoma
<img src="assets/images/image-20251212-7dcd9092.jpeg" alt="img-82.jpeg"></p>
<p>Basal cell carcinoma
<img src="assets/images/image-20251212-d95365b6.jpeg" alt="img-83.jpeg">
<img src="assets/images/image-20251212-5cd3c193.jpeg" alt="img-84.jpeg">
<img src="assets/images/image-20251212-d419d5ae.jpeg" alt="img-85.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="benign-mesenchymal-tumors">BENIGN MESENCHYMAL TUMORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#benign-mesenchymal-tumors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-lipoma-plate-9">1) LIPOMA (plate 9)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-lipoma-plate-9" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition-origin">Definition &amp; origin:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition-origin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A benign tumor of adipose tissue. It is the most common soft tissue tumor.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Anywhere in the body, but most commonly subcutaneous tissue, particularly at the region of shoulders, neck, back and buttocks.
2- Intermuscular septa.
3- Mediastinum, mesentery, omentum, retroperitoneal.
4- Wall of stomach and intestine, and organs as kidney.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-picture">Gross Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A capsulated globular or ovoid, commonly lobulated yellowish soft greasy mass.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic-picture">Microscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The tumor consists of lobules composed of mature fat cells (adipocytes) which are large vacuolated cells with flattened eccentric nuclei. The lobules are separated by fibrovascular septa.</li>
<li>Rarely lipoma consists of immature or embryonic fat cells which are smaller than mature fat cells showing central nuclei and cytoplasmic vacuoles. This type of lipoma is called hibernoma</li>
</ul>
<p>Secondary changes &amp; malignant transformation: Malignant change into liposarcoma is extremely rare.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-fibroma">2) FIBROMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-fibroma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; origin: An uncommon benign tumor of fibrous tissue
Sites: Dermis - Periosteum of bone - Organs as ovary
Gross Picture: A grayish white firm globular mass.
Microscopic Picture: The tumor consists of variable proportions of fibroblasts, collagen and blood vessels. Fibroblasts may be numerous "cellular fibroma". Fibroblasts appear as spindle shaped cells with elongated nuclei showing tapering ends. Hyaline or myxoid changes may occur.</p>
<p>Secondary changes &amp; malignant transformation: Hyalinosis, myxomatous change &amp; calcification may occur. Malignant change into fibrosarcoma is very rare.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="fibromatosis">FIBROMATOSIS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fibromatosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Fibromatosis is a tumor-like non neoplastic aggressive proliferation of fibrous tissue extending to neighboring structures as muscle (benign infiltration), resulting in a noncapsulated irregular mass, that commonly recurs after surgical excision. The proliferating fibroblasts show no atypia and there is no distant spread of the lesion.. Aetiology is not clear.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="desmoid-tumor-aggressive-fibromatosis">DESMOID TUMOR (AGGRESSIVE FIBROMATOSIS):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#desmoid-tumor-aggressive-fibromatosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Desmoid tumor belongs to a group of lesions called fibromatosis of unclear pathogenesis Fibromatosis is characterized by non neoplastic aggressive reactive proliferation of fibrous tissue extending to neighboring structures (benign infiltration) resulting in a noncapsulated irregular tumor- like mass, that commonly recurs after surgical excision.</p>
<p>The proliferating fibroblasts show no features of malignancy &amp; the lesion does not metastasize.</p>
<p>The most common form of fibromatosis is abdominal desmoid which arises from the musculo-aponeurotic structures of the anterior abdominal wall in woman during or after pregnancy. There are many other types of fibromatosis as extra-abdominal desmoid, penile fibromatosis, palmar and plantar fibromatosis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-chondroma-plate-9">3) CHONDROMA (plate 9)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-chondroma-plate-9" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: A benign tumor of cartilage</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Within the interior of bone (enchondroma); most commonly short bones of hands &amp; feet test, less commonly at ends of long bones or in flat bones as pelvis; ribs, sternum &amp; scapula Enchondroma is usually solitary, but rarely multiple (enchondromatosis, Oilier's disease</p>
<p>2- 0 n the surface of bone (subperiosteal or juxtacortical chondroma).
3- Extraskeletal soft tissue chondroma and bronchial chondroma are rare.
Gross Picture: A globular well demarcated mass, commonly nodular or lobulated. A thin outer capsule may be seen. The tumor is bluish gray and translucent.</p>
<p>Microscopic Picture: Nodules of cartilage composed of hyaline matrix and cartilage cells residing inside their lacunae. Cartilage cells (chondrocytes) are rounded with vacuolated cytoplasm.</p>
<p>Secondary changes &amp; malignant transformation: Myxoid change, calcification &amp; ossification are common .Malignant change into chondrosarcoma is rare in solitary</p>
<p>chondroma &amp; more common in case of enchondromatosis.residing inside their lacunae. Cartilage cells (chondrocytes) are rounded with vacuolated cytoplasm.
4) OSTEOCHONDROMA (Exostosis, cancellous osteoma orechondroma)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="definition-origin-and-sites">Definition, Origin and Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition-origin-and-sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Osteochondroma is a developmental tumor-like abnormality (hamartoma) rather than a true neoplasm. It arises from aberrant lateral growth of the epiphyseal cartilage. They occur in long bones &amp; stop growing after puberty.</p>
<p>Gross Picture: The lesion may be single or multiple (multiple exostosis, osteochondromatosis).</p>
<p>The multiple type is a hereditary autosomal dominant disease. The lesion appears as a mushroomshaped lateral projection composed of a bony stalk and head covered by a cartilaginous cap.</p>
<p>Microscopic Picture: Cancelious bone covered by cartilage.
Complications: Malignant change into chondrosarcoma is more common in case of multiple exostosis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-osteoma">5) OSTEOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-osteoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="osteoid-osteoma">OSTEOID OSTEOMA:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#osteoid-osteoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: Benign bone tumor composed of osteoid tissue
Sites: Any bone, the commonest are femur and tibia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gross-picture">Gross Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The tumor is solitary, less than 2 cm in diameter (commonly less than 1 cm ). Its substance appears pink, gritty and friable. Osteoid osteomas arising below the periosteum are famous of exciting a tremendous amount of reactive bone that encircles the tumor so that in X ray films the tumor appears as a radiolucent small lesion (nidus), with dense sclerotic margins.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic-picture">Microscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Trabeculae of poorly mineralized osteoid bone rimmed by proliferating osteoblasts. The intervening stroma is loose and richly vascularized.</p>
<p>Complications: Osteoid osteoma causes a characteristic nocturnal pain which is dramatically improved by aspirin. Pain is caused by excess production of prostaglandin E2.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="compact-osteoma-ivory-osteoma">COMPACT OSTEOMA: (Ivory Osteoma):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#compact-osteoma-ivory-osteoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition, Origin &amp; Sites: Benign tumor arising in membranous bones of the skull.
Gross Picture: A hemispherical, noncapsulated hard ivory-like mass.
Microscopic Picture: concentrically arranged bone lamellae.
Complications: Disfigurement and pressure symptoms e.g. proptosis.
N.B.: OSTEOCHONDROMA is sometimes regarded as a type of osteoma called cancellous osteoma (describe)</p>
<p>Remark: Osteoblastoma is a similar lesion to osteoid osteoma with the following differences</p>
<ul>
<li>Larger</li>
<li>Painless</li>
<li>More common in the spine.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-myxoma">6) MYXOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-myxoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: A rare benign tumor arising from remnants of primitive mesenchyme.</p>
<p>Sites: I he commonest sites are the heart (particularly atrial) and jaw (in relation to teeth).</p>
<p>Gross Picture: A soft gelatinous mass.
Microscopy: Stellate shaped myxoma cells embedded in mucoid matrix.
Complications &amp; secondary changes: Cardiac myxoma may be serious. It may be pedunculated and blocks the atrlo-ventricular valves. Malignant change may occur.</p>
<p>Secondary hemorrhage and cyst formation may occur.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-benign-tumors-of-muscles-myomas">7) BENIGN TUMORS OF MUSCLES (MYOMAS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-benign-tumors-of-muscles-myomas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-leiomyoma">A) LEIOMYOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-leiomyoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: A benign tumor of smooth muscle.
Sites: It is a common tumor. Sites include:
1- Uterus is the most common site. Leiomyoma is the commonest tumor in females. It occurs during the reproductive period of life and is oestrogendependent.
2- Wall of oesophagus, stomach, intestine, urinary bladder and skin.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="gross-picture-of-uterine-leiomyoma">Gross Picture (of uterine leiomyoma):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-picture-of-uterine-leiomyoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Single or multiple.</li>
<li>Occurs within the myometrium (intramural, interstitial), but may also occur beneath the serosa (subserous) or immediately beneath the endometrium (submucous).</li>
<li>Sharply circumscribed, round and firm.</li>
<li>Uncapsulated but may acquire false capsule of compressed surrounding muscles.</li>
<li>The cut section is grayish or grayish brown and usually shows a whorly appearance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic-picture">Microscopic Picture:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-picture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Interlacing bundles of smooth muscle cells, which are spindle shaped cells that differ from fibroblasts in having more abundant eosinophilic cytoplasm and rod-shaped nuclei having blunt (non-tapering) ends.
2- Fibrous stroma containing blood vessels. This fibrous stroma may be abundant (particularly after the menopause) and the tumor may then be called fibromyoma or fibroid.
3- Secondary changes as hyaline, myxoid and cystic changes, ischemic necrosis and calcification are common.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Malignant change into leiomyosarcoma is extremely rare. 2-Uterine myoma may lead to uterine bleeding and infertility</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-rhabdomyoma">B) RHABDOMYOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-rhabdomyoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: An extremely rare benign tumor of striated muscles.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-benign-tumors-of-vessels-angioma">8) BENIGN TUMORS OF VESSELS (ANGIOMA)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-benign-tumors-of-vessels-angioma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition">Definition:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Benign lesions ( hamartomas) composed of vascular spaces filled with Blood (hemangioma) or Lymph (lymphangioma).</li>
<li>They are usually detected in early life (congenital tumor-like malformations (hamartomas) rather than true neoplasms.</li>
<li>They do not change malignant.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a-hemangioma-figs-18-19">A) HEMANGIOMA (Figs. 18 &amp; 19)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-hemangioma-figs-18-19" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition: These are benign noncapsulated lesions composed of vascular spaces filled with either blood (hemangioma) or lymph (lymphangioma). They are usually detected in early life and represent congenital tumor-like malformations (hamartomas) rather than true neoplasms. They do not change malignant.</p>
<table><thead><tr><th style="text-align: left;">CAPILLARY HEMANGIOMA</th><th style="text-align: left;">CAVERNOUS HEMANGIOMA</th></tr></thead><tbody><tr><td style="text-align: left;">Sites:</td><td style="text-align: left;">Sites:</td></tr><tr><td style="text-align: left;">1- Skin, often since birth (birth mark).</td><td style="text-align: left;">1- Skin, particularly of the face.</td></tr><tr><td style="text-align: left;">2- Mucus membranes of lip and tongue.</td><td style="text-align: left;">2- Mucus membranes of lip &amp; tongue.</td></tr><tr><td style="text-align: left;">3- Organs as brain &amp; kidney</td><td style="text-align: left;">Macrochelia &amp; macroglossia may</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">occur.</td></tr><tr><td style="text-align: left;"></td><td style="text-align: left;">3- Organs as liver, spleen &amp; muscles</td></tr><tr><td style="text-align: left;">Gross: A deep red well defined patch.</td><td style="text-align: left;">Gross: A purple well defined soft swelling.</td></tr><tr><td style="text-align: left;">Microscopy:</td><td style="text-align: left;">Microscopy:</td></tr><tr><td style="text-align: left;">Small vascular spaces lined by</td><td style="text-align: left;">Wide vascular spaces lined by</td></tr><tr><td style="text-align: left;">endothelium &amp; contain blood.</td><td style="text-align: left;">endothelium &amp; filled with blood.</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-lymphangioma">B) LYMPHANGIOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-lymphangioma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: A benign hamartomatous (tumor-like) lesion of lymphatic vessels.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Skin particularly of head, neck and axilla.
2- Mucous membranes e.g. lip and tongue
3- Viscera as spleen, liver &amp; kidney</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-gross-microscopic-features">Types, Gross &amp; Microscopic Features:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-gross-microscopic-features" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cavernous lymphangioma: This is the most common type:
Grossly: A grayish pink swelling that may cause enlargement macrochelia (lip enlargement) or macroglossia (tongue enlargement).
Microscopically: wide vascular channels, filled with pale eosinophilic lymph &amp;
Cystic lymphangioma (cystic hygroma):
Grossly: a huge congenital cystic swelling, composed of widely cystic lymphatic channels. It occurs at the side of the neck and may cause troubles delivery of the baby.</p>
<p>Microscopically: like cavernous lymphangioma, but wider vascular lymphatic channels.</p>
<p>Capillary lymphangioma: A small lesion composed of capillary spaces lined by endothelium &amp;filled with lymph
C) HEMANGIOENDOTHELIOMA: A rarer tumor composed of capillary spaces associated with prominent proliferation of endothelial cells. Some of these tumors are benign and others are of low grade malignancy
D) OTHER BENIGN VASCULAR TUMORS: Glomangioma &amp; sclerosing hemangioma: See systemic pathology.
<img src="assets/images/image-20251212-7ca7f332.jpeg" alt="img-86.jpeg"></p>
<p>Fig. 18 Capillary hemangioma
<img src="assets/images/image-20251212-3e29c68a.jpeg" alt="img-87.jpeg"></p>
<p>Fig. 19 Cavernous hemangioma</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="9-benign-tumours-of-nerve-sheath-see-special">9) BENIGN TUMOURS OF NERVE SHEATH (see special)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#9-benign-tumours-of-nerve-sheath-see-special" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="malignant-mesenchymal-tumors-sarcomas">MALIGNANT MESENCHYMAL TUMORS (SARCOMAS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#malignant-mesenchymal-tumors-sarcomas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>GENERAL CHARACTERS: See table page</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="classification">CLASSIFICATION:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A) Differentiated Sarcomas:</p>
<p>1- Liposarcoma
2- Fibrosarcoma
3- Rhabdomyosarcoma
4- Leiomyosarcoma
5- Angiosarcoma &amp; other malignant vascular tumors.
6- 0steosarcoma 7Chondrosarcoma
B) Undifferentiated Sarcomas: These are sarcomas derived from different cell types (fibroblasts, osteoblasts, lipoblasts... etc.) but without differentiation that points to their cell of origin. These sarcomas are sometimes designated according to the predominant cell pattern e.g.
a. Round cell sarcoma,
b. Spindle cell sarcoma,
c. Giant cell sarcoma</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-liposarcoma">1) LIPOSARCOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-liposarcoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Origin: A malignant tumor of adipose tissue.
Sites: Retroperitoneal, mesenteric, mediastinal, intermuscular, subcutaneous.
Gross Picture: Large soft mass with foci of necrosis and hemorrhage.
Microscopic Picture: In well differentiated liposarcoma, the malignant cells contain abundant intracytoplasmic fat. In undifferentiated (pleomorphic) liposarcoma, the malignant cells are extremely pleomorphic with very poor lipoblastic differentiation. Sometimes liposarcoma shows myxoid foci (myxoliposarcoma).</p>
<p>Spread: Direct and blood spread. The well differentiated types have a much better prognosis than the other types.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-fibrosarcoma">2) FIBROSARCOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-fibrosarcoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: A malignant tumor of fibrous tissue. Sites: Subcutaneous, periosteal, intermuscular...</p>
<p>Gross: A large grayish mass with areas of necrosis and hemorrhage.
Microscopy: In well differentiated fibrosarcoma the malignant spindle cells are separated by abundant collagenous stroma. In less differentiated forms there is little collagen and more marked cellular anaplasia.</p>
<p>Spread: Direct &amp; blood spread. Well differentiated fibrosarcoma has a better prognosis due to slow spread.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-rhabdomyosarcoma">3) RHABDOMYOSARCOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-rhabdomyosarcoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A malignant tumor of striated muscle. Three main types:
1- Embryonal Rhabdomyosarcoma (sarcoma botryoides): occurs in children; mainly in urinary bladder, vagina and cervix. It consists of small spindle cells with dark nuclei in a myxoid matrix.</p>
<p>2- Pleomorphic Rhabdomyosarcoma: occurs in adults in intermuscular septa and soft tissue. It consists of extremely pleomorphic cells, some of which may show cytoplasmic cross striations (strap cells).</p>
<p>3- Alveolar Rhabdomyosarcoma: consists of malignant cells exhibiting alveolar arrangement.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-leiomyosarcoma">4) LEIOMYOSARCOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-leiomyosarcoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Definition &amp; Origin: A malignant tumor of smooth muscle.
Sites: Most commonly uterus and GIT
Gross: Large fleshy mass with areas of hemorrhage and necrosis.
Microscopy: Malignant spindle cells with eosinophilic cytoplasm and large dark nuclei. Cytoplasmic actin can be detected by immunohistochemistry.</p>
<p>Spread: Direct and blood spread (faster in less differentiated tumors)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-othersarcomas">5) OTHERSARCOMAS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-othersarcomas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Malignant vascular tumors, osteosarcoma, chondrosarcoma... etc: See systemic pathology</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-lymphoma-leukemia">6) LYMPHOMA &amp; LEUKEMIA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-lymphoma-leukemia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Lymphomas are a group of primary malignant neoplasms of lymphoid tissue arising from B or T lymphocytes or rarely histiocytes.</p>
<p>Leukemia is a malignant proliferation of one of the leukocyte forming tissue</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="miscellaneous-benign-malignant-tumors">MISCELLANEOUS BENIGN &amp; MALIGNANT TUMORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#miscellaneous-benign-malignant-tumors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>PIGMENTED (MELANOCYTIC) TUMORS</li>
</ol>
<p>Definition: These are benign &amp; malignant tumors arising from melanocytes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Skin</li>
<li>Mucous membranes &amp; mucocutaneous junctions (as conjunctiva, rectum, mouth &amp; vagina)</li>
<li>Eye as choriod and iris.</li>
<li>Leptomeninges.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="classification">Classification:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Pigmented nevus or mole: It may be:</p>
<ul>
<li>Congenital nevus:</li>
<li>Acquired nevus including junctional, intradermal &amp; combined types.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-malignant-melanoma">2- Malignant Melanoma.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-malignant-melanoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It may grow vertically (nodular melanoma) .This type is more serious &amp; spreads rapidly</li>
<li>It may grow radially. This type is less dangerous than nodular melanoma</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-benign-lesion-nevus-or-mole">A) BENIGN Lesion: (NEVUS or MOLE):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-benign-lesion-nevus-or-mole" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition: Benign tumour of the melanocytes. It is present in nearly every individual and usually dates since birth, so it is considered as a hamartomatous malformation.</p>
<p>Sites: Skin is the most common site.
Gross Picture: Small brown to black macules. Old nevi become depigmented
Microscopic Picture: Acquired nevi develop along three phases:
a) Junctional Nevus: Nests of nevus cells are seen, at the dermo-epidermal junction. These nevus cells are rounded melanocytes with ovoid nuclei and cytoplasmic melanin granules.
b) Compound Nevus: This phase is characterized by appearance of intradermal groups of nevus cells along with the intraepidermal (junctional) nests.
c) Intradermal Nevus: Over time, the intraepidermal nests disappear. Simultaneously, the dermal nevus cells become spindled and lose their melanin-7 depigmantation of old nevi.
d) Other Types of nevi include</p>
<p>Blue Nevus which is a congenital skin nevus appears blue in color. Microscopically it consists of deep intradermal pigmented elongated melanocytes. Malignant transformation is very rare.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="malignant-transformation-of-nevi">Malignant Transformation of Nevi:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#malignant-transformation-of-nevi" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is relatively more common in patients with large number of acquired nevi. Malignancy is suspected when the size of nevus enlarges with ulceration, color changes &amp; regional lymph node enlargement</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-malignant-melanoma">B) MALIGNANT MELANOMA:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-malignant-melanoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Definition &amp; Origin: A malignant tumor of melanocytes. It commonly arises de novo, but nodular melanoma may arise on top of pre-existing acquired or congenital nevi. Malignant transformation of a pre-existing nevus is suspected when the size enlarges with ulceration, color changes and regional lymph node enlargement.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Skin is the most common site (any skin including head neck, scrotum, palms of hands, soles of feet etc).</p>
<p>2- Rare sites include:
a) mucous membranes &amp; mucocutaneous junctions as
b) conjunctiva, rectum, mouth &amp; vagina)
c) eye as choroid and iris.
d) leptomeninges.</p>
<p>Age: Most common between 40-60years, but younger and older ages may be affected.
Types: Clark classified malignant melanoma into:Two main patterns of growth: Radial and vertical.</p>
<p>A- Melanomas with Radial Pattern of Growth: Tumor grows laterally within the epidermis (in situ).</p>
<p>Minimal dermal infiltration occurs later. Subtypes include:
(1)Lentigo maligna: Arises from the sun-exposed skin of the elderly. The tumour appears as a slowly growing flat lesion of varying shades of brown colour. Microscopically the tumour is composed of dysplastic pleomorphic melanocytes spreading along the basal layer of epidermis and skin appendages. The prognosis is good but invasion and metastasis can occur, often after 10 years.
(2)Superficial spreading melanoma: Occurs on any area of the skin but is most common on the back of men and lower legs in women. The tumour appears as a flat or slightly raised brown to black lesion with irregular border. Microscopically there is proliferation of atypical melanocytes at the dermoepidermal junction together with invasion of the epidermis by malignant cells arranged singly or in small groups. Sooner or later there is vertical growth phase, the dermis is invaded and a nodule develops.
(3)Acrallentiginous melanoma: Affects the palms and soles. The lesion appears as a pigmented macule. Histologically it resembles lentigo maligna. Soon, however an invasive often spindlecelled tumour arises and the prognosis is poor.</p>
<p>B- Melanoma with Vertical Pattern of Growth (Nodular Melanoma) A malignant tumor of melanocytes. It commonly arises de novo, but may arise on top of pre-existing acquired or congenital nevi. Most common above age of 40 y . The tumour forms a rapidly growing dark brown nodular ulcerating mass. Microscopically the malignant cells invade the epidermis and dermis (vertical growth). The depth of invasion in the dermis and subcutaneous fat is an important prognostic factor. The tumour cells show one of two patterns:
a) Masses of round or polyhydral epithelioid-like cells separated by fine vascular stroma.
b) Spindle shaped malignant cells scattered or in bundles.</p>
<p>Melanin pigment is found both intracellular and extracellular. Few tumours are nonpigmented and are known as amelanotic melanomas.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sites">Sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1- Skin is the most common site (including head neck, scrotum, palms of hands, soles of feet ... etc).
2- Rare sites include
a) mucous membranes &amp; mucocutaneous junctions
b) eye as choriod and iris.
c) leptomeninges..</p>
<p>Grossly: 1-3 cm firm dark brown ulcerating nodule
Microscopy Anaplastic pigmented melanocytes infiltrate the epidermis&amp; dermis.. Rarely the cells do not produce melanin (amelanotic melanoma).Such tumors may be difficult to diagnose except by immunohistochemistry(searching for melanoma antigensHMB-45, S100 &amp; Melan a) .</p>
<p>Prognosis: It depends on the depth of invasion by measuring the vertical extent of tumor below the stratum granulosum (Clark's level). However prognosis is generally poor due to rapid spread of tumor by all routes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spread">Spread:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spread" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) Local spread
b) lymphatic spread to regional lymph nodes
c) Blood spread.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-teratoma">2) TERATOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-teratoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition-origin-sites">Definition, origin &amp; sites:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition-origin-sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Teratoma is a composite tumor containing structures derived from ectoderm, mesoderm &amp; endoderm. It arises from primitive germ cells or totipotent cells that may exist in post-natal life in some places as ovary, testis, sacrococygeal region &amp; mediastinum. The structure of teratoma is foreign to the site from which it arises</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="origin">Origin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#origin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>During early fetal development the primitive structural cells are called totipotent cells which can give rise to all three embryonic cell types (ectoderm, endoderm and mesoderm). Through action of placental chemical organizers - organs are formed from these primitive cells &amp; the later progressively disappear.</li>
<li>Sometimes some primitive totipotent cells that are directed towards the gonads (totipotent germ cells) persist in the goads or arrest along the line of their</li>
</ul>
<p>migration (midline: base of skull, mediastinum, sacrococygeal ... etc) and remain in their primitive state without prenatal maturation</p>
<ul>
<li>The born fetus is usually structurally normal .However if the totipotent cells proliferate in post natal life, they give rise to a tumor composed of a mixture of ectodermal, endodermal and mesodermal structures, but these structures will not form mature organs (due to lack of placental chemical organizers).
N.B.: Tumors that arise from the totipotent cells are called teratomas (composed of a mixture of ectodermal, endodermal and mesodermal structures) and may be benign or malignant. However tumors that do not arise from totipotent cells, but from one of the embryonic cells (ectoderm, mesoderm or endoderm) are called embryonic tumors which are almost always malignant.</li>
</ul>
<p>Age: Any age; children, young adults or elderly.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types">Types:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>A- MATURE TERATOMA (Benign Teratoma):
These tumors consist of a haphazard mixture of mature ectodermal structures such as skin, neuroglial cells &amp; teeth, mature endodermal structures such as thyroid tissue &amp; other types of glandular epithelium &amp; mature mesodermal structures such as cartilage, bone, adipose tissue, fibrous tissue, muscle ... etc. It maybe cystic &amp; consist predominantly of skin &amp; hairs (dermoid cyst)
Malignant transformation occurs in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">1 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">1%</span></span></span></span></span> of mature teratomas (any type of malignancy, but squamous cell carcinoma is the most common).</p>
<p>Microscopically: These mixed mature structures can be easily recognized
Grossly, mature teratomas are of two types:
a) Cystic Teratoma (DERMOID CYST) (Fig 20): Commonest in ovary. Usually large.</p>
<p>It consists of: - A dermoid ridge which IS a solid part covered by skin.
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> The rest of the tumor is cystic and contains sebaceous material, tufts of hair, teeth and other structures.
b) Solid Teratoma: Less common</p>
<p>B- IMMATURE TERATOMA (Malignant Teratoma):</p>
<ul>
<li>
<p>It consists of a varied amount of immature tissues (immature cartilage, neuroepithelium, glands... etc).</p>
</li>
<li>
<p>The degree of malignancy and spread is proportionate to the degree of immaturity.</p>
</li>
<li>
<p>According to the proportion of immature to mature structures,</p>
</li>
<li>
<p>This group is subtyped as grade I, grade II &amp; grade III</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="c-monodermal-teratomas-specialized-teratomas">C- MONODERMAL TERATOMAS (Specialized Teratomas):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-monodermal-teratomas-specialized-teratomas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>These are teratomas that differentiate along the line of a single abnormal tissue.
Examples:
a) Struma ovarii: A benign ovarian teratoma composed of thyroid tissue.
b) Ovarian or testicular choriocarcinoma: A malignant placental epithelial tumor.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-embryonic-tumors-fig-21">3) EMBRYONIC TUMORS (Fig.21)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-embryonic-tumors-fig-21" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition-origin-and-age">Definition, origin and age:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition-origin-and-age" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Malignant tumors derived from embryonic cell remnants ( multipotential cells)
(Ectoderm, endoderm or mesoderm) in infants and young children
Structure: They consist of primitive embryonic (undifferentiated) malignant small round cells. However some of these cells may partially differentiate into mature tissues of the same class from which these embryonic cells are derived (e.g. mesodermal tissues as smooth muscle &amp; cartilage in embryonic tumors derived from mesodermal cells)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples">Examples:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Neuroblastoma of adrenal medulla &amp; sympathetic ganglia.
2- Retinoblastoma of eye.
3- Nephroblastoma of kidney.
4- Hepatoblastoma of liver.
5- Medulloblastoma of brain.
<img src="assets/images/image-20251212-861c0c38.jpeg" alt="img-88.jpeg"></p>
<p>Fig. 20 Dermoid cyst
<img src="assets/images/image-20251212-ed2bbdd0.jpeg" alt="img-89.jpeg"></p>
<p>Fig. 21 Embryoma kidney</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="characteristics-of-carcinoma-and-sarcoma">CHARACTERISTICS OF CARCINOMA AND SARCOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#characteristics-of-carcinoma-and-sarcoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th style="text-align: center;">CARCINOMA</th><th style="text-align: center;">SARCOMA</th></tr></thead><tbody><tr><td style="text-align: center;">Definition: Malignant tumor of epithelium Most common form of malignancy.</td><td style="text-align: center;">Definition: Malignant tumor of mesenchyme. Much less common than carcinoma.</td></tr><tr><td style="text-align: center;">Age: Usually (but not always) above age of 40 years.</td><td style="text-align: center;">Age: Usually (but not always below age of 20 years.</td></tr><tr><td style="text-align: center;">Growth rate: Rapid</td><td style="text-align: center;">Growth rate: Faster than carcinoma.</td></tr><tr><td style="text-align: center;">Mode of growth: Infiltrative &amp; expansile</td><td style="text-align: center;">Mode of growth: as carcinoma, but its rapid rate of growth gives it a more expansile appearance</td></tr><tr><td style="text-align: center;">Gross Features: 1-Size is usually less bulky than sarcoma. 2-Consistency: Usually hard.3Colour is usually Grayish. 4-Carcinoma may arise inside a solid organ (as endocrine gland, liver or kidney) &amp; forms an irregular growth. 5-Carcinoma can also arise from surface epithelium (as skin or mucous membranes) forming a fungating cauliftower mass or an ulcerative growth .It can also invade under the surface (as if inside a solid organ)a infiltrative pattern</td><td style="text-align: center;">Gross Features: 1-Most sarcomas form bulky masses. 2-Consistency: Usually soft and fleshy. 3-Colour is tinged pink due to richer vascularity. 4-Sarcomas arising in a solid organ forms a bulky growth, more regular (expansile). than carcinoma. 5-Sarcomas do not arise from surface epithelium therefore do not classically appear as ulcerating or cauliflower masses, but they can arise from subepithelial mesenchyme (as if in a solid organ) , and appear as bulky expansile growth.</td></tr><tr><td style="text-align: center;">Remark: Carcinoma is derived from the Greek "carcinos" meaning a crab to describe their infiltrative mode.</td><td style="text-align: center;">Remark: Sarcoma is derived from the Greek "sarc" which means ftesh to describe their fleshy consistency.</td></tr><tr><td style="text-align: center;">Microscopic Features: 1-Cellular anaplasia: Usually less marked than sarcoma. 2Histological differentiation: depends on arrangement of the tumor cells. When the tumor is anaplastic, it may be confused with undifferentiated sarcoma. It is worth nothing that, both in cases of carcinoma and sarcoma, poor grades of histological differentiation are associated with high grades of celluar anaplasia. 3-Cell cohesion: Neoplastic cells exhibit variable grades of cohesion. This is however poor in anaplastic carcinomas. 4Blood vessels are less and better formed than in sarcoma. 5- Hemorrhage, necrosis and secondary changes are usually less profound than in sarcoma.</td><td style="text-align: center;">Microscopic Features: 1-Cellular anaplasia is generally greater than carcinoma. &lt;br&gt; 2-Histological differentiation depends in most cases on cell products which may be intracellular (as fat in case of liposarcoma) or extracellular (matrix) as collagen in case of fibrosarcoma and osteoid in osteosarcoma. Thus if a sarcoma arising for example from osteoblasts, shows no osteoid, it is considered undifferentiated. 3-Cell cohesion is often absent and the tumor cells occur singly. 4-Blood vessels are more numerous and thin- walled.5-Hemorrhage, necrosis and secondary changes as hyaline and myxomatous changes are common.</td></tr><tr><td style="text-align: center;">Distant spread-usually slower than sarcomaoccurs early by lymphatics then later by blood, but some carcinomas spread relatively early by blood (carcinoma of thyroid, breast, lung, kidney, prostate &amp; placenta)</td><td style="text-align: center;">Distant spread-usually faster than carcinoma -occurs early by blood &amp; rarely (10%) by lymphatics.</td></tr></tbody></table>
<table><thead><tr><th style="text-align: left;">TNM Staging of carcinoma:</th><th style="text-align: left;">TNM Staging of sarcoma:</th></tr></thead><tbody><tr><td style="text-align: left;">T: represents tumor state &amp; size, graded &lt;br&gt; as Tis (tumor in situ), T1, T2 T3 &amp; T4.</td><td style="text-align: left;">TNM system (modified)</td></tr><tr><td style="text-align: left;">N: represents the degree of spread to &lt;br&gt; lymph nodes and is graded as NO,N1,N2 &amp; &lt;br&gt; N3 (NO means absent)</td><td style="text-align: left;">T: usually graded as T1 or T2 according to &lt;br&gt; size</td></tr><tr><td style="text-align: left;">M: represents metastases due to blood &lt;br&gt; spread and is graded as MO (absent) or &lt;br&gt; M1 (present).</td><td style="text-align: left;">N: usually graded as NO &amp; N1 &lt;br&gt; M: graded as MO &amp; M1</td></tr><tr><td style="text-align: left;">Examples T1 NOMO is early cancer stage &lt;br&gt; (better prognosis), while T4 N3 M1 is an &lt;br&gt; advanced stage (worst prognosis).</td><td style="text-align: left;"></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="characteristics-of-locally-malignant-tumors">CHARACTERISTICS OF LOCALLY MALIGNANT TUMORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#characteristics-of-locally-malignant-tumors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>This is a group of intermediate malignant tumors characterized by</li>
</ul>
<p>1- A slower rate of growth than frank malignant tumors
2- Local invasion without distant spread
3- Microscopic features of malignancy.</p>
<ul>
<li>They may changes into frank malignant tumors.</li>
<li>Examples of locally malignant tumors:</li>
</ul>
<p>1- Basal cell carcinoma.
2- Giant cell tumour of bone (Osteoclastoma) (grade II).
3- Adamantinoma.
4- Craniopharyngioma.
5- Bronchial adenoma.
6- Carcinoid tumour.
7- Astrocytoma (grade II).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="remarks">REMARKS:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#remarks" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Carcinomas arise from epithelium, while sarcomas arise from mesenchyme. The normal epithelium is characterized by cohesive (adherent) cells resting on basement membranes. The type (differentiation) of normal epithelial tissue is determined by cell type &amp; cell arrangement (e.g. glandular or stratified). The normal mesenchyme mostly consists of noncohesive spindle cells The type (differentiation) of mesenchyme is largely determined by cell products which may be extracellular as collagen (fibroblasts) &amp; osteoid (osteoblasts) or intracellular as actin &amp; myosin.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="tumour-like-lesions">TUMOUR-LIKE lesions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tumour-like-lesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hamartomas: Hemangioma - lymphangioma &amp; Pigmented nevi-Osteochondroma/ osteochondromatosis.</li>
<li>Granuloma</li>
<li>Choristoma: microscopically normal tissue in abnormal sites</li>
<li>Fibromatosis &amp; desmoid</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hamartoma">HAMARTOMA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hamartoma" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This is a tumor-like developmental malformation formed of noncapsulated mature tissues of the affected organ, arranged haphazardly. It usually stops growing after puberty. Some hamartomas are precancerous.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples-of-hamartomas">Examples of hamartomas:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-of-hamartomas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Lung hamartoma (a mixture of cartilage, smooth muscle and bronchial mucosal tissue).
2- 2-Kidney hamartoma
3- Angiomas,
4- Pigmented nevi.
5- Exostosis &amp; neurofibromatosis are regarded as hamartomatous malformations.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="factors-influencing-the-prognosis-of-malignant-tumors">FACTORS INFLUENCING THE PROGNOSIS OF MALIGNANT TUMORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-influencing-the-prognosis-of-malignant-tumors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Tumor Type: e.g. malignant melanoma &amp; most sarcomas have poorer prognosis than carcinomas.
2- Tumor Site: e.g. superficial tumors as those arising from skin are diagnosed earlier and treated easier than deeply seated tumors and brain tumors.
3- Differentiation: Well differentiated tumors grow slower than less differentiated ones.
4- Tumor Stage: There are different methods for tumor staging, one of the popular methods is the TNM system:
5- Immune Host Responses:</p>
<ul>
<li>The tumor cells have antigens capable of evoking an immune response.</li>
<li>The immune response includes cellular factors as cytotoxic T cells, killer (K) cells, natural killer (NK) cells &amp; activated macrophages. Humoral factors (immunoglobulins &amp; complement) participate by an opsonin effect.</li>
<li>Immunodeficiency states as AIDS and immunosuppressive therapy increase the incidence of development of some tumors in these patients as lymphomas and KaposI sarcoma.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diagnosis-prognosis-management-laboratory-diagnosis-of-neoplasia">DIAGNOSIS, PROGNOSIS &amp; MANAGEMENT LABORATORY DIAGNOSIS OF NEOPLASIA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnosis-prognosis-management-laboratory-diagnosis-of-neoplasia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1- Biopsy specimens: Stained paraffin sections or frozen sections can easily prepared and microscopicallyexamined.
2- Fine-needle aspiration Using a needle, aspiration of tumor cells is obtained, stained and examined microscopically
3- Cytological Examination Fluids such as ascites, pleural effusions, CSF and urine may contain related tumors. Using a centrifuge, any floating cells detached malignant cells form a sediment, from which films can be prepared on glass slides, stained andexamined.
4- DNA Flow Cytometry: Measurement of the DNA content of tumor cells by flow cytometry shows abnormal DNA content.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-tumor-markers-fig-22">5- Tumor Markers (Fig. 22):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-tumor-markers-fig-22" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These are tumor-derived or associated molecules. They may be secreted in the blood (serum tumor markers) and can be detected within the tumor cells (tissue tumor markers).
a) Serum Tumor markers detected within the blood:</p>
<p>Assessment of the level of these markers helps in diagnosis and follow up of tumor e.g.:</p>
<ul>
<li>Carcinoembryonic antigen (CEA) in cases of cancer colon, stomach, pancreas and breast.</li>
<li>Alphafetoprotein (AFP) in cases of hepatic cancer and germ cell tumors.</li>
<li>Prostatic specific antigen (PSA) and prostatic acid phosphatase in case of cancer prostate.
b) Tissue Markers localized within tumor cellsThese can be detected by a special technique called</li>
</ul>
<p>IMMUNOHISTOCHEMISTRY. Tissue tumor markers may be detected on the cell membrane, cytoplasm or nuclei. Assessment of tumor markers can be of diagnostic value (particularly in undifferentiated malignant tumors). Some Markers or of prognostic value (as Her 2 which denotes <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">\</mi></mrow><annotation encoding="application/x-tex">\backslash</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">\</span></span></span></span></span> higher tendency for metastases). Few examples of diagnostic tumor markers are given:</p>
<ul>
<li>
<p>Cytokeratin and EMA (epithelial membrane antigen) in epithelial tumors Icarcinoma</p>
</li>
<li>
<p>Vimentin in mesenchymal tumors Isarcoma.</p>
</li>
<li>
<p>Common leukocyte antigen for lymphomas.</p>
</li>
<li>
<p>S-100 protein in neural tumors, melanoma &amp; cartilaginous tumors</p>
</li>
<li>
<p>HMB 45 in melanoma.</p>
</li>
<li>
<p>Desmin in muscle tumors.</p>
</li>
</ul>
<p>6- Efficiency of treatment: There are three main methods of treatment of malignant tumors (used separately or in various combinations) including surgery, chemotherapy (anti cancer drugs) and irradiation. The efficiency of surgery, the proper choice of chemotherapy and radiotherapy are of great importance. Irradiation is planned according to the degree of response of the tumor to irradiation (radiosensitivity)</p>
<p>7- Age: Tumors of infants and children are generally regarded of poorer prognosis (with exceptions).</p>
<p>8- Tumor Hormone Receptors: The growth of some tumors depends partly on hormone stimulation. The cells of such tumors have hormone receptors. Examples include oestrogen receptor positive breast carcinoma and androgen receptor positive prostatic carcinoma. Depriving these tumors from hormone stimulation helps in controlling their growth. Example anti-oestrogen therapy ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>±</mo></mrow><annotation encoding="application/x-tex">\pm</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6667em; vertical-align: -0.0833em;"></span><span class="mord">±</span></span></span></span></span> oophorectomy) for breast cancer and antiandrogen therapy ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>±</mo></mrow><annotation encoding="application/x-tex">\pm</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6667em; vertical-align: -0.0833em;"></span><span class="mord">±</span></span></span></span></span> orchidectomy) for prostatic cancer. Thus, a hormone receptor positive Tumor is better than a hormone receptor negative Tumor.</p>
<p>9- Growth Fraction (GF): This is the proportion of cells within the neoplasm entering the cell cycle (i.e. out of GO phase). The importance of GF is that most antineoplastic drugs act on dividing cells; thus tumors with high GF are the most susceptible to anticancer agents &amp; are also the most rapidly growing if left untreated.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="management-of-benign-malignant-tumours">MANAGEMENT OF BENIGN &amp; MALIGNANT TUMOURS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management-of-benign-malignant-tumours" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>SURGERY: Benign tumours - removal of tumour only (Iumpectomy)</li>
</ul>
<p>Malignant tumours- removal of tumour, the tissues around it sometimes the whore organ and removal of draining lymph nodes (radical surgery)</p>
<ul>
<li>CHEMOTHERAPY: interferes with metabolism of proliferating cells
a) Protein synthesis
b) DNA block</li>
<li>RADIOTHERAPY: causes DNA breaks
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Direct damage of DNA molecule
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Breaks in cell &amp; organelle membranes
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Inhibition of important proteins &amp; enzymes
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Toxic damage by ionization of Intra cellular water</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hormonal-therapy">- HORMONAL THERAPY:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hormonal-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>a) Drugs
b) Surgical ablation (removal of ovaries or castration)</p>
<ul>
<li>IMMUNOTHERAPY</li>
<li>Non specific vaccines BeG boosts immunity in general</li>
<li>Interferon &amp; interleukin 2 therapy</li>
<li>GENE THERAPY</li>
<li>VIROTHERAPY ( under trial in animals) NEW
<img src="assets/images/image-20251212-b9dbcac6.jpeg" alt="img-90.jpeg"></li>
</ul>
<p>Fig. 22 CEA positive brown tumour cells</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Dist of growth &amp; neoplasia</td><td style="text-align: left;">ALL</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cytology">CYTOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cytology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Is the science of cell structure. Compared to histology, the diagnostic criteria are few and depend solely on nuclear and cytoplasmic features of cells. It is unlike histology, where the cellular features as well as the pattern and the relationship of the cells with their surroundings are all taken into consideration.</p>
<p>Despite these diagnostic limitations, cytology is a rapid - inexpensive - non invasive method of patient evaluation and it is rapidly gaining precedence over many diagnostic techniques because:</p>
<ol>
<li>Easy technique</li>
<li>Rapid: can take many samples in a short time</li>
<li>Inexpensive: requires few personnel and minimal equipment</li>
<li>Repeatable: Non invasive method which offers no inconvenience to the patient</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses">Uses:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Screening: Early detection of premalignant &amp; early invasive neoplasia</li>
</ol>
<ul>
<li>Cervico-vaginal PAP smears</li>
<li>Breast carcinoma screening programs</li>
<li>Urine screening</li>
<li>Sputum screening for bronchogenic carcinoma</li>
</ul>
<ol start="2">
<li>Initial diagnosis</li>
<li>Follow up and monitoring of treatment</li>
<li>Research and tissue culture material</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cytology-samples">CYTOLOGY SAMPLES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cytology-samples" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-fluids">1)FLUIDS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-fluids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Effusions</p>
<ol>
<li>Pleural</li>
<li>Pericardial</li>
<li>Ascitic fluid</li>
<li>Joint contents</li>
</ol>
<p>Urine
CSF</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-smears">2) SMEARS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-smears" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Cervico-vaginal PAP smears</li>
<li>Testicular aspirate! imprint</li>
<li>Imprint of mass! organ e.g. Lymph nodes</li>
<li>Brush samples: bronchial!gastric</li>
</ul>
<p>3)SPUTUM</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-brush-and-lavage">4)BRUSH AND LAVAGE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-brush-and-lavage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Bladder&amp; gastric wash, bronchial brush and lavage and rectal brush ...
5) FNAC/FNAB: fine needle aspiration cytology or biopsy</p>
<p>A 10 ml syringe with a 22-23 gauge needle used to aspirate material from Superficial organs:</p>
<p>Lymph nodes- salivary glands-thyroid-breast-subcutaneous swellings Deep organs (Ultrasound guided): Liver -kidney-pancreas-retroperitoneal-prostate etc</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-discharge">6) DISCHARGE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-discharge" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Nipple</li>
<li>Conjunctival</li>
<li>Ear</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="technical-aspects">TECHNICAL ASPECTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#technical-aspects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-processing">A) PROCESSING<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-processing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Fluids are :centrifuged and extra sediment is processed like tissue and made into cell blocks. A special centrifuge called cytospin is used for very clear samples</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-fixatives">B) FIXATIVES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-fixatives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>95</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">95 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">95%</span></span></span></span></span> ethanol is a routine fixative</li>
<li>Cytofix spray</li>
<li>Special fixatives according to sample type</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-stains">C) STAINS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-stains" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="routine">Routine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#routine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>PAP All samples since it shows good cytoplasmic detail as well as good nuclear detail Hematoxylin and eosin: FNAC &amp; rest of sediment Giemsa important for fine needle aspirates. It shows good nuclear detail Toluidene blue or Diff Quick: For immediate diagnosis (rush sample)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="special-stains">Special stains<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#special-stains" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>PAS: for glycogen - mucous - fungus
Silver stains: Fungus - inclusions
Immunohistochemical stains &amp; Tumour markers</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examination-of-sample-diagnosis">EXAMINATION OF SAMPLE &amp; DIAGNOSIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examination-of-sample-diagnosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The cytologist should preferably take the sample himself or be present with the clinician, to ensure proper fixation and sufficient sampling</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="gross-examination">GROSS EXAMINATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gross-examination" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The cytologist examines the gross appearance of the sample and describes it: color, volume and whether sample is clear or turbid.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="microscopic-examination">MICROSCOPIC EXAMINATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microscopic-examination" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Low power is important for:</p>
<ul>
<li>Determination of adequacy (are there enough cells &amp; are the cells representative of the tissue being examined).</li>
<li>Pattern &amp; background</li>
<li>Cell types</li>
</ul>
<p>At this level abnormal cells or groups can be marked for later high power use and an idea about the disease category is formed: Inflammation - degeneration, repair, neoplasia. Inadequate smears can be dismissed</p>
<p>High power + Oil immersion are important for: The determination of the benign or malignant nature of cells examined depending on cytoplasmic features &amp; nuclear details:</p>
<ol>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">N</mi><mi mathvariant="normal">/</mi><mi mathvariant="normal">C</mi></mrow><annotation encoding="application/x-tex">\mathrm{N} / \mathrm{C}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathrm">N</span><span class="mord">/</span><span class="mord mathrm">C</span></span></span></span></span> ratio</li>
<li>Cell &amp; nuclear shape and size</li>
<li>Cell &amp; nuclear membranes</li>
<li>Others: Inclusion bodies</li>
</ol>
<p>Bacteria/fungi/parasites
Nucleoli-mitotic figures-chromatin pattern
Artifacts</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-features-of-benign-malignant-smears">GENERAL FEATURES OF BENIGN &amp; MALIGNANT SMEARS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-features-of-benign-malignant-smears" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>General features of Benign cells (Fig. 23)
<img src="assets/images/image-20251212-d72bf3c6.jpeg" alt="img-91.jpeg"></p>
<ol>
<li>NUCLEI :Equal size - same shape (round or oval) - normal size</li>
<li>NUCLEAR MEMBRANE: Smooth - regular</li>
<li>CHROMATIN: Fine &amp; uniform diffuse distribution</li>
<li>NO NUCLEOLUS: (few exceptions)</li>
<li>CLEAN BACKGROUND: No tumour diathesis</li>
<li>N/C RATIO: Normal according to the cell type</li>
</ol>
<p>General features of malignant cells (Fig. 24)
<img src="assets/images/image-20251212-c7f4a791.jpeg" alt="img-92.jpeg"></p>
<ol>
<li>NUCLEI: Enlarged - different sizes (pleomorphic) and hyperchromatic</li>
<li>NUCLEAR MEMBRANE: Irregular with angulations</li>
<li>CHROMATIN: Angulated - Clumped - irregular distribution</li>
<li>PROMINANT NUCLEOLUS: may be angulated</li>
<li>DIRTY BACKGROUND (tumour diathesis): RBCs , necrotic cells and Inflammatory cells. This is a sign of invasion</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>N</mi><mi mathvariant="normal">/</mi><mi>C</mi></mrow><annotation encoding="application/x-tex">N / C</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal" style="margin-right: 0.10903em;">N</span><span class="mord">/</span><span class="mord mathnormal" style="margin-right: 0.07153em;">C</span></span></span></span></span> RATIO: Increased due to nuclear enlargement</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Suptopic</th></tr></thead><tbody><tr><td style="text-align: left;">Cytology</td><td style="text-align: left;">mportance of cytology &lt;br&gt; Cytology samples &lt;br&gt; Bemgn &amp; malignant cell features &lt;br&gt; Rest category B</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="environmental-pathology">ENVIRONMENTAL PATHOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#environmental-pathology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Environmental pathology includes a group of diseases that result from environmental factors as:
(1) Chemical factors: e.g. heavy metals and industrial organic. compounds.
(2) Physical agents: e.g. extremes of temperature, radiation ... etc.
(3) Nutritional: toxic compounds in food
(4) Occupational: as pneumoconiosis ( dust diseases of the lung)
(5) Cultural agents: e.g. smoking, alcohol ... etc.
(6) Others: e.g. air pollution.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-chemical-injury">I) CHEMICAL INJURY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-chemical-injury" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>(1) Methyl alcohol: is found in solvents, paint removers and antifreeze. Its metabolites, formic acid and formaldehyde, are toxic to the retina and cortical neurons.
(2) Insecticides: as chlorinated hydrocarbons and phosphates. These are readily absorbed through the skin, respiratory tract and gastrointestinal tract and stored in adipose tissue. cause CNS disturbances, muscle twitches and paralysis, cardiac arrhythmias, impotence and infertility.
(3) Carbon monoxide (CO): CO is released by incomplete combustion. It forms stable carboxyhemoglobin incapable of binding to oxygen. It gives the skin a cherry red colour.
(4) Lead: Sources of lead are car exhaust, lead paints, lead water pipes ... etc. Lead causes chronic tubulo-interstitial nephritis, peripheral neuritis, cerebral edema and ginival lead line.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-physical-injury">II) PHYSICAL INJURY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-physical-injury" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>(1) Frostbite: Exposure to severe cold causes temporary arteriolar spasm and capillary stasis. This causes ischaemia and gangrene of the fingers, toes, nose and ear.
(2) Heat stroke: Results from exposure to heat. Excessive sweating and generalized vasodilatation occur leading to hypotension, cell hypoxia and hyperkalemia.
(3) Electrical injury: according to the type of current, voltage, path and duration of contact, electric current causes:
(a) Skin burns.
(b) Explosion of solid organs.
(c) Bone fractures.
(d) Rupture of small vessels and focal haemorrhage.</p>
<p>(e) Sudden death due to disruption of neural regulatory impulses causing cardiac or respiratory arrest.
(4) Radiation injury</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="radiationpathology">RADIATIONPATHOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#radiationpathology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>RADIATION: Any form of energy carried across space
IRRADIATION: Application of radiant energy to tissues</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sources">SOURCES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sources" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Natural (background radiation)</li>
</ol>
<p>1- Cosmic rays solar (sun)- galactic (stars): Ultraviolet (UV) rays, infrared rays, &amp; atomic particles
N.B.: Ozone layer prevents harmful doses &amp; substances from reaching us.</p>
<p>2- Radioactive substances in earth crust, these emit radiant energy (radioactive decay) e.g.: uranium 234,235 &amp; 238 (natural isotopes)
2. Artificial</p>
<p>Industrial products -Nuclear explosions (weapons)- Nuclear power plants which may be a source of leakage or accidental release in atmosphere, of damaging radiation resulting in atmospheric pollution <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>1</mn></msup></mrow><annotation encoding="application/x-tex">{ }^{1}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8141em;"></span><span class="mord"><span class="mord"></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8141em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1</span></span></span></span></span></span></span></span></span></span></span></span></span>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-radiation">TYPES OF RADIATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-radiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>NON IONIZING: Electromagnetic waves (EMW) of long wave length e.g. Radio waves, infrared waves &amp; ultraviolet waves or rays</li>
<li>IONIZING:
a. Atomic particles or particulate radiation (atomic energy/nuclear energy)
b. Electromagnetic waves (EMW) of short wave length e.g.: X rays &amp; gamma rays
N.B.: UV rays may cause ionization and damage if there is prolonged exposure</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses-of-radiation">USES of RADIATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses-of-radiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>In Industry: sterilization and pasteurization- energy generators (nuclear power plants produce heat and electricity from fission reactions)- microwave ovens and radio and TV.</li>
<li>War: atomic weapons e.g. bombs</li>
<li>Science: geology and archeology (carbon dating)- oceanography</li>
<li>Medicine:</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="diagnosis">Diagnosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Radiodiagnosis: X-rays- CT scans- MRI (magnetic resonance imaging) for lesions of bone /soft tissue. Use of dyes can show lesions in GIT (barium swallow). Blood vessel abnormalities (angiography) and urinary tract abnormalities (pyelography)</li>
<li>Tissue diagnosis-Electron microscope</li>
<li>Functional diagnosis</li>
</ul>
<ol>
<li>PET (positron emission tomography): Where a radioactive tracer is injected, and the time taken for it to circulate is a measure of left ventricular contractility.</li>
<li>Radioactive iodine is taken up by suspicious thyroid nodules for diagnosis of cold &amp; hot (active) nodules (a measure of activity of thyroid cells in the nodule)</li>
</ol>
<ul>
<li>
<ol start="6">
<li>Treatment (Nuclear medicine / radiotherapy) especially cancer (palliative or curative) e.g. Cobalt 60</li>
</ol>
</li>
</ul>
<ol start="5">
<li>Others: e.g. sterilization of sutures, short wave treatment for joint disorders, diathermy (surgical procedure by heat application) and radioisotopes for thyroid disorders.</li>
</ol>
<p>1 atmospheric pollution with radiant energy is called: radioactive fallout (the radiant energy present in the atmosphere after any form of leakage or explosion)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definitions">Definitions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definitions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Radioactivity: SPONTANEOUS change of unstable atomic nuclei ( radioisotope) to another stable state, with the emission of radiant energy
Radioisotope or radionucleide: A radioactive form of an element (i.e. atoms of the same substance containing different number of neutrons) NB to stabilize an atom the number of neutrons must <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> number of protons in nucleus. A radioisotope is therefore an unstable nucleus with increased or decreased number of neutrons</p>
<p>Unstable atom/element/molecule emits ionizing radiation till a stable new atom is formed,
N.B.: Isotope: different forms of the same element e.g.C12, C13, C14</p>
<p>Isotope (stable) since atomic number (number of protons) <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo><mn>1</mn><mi mathvariant="normal">/</mi><mn>2</mn></mrow><annotation encoding="application/x-tex">=1 / 2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1/2</span></span></span></span></span> atomic weight (number of protons + neutrons)
radioactive form of isotope ( C14 radioisotope) where number of neutrons is more than protons</p>
<p>Ion: positively or negatively charged atom (an atom which has lost an outer electron has a +ve charge &amp; an atom, which has gained an outer orbit electron, has a -ve charge). These charged atoms react with one another forming
free radicals which are also highly reactive because they carry unpaired electrons in the outer shell.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mode-of-action-of-ionizing-radiation">MODE OF ACTION OF IONIZING RADIATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mode-of-action-of-ionizing-radiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-direct-or-target-theory">1. Direct or Target theory:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-direct-or-target-theory" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Direct injury (inactivation/ alteration of):</p>
<ul>
<li>DNA:
a- Damage to mitotic spindle causes suppression in mitotic activity
b- DNA structural abnormalities: Gene damage and chromosomal damage e.g. point mutation translocation- amplification and chromosomal fragmentation (dysjunction with abnormal random fusion) (structure abnormality)
c- DNA functional abnormality: abnormal gene expression (functional abnormality)</li>
<li>Enzyme injury</li>
<li>Cell and nuclear membrane injury</li>
</ul>
<ol start="2">
<li>Indirect or Poison theory: one or more hits affect water molecules in cell or tissue causes ionization of water resulting in free radical <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo stretchy="false">(</mo><mi mathvariant="normal">H</mi><mo separator="true">,</mo><mrow><mi mathvariant="normal">O</mi><mi mathvariant="normal">H</mi></mrow><mo stretchy="false">)</mo></mrow><annotation encoding="application/x-tex">(\mathrm{H}, \mathrm{OH})</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord mathrm">H</span><span class="mpunct">,</span><span class="mspace" style="margin-right: 0.1667em;"></span><span class="mord"><span class="mord mathrm">OH</span></span><span class="mclose">)</span></span></span></span></span> (chemical injury) and formation of hydrogen peroxide (H20 2) chemical injury</li>
</ol>
<p>Effects: These react with DNA, enzymes &amp; cell and nuclear membranes resulting in damage</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="effects-of-radiation">EFFECTS OF RADIATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#effects-of-radiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>on non living tissue (elements): it produces radioisotope on living tissue: it DEPENDS ON:
(1) Dose: Mild doses produce no visible effects to mild effects. All cells die if doserem <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1000</mn><mo>−</mo><mn>800</mn></mrow><annotation encoding="application/x-tex">1000-800</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7278em; vertical-align: -0.0833em;"></span><span class="mord">1000</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">−</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">800</span></span></span></span></span>
(2) Rate, duration of exposure, distance from source and Penetration power
(3) Type of tissue</p>
<ul>
<li>Radiosensitive: actively mitotic cell e.g. labile cells</li>
<li>Radioresponsive: mitotic only on injury e.g. stable cells</li>
<li>Radioresistant: non mitotic e.g. permanent cells
(4) Oxygen effect. The more vascularized, the more oxygenated and the higher the temperature, the more ionization of water and free radicals &amp; Hproduction is facilitated.
N.B.: The angiogenesis accompanying malignant tumors raises the temperature of the tumor &amp; its oxygen content</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="manifestations-of-radiation-damage">MANIFESTATIONS OF RADIATION DAMAGE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#manifestations-of-radiation-damage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Immediate effects (hours - days)</li>
<li>Early effects (after 1 week)</li>
<li>Late or delayed effects( months to years)
N.B.: permissible dose of radiation for ages 18-25 years is 5 rem / year</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-cells">A. CELLS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Atrophy &amp; Vacuolar Degeneration of cells up to necrosis in addition to an acute inflammatory reaction</li>
<li>Later followed by chronic inflammation and healing by fibrosis</li>
<li>Very late, cells mutate</li>
<li>If the mutation is at the level of somatic cells a tumour occurs Carcinogenesis (oncogenesis) but if it occurs at the level of the germ cell the result is genetic abnormalities (teratogenesis) and the mutation is transmitted to offspring</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-tissue">B. TISSUE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-tissue" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Blood vessels dilatation, congestion and tissue shows edema (acute inflammatory: mild early: changes) orsevere early damage to vessel wall (fibrinoid necrosis), resulting in tissue hemorrhage, thrombophlebitis with resultant ischemia of tissue. More ischemia occurs later when endarteritis obliterans occurs with chronicity.</li>
<li>Connective tissue:</li>
</ul>
<p>Early: edema and acute inflammatory cells (PNLs &amp; macrophages).
Later chronic inflammation occurs and healing by fibrosis and scarring.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-effects-of-radiation-on-individual-organs">C. EFFECTS OF RADIATION ON INDIVIDUAL ORGANS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-effects-of-radiation-on-individual-organs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="during-treatment">(During treatment)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#during-treatment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Skin: Early:Acute radiodermatitis: (acute inflammation) erythema, swelling and epidermal desquamation or radiation ulcers due to surface necrosis
Later: Atrophy of skin appendages (alopecia and hypopigmentation)
Very late: Basal cell carcinoma or squamous cell carcinoma</li>
<li>GIT: Early: mucosal inflammation, ulceration &amp; radiation colitis with diarrhea and pain
Late: fibrosis and atrophy leading to malabsorption</li>
<li>Testis and ovary (germ cells) early: destruction -late: fibrosis and sterility</li>
<li>Lungs: Acute respiratory distress syndrome (ARDS) - late: pulmonary fibrosis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="5-haemopoietic-lymphopoietic">5. Haemopoietic &amp; lymphopoietic:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-haemopoietic-lymphopoietic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>BM depression: anemia, thrombocytopenia &amp; leukopenia (pancytopenia) or total destruction of bone marrow (aplasia)
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="bold">L</mi><mi mathvariant="bold">N</mi></mrow><annotation encoding="application/x-tex">\mathbf{L N}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6861em;"></span><span class="mord"><span class="mord mathbf">LN</span></span></span></span></span></span> atrophy or destruction with decrease lymphocytic count in peripheral blood; finally fibrosis Later/delayed: Leukemia-lymphoma
6. Bone: Osteomyelitis- radiation necrosis</p>
<ul>
<li>Bone marrow hypoplasia or aplasia (destruction) with risk of leukemia later</li>
<li>Osteosarcoma</li>
</ul>
<ol start="7">
<li>Others: radiation nephritis, BV vasculitis and thrombosis (radiation vasculitis)</li>
<li>Long term effects: carcinogenesis or genetic defects (teratogenesis)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-effects-of-total-body-radiation">D. EFFECTS OF TOTAL BODY RADIATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-effects-of-total-body-radiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>(1 dose exposure of all body as in radioactive fall out in accidents, wars &amp; background radiation pollution)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="systemic">SYSTEMIC<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#systemic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A. Early or acute radiation effects due to sudden whole body exposure radiation syndrome</p>
<ul>
<li>Radiation sickness or mild radiation syndrome: (non -lethal) 50-200 rem (0.5-2 Sv)</li>
<li>Fatigue, anorexia and nausea (mild GIT syndrome)</li>
<li>Transient drop in peripheral blood counts(mild )</li>
<li>Haemopoietic syndrome: 200-600rem (2-6Sv) causing: BM depression: pancytopenia (severe)</li>
<li>Gastrointestinal syndrome: 300-1000 rem(3-1 OSv) producing: Severe diarrhea, vomiting (Severe) &amp; GIT hemorrhage</li>
<li>Cerebral syndrome: <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo><mn>1000</mn></mrow><annotation encoding="application/x-tex">&gt;1000</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">1000</span></span></span></span></span> rem (1 OSv) ending in convulsions and coma (lethal)
B. Late effects (survivors of accidents with very low dose exposure or slow cummulative whole body exposure in industrial pollution &amp; natural background radiation) Malignancy e.g. leukemia
Genetic disorders ( in offspring)
Infertility &amp; complications of fibrosis at various sites
LOCAL Describe effects on various organs (see above)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="radiation-protection">RADIATION PROTECTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#radiation-protection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>1- Shield effect: lead aprons and concrete walls prevent penetration
2- Radiation surveillance and measurement: Dosimeters for personnel and Geiger counters &amp; solid state detectors for checking the presence of radioactivity in environment
3- Bone marrow replacement can be life saving if done early in people who have been exposed to total body radiation (accidents, wars)
4- Chemical protection: cysteine and glutathione</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="neoplasm-s-and-radiation">NEOPLASM'S AND RADIATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neoplasm-s-and-radiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Ionizing radiation may playa role in cancer treatment or cancer induction
In Cancer treatment (Radiotherapy): It depends on radiosensitivity of tumor cells.
Radiosensitivity: Is the amount of damage produced in a tumor that is directly proportionate to &amp; correlates with degree of mitotic activity of tissue or tumor. Actively mitotic cells are particularly vulnerable &amp; with damage of mitotic spindle, mitotic activity &amp; cell proliferation is inhibited within the tumor tissue this helps in confining the tumor &amp; preventing its spread. The other mode of action is DNA &amp; chromosomal damage, which is incompatible with life of the tumor cell &amp; the cell dies. Normal tissue survives the radiation dose since its rate of proliferation is lower than tumor.</p>
<table><thead><tr><th style="text-align: left;"></th><th style="text-align: left;">Permanent cells &lt;br&gt; (No mitotic ability)</th><th style="text-align: left;">Stable cells &lt;br&gt; (Low mitotic ability)</th><th style="text-align: left;">Labile cells &lt;br&gt; (High mitotic ability)</th></tr></thead><tbody><tr><td style="text-align: left;">Degree of radio- &lt;br&gt; sensitivity</td><td style="text-align: left;">Radioresistant</td><td style="text-align: left;">Radioresponsive</td><td style="text-align: left;">Radiosensitive</td></tr><tr><td style="text-align: left;">Normal cells</td><td style="text-align: left;">Adult neurons &lt;br&gt; Striated muscle</td><td style="text-align: left;">Muscle (smooth) &lt;br&gt; CT &lt;br&gt; Liver &lt;br&gt; Endocrine organs &lt;br&gt; Glial cells</td><td style="text-align: left;">Bone marrow &lt;br&gt; Intestinal epithelium &lt;br&gt; Hair follicles &lt;br&gt; Gonads &lt;br&gt; Skin</td></tr><tr><td style="text-align: left;">Tumors</td><td style="text-align: left;">Ganglioneuroma</td><td style="text-align: left;">Sarcomas &lt;br&gt; Gliomas &lt;br&gt; Hepatoma</td><td style="text-align: left;">Leukemia Lymphomas &lt;br&gt; Germinoma &lt;br&gt; gonads) Embryomas</td></tr></tbody></table>
<p>1- Curative by killing tumor cells leading to spontaneous cure (Melanoma and Hypernephroma)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-palliative-by">2- Palliative by<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-palliative-by" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Decreasing tumor size through killing some cells or inhibiting growth and therefore slowing tumor both primary &amp; secondaries in addition to delaying spread</li>
<li>Relief of pain by decreasing size of tumor and its pressure effects</li>
<li>Control of hemorrhage by thrombosis and endarteritis obliterans
N.B.: Monoclonal antibodies tagged with radioisotope can be used as a form of cancer therapy against cancer cells carrying the target antigens</li>
<li>Cancer induction: The dangers from this source have greatly increased in recent years. The ionizing activity of X-rays &amp; atomic radiation produce many changes in nuclear DNA ranging from single gene mutations to gross chromosomal abnormalities with damage of chromosomes in the form of breaks &amp; random fusion producing mutant tumor cells (carcinogenesis).</li>
</ul>
<table><thead><tr><th style="text-align: left;">Source of radiation</th><th style="text-align: left;">Possible tumors</th><th style="text-align: left;">Type of radiant energy</th></tr></thead><tbody><tr><td style="text-align: left;">X-ray workers</td><td style="text-align: left;">Skin cancer-leukemia</td><td style="text-align: left;">Ionizing X-rays</td></tr><tr><td style="text-align: left;">Mining of radioactive sub- &lt;br&gt; tances</td><td style="text-align: left;">Lung cancer</td><td style="text-align: left;">Atomic energy (particulate &lt;br&gt; &amp; rays)</td></tr><tr><td style="text-align: left;">Atomic explosions</td><td style="text-align: left;">Skin cancer-leukemia-bone &lt;br&gt; cancer</td><td style="text-align: left;">Atomic energy (particulate &lt;br&gt; &amp; rays)</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-nutritional-disorders">III)NUTRITIONAL DISORDERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-nutritional-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Nutrients are chemicals in foods that are used by the body for growth, maintenance, and energy. Nutrients that cannot be synthesized by the body and must be derived from the diet are considered essential. They include vitamins, minerals, some amino acids, and some fatty acids. Nutrients that the body can synthesize from other compounds, although they may also be derived from the diet, are considered nonessential.
N.B.: Macronutrients are required by the body in relatively large amounts; micronutrients are needed in minute amounts.</p>
<p>Lack of nutrients can result in deficiency syndromes (e.g. pellagra) or other disorders (Under nutrition .(Excess intake of macronutrients can lead to obesity and the Metabolic Syndrome. Excess intake of micronutrients can be toxic. Also, the balance of various types of nutrients, such as how much unsaturated versus saturated fat is consumed is important e.g. atherosclerotic plaques.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="examples-of-nutritional-disorders">EXAMPLES OF NUTRITIONAL DISORDERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-of-nutritional-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Protein-calorie disorders:
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> In children: marasmus -kwashiorkor (growth &amp; mental retardation)
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> in adults: starvation- cachexia- immunodeficiency</li>
<li>Eating disorders: Anorexia nervosa &amp; bulimia nervosa</li>
<li>Nutritional excesses: Obesity</li>
<li>Antioxidants and minerals (trace elements &amp; Fe) :</li>
</ul>
<ol>
<li>Decreased levels of zinc is responsible for delayed wound healing</li>
<li>Decreased levels of iodine is responsible for goiter</li>
<li>Decreased levels of Fe is responsible for anemia</li>
<li>lead or mercury toxicity is responsible for neuropathy</li>
</ol>
<ul>
<li>Vitamin deficiency - Hypervitaminosis ( mostly fat soluble vitamins)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vitamin-deficiencies">VITAMIN DEFICIENCIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-deficiencies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Vitamins are micronutrients (organic chemical compounds) found in a large variety of foods. They are essential for health because they serve as critical catalytic cofactors which speed up reactions without being consumed or prosthetic groups on enzymes involved in vital metabolic reaction. The body usually cannot synthesize them by itself.</li>
</ul>
<p>Fat-soluble vitamins A, D, E &amp; K. Found mostly in fatty foods (dairy products and meat).These are storable, but do not get absorbed through the gut in biliary insufficiency and other forms of fat malabsorption</p>
<p>Water-soluble vitamins ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>B</mi><mi mathvariant="normal">&amp;</mi><mi>C</mi></mrow><annotation encoding="application/x-tex">B \&amp; C</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal" style="margin-right: 0.05017em;">B</span><span class="mord">&amp;</span><span class="mord mathnormal" style="margin-right: 0.07153em;">C</span></span></span></span></span>, and folic acid) are available in most food stuffs as fruits, vegetables &amp; animal products ( only B12 is found exclusively in meat). The body does not store them well.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="disorders-responsible-for-hypovitaminosis">Disorders responsible for Hypovitaminosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disorders-responsible-for-hypovitaminosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Iry: Malnutrition, decreased intake
2ry:</p>
<ul>
<li>Malabsorption</li>
<li>Increased metabolism i.e. relative insufficiency e.g. folic acid in pregnancy</li>
<li>Presence of an antagonist e.g. methotrexate is a folic acid antagonist</li>
<li>Debilitating diseases &amp; malignancy</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="vitamin-a">Vitamin A<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Vitamin A, is derived from Retinol found in dairy products and meat whilst the previtamin B carotene is found in yellow fruit and leafy vegetables. The body stores it in the liver and shuttles it around on retinol-binding protein</li>
<li>Obvious deficiencies are common in the poor nations. Between 100 and 140 million children are vitamin A deficient.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="functions-of-vitamin-a">FUNCTIONS OF VITAMIN A:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#functions-of-vitamin-a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Vitamin A is involved in gene expression, cell growth and differentiation and its functions include:</p>
<ol>
<li>Maintanance of specialized epithelium especially the mucin secreting types.</li>
<li>Important for vital pigments in the retina.</li>
<li>Increases the immunity.</li>
<li>Antioxidant function.</li>
<li>Anticarcinogenic due to its regulatory effect on cell growth</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vitamin-a-deficiency">Vitamin A deficiency:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-a-deficiency" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- The best known symptoms of deficiency are</p>
<ul>
<li>The first complaint in vitamin A deficiency is diminished vision in the dark</li>
<li>Xerophthalmia or dry eye results from inadequate function of the lacrimal glands which</li>
<li>produce conjunctival dryness</li>
<li>Bitot's spots( keratin plaques) result in opacification of cornea</li>
<li>Keratomalacia: degeneration of cornea with dryness, softening and ulcerations</li>
<li>Blindness is the end result.</li>
</ul>
<p>2- Other problems due to squamous metaplasia include kidney stones, obstruction of the sweat and sebaceous glands leading to acne and lung infections.
3- Immunodeficiency.
4- Increase susceptibility to cancer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vitamin-d">Vitamin D<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>While some vitamin D is supplied by the diet (yolk of eggs, as well as in various oils particularly fish liver oil and fats), most of it is made in the body, by the action of ultraviolet light on 7dehydrocholesterol in the skin. After 25-hydroxylation in the liver, it is completely activated by 1hydroxylation in the kidney. Its function is to maintain adequate Ca and phosphorus levels for normal mineralization of bone.</li>
<li>Vitamin D deficiency occurs due to lack of dietary sources, lack of exposure to sun, liver and kidney diseases, fat malabsorption or inborn errors of metabolism</li>
</ul>
<p>(vitamin D resistant rickets; type I lacks 1-hydroxylase in the kidney, type II probably lacks vitamin 0 receptors).</p>
<ul>
<li>Vitamin D deficiency blocks mineralization of the osteoid laid down in remodeling of bone leading to osteomalacia in adults and impaired mineralization of the epiphyseal cartilage leading to rickets in children.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="rickets">Rickets:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#rickets" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-sequence-of-events">The sequence of events:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-sequence-of-events" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- The epiphyseal cartilage does not even calcify. Instead, it overgrows.
2- Deposition of osteoid among inadequately mineralized cartilaginous remnants.
3- Enlargement and lateral expansion of osteochondral junction
4- Loss of structural rigidity leading to deformities.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-features-of-rickets">Pathological features of rickets:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-features-of-rickets" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>I) The bone abnormalities of rickets, include</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-head">1. Head :<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-head" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) delayed closure of fontanelles,
b) craniotabes softening of the skull bones resulting in the bone popping in and out similar to pressing on a Ping-Pong ball.
c) frontal bossing unusually prominent forehead.
d) delayed eruption of temporary teeth</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-chest">2. Chest:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-chest" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a) rachitic rosary (knobs on the costochondral junctions due to overgrowth of cartilage),
b) pigeon breast (anterior protrusion of the sternum, pulled forward by the respiratory muscles),
c) Harrison's groove: a horizontal line at the lower margin of the thorax where the diaphragm attaches to the ribs. It appears in rickets because the patients lack the mineralized calcium in their bones necessary to harden them; thus the diaphragm, which is always in tension, pulls the softened bone inward
3. Vertebrae: lumbar lordosis (excessive inward curve of the spine)
4. Bow legs and trifoil pelvic deformities.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-somatic-lesions">II) Somatic lesions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-somatic-lesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>lymph node and adenoid enlargement and splenomegaly due to hyperplasia.</li>
<li>Weak tendons and muscles.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="iii-general-lesions">III) General lesions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-general-lesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Overweight due to limited movements.</li>
<li>Protuberant abdomen due to weak muscles (Potts belly), lordosis.</li>
<li>Lymph node enlargement, splenomegaly</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="osteomalacia">Osteomalacia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#osteomalacia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Occurs in adults, commonly in females as a result of repeated pregnancies with vitamin D deficiency.</li>
<li>Osteomalacia means "soft bones", the osteoid does not mineralize properly, during bone remodeling and it accumulates. The bone density and cortical thickness are decreased, predisposing to fractures .Bones are soft, easily bent resulting in a trifoil pelvis (this deformity is responsible for obstruction of labour), bowing of legs &amp; lumbar lordosis.</li>
<li>In osteomalacia, the non-calcified bone looks pale on x-ray and has a tendency to break.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vitamin-k">Vitamin K<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-k" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>This is the cofactor for the synthesis of gamma-carboxy glutamic acid, which is required for the calcium-binding clotting factors II, VII, IX, and X, plus protein C, S, and Z .</li>
<li>Although our intestinal flora makes a little vitamin K for us, it is inadequate and it is usually complemented from the diet. It is present in oils, green leafy vegetables and dairy products</li>
<li>Vitamin K is hard to avoid in the diet, we store several weeks' supply.</li>
<li>Deficiency is seen mostly in newborns and in those with lipid malabsorption or rarely due to wiping out the bacterial flora with antibiotics</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathology-of-vitamin-k-deficiency">Pathology of vitamin K Deficiency:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathology-of-vitamin-k-deficiency" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Hemorrhagic disease of the newly born</li>
<li>Petechia, ecchymosis and haematomas occur in any tissue following minor trauma.</li>
<li>Persistent bleeding follows wounds and surgical incision.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vitamin-c-ascorbic-acid">Vitamin C (ascorbic acid)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-c-ascorbic-acid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Humans, cannot synthesize it and its reserves are limited so the deficiency manifestations appear after 30-40 days. In the diet, it is present in citrus fruits and tomatoes</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="vitamin-c-functions">Vitamin C functions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-c-functions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>It is involved in developing and maintaining collagen, synthesizing chondroitin sulfate.</li>
<li>Antioxidant as it protects the body against oxidative stress and is a , cofactor in several vital enzymatic reactions and maintains Fe and Cu In vanous oxygenases in a reduced state.</li>
<li>Synthesis of neurotransmitors.</li>
<li>Important in immune functions.</li>
<li>Increases intestinal absorption of iron and folic acid.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-deficiency-syndrome-is-scurvy">The deficiency syndrome is "scurvy:"<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-deficiency-syndrome-is-scurvy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Occurs in people who eat very poorly for several weeks. In the poor nations, scurvy occurs in children whose mothers feed them with un-supplemented formula.</li>
<li>Scurvy is a distinctive clinical syndrome related to problems with osteoid synthesis and collagen support of the blood vessels.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-features-of-scurvy">Pathological features of scurvy:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-features-of-scurvy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>In children, the osteoblasts lay down scanty, poor-quality osteoid. The end result is deformities similar to rickets (enlargement of bony ends rosary bed, sternal depression, bowing of legs and defective teeth formation).</li>
<li>In both children and adults, the capillaries weaken. Patients bruise easily, and bleeding gums, and petechiae around the hair follicles. Eventually, hemorrhages beneath the periosteum develop, making this the most painful of the deficiency diseases.</li>
<li>Wounds heal poorly.</li>
<li>A secondary functional folic acid deficiency develops, because vitamin C is responsible for maintaining folate in its reduced state leading to anemia.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vitamin-b1-thiamine">Vitamin B1 (thiamine)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-b1-thiamine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This vitamin is important in carbohydrate metabolism, synthesis of ATP and it also maintains nerves. Thiamine deficiency was seen classically in people subsisting on polished rice, and today in alcoholics, cancer victims who do not eat, women with extreme vomiting of pregnancy, and in children and adults who have been starved.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="thiamine-deficiency">Thiamine deficiency<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#thiamine-deficiency" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A cardiomyopathy, with a flabby, failing heart ("wet beriberi"), plus generalized dilatation of arterioles requiring "high output"</li>
<li>A peripheral neuropathy ("dry beriberi"), with numb fingers and toes, weak muscles, and lost reflexes. First the myelin, then the axons and even the motor and sensory neurons go.)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="vitamin-b3-niacin-nicotinic-acid">Vitamin B3 (niacin, nicotinic acid)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vitamin-b3-niacin-nicotinic-acid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Formed from spare tryptophan.</li>
<li>Niacin in maize ("corn") is poorly absorbed, maize is low in tryptophan.</li>
<li>Pellagra ("dry skin") used to be endemic in southern "corn belt" (corn eating societies and In an alcoholics.
Niacin deficiency ("pellagra"): produces the "three D's"</li>
</ul>
<ol>
<li>Dermatitis: Red, thick, scaly, sharply demarcated, irregularly pigmented skin, especially sun-exposed regions; and "beefy red tongue"; Microscopically: acanthosis, confluent parakeratosis, hyperkeratosis and increased pigmentation..</li>
<li>Diarrhea: The mucosa of the colon is hyperemic and covered by pseudomembrane. Microscopically: hyperaemia, areas of necrosis and mononuclear inflammatory cellular infiltration .</li>
<li>Dementia: Mental illness and loss of neurons in frontal lobes; and demylination of the lateral and posterior column (subacute combined degeneration). The fourth "D" is "death".</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b12-cyanocobal-amine-folic-acid">B12 (Cyanocobal-amine) &amp; Folic acid<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b12-cyanocobal-amine-folic-acid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Coenzyme for nucleic acid &amp; RBC production. Folic acid is also an important for proper nerve function. Present in vegetables &amp;fruit (bananas &amp; lemons). Responsible for megaloblastic anemia in addition to Neurological damage in cases of folic acid deficiency</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-cultural-factors">IV) CULTURAL FACTORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-cultural-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Tobacco smoking: Predisposes to:
(a) Coronary atherosclerosis and ischemic heart diseases.
(b) Chronic obstructive lung diseases.
(c) Bronchial carcinoma by its chemical carcinogens.
(d) Fetal hypoxia and premature deaths.</p>
</li>
<li>
<p>Alcohol abuse: Predisposes to:
(a) Fatty change in the liver, alcoholic hepatitis and cirrhosis.
(b) Cardiomyopathy and hypertension.
(c) Acute gastritis, chronic gastritis and pancreatitis.
(d) Testicular atrophy and decreased fertility.
(e) Peripheral neuritis.
(f) Cancer of the oral cavity, pharynx, esophagus, liver and breast.</p>
</li>
<li>
<p>Street drugs:
(a) Bango: May lead to:</p>
</li>
</ol>
<ul>
<li>Adverse behavior and psychological reactions.</li>
<li>Deterioration of pulmonary, reproductive and immunologic functions.
(b) Cocaine: Increases synthesis of norepinephrines and dopamine causing:</li>
<li>Euphoria.</li>
<li>Tachycardia, hypertension and arrhythmias. (c) Heroin: Addiction may result in:
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Disseminated angitis.
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Meningitis and brain infections.
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Transmitted infections: AIDS, hepatitis ... etc. - Infective endocarditis.
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo></mrow><annotation encoding="application/x-tex">&gt;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span></span></span></span></span> Peripheral neuropathy.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="v-air-pollution">V) AIR POLLUTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-air-pollution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The pollutants may be bacteria, gases, particles or fibers. The inhalation of pollutants may cause:
(1) Acute or chronic inflammation, e.g. chronic bronchitis.
(2) Allergic reactions, e.g. bronchial asthma.
(3) Immunologic injury.
(4) Granulomatous reactions, e.g. pneumoconiosis.
(5) Mutagenic and tumour promoting effects may lead to neoplasia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: center;">Topic</th><th style="text-align: center;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: center;">Environmental</td><td style="text-align: center;">Chemical &amp; cultural factors</td></tr><tr><td style="text-align: center;">Ionizing radiation</td><td style="text-align: center;">Air pollution</td></tr><tr><td style="text-align: center;">Vitamins</td><td style="text-align: center;">Mode of action-effects manifestations &lt;br&gt; of radiation damage- neoplasms and radiation</td></tr><tr><td style="text-align: center;"></td><td style="text-align: center;">Rest C</td></tr><tr><td style="text-align: center;"></td><td style="text-align: center;">A-D-K</td></tr><tr><td style="text-align: center;"></td><td style="text-align: center;">C</td></tr><tr><td style="text-align: center;"></td><td style="text-align: center;">Rest C</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="heredity-genes-disease">HEREDITY- GENES &amp; DISEASE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#heredity-genes-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The nucleus is the genetic factory; it contains a diploid number of chromosomes (46) i.e. 22 pairs of autosomes +1 pair of sex chromosomes.</p>
<p>A chromosome is 1 molecule of DNA (as a double helix). This may carry up to 50,000 genes &amp; its basic structure is the nucleotide (base pair + ribose +phosphate)</p>
<p>Gene is the unit of the chromosome responsible for synthesis of 1 specific protein which may be composed of 1-20,000 nucleotides (base pairs)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chromosomes-are-important-in">Chromosomes are important in:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chromosomes-are-important-in" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Cell division</li>
<li>Carry hereditary traits on genes</li>
<li>Have genes responsible for protein synthesis (structural proteins, hormones, receptor proteins, intracellular messengers and enzymes)
N.B.: Somatic cells are diploid</li>
</ol>
<p>Germ cells (ovum/sperm) are haploid (half the number of chromosomes)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="developmental-genetic-disorders">DEVELOPMENTAL &amp; GENETIC DISORDERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#developmental-genetic-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="terminology">Terminology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#terminology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Developmental &amp; Congenital disorders: disorders due to events occurring just before birth which are not necessarily inherited e.g. exposure to radiation-viruses-drugs or spontaneous mutation during pregnancy</li>
<li>Inherited disorders: Are genetic disorders which are transmitted from 1 generation to another</li>
<li>Genetic disorders: Are diseases caused by abnormalities in genes or chromosomes.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="genetic-disorders">Genetic disorders<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#genetic-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mutations">Mutations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mutations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Mutation is a permanent change in the DNA which may occur spontaneously or due to external agents as radiation, chemicals &amp; viruses.</p>
<p>Mutations may affect germ or somatic cells.
1- Germ cell mutations: affect germ cells and result in hereditary diseases.
2- Somatic cell mutations: affect the tissue stem cell population or somatic non germ cell population. Such mutations may be responsible for:
A. Congenital disorders</p>
<p>B. Reversible growths i.e. hyperplasia-hypertrophy- congenital abnormality but not hereditary disorders.
C. Tumor cells (irreversible)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types-of-mutations">Types of mutations:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-mutations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Chromosome mutations:
A) Genome mutations: Loss or gain of the whole chromosome (numerical) monosomy or trisomy
B) Rearrangement of the genetic material which gives rise to visible structural changes in the chromosome.</li>
<li>Gene mutations: Partial or complete deletion of gene or more often affect single base. E.g. single point gene mutation</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="effects-of-mutations">Effects of mutations:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#effects-of-mutations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Abnormal proteins. &amp; Lack of the protein synthesis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-genetic-disorders">Types of Genetic Disorders:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-genetic-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Cytogenetic: Chromosomal ( number. and structural) disorders.</li>
<li>Single gene disorders: Mutant gene with large effect ( Mendelian disorders) &amp; single gene disorders with non classic inheritance.</li>
<li>Multifactorial inheritance: Influenced by both genetic and environmental factors.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-cytogenetic-hromosomal-abnormality">1. CYTOGENETIC HROMOSOMAL ABNORMALITY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-cytogenetic-hromosomal-abnormality" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Abnormalities of chromosomes may be either numerical or structural and may involve the autosomes, the sex chromosomes or both simultaneously. Numerical abnormalities represent about <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>60</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">60 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">60%</span></span></span></span></span> of all chromosome abnormalities.
A. Abnormalities in number of chromosomes:</p>
<p>1- Polyploid: Increased number of chromosomes by an exact multiple of haploid e.g.:
tetraploid loctaploid ( <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>4</mn><mi mathvariant="normal">/</mi><mn>8</mn></mrow><annotation encoding="application/x-tex">4 / 8</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">4/8</span></span></span></span></span> sets of chromosomes i.e. extra diploid sets)
a- if it occurs in somatic cells, it produces hypertrophy
b- if it occurs in germ cells, it is incompatible with life.
2- Aneuploid Increased or decreased number of chromosomes, but not by a multiple of the haploid e.g. triploid ( 3 whole sets of chromosomes i.e. an extra haploid set
a- if it occurs in somatic cells, it leads to some types of neoplasia.
b- if it occurs in germ cells (gametes) as monosmy (less by 1 chromosome) or trisomy (more by 1 chromosome, trisomy21) e.g. Down's syndrome</p>
<p>3- Mosaicism: Presence of more than one population of cells with normal chromosome number and the other with extra or missing chromosomes due to mitotic errors e.g. <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>45</mn><mi>x</mi><mi mathvariant="normal">/</mi><mn>47</mn><mi>x</mi><mi>x</mi><mi>x</mi></mrow><annotation encoding="application/x-tex">45 x / 47 x x x</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">45</span><span class="mord mathnormal">x</span><span class="mord">/47</span><span class="mord mathnormal">xxx</span></span></span></span></span> mosaic
B. Abnormalities in structure of chromosomes</p>
<ul>
<li>Accidental breaks with bad repair &amp; abnormal fusion as in spontaneous mutations or exposure to teratogens (irradiation-viruses-drugs)</li>
<li>Deletion: missing a part of chromosome</li>
<li>Duplication: A portion of the chromosome is duplicated resulting in extra genetic material</li>
<li>Translocation <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> When a portion of one chromosome is transferred to another chromosome. Or when segments exchange places on 2 chromosomes)</li>
<li>Dysjunction with random fusion=breaking usually at centromere but with abnormal random fusion
C. Abnormalities in sex chromosomes: Turners syndrome &amp; Kleinefelters syndrome Syndromes Associated with Sex Chromosome Abnormalities
(1)Klinefelter's syndrome: Male with karyotype (47, xxy). The syndrome is characterized by eunuchoid built, infertility, atrophic testis and gynecomastia.
(2)Turner's syndrome: Female with karyotype (45, x). The syndrome is characterized by atrophic ovaries, infantile external genitalia, lack of secondary sex characteristics, amenorrhea and congenital heart disease specially aortic coarctation.
(3)47, xxx syndrome: Female showing normal physical and reproductive development. However there may be difficulty in auditory perception and receptive and expressive language skills.
(4)47, xyy syndrome: Tall male with no apparent abnormality in physical and reproductive development. There may be a risk of criminal behaviour.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-single-gene-disease-mendelian-disorders">2. SINGLE GENE DISEASE ( Mendelian disorders)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-single-gene-disease-mendelian-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Genes on chromosomes affect function i.e. the distribution pattern of genes is important for they act either by enhancing or suppressing neighboring genes. All are the result of expressed mutations in a single gene with large effect.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="inherited-single-gene-disorders">Inherited single gene disorders<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inherited-single-gene-disorders" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Autosomal dominant: The mutated gene is dominant to its allele. All offspring are affected (homozygous &amp; heterozygous) e.g. familial hypercholesterolemia, adult polycstic kidney, multiple exostosis and polyposis coli.</p>
</li>
<li>
<p>Autosomal recessive: The mutated gene is recessive to its allele some offspring are affected (only homozygous) e.g. Thalassemia &amp; mental retardation</p>
</li>
<li>
<p>Sex linked on chromosome <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>X</mi></mrow><annotation encoding="application/x-tex">X</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord mathnormal" style="margin-right: 0.07847em;">X</span></span></span></span></span>, usually recessive (carrier), appearing in males with the female acting as a carrier for the abnormal gene e.g. hemophilia &amp; Duchenne muscular dystrophy. Rarely if the abnormal gene is dominant, it will appear in both sexes.
N.B.: alleles are DNA sequences that code for a gene, but sometimes the term is used to refer to a non-gene sequence.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-metabolic-disorders-errors-of-metabolism">3. METABOLIC DISORDERS (Errors of metabolism)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-metabolic-disorders-errors-of-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>These are inherited disorders of single genes which code for enzymes.
Mechanism is like single gene abnormality but the result is defective enzyme synthesis</p>
<ul>
<li>Carbohydrates: glycogen storage disease</li>
<li>Lipids &amp; amino acids:lysosomal storage disease</li>
<li>Membrane transport enzymes:cystic fibrosis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-multifactorial">4. MULTIFACTORIAL<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-multifactorial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Multifactorial disorders require the interaction of environmental and genetic factors as diabetes mellitus and hypertension.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="genetic-cancer-syndromes">GENETIC CANCER SYNDROMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#genetic-cancer-syndromes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Neurofibromatosis type 1 (von Recklinghausen disease)</li>
<li>Multiple endocrine neoplasms (MEN)</li>
<li>Familial breast cancer</li>
<li>Familial adenomatous polyposis coli</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="priorities">PRIORITIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#priorities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
<table><thead><tr><th style="text-align: left;">Topic</th><th style="text-align: left;">Subtopic</th></tr></thead><tbody><tr><td style="text-align: left;">Genetic disorders</td><td style="text-align: left;">Terminology &lt;br&gt; Types of Genetic disorders (list only) &lt;br&gt; Rest C</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="techniques-used-in-surgical-pathologyservices">TECHNIQUES USED IN SURGICAL PATHOLOGYSERVICES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#techniques-used-in-surgical-pathologyservices" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Surgical Pathology is that part of Anatomic Pathology concerned with the study of tissue and organ samples removed from patients, either by biopsy or through a surgical procedure, in an attempt to obtain diagnosis of a lesion or disease. The pathologist is therefore able to advise the attending physician as to the nature of the disease, the prognosis, and the need for additional sampling or exploration.
Cytopathology is the study and evaluation of cells present in smears, fine needle aspirates and body fluids. Analysis of nuclear and cytoplasmic characteristics permit diagnosis of various disease processes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-value-of-tissue-sample-in-variable-lesions">The value of tissue sample in variable lesions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-value-of-tissue-sample-in-variable-lesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Determine a tissue diagnosis where clinical diagnosis is doubt e.g. liver core biopsy in cases of cirrhosis of unknown etiology.</li>
<li>Ascertain whether benign or malignant e.g. gastric ulcer biopsy.</li>
<li>Ascertain extent of spread of disease.</li>
<li>In itself, the biopsy with excision of the lesion may be a form of local treatment e.g. excision biopsy of rodent ulcer.
N.B.: biopsy is a form of special investigation and should interpreted in the light of the clinical picture.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="methods-for-tissue-sampling">Methods for tissue sampling:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#methods-for-tissue-sampling" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1- Excision biopsy: The whole lesion removal.
2- Incision biopsy: Part of the lesion is sampled.
3- Core needle biopsy.
4- Endoscopic biopsy.
5- Punch biopsy.
6- Frozen section: Examination of fresh samples.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-routine-specimen-manipulation">The Routine Specimen manipulation:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-routine-specimen-manipulation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a. Labeling: Each specimen must be labeled with the patient's name, hospital number, source of the tissue and site and side of the body.
b. Specimen Fixation: Universal precautions are to be exercised in handling and transporting all surgical pathology specimens. Proper and timely fixation is a critical step in tissue preparation for diagnosis.</p>
<p>There are five major groups of fixatives, classified according to mechanism of action:</p>
<ul>
<li>Aldehydes include formaldehyde (formalin)</li>
<li>Mercurials</li>
<li>Alcohols</li>
<li>Oxidizing agents</li>
<li>Picrates
c. Tissue Processing: Once the tissue has been fixed, it must be processed into a form in which it can be made into thin microscopic sections. The usual way this is done is with paraffin. Tissues embedded in paraffin, which is similar in density to tissue, can be sectioned at anywhere from 3 to 10 microns, usually 6-8 routinely. The technique of getting fixed tissue into paraffin is called tissue processing. The main steps in this process are dehydration and clearing.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ancillary-diagnostic-techniques">Ancillary diagnostic techniques<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ancillary-diagnostic-techniques" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Are techniques that aid in the diagnosis when routine methods fail to provide the answer</p>
<ul>
<li>Cyto/histochemistry: Is the light microscopic study of the chemistry of cells and tissues after treating them with special reagents</li>
<li>Immuno cyto/histochemistry: Immunohistochemistry (IH) is a technique for identifying cellular or tissue constituents (antigens) which may be normal tissue constituents or produced as a result of a pathologic process. IH techniques are based on the specificity antibody-antigen binding. The site of antibody binding is identified either by direct labeling of the antibody, or by use of a secondary labeling method.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="molecular-pathology-cytogenetics">- Molecular pathology &amp; Cytogenetics:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#molecular-pathology-cytogenetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Molecular pathology entails the study of the biochemical based changes in a single nucleotide in genomic DNA resulting in a defective gene product, which may produce a lesion in some disorders as congenital diseases and cancer. The method used is Polymerase Chain Reaction Technology (PCR), which allows the analysis of DNA or RNA from any specimen by means of amplifying the length of DNA understudy a million times, and therefore can detect even minute amounts.</p>
<p>Cytogenetics: Involves the study of abnormal chromosomes and genes responsible for certain diseases by a process of karyotyping.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a-cyto-histochemistry">A) Cyto/histochemistry<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-cyto-histochemistry" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Is the light microscopic study of the chemistry of cells and tissues after treating them with special reagents. Each tissue type has characteristic features and preponderance of one particular substance characteristic of the tissue or cell</p>
<ol>
<li>Mucin stains: Alcian blue -PAS (peroidic acid-Schiff) - Mucicarmine</li>
<li>Fat stains:</li>
<li>Connective tissue stains: The trichrome stain helps to highlight the supporting collagenous stroma in sections from a variety of organs.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-immunohistochemistry">B) Immunohistochemistry<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-immunohistochemistry" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Immunohistochemistry is the localization of PROTEINS in tissue sections by the use of labeled antibodies as specific reagents through antigen-antibody interactions that are visualized by a marker such as enzyme labels have been introduced e.g peroxidase and alkaline phosphatase. Since immunohistochemistry involves specific antigen-antibody reaction, it has become a crucial technique and widely used in many medical research laboratories as well as clinical diagnostics.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="advantages">Advantages:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#advantages" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Remarkable sensitivity and specificity.</li>
<li>Applicability to routinely processed material even if stored to long time.</li>
<li>It is compatible with most of the fixatives currently in use and in cytological preparations and even previously stained sections.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="methods">Methods:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#methods" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>There are numerous immunohistochemistry methods that may be used to localize antigens.</li>
<li>The selection of a suitable method should be based on parameters such as the type of specimen under investigation and the degree of sensitivity required.
<img src="assets/images/image-20251212-13120af1.jpeg" alt="img-93.jpeg">
(Fig. 25) Methods of Immunohistochemistry</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="1-direct-method">1- Direct Method<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-direct-method" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Direct method is one step staining method, and involves a labeled antibody reacting directly with the antigen in tissue sections.</li>
<li>This technique utilizes only one antibody and the procedure is short and quick. However, it is insensitive due to little signal amplification and rarely used since the introduction of indirect method.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-indirect-method">2- Indirect Method:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-indirect-method" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Indirect method involves an unlabeled primary antibody (first layer) which react with tissue antigen, and a labeled secondary antibody (second layer) react with primary antibody.</li>
<li>This method is more sensitive due to signal amplification through several secondary antibody reactions with different antigenic sites on the primary antibody.</li>
<li>The second layer antibody is labeled with an enzyme such as peroxidase, alkaline phosphatase or glucose oxidase.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-pap-method-peroxidase-anti-peroxidase-method">3- PAP Method (peroxidase anti-peroxidase method):<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-pap-method-peroxidase-anti-peroxidase-method" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>4- Avidin-Biotin Complex (ABC) Method:
5- Labeled Strept Avidin Biotin (LSAB) Method:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="summary">Summary<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#summary" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Immunohistochemistry is a method of detecting the presence of specific proteins in cells or tissues and consists of the following steps:</p>
<p>1- Primary antibody binds with the specific antigen.
2- The antigen antibody complex is bound by enzyme conjugated secondary antibody.
3- In the presence of the substrate and chromogen, the enzyme form colored deposit a sites of antigen antibody binding.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples-of-diagnostic-applications-of-immunohistochemistry">Examples of diagnostic applications of immunohistochemistry:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-of-diagnostic-applications-of-immunohistochemistry" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Immunohistochemistry has assumed an increasingly prominent role in diagnostic breast pathology as it now frequently used in the evaluation of many epithelial proliferations of the breast.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="common-applications-include-the-use-of">Common applications include the use of:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#common-applications-include-the-use-of" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Myoepithelial markers (actin) to evaluate for stromal invasion.</li>
<li>Cytokeratin stains to detect metastases in lymph nodes.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="immunohistochemistry-a-prognostic-as-well-as-diagnostic-tool">Immunohistochemistry: a prognostic as well as diagnostic tool:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunohistochemistry-a-prognostic-as-well-as-diagnostic-tool" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The assessment of proliferating cell populations has been used to aid in the differentiation of benign from malignant neoplasms.</li>
<li>The assessment of proliferation markers and oncogenic determinants holds information regarding prognosIs.</li>
<li>For example: Ki-67, p53 protein, bcl-2, are useful in understanding the biology of certain neoplasms and may carry prognostic information that influences clinical management.</li>
</ul>
<p>Topic
Techniques</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="subtopic">Subtopic<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#subtopic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Methods for tissue sampling
Ancilliary diagnostic techniques
Examples of diagnostic applications of immunohistochemistry</p>
<p>Immunohistochemistry: a prognostic as well as diagnostic tool:</p>
<p>Rest categ C including method of immunohisto</p>
<p>Chandrasoma, P. and Taylor, C.R.: Concise Pathology. 3' edition. McGraw Hill Education 1997
EI Hindawi, A.: Basic General Pathology. Faculty of Medicine, Cairo University 2009
Reid,R Callander, R Ramsden I, Roberts,F . MacFarlane,PS. Pathology Illustrated 6th edition, Elsevier Science Health Science div 2005
Jones, E. &amp; Morris, A. Cell biology &amp; Genetics. Mosby, London Philadelphia SI Louis, Sydney, Tokyo. 1998
Kumar,v., Abbas A.K. Cotran, R.S. Robbins,&amp; Cotran Basic Pathology. 7" edition, W.B. Saunders Co., Philadelphia, London, Toronto, Sydney, New York, Sydney &amp; Tokyo. 2005
Stevens,J. &amp; Lowe,J.: Pathology. Mosby. 1998
Underwood, J.C.E.: General and Systematic Pathology. 3' edition. Churchill Livingstone. Edinburgh, London, Madrid, Melbourne, New York &amp; Tokyo. 2000</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="web">WEB<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#web" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><a href="http://www.medicine.cu.edu.eg/beta/enljcalpro/2428.html" target="_blank" rel="noopener noreferrer">http://www.medicine.cu.edu.eg/beta/enljcalpro/2428.html</a>
<a href="http://www.kasralainy.edu.eg/elearning/" target="_blank" rel="noopener noreferrer">http://www.kasralainy.edu.eg/elearning/</a>
<a href="http://www.pathmax.com/" target="_blank" rel="noopener noreferrer">http://www.pathmax.com/</a>
<a href="http://www-medJib.med.utah.edu/WebPath/LABS/LABMENU.html%5C#2" target="_blank" rel="noopener noreferrer">http://www-medJib.med.utah.edu/WebPath/LABS/LABMENU.html\#2</a>
http:/Iwww.med.uiuc.edu/PathAtlasf/titlePage.htmI
<a href="http://www.medscape.com/pathologyhome" target="_blank" rel="noopener noreferrer">http://www.medscape.com/pathologyhome</a>
<a href="http://www.gwumc.edu/deptlpath/2F.HTM" target="_blank" rel="noopener noreferrer">http://www.gwumc.edu/deptlpath/2F.HTM</a>
<a href="http://www.path" target="_blank" rel="noopener noreferrer">http://www.path</a>. uiowa.ed u/vi rtualsl idebox/
<a href="http://web.med.unsw.edu.au/pathology/Pathmus/pathmus.htm%5C#1" target="_blank" rel="noopener noreferrer">http://web.med.unsw.edu.au/pathology/Pathmus/pathmus.htm\#1</a> nteractiveImages
<a href="http://www.virtualpathology.leeds.ac.ukf" target="_blank" rel="noopener noreferrer">http://www.virtualpathology.leeds.ac.ukf</a>
<a href="http://histopathsho.34sp.comfindex.htm" target="_blank" rel="noopener noreferrer">http://histopathsho.34sp.comfindex.htm</a>
<a href="http://pathology.class.kmu.edu.tw/index.htm" target="_blank" rel="noopener noreferrer">http://pathology.class.kmu.edu.tw/index.htm</a>
<a href="http://www.gJa.ac.ukffaculties/medicine/teaching/MedCALlist.htm" target="_blank" rel="noopener noreferrer">http://www.gJa.ac.ukffaculties/medicine/teaching/MedCALlist.htm</a>
Some of the images &amp; pictographs Have been taken from the above sites &amp; books</p></div></div></div></div></div></div></div><div data-testid="stAppIframeResizerAnchor" data-iframe-height="true" class="st-emotion-cache-1dumvfu eht7o1d9"></div></section></div></div></div><div data-testid="portal" id="portal" class="st-emotion-cache-1q6lfs0 e19n7mk11"></div></div><div class=""></div></div>
  

</body></html>